<?xml version="1.0" encoding="UTF-8"?><search-results xmlns="http://www.w3.org/2005/Atom" xmlns:cto="http://www.elsevier.com/xml/cto/dtd" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:opensearch="http://a9.com/-/spec/opensearch/1.1/" xmlns:dc="http://purl.org/dc/elements/1.1/"><opensearch:totalResults>2992343</opensearch:totalResults><opensearch:startIndex>2500</opensearch:startIndex><opensearch:itemsPerPage>100</opensearch:itemsPerPage><opensearch:Query role="request" searchTerms="heart" startPage="2500"/><link ref="self" href="http://api.elsevier.com:80/content/search/index:scopus?start=2500&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><link ref="first" href="http://api.elsevier.com:80/content/search/index:scopus?start=0&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><link ref="prev" href="http://api.elsevier.com:80/content/search/index:scopus?start=2400&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><link ref="next" href="http://api.elsevier.com:80/content/search/index:scopus?start=2600&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><link ref="last" href="http://api.elsevier.com:80/content/search/index:scopus?start=4900&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929330388"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929330388?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929330388&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929330388&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929330388</prism:url><dc:identifier>SCOPUS_ID:84929330388</dc:identifier><eid>2-s2.0-84929330388</eid><dc:title>Genome-wide definition of promoter and enhancer usage during neural induction of human embryonic stem cells</dc:title><dc:creator>Poletti V.</dc:creator><prism:publicationName>PLoS ONE</prism:publicationName><prism:eIssn>19326203</prism:eIssn><prism:volume>10</prism:volume><prism:issueIdentifier>5</prism:issueIdentifier><prism:coverDate>2015-05-15</prism:coverDate><prism:coverDisplayDate>15 May 2015</prism:coverDisplayDate><prism:doi>10.1371/journal.pone.0126590</prism:doi><dc:description>© 2015 Poletti et al. Genome-wide mapping of transcriptional regulatory elements is an essential tool for understanding the molecular events orchestrating self-renewal, commitment and differentiation of stem cells. We combined high-throughput identification of transcription start sites with genome- wide profiling of histones modifications to map active promoters and enhancers in embryonic stem cells (ESCs) induced to neuroepithelial-like stem cells (NESCs). Our analysis showed that most promoters are active in both cell types while approximately half of the enhancers are cell-specific and account for most of the epigenetic changes occurring during neural induction, and most likely for the modulation of the promoters to generate cell-specific gene expression programs. Interestingly, the majority of the promoters activated or upregulated during neural induction have a "bivalent" histone modification signature in ESCs, suggesting that developmentally-regulated promoters are already poised for transcription in ESCs, which are apparently pre-committed to neuroectodermal differentiation. Overall, our study provides a collection of differentially used enhancers, promoters, transcription starts sites, protein-coding and non-coding RNAs in human ESCs and ESC-derived NESCs, and a broad, genome-wide description of promoter and enhancer usage and of gene expression programs characterizing the transition from a pluripotent to a neural-restricted cell fate.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60082964</affiliation-url><afid>60082964</afid><affilname>Fondazione San Raffaele del Monte Tabor</affilname><name-variant>Fondazione San Raffaele del Monte Tabor</name-variant><affiliation-city>Milan</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006105</affiliation-url><afid>60006105</afid><affilname>Genethon</affilname><name-variant>Généthon</name-variant><affiliation-city>Evry</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030318</affiliation-url><afid>60030318</afid><affilname>Universita degli Studi di Milano</affilname><name-variant>University of Milan</name-variant><affiliation-city>Milan</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004591</affiliation-url><afid>60004591</afid><affilname>Universita degli Studi di Modena e Reggio Emilia</affilname><name-variant>University of Modena</name-variant><affiliation-city>Modena</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003349</affiliation-url><afid>60003349</afid><affilname>Institute for Biomedical Technologies, Segrate</affilname><name-variant>Institute of Biomedical Technologies</name-variant><affiliation-city>Segrate</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:100955730</affiliation-url><afid>100955730</afid><affilname>Institut Imagine</affilname><name-variant>Institut Imagine</name-variant><affiliation-city>Paris</affiliation-city><affiliation-country>France</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">15</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:25655343700</author-url><authid>25655343700</authid><authname>Poletti V.</authname><surname>Poletti</surname><given-name>Valentina</given-name><initials>V.</initials><afid>60082964</afid><afid>60006105</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:25655343700</author-url><authid>25655343700</authid><authname>Poletti V.</authname><surname>Poletti</surname><given-name>Valentina</given-name><initials>V.</initials><afid>60082964</afid><afid>60006105</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55278086200</author-url><authid>55278086200</authid><authname>Carri A.</authname><surname>Carri</surname><given-name>Alessia Delli</given-name><initials>A.D.</initials><afid>60030318</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56054610800</author-url><authid>56054610800</authid><authname>Tagliazucchi G.</authname><surname>Tagliazucchi</surname><given-name>Guidantonio Malagoli</given-name><initials>G.M.</initials><afid>60004591</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6506506826</author-url><authid>6506506826</authid><authname>Faedo A.</authname><surname>Faedo</surname><given-name>Andrea</given-name><initials>A.</initials><afid>60030318</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:48161775000</author-url><authid>48161775000</authid><authname>Petiti L.</authname><surname>Petiti</surname><given-name>Luca</given-name><initials>L.</initials><afid>60004591</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:54398971100</author-url><authid>54398971100</authid><authname>Mazza E.</authname><surname>Mazza</surname><given-name>Emilia Maria Cristina</given-name><initials>E.M.C.</initials><afid>60004591</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:13403279300</author-url><authid>13403279300</authid><authname>Peano C.</authname><surname>Peano</surname><given-name>Clelia</given-name><initials>C.</initials><afid>60003349</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7005285574</author-url><authid>7005285574</authid><authname>De Bellis G.</authname><surname>De Bellis</surname><given-name>Gianluca</given-name><initials>G.</initials><afid>60003349</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:6701569893</author-url><authid>6701569893</authid><authname>Bicciato S.</authname><surname>Bicciato</surname><given-name>Silvio</given-name><initials>S.</initials><afid>60004591</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:14052441300</author-url><authid>14052441300</authid><authname>Miccio A.</authname><surname>Miccio</surname><given-name>Annarita</given-name><initials>A.</initials><afid>60004591</afid><afid>100955730</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:14052441300</author-url><authid>14052441300</authid><authname>Miccio A.</authname><surname>Miccio</surname><given-name>Annarita</given-name><initials>A.</initials><afid>60004591</afid><afid>100955730</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:7006141716</author-url><authid>7006141716</authid><authname>Cattaneo E.</authname><surname>Cattaneo</surname><given-name>Elena</given-name><initials>E.</initials><afid>60030318</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:7006100372</author-url><authid>7006100372</authid><authname>Mavilio F.</authname><surname>Mavilio</surname><given-name>Fulvio</given-name><initials>F.</initials><afid>60006105</afid><afid>60004591</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:7006100372</author-url><authid>7006100372</authid><authname>Mavilio F.</authname><surname>Mavilio</surname><given-name>Fulvio</given-name><initials>F.</initials><afid>60006105</afid><afid>60004591</afid></author><intid>35944852</intid><article-number>0126590</article-number><source-id>10600153309</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929407724"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929407724?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929407724&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929407724&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929407724</prism:url><dc:identifier>SCOPUS_ID:84929407724</dc:identifier><eid>2-s2.0-84929407724</eid><dc:title>Early detection of breast cancer using total biochemical analysis of peripheral blood components: A preliminary study</dc:title><dc:creator>Zelig U.</dc:creator><prism:publicationName>BMC Cancer</prism:publicationName><prism:eIssn>14712407</prism:eIssn><prism:volume>15</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:coverDate>2015-05-15</prism:coverDate><prism:coverDisplayDate>May 15, 2015</prism:coverDisplayDate><prism:doi>10.1186/s12885-015-1414-7</prism:doi><dc:description>© 2015 Zelig et al.; licensee BioMed Central. Background: Most of the blood tests aiming for breast cancer screening rely on quantification of a single or few biomarkers. The aim of this study was to evaluate the feasibility of detecting breast cancer by analyzing the total biochemical composition of plasma as well as peripheral blood mononuclear cells (PBMCs) using infrared spectroscopy. Methods: Blood was collected from 29 patients with confirmed breast cancer and 30 controls with benign or no breast tumors, undergoing screening for breast cancer. PBMCs and plasma were isolated and dried on a zinc selenide slide and measured under a Fourier transform infrared (FTIR) microscope to obtain their infrared absorption spectra. Differences in the spectra of PBMCs and plasma between the groups were analyzed as well as the specific influence of the relevant pathological characteristics of the cancer patients. Results: Several bands in the FTIR spectra of both blood components significantly distinguished patients with and without cancer. Employing feature extraction with quadratic discriminant analysis, a sensitivity of ~90 % and a specificity of ~80 % for breast cancer detection was achieved. These results were confirmed by Monte Carlo cross-validation. Further analysis of the cancer group revealed an influence of several clinical parameters, such as the involvement of lymph nodes, on the infrared spectra, with each blood component affected by different parameters. Conclusion: The present preliminary study suggests that FTIR spectroscopy of PBMCs and plasma is a potentially feasible and efficient tool for the early detection of breast neoplasms. An important application of our study is the distinction between benign lesions (considered as part of the non-cancer group) and malignant tumors thus reducing false positive results at screening. Furthermore, the correlation of specific spectral changes with clinical parameters of cancer patients indicates for possible contribution to diagnosis and prognosis.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115245330</affiliation-url><afid>115245330</afid><affilname>Todos Medical Ltd</affilname><name-variant>Todos Medical Ltd</name-variant><affiliation-city>Rehovot</affiliation-city><affiliation-country>Israel</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022119</affiliation-url><afid>60022119</afid><affilname>Rabin Medical Center Israel</affilname><name-variant>Rabin Medical Center</name-variant><affiliation-city>Petah Tiqwa</affiliation-city><affiliation-country>Israel</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005037</affiliation-url><afid>60005037</afid><affilname>Tel Aviv University, Sackler Faculty of Medicine</affilname><name-variant>Tel Aviv University</name-variant><affiliation-city>Ramal Aviv</affiliation-city><affiliation-country>Israel</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030184</affiliation-url><afid>60030184</afid><affilname>Soroka University Medical Center</affilname><name-variant>Soroka University Medical Center</name-variant><affiliation-city>Beer Sheba</affiliation-city><affiliation-country>Israel</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027161</affiliation-url><afid>60027161</afid><affilname>Ben-Gurion University of the Negev</affilname><name-variant>Ben Gurion University of the Negev</name-variant><affiliation-city>Beer Sheba</affiliation-city><affiliation-country>Israel</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027161</affiliation-url><afid>60027161</afid><affilname>Ben-Gurion University of the Negev</affilname><name-variant>Ben Gurion University of the Negev</name-variant><affiliation-city>Beer Sheba</affiliation-city><affiliation-country>Israel</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022119</affiliation-url><afid>60022119</afid><affilname>Rabin Medical Center Israel</affilname><name-variant>Rabin Medical Center</name-variant><affiliation-city>Petah Tiqwa</affiliation-city><affiliation-country>Israel</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005037</affiliation-url><afid>60005037</afid><affilname>Tel Aviv University, Sackler Faculty of Medicine</affilname><name-variant>Tel Aviv University</name-variant><affiliation-city>Ramal Aviv</affiliation-city><affiliation-country>Israel</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">15</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6506709985</author-url><authid>6506709985</authid><authname>Zelig U.</authname><surname>Zelig</surname><given-name>Udi</given-name><initials>U.</initials><afid>115245330</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56646543000</author-url><authid>56646543000</authid><authname>Barlev E.</authname><surname>Barlev</surname><given-name>Eyal</given-name><initials>E.</initials><afid>60022119</afid><afid>60005037</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56646543000</author-url><authid>56646543000</authid><authname>Barlev E.</authname><surname>Barlev</surname><given-name>Eyal</given-name><initials>E.</initials><afid>60022119</afid><afid>60005037</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56646235200</author-url><authid>56646235200</authid><authname>Bar O.</authname><surname>Bar</surname><given-name>Omri</given-name><initials>O.</initials><afid>115245330</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56646096300</author-url><authid>56646096300</authid><authname>Gross I.</authname><surname>Gross</surname><given-name>Itai</given-name><initials>I.</initials><afid>60030184</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56646545200</author-url><authid>56646545200</authid><authname>Flomen F.</authname><surname>Flomen</surname><given-name>Felix</given-name><initials>F.</initials><afid>115245330</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:22962891100</author-url><authid>22962891100</authid><authname>Mordechai S.</authname><surname>Mordechai</surname><given-name>Shaul</given-name><initials>S.</initials><afid>60027161</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55710112200</author-url><authid>55710112200</authid><authname>Kapelushnik J.</authname><surname>Kapelushnik</surname><given-name>Joseph</given-name><initials>J.</initials><afid>60005037</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7007044186</author-url><authid>7007044186</authid><authname>Nathan I.</authname><surname>Nathan</surname><given-name>Ilana</given-name><initials>I.</initials><afid>60027161</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7006487599</author-url><authid>7006487599</authid><authname>Kashtan H.</authname><surname>Kashtan</surname><given-name>Hanoch</given-name><initials>H.</initials><afid>60022119</afid><afid>60005037</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7006487599</author-url><authid>7006487599</authid><authname>Kashtan H.</authname><surname>Kashtan</surname><given-name>Hanoch</given-name><initials>H.</initials><afid>60022119</afid><afid>60005037</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:6602753110</author-url><authid>6602753110</authid><authname>Wasserberg N.</authname><surname>Wasserberg</surname><given-name>Nir</given-name><initials>N.</initials><afid>60022119</afid><afid>60005037</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:6602753110</author-url><authid>6602753110</authid><authname>Wasserberg N.</authname><surname>Wasserberg</surname><given-name>Nir</given-name><initials>N.</initials><afid>60022119</afid><afid>60005037</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:14525228700</author-url><authid>14525228700</authid><authname>Madhala-Givon O.</authname><surname>Madhala-Givon</surname><given-name>Osnat</given-name><initials>O.</initials><afid>60022119</afid><afid>60005037</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:14525228700</author-url><authid>14525228700</authid><authname>Madhala-Givon O.</authname><surname>Madhala-Givon</surname><given-name>Osnat</given-name><initials>O.</initials><afid>60022119</afid><afid>60005037</afid></author><authkeywords>Breast cancer detection | Infrared spectroscopy | Mononuclear cells | Plasma</authkeywords><intid>1785955354</intid><article-number>408</article-number><source-id>28747</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929453527"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929453527?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929453527&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929453527&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929453527</prism:url><dc:identifier>SCOPUS_ID:84929453527</dc:identifier><eid>2-s2.0-84929453527</eid><dc:title>Responsiveness in DoC and individual variability</dc:title><dc:creator>Sannita W.</dc:creator><prism:publicationName>Frontiers in Human Neuroscience</prism:publicationName><prism:issn>16625161</prism:issn><prism:eIssn>16625161</prism:eIssn><prism:volume>9</prism:volume><prism:issueIdentifier>MAY</prism:issueIdentifier><prism:coverDate>2015-05-15</prism:coverDate><prism:coverDisplayDate>15 May 2015</prism:coverDisplayDate><prism:doi>10.3389/fnhum.2015.00270</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025153</affiliation-url><afid>60025153</afid><affilname>Universita degli Studi di Genova</affilname><name-variant>University of Genova</name-variant><affiliation-city>Genoa</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:108125039</affiliation-url><afid>108125039</afid><affilname>RAN (Research in Advanced Neuro-rehabilitation)</affilname><name-variant>Institute S. Anna - RAN (Research in Advanced Neuro-rehabilitation)</name-variant><affiliation-city>Crotone</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026415</affiliation-url><afid>60026415</afid><affilname>Stony Brook University State University of New York</affilname><name-variant>State University of New York at Stony Brook</name-variant><affiliation-city>Stony Brook</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7004379336</author-url><authid>7004379336</authid><authname>Sannita W.</authname><surname>Sannita</surname><given-name>Walter G.</given-name><initials>W.G.</initials><afid>60025153</afid><afid>108125039</afid><afid>60026415</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7004379336</author-url><authid>7004379336</authid><authname>Sannita W.</authname><surname>Sannita</surname><given-name>Walter G.</given-name><initials>W.G.</initials><afid>60025153</afid><afid>108125039</afid><afid>60026415</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7004379336</author-url><authid>7004379336</authid><authname>Sannita W.</authname><surname>Sannita</surname><given-name>Walter G.</given-name><initials>W.G.</initials><afid>60025153</afid><afid>108125039</afid><afid>60026415</afid></author><authkeywords>Brain | Disorder of consciousness | Physiology | Variability | Vegetative state</authkeywords><intid>535964685</intid><article-number>270</article-number><source-id>19700175164</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929378554"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929378554?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929378554&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929378554&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929378554</prism:url><dc:identifier>SCOPUS_ID:84929378554</dc:identifier><eid>2-s2.0-84929378554</eid><dc:title>Selenium and chronic diseases: A nutritional genomics perspective</dc:title><dc:creator>Méplan C.</dc:creator><prism:publicationName>Nutrients</prism:publicationName><prism:eIssn>20726643</prism:eIssn><prism:volume>7</prism:volume><prism:issueIdentifier>5</prism:issueIdentifier><prism:pageRange>3621-3651</prism:pageRange><prism:coverDate>2015-05-15</prism:coverDate><prism:coverDisplayDate>15 May 2015</prism:coverDisplayDate><prism:doi>10.3390/nu7053621</prism:doi><dc:description>© 2015 by the authors; licensee MDPI, Basel, Switzerland. Mechanistic data have revealed a key role for selenium (Se) and selenoproteins in biological pathways known to be altered in multifactorial diseases, such as cellular maintenance, response to oxidative stress and correct protein folding. Although epidemiological studies indicate that low Se intake is linked to increased risk for various chronic diseases, supplementation trials have given confusing outcomes, suggesting that additional genetic factors could affect the relationship between Se and health. Genetic data support this hypothesis, as risk for several chronic diseases, in particular cancer, was linked to a number of single nucleotide polymorphisms (SNP) altering Se metabolism, selenoprotein synthesis or activity. Interactions between SNPs in selenoprotein genes, SNPs in related molecular pathways and biomarkers of Se status were found to further modulate the genetic risk carried by the SNPs. Taken together, nutritional genomics approaches uncovered the potential implication of some selenoproteins as well as the influence of complex interactions between genetic variants and Se status in the aetiology of several chronic diseases. This review discusses the results from these genetic associations in the context of selenoprotein functions and epidemiological investigations and emphasises the need to assess in future studies the combined contribution of Se status, environmental stress, and multiple or individual SNPs to disease risk.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006222</affiliation-url><afid>60006222</afid><affilname>Newcastle University, United Kingdom</affilname><name-variant>University of Newcastle upon Tyne</name-variant><affiliation-city>Newcastle</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006222</affiliation-url><afid>60006222</afid><affilname>Newcastle University, United Kingdom</affilname><name-variant>University of Newcastle upon Tyne</name-variant><affiliation-city>Newcastle</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6506342380</author-url><authid>6506342380</authid><authname>Méplan C.</authname><surname>Méplan</surname><given-name>Catherine</given-name><initials>C.</initials><afid>60006222</afid><afid>60006222</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6506342380</author-url><authid>6506342380</authid><authname>Méplan C.</authname><surname>Méplan</surname><given-name>Catherine</given-name><initials>C.</initials><afid>60006222</afid><afid>60006222</afid></author><authkeywords>Cancer | Glutathione peroxidase | Nutritional genomics | Selenium | Selenoprotein P | Single nucleotide polymorphisms</authkeywords><intid>1535944002</intid><source-id>19700188323</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929378759"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929378759?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929378759&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929378759&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929378759</prism:url><dc:identifier>SCOPUS_ID:84929378759</dc:identifier><eid>2-s2.0-84929378759</eid><dc:title>Influence of self-reported chronic rhinosinusitis on health-related quality of life: A population-based survey</dc:title><dc:creator>Fu Q.</dc:creator><prism:publicationName>PLoS ONE</prism:publicationName><prism:eIssn>19326203</prism:eIssn><prism:volume>10</prism:volume><prism:issueIdentifier>5</prism:issueIdentifier><prism:coverDate>2015-05-15</prism:coverDate><prism:coverDisplayDate>15 May 2015</prism:coverDisplayDate><prism:doi>10.1371/journal.pone.0126881</prism:doi><dc:description>© 2015 Fu et al. Chronic rhinosinusitis (CRS) is a frequently occurring chronic respiratory disease. There is evidence that effective treatment of CRS can improve patients' quality of life, but the data regarding the extent to which CRS impairs patients' quality of life (QoL) is sparse. This study aimed to evaluate the effect of self-reported CRS on health-related QoL and to determine whether the influence was associated with gender, age and socio-economic status. A four-stage randomsampling method was used to select the participants fromthe general population in Guangzhou, China. All participants were interviewed face-to-face at their homes using a standardized questionnaire. The health-related QoL of each participant was assessed using the SF-36 Health Survey. The scores of the SF-36 after adjusting for gender, age, socioeconomic conditions, smoking and some important comorbid conditions were compared between the CRS group and the non-CRS group using analysis of covariance. A multiple linear regression model with interaction terms was established to determine whether CRS affected QoL to the same degree across the different subpopulations. Among a total of 1,411 participants aged at least 15 years, 118 persons (8.4%) had self-reported CRS. Subjects with CRS had an increased prevalence of allergic rhinitis, chronic obstructive pulmonary disease and gout than subjects without CRS. The CRS group had lower scores in all eight domains and the physical andmental component summary than those without CRS (P&lt;0.05), and the greatest differences were in role emotional function (RE), general health (GH) and role physical function (RP). The impairments of the CRS participants in RE and RP were greater among the females than the males. Moreover, physical domains were affected to greater degrees among the elderly and those with high-level education. In conclusion, CRS is a common chronic disorder. Persons with self-reported CRS perceived themselves as having impaired QoL in both the physical andmental domains. These findings shed new light on the health burden of CRS and should be taken into account by clinicians involved in the care of CRS patients.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021182</affiliation-url><afid>60021182</afid><affilname>Sun Yat-Sen University</affilname><name-variant>Sun Yat-Sen University</name-variant><affiliation-city>Guangzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:107965961</affiliation-url><afid>107965961</afid><affilname>Guangzhou Medical University</affilname><name-variant>Guangzhou Medical University</name-variant><affiliation-city>Guangzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002593</affiliation-url><afid>60002593</afid><affilname>Southern Medical University</affilname><name-variant>Southern Medical University</name-variant><affiliation-city>TongHe</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56533027200</author-url><authid>56533027200</authid><authname>Fu Q.</authname><surname>Fu</surname><given-name>Qing Ling</given-name><initials>Q.L.</initials><afid>60021182</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56643468400</author-url><authid>56643468400</authid><authname>Ma J.</authname><surname>Ma</surname><given-name>Jin Xiang</given-name><initials>J.X.</initials><afid>107965961</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:14070561800</author-url><authid>14070561800</authid><authname>Ou C.</authname><surname>Ou</surname><given-name>Chun Quan</given-name><initials>C.Q.</initials><afid>60002593</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56114422200</author-url><authid>56114422200</authid><authname>Guo C.</authname><surname>Guo</surname><given-name>Cui</given-name><initials>C.</initials><afid>60002593</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56643665500</author-url><authid>56643665500</authid><authname>Shen S.</authname><surname>Shen</surname><given-name>Shuang Quan</given-name><initials>S.Q.</initials><afid>60002593</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56593377500</author-url><authid>56593377500</authid><authname>Xu G.</authname><surname>Xu</surname><given-name>Geng</given-name><initials>G.</initials><afid>60021182</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:26025986700</author-url><authid>26025986700</authid><authname>Shi J.</authname><surname>Shi</surname><given-name>Jianbo</given-name><initials>J.</initials><afid>60021182</afid></author><intid>35944341</intid><article-number>0126881</article-number><source-id>10600153309</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929321843"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929321843?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929321843&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929321843&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0303846715001560"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929321843</prism:url><dc:identifier>SCOPUS_ID:84929321843</dc:identifier><eid>2-s2.0-84929321843</eid><dc:title>Factors affecting the evacuation rate of intracerebral hemorrhage in basal ganglia treated by minimally invasive craniopuncture</dc:title><dc:creator>Wang T.</dc:creator><prism:publicationName>Clinical Neurology and Neurosurgery</prism:publicationName><prism:issn>03038467</prism:issn><prism:eIssn>18726968</prism:eIssn><prism:volume>134</prism:volume><prism:pageRange>104-109</prism:pageRange><prism:coverDate>2015-05-15</prism:coverDate><prism:coverDisplayDate>15 May 2015</prism:coverDisplayDate><prism:doi>10.1016/j.clineuro.2015.04.020</prism:doi><pii>S0303846715001560</pii><dc:description>© 2015 Elsevier B.V. All rights reserved. Objective Minimally invasive craniopuncture has been used to treat intracerebral hemorrhage (ICH) for over 20 years in China. However, one-off total evacuation of hematoma cannot be achieved through this procedure because it is not an open surgery. This study is designed to identify factors that can increase the hematoma evacuation rate (ER) of this procedure and to evaluate the influence of ER on long-term outcome. Methods A total of 309 patients with basal ganglia ICH treated by minimally invasive craniopuncture were analyzed retrospectively. Univariate and multivariate linear regression analyses were used to identify factors correlated with a high ER. The correlation between ER and long-term outcome was also analyzed by logistic regression and the Spearman correlation. Results A low hematoma mean CT number (β = -0.773, p &lt; 0.001) and postoperative cerebrospinal fluid (CSF) outflow (β = 0.193, p &lt; 0.001) were found to be independent factors associated with a high ER. In patients with 30-50 ml of hematoma, a high ER was correlated with a high Barthel index improvement (r = 0.611, p &lt; 0.001) and a high modified Rankin scale decline (r = 0.517, p &lt; 0.001). In patients with 50-80 ml of hematoma, a high ER was a protective factor of case fatality (B = -2.297, p = 0.005). Conclusions The hematoma mean CT number can predict the efficiency of minimally invasive craniopuncture in patients with ICH. In patients with ventricular involvement, the tip of the puncture needle should be placed close to the tear in the ventricle rather than at the center of the hematoma to facilitate postoperative CSF outflow.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112119011</affiliation-url><afid>112119011</afid><affilname>The Fourth Affiliated Hospital of China Medical University</affilname><name-variant>The Fourth Affiliated Hospital of China Medical University</name-variant><affiliation-city>Liao Ning</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56463160600</author-url><authid>56463160600</authid><authname>Wang T.</authname><surname>Wang</surname><given-name>Tingzhong</given-name><initials>T.</initials><afid>112119011</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56643740000</author-url><authid>56643740000</authid><authname>Guan Y.</authname><surname>Guan</surname><given-name>Yongchang</given-name><initials>Y.</initials><afid>112119011</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56643578700</author-url><authid>56643578700</authid><authname>Du J.</authname><surname>Du</surname><given-name>Jinghua</given-name><initials>J.</initials><afid>112119011</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56175417100</author-url><authid>56175417100</authid><authname>Liu G.</authname><surname>Liu</surname><given-name>Guojun</given-name><initials>G.</initials><afid>112119011</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56256154500</author-url><authid>56256154500</authid><authname>Gao F.</authname><surname>Gao</surname><given-name>Fei</given-name><initials>F.</initials><afid>112119011</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56175638200</author-url><authid>56175638200</authid><authname>Zhao X.</authname><surname>Zhao</surname><given-name>Xianlin</given-name><initials>X.</initials><afid>112119011</afid></author><authkeywords>CT number | Hematoma evacuation rate | Intracerebral hemorrhage | Minimally invasive craniopuncture</authkeywords><intid>1785944387</intid><source-id>14895</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929460232"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929460232?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929460232&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929460232&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929460232</prism:url><dc:identifier>SCOPUS_ID:84929460232</dc:identifier><eid>2-s2.0-84929460232</eid><dc:title>Can apparent resting state connectivity arise from systemic fluctuations?</dc:title><dc:creator>Tong Y.</dc:creator><prism:publicationName>Frontiers in Human Neuroscience</prism:publicationName><prism:issn>16625161</prism:issn><prism:eIssn>16625161</prism:eIssn><prism:volume>9</prism:volume><prism:issueIdentifier>MAY</prism:issueIdentifier><prism:coverDate>2015-05-15</prism:coverDate><prism:coverDisplayDate>15 May 2015</prism:coverDisplayDate><prism:doi>10.3389/fnhum.2015.00285</prism:doi><dc:description>© 2015 Tong, Hocke, Fan, Janes and Frederick. It is widely accepted that the fluctuations in resting state blood oxygenation level dependent (BOLD) functional MRI (fMRI) reflect baseline neuronal activation through neurovascular coupling; this data is used to infer functional connectivity in the human brain during rest. Consistent activation patterns, i.e., resting state networks (RSN) are seen across groups, conditions, and even species. In this study, we show that some of these patterns can also be generated from the dynamic, systemic, non-neuronal physiological low frequency oscillations (sLFOs) in the BOLD signal alone. We have previously used multimodal imaging to demonstrate the wide presence of the same sLFOs in the brain (BOLD) and periphery with different time delays. This study shows that these sLFOs from BOLD signals alone can give rise to stable spatial patterns, which can be detected during resting state analyses. We generated synthetic resting state data for 11 subjects based only on subject-specific, dynamic sLFO information obtained from resting state data using concurrent peripheral optical imaging or a novel recursive procedure. We compared the results obtained by performing a group independent component analysis (ICA) on this synthetic data (i.e., the result from simulation) to the results obtained from analysis of the real data. ICA detected most of the eight well-known RSNs, including visual, motor, and default mode networks (DMNs), in both the real and the synthetic data sets. These findings suggest that RSNs may reflect, to some extent, vascular anatomy associated with systemic fluctuations, rather than neuronal connectivity.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015527</affiliation-url><afid>60015527</afid><affilname>McLean Hospital</affilname><name-variant>McLean Hospital</name-variant><affiliation-city>Belmont</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002746</affiliation-url><afid>60002746</afid><affilname>Harvard Medical School</affilname><name-variant>Harvard Medical School</name-variant><affiliation-city>Boston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023143</affiliation-url><afid>60023143</afid><affilname>Tufts University</affilname><name-variant>Tufts University</name-variant><affiliation-city>Medford</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7202614633</author-url><authid>7202614633</authid><authname>Tong Y.</authname><surname>Tong</surname><given-name>Yunjie</given-name><initials>Y.</initials><afid>60015527</afid><afid>60002746</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7202614633</author-url><authid>7202614633</authid><authname>Tong Y.</authname><surname>Tong</surname><given-name>Yunjie</given-name><initials>Y.</initials><afid>60015527</afid><afid>60002746</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:54383352600</author-url><authid>54383352600</authid><authname>Hocke L.</authname><surname>Hocke</surname><given-name>Lia M.</given-name><initials>L.M.</initials><afid>60015527</afid><afid>60023143</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:54383352600</author-url><authid>54383352600</authid><authname>Hocke L.</authname><surname>Hocke</surname><given-name>Lia M.</given-name><initials>L.M.</initials><afid>60015527</afid><afid>60023143</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56647269600</author-url><authid>56647269600</authid><authname>Fan X.</authname><surname>Fan</surname><given-name>Xiaoying</given-name><initials>X.</initials><afid>60015527</afid><afid>60002746</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56647269600</author-url><authid>56647269600</authid><authname>Fan X.</authname><surname>Fan</surname><given-name>Xiaoying</given-name><initials>X.</initials><afid>60015527</afid><afid>60002746</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:13006473600</author-url><authid>13006473600</authid><authname>Janes A.</authname><surname>Janes</surname><given-name>Amy C.</given-name><initials>A.C.</initials><afid>60015527</afid><afid>60002746</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:13006473600</author-url><authid>13006473600</authid><authname>Janes A.</authname><surname>Janes</surname><given-name>Amy C.</given-name><initials>A.C.</initials><afid>60015527</afid><afid>60002746</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56648192500</author-url><authid>56648192500</authid><authname>deB Frederick B.</authname><surname>deB Frederick</surname><given-name>Blaise</given-name><initials>B.</initials><afid>60015527</afid><afid>60002746</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56648192500</author-url><authid>56648192500</authid><authname>deB Frederick B.</authname><surname>deB Frederick</surname><given-name>Blaise</given-name><initials>B.</initials><afid>60015527</afid><afid>60002746</afid></author><authkeywords>BOLD fMRI | Cerebral blood flow | Resting state networks | Slow oscillations | Systemic oscillations</authkeywords><intid>1785965244</intid><article-number>285</article-number><source-id>19700175164</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929359043"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929359043?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929359043&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929359043&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929359043</prism:url><dc:identifier>SCOPUS_ID:84929359043</dc:identifier><eid>2-s2.0-84929359043</eid><dc:title>Black tea protects against hypertension-associated endothelial dysfunction through alleviation of endoplasmic reticulum stress</dc:title><dc:creator>Cheang W.</dc:creator><prism:publicationName>Scientific Reports</prism:publicationName><prism:eIssn>20452322</prism:eIssn><prism:volume>5</prism:volume><prism:coverDate>2015-05-15</prism:coverDate><prism:coverDisplayDate>15 May 2015</prism:coverDisplayDate><prism:doi>10.1038/srep10340</prism:doi><pii>srep10340</pii><dc:description>© 2015 Macmillan Publishers Limited. Hypertensive patients have been found to be associated with elevated levels of homocysteine, known as hyperhomocysteinemia. Homocysteine (Hcy) can induce endoplasmic reticulum (ER) stress in endothelial cells. This study aims to investigate whether black tea (BT) protects against hypertension-associated endothelial dysfunction through alleviation of ER stress. Rat aortae and cultured rat aortic endothelial cells were treated with Hcy, BT extract, and theaflavin-3,3′-digallate (TF&lt;inf&gt;3&lt;/inf&gt;). Male Sprague Dawley rats were infused with angiotensin II (Ang II) to induce hypertension and orally administrated with BT extract at 15â €‰mg/kg/day for 2 weeks. Hcy impaired endothelium-dependent relaxations of rat aortae and led to ER stress in endothelial cells, which were ameliorated by co-incubation of BT extract and TF&lt;inf&gt;3&lt;/inf&gt;. The blood pressure of Ang II-infused rats and plasma Hcy level were normalized by BT consumption. Impaired endothelium-dependent relaxations in renal arteries, carotid arteries and aortae, and flow-mediated dilatations in third-order mesenteric resistance arteries were improved. Elevations of ER stress markers and ROS level, plus down-regulation of Hcy metabolic enzymes in aortae from Ang II-infused rats were prevented by BT treatment. Our data reveal the novel cardiovascular benefits of BT in ameliorating vascular dysfunctions, providing insight into developing BT into beneficial dietary supplements in hypertensive patients.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002798</affiliation-url><afid>60002798</afid><affilname>Chinese University of Hong Kong</affilname><name-variant>The Chinese University of Hong Kong</name-variant><affiliation-city>Hong Kong</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014933</affiliation-url><afid>60014933</afid><affilname>Methodist Hospital Houston</affilname><name-variant>Methodist Hospital</name-variant><affiliation-city>Houston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002798</affiliation-url><afid>60002798</afid><affilname>Chinese University of Hong Kong</affilname><name-variant>The Chinese University of Hong Kong</name-variant><affiliation-city>Hong Kong</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014347</affiliation-url><afid>60014347</afid><affilname>Hong Kong Baptist University</affilname><name-variant>Hong Kong Baptist University</name-variant><affiliation-city>Hong Kong</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">11</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:37025604300</author-url><authid>37025604300</authid><authname>Cheang W.</authname><surname>Cheang</surname><given-name>Wai San</given-name><initials>W.S.</initials><afid>60002798</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:12771642900</author-url><authid>12771642900</authid><authname>Ngai C.</authname><surname>Ngai</surname><given-name>Ching Yuen</given-name><initials>C.Y.</initials><afid>60002798</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56644261800</author-url><authid>56644261800</authid><authname>Tam Y.</authname><surname>Tam</surname><given-name>Ye Yen</given-name><initials>Y.Y.</initials><afid>60002798</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:48361660600</author-url><authid>48361660600</authid><authname>Tian X.</authname><surname>Tian</surname><given-name>Xiao Yu</given-name><initials>X.Y.</initials><afid>60014933</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7403973084</author-url><authid>7403973084</authid><authname>Wong W.</authname><surname>Wong</surname><given-name>Wing Tak</given-name><initials>W.T.</initials><afid>60014933</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:35306245500</author-url><authid>35306245500</authid><authname>Zhang Y.</authname><surname>Zhang</surname><given-name>Yang</given-name><initials>Y.</initials><afid>60002798</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7401968520</author-url><authid>7401968520</authid><authname>Lau C.</authname><surname>Lau</surname><given-name>Chi Wai</given-name><initials>C.W.</initials><afid>60002798</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:55579848600</author-url><authid>55579848600</authid><authname>Chen Z.</authname><surname>Chen</surname><given-name>Zhen Yu</given-name><initials>Z.Y.</initials><afid>60002798</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56637080600</author-url><authid>56637080600</authid><authname>Bian Z.</authname><surname>Bian</surname><given-name>Zhao Xiang</given-name><initials>Z.X.</initials><afid>60014347</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:34770945300</author-url><authid>34770945300</authid><authname>Huang Y.</authname><surname>Huang</surname><given-name>Yu</given-name><initials>Y.</initials><afid>60002798</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:56644132400</author-url><authid>56644132400</authid><authname>Leung F.</authname><surname>Leung</surname><given-name>Fung Ping</given-name><initials>F.P.</initials><afid>60014347</afid></author><intid>1535944288</intid><article-number>10340</article-number><source-id>21100200805</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929379704"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929379704?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929379704&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929379704&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929379704</prism:url><dc:identifier>SCOPUS_ID:84929379704</dc:identifier><eid>2-s2.0-84929379704</eid><dc:title>Exaggerated acute lung injury and impaired antibacterial defenses during Staphylococcus aureus infection in rats with the metabolic syndrome</dc:title><dc:creator>Feng X.</dc:creator><prism:publicationName>PLoS ONE</prism:publicationName><prism:eIssn>19326203</prism:eIssn><prism:volume>10</prism:volume><prism:issueIdentifier>5</prism:issueIdentifier><prism:coverDate>2015-05-15</prism:coverDate><prism:coverDisplayDate>15 May 2015</prism:coverDisplayDate><prism:doi>10.1371/journal.pone.0126906</prism:doi><dc:description>© 2015 Feng et al. Rats with Metabolic Syndrome (MetaS) have a dysregulated immune response to the aseptic trauma of surgery. We hypothesized that rats with MetaS would have dysregulated inflammation, increased lung injury, and less effective antibacterial defenses during Staphylococcus (S.) aureus sepsis as compared to rats without MetaS. Low capacity runner (LCR; a model of MetaS) and high capacity runner (HCR) rats were challenged intravenously with S. aureus bacteria. After 48 h, inflammatory mediators and bacteria were quantified in the blood, bronchoalveolar lavage fluid (BALF), and lung homogenates. Lungs were analyzed histologically. BALF protein and lung wet-dry ratios were quantified to assess for vascular leak. Endpoints were compared in infected LCR vs HCR rats. LCR rats had higher blood and lung S. aureus counts, as well as higher levels of IL-6 in plasma, lungs and BALF, MIP- 2 in plasma and lung, and IL-17A in lungs. Conversely, LCR rats had lower levels of IL-10 in plasma and lungs. Although lactate levels, and liver and renal function tests were similar between groups, LCR rats had higher BALF protein and lung wet-dry ratios, and more pronounced acute lung injury histologically. During S. aureus bacteremia, as compared with HCR rats, LCR (MetaS) rats have heightened pro-inflammatory responses, accompanied by increased acute lung injury and vascular leak. Notably, despite an augmented proinflammatory phenotype, LCR rats have higher bacterial levels in their blood and lungs. The MetaS state may exacerbate lung injury and vascular leak by attenuating the inflammationresolving response, and by weakening antimicrobial defenses.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023691</affiliation-url><afid>60023691</afid><affilname>University of California, San Francisco</affilname><name-variant>University of California, San Francisco</name-variant><affiliation-city>San Francisco</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025084</affiliation-url><afid>60025084</afid><affilname>Shanghai Jiaotong University</affilname><name-variant>Shanghai Jiaotong University</name-variant><affiliation-city>Shanghai</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60033182</affiliation-url><afid>60033182</afid><affilname>University of Michigan Medical School</affilname><name-variant>University of Michigan Medical School</name-variant><affiliation-city>Ann Arbor</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56643535300</author-url><authid>56643535300</authid><authname>Feng X.</authname><surname>Feng</surname><given-name>Xiaomei</given-name><initials>X.</initials><afid>60023691</afid><afid>60025084</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56643535300</author-url><authid>56643535300</authid><authname>Feng X.</authname><surname>Feng</surname><given-name>Xiaomei</given-name><initials>X.</initials><afid>60023691</afid><afid>60025084</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7006990668</author-url><authid>7006990668</authid><authname>Maze M.</authname><surname>Maze</surname><given-name>Mervyn</given-name><initials>M.</initials><afid>60023691</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:26643330000</author-url><authid>26643330000</authid><authname>Koch L.</authname><surname>Koch</surname><given-name>Lauren G.</given-name><initials>L.G.</initials><afid>60033182</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7102339097</author-url><authid>7102339097</authid><authname>Britton S.</authname><surname>Britton</surname><given-name>Steven L.</given-name><initials>S.L.</initials><afid>60033182</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7005796339</author-url><authid>7005796339</authid><authname>Hellman J.</authname><surname>Hellman</surname><given-name>Judith</given-name><initials>J.</initials><afid>60023691</afid></author><intid>1035939803</intid><article-number>0126906</article-number><source-id>10600153309</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928254376"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928254376?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928254376&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928254376&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0024320514006754"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928254376</prism:url><dc:identifier>SCOPUS_ID:84928254376</dc:identifier><eid>2-s2.0-84928254376</eid><dc:title>Epigenetics, the missing link in hypertension</dc:title><dc:creator>Raftopoulos L.</dc:creator><prism:publicationName>Life Sciences</prism:publicationName><prism:issn>00243205</prism:issn><prism:eIssn>18790631</prism:eIssn><prism:volume>129</prism:volume><prism:pageRange>22-26</prism:pageRange><prism:coverDate>2015-05-15</prism:coverDate><prism:coverDisplayDate>15 May 2015</prism:coverDisplayDate><prism:doi>10.1016/j.lfs.2014.08.003</prism:doi><pii>S0024320514006754</pii><dc:description>© 2014 Elsevier Inc. Epigenetics refers to functional alterations in gene expression or phenotype without any change of the underlying DNA sequence. It is the study of the potential of a cell or organism to express different traits through functional regulation of its gene transcription. Though it is met as a necessary process in biology, epigenetics may often play a crucial part in the development of specific pathologic conditions, including cardiovascular diseases and hypertension.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003720</affiliation-url><afid>60003720</afid><affilname>Hippokration General Hospital</affilname><name-variant>Hippokration General Hospital</name-variant><affiliation-city>Athens</affiliation-city><affiliation-country>Greece</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003720</affiliation-url><afid>60003720</afid><affilname>Hippokration General Hospital</affilname><name-variant>Hippokration General Hospital</name-variant><affiliation-city>Athens</affiliation-city><affiliation-country>Greece</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60045846</affiliation-url><afid>60045846</afid><affilname>Maternity District Hospital Elena Venizelou</affilname><name-variant>Elena Venizelou Hospital</name-variant><affiliation-city>Athens</affiliation-city><affiliation-country>Greece</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:16480860100</author-url><authid>16480860100</authid><authname>Raftopoulos L.</authname><surname>Raftopoulos</surname><given-name>Leonidas</given-name><initials>L.</initials><afid>60003720</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6507411159</author-url><authid>6507411159</authid><authname>Katsi V.</authname><surname>Katsi</surname><given-name>Vasiliki</given-name><initials>V.</initials><afid>60003720</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35482154100</author-url><authid>35482154100</authid><authname>Makris T.</authname><surname>Makris</surname><given-name>Thomas</given-name><initials>T.</initials><afid>60045846</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55873309000</author-url><authid>55873309000</authid><authname>Tousoulis D.</authname><surname>Tousoulis</surname><given-name>Dimitrios</given-name><initials>D.</initials><afid>60003720</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:36045489100</author-url><authid>36045489100</authid><authname>Stefanadis C.</authname><surname>Stefanadis</surname><given-name>Christodoulos</given-name><initials>C.</initials><afid>60003720</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7003809141</author-url><authid>7003809141</authid><authname>Kallikazaros I.</authname><surname>Kallikazaros</surname><given-name>Ioannis</given-name><initials>I.</initials><afid>60003720</afid></author><authkeywords>DNA methylation | Epigenetics | Histone modification | Hypertension | nc-RNAs</authkeywords><intid>1535753397</intid><source-id>20473</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929359056"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929359056?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929359056&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929359056&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929359056</prism:url><dc:identifier>SCOPUS_ID:84929359056</dc:identifier><eid>2-s2.0-84929359056</eid><dc:title>Health behaviors of breast cancer survivors with hypertension: A propensity analysis of KNHANES III-V (2005-2012)</dc:title><dc:creator>Jeong J.</dc:creator><prism:publicationName>PLoS ONE</prism:publicationName><prism:eIssn>19326203</prism:eIssn><prism:volume>10</prism:volume><prism:issueIdentifier>5</prism:issueIdentifier><prism:coverDate>2015-05-15</prism:coverDate><prism:coverDisplayDate>15 May 2015</prism:coverDisplayDate><prism:doi>10.1371/journal.pone.0127346</prism:doi><dc:description>© 2015 Jeong et al. Objective: This study examines health behaviors of breast cancer survivors with hypertension and compares them with those of non-cancer individuals with hypertension. Methods: In this cross-sectional study, a total of 10,996 hypertensive adults (&gt; 19 years) who participated in the 2005-2012 Korean National Health and Nutrition Examination Survey (KNHANES) were considered. Data on alcohol consumption, smoking, physical activity, antihypertensive medication adherence, self-reported diet control, and sodium intake were collected through self-report questionnaire. A total of 64 breast cancer survivors with hypertension and 10,932 non-cancer participants with hypertension were identified. To better compare health behaviors of the two groups, 56 breast cancer survivors and 280 non-cancer participants were selected through the 1:5 nearest available matching based on estimated propensity scores. Multivariate analysis was conducted to determine any differences between the two groups. Results: According to multivariate analysis, breast cancer survivors with hypertension (n = 56) were significantly less likely to consume alcohol (odds ratio (OR): 3.75; 95% confidence interval (CI): 1.06-13.29) but significantly more likely to have sodium intake of more than 2400 mg (OR: 2.98; 95% CI: 1.27-6.97) than the propensity-matched control group (n = 280). There was no significant difference in other health behaviors between the two groups. Conclusions: Breast cancer survivors require active interventions for healthy behaviors related to the management of comorbid conditions such as hypertension to reduce the risk of cardiovascular disease and improve their overall survival rate.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007215</affiliation-url><afid>60007215</afid><affilname>Chonnam National University</affilname><name-variant>Chonnam National University</name-variant><affiliation-city>Gwangju</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007215</affiliation-url><afid>60007215</afid><affilname>Chonnam National University</affilname><name-variant>Chonnam National University</name-variant><affiliation-city>Gwangju</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56643662700</author-url><authid>56643662700</authid><authname>Jeong J.</authname><surname>Jeong</surname><given-name>Ju Ri</given-name><initials>J.R.</initials><afid>60007215</afid><afid>60007215</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56643662700</author-url><authid>56643662700</authid><authname>Jeong J.</authname><surname>Jeong</surname><given-name>Ju Ri</given-name><initials>J.R.</initials><afid>60007215</afid><afid>60007215</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56643605600</author-url><authid>56643605600</authid><authname>Kim S.</authname><surname>Kim</surname><given-name>Sun</given-name><initials>S.</initials><afid>60007215</afid><afid>60007215</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56643605600</author-url><authid>56643605600</authid><authname>Kim S.</authname><surname>Kim</surname><given-name>Sun</given-name><initials>S.</initials><afid>60007215</afid><afid>60007215</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56644007600</author-url><authid>56644007600</authid><authname>Jo S.</authname><surname>Jo</surname><given-name>So Ra</given-name><initials>S.R.</initials><afid>60007215</afid><afid>60007215</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56644007600</author-url><authid>56644007600</authid><authname>Jo S.</authname><surname>Jo</surname><given-name>So Ra</given-name><initials>S.R.</initials><afid>60007215</afid><afid>60007215</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55820650700</author-url><authid>55820650700</authid><authname>Joh J.</authname><surname>Joh</surname><given-name>Ju Youn</given-name><initials>J.Y.</initials><afid>60007215</afid><afid>60007215</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55820650700</author-url><authid>55820650700</authid><authname>Joh J.</authname><surname>Joh</surname><given-name>Ju Youn</given-name><initials>J.Y.</initials><afid>60007215</afid><afid>60007215</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:52363787700</author-url><authid>52363787700</authid><authname>Kim Y.</authname><surname>Kim</surname><given-name>Yeon Pyo</given-name><initials>Y.P.</initials><afid>60007215</afid></author><intid>1535944995</intid><article-number>e0127346</article-number><source-id>10600153309</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929340008"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929340008?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929340008&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929340008&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929340008</prism:url><dc:identifier>SCOPUS_ID:84929340008</dc:identifier><eid>2-s2.0-84929340008</eid><dc:title>Hypolipidemic effects and safety of Lactobacillus Reuteri 263 in a hamster model of hyperlipidemia</dc:title><dc:creator>Huang W.</dc:creator><prism:publicationName>Nutrients</prism:publicationName><prism:eIssn>20726643</prism:eIssn><prism:volume>7</prism:volume><prism:issueIdentifier>5</prism:issueIdentifier><prism:pageRange>3767-3782</prism:pageRange><prism:coverDate>2015-05-15</prism:coverDate><prism:coverDisplayDate>15 May 2015</prism:coverDisplayDate><prism:doi>10.3390/nu7053767</prism:doi><dc:description>© 2015 by the authors; licensee MDPI, Basel, Switzerland. We aimed to verify the beneficial effects of probiotic strain Lactobacillus reuteri 263 (Lr263) on hypolipidemic action in hamsters with hyperlipidemia induced by a 0.2% cholesterol and 10% lard diet (i.e., high-cholesterol diet (HCD)). Male Golden Syrian hamsters were randomly divided into two groups: normal (n = 8), standard diet (control), and experimental (n = 32), a HCD. After a two-week induction followed by a six-week supplementation with Lr263, the 32 hyperlipidemic hamsters were divided into four groups (n = 8 per group) to receive vehicle or Lr263 by oral gavage at 2.1, 4.2, or 10.5 × 10&lt;sup&gt;9&lt;/sup&gt; cells/kg/day for 6 weeks, designated the HCD, 1X, 2X and 5X groups, respectively. The efficacy and safety of Lr263 supplementation were evaluated by lipid profiles of serum, liver and feces and by clinical biochemistry and histopathology. HCD significantly increased serum levels of total cholesterol (TC), triacylglycerol (TG) cholesterol, high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C), LDL-C/HDL-C ratio, hepatic and fetal TC and TG levels, and degree of fatty liver as compared with controls. Lr263 supplementation dose dependently increased serum HDL-C level and decreased serum TC, TG, LDL-C levels, LDL-C/HDL-C ratio, hepatic TC and TG levels, and fecal TG level. In addition, Lr263 supplementation had few subchronic toxic effects. Lr263 could be a potential agent with a hypolipidemic pharmacological effect.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60092855</affiliation-url><afid>60092855</afid><affilname>National Taiwan Sport University</affilname><name-variant>National Taiwan Sport University</name-variant><affiliation-city>Taoyuan</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60092855</affiliation-url><afid>60092855</afid><affilname>National Taiwan Sport University</affilname><name-variant>National Taiwan Sport University</name-variant><affiliation-city>Taoyuan</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022095</affiliation-url><afid>60022095</afid><affilname>Taipei Medical University</affilname><name-variant>Taipei Medical University</name-variant><affiliation-city>Taipei</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60092855</affiliation-url><afid>60092855</afid><affilname>National Taiwan Sport University</affilname><name-variant>National Taiwan Sport University</name-variant><affiliation-city>Taoyuan</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60086685</affiliation-url><afid>60086685</afid><affilname>Lotung Poh-Ai Hospital</affilname><name-variant>Lo-Tung Poh-Ai Hospital</name-variant><affiliation-city>I-lan</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022095</affiliation-url><afid>60022095</afid><affilname>Taipei Medical University</affilname><name-variant>Taipei Medical University</name-variant><affiliation-city>Taipei</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029078</affiliation-url><afid>60029078</afid><affilname>Shih Chien University</affilname><name-variant>Shih Chien University</name-variant><affiliation-city>Taipei</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">11</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55615697100</author-url><authid>55615697100</authid><authname>Huang W.</authname><surname>Huang</surname><given-name>Wen Ching</given-name><initials>W.C.</initials><afid>60092855</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7601429931</author-url><authid>7601429931</authid><authname>Chen Y.</authname><surname>Chen</surname><given-name>Yi Ming</given-name><initials>Y.M.</initials><afid>60092855</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55662784400</author-url><authid>55662784400</authid><authname>Kan N.</authname><surname>Kan</surname><given-name>Nai Wen</given-name><initials>N.W.</initials><afid>60092855</afid><afid>60022095</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55662784400</author-url><authid>55662784400</authid><authname>Kan N.</authname><surname>Kan</surname><given-name>Nai Wen</given-name><initials>N.W.</initials><afid>60092855</afid><afid>60022095</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56643620100</author-url><authid>56643620100</authid><authname>Ho C.</authname><surname>Ho</surname><given-name>Chun Sheng</given-name><initials>C.S.</initials><afid>60092855</afid><afid>60086685</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56643620100</author-url><authid>56643620100</authid><authname>Ho C.</authname><surname>Ho</surname><given-name>Chun Sheng</given-name><initials>C.S.</initials><afid>60092855</afid><afid>60086685</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:36669629500</author-url><authid>36669629500</authid><authname>Wei L.</authname><surname>Wei</surname><given-name>Li</given-name><initials>L.</initials><afid>60022095</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56643563900</author-url><authid>56643563900</authid><authname>Chan C.</authname><surname>Chan</surname><given-name>Ching Hung</given-name><initials>C.H.</initials><afid>60029078</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56152467100</author-url><authid>56152467100</authid><authname>Huang H.</authname><surname>Huang</surname><given-name>Hui Yu</given-name><initials>H.Y.</initials><afid>60029078</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:35205299500</author-url><authid>35205299500</authid><authname>Huang C.</authname><surname>Huang</surname><given-name>Chi Chang</given-name><initials>C.C.</initials><afid>60092855</afid><afid>60092855</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:35205299500</author-url><authid>35205299500</authid><authname>Huang C.</authname><surname>Huang</surname><given-name>Chi Chang</given-name><initials>C.C.</initials><afid>60092855</afid><afid>60092855</afid></author><authkeywords>Cholesterol | High-cholesterol diet | Hypolipidemic | Lipid-lowering | Triglyceride</authkeywords><intid>2035939503</intid><source-id>19700188323</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929379620"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929379620?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929379620&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929379620&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929379620</prism:url><dc:identifier>SCOPUS_ID:84929379620</dc:identifier><eid>2-s2.0-84929379620</eid><dc:title>Liver injury and fibrosis induced by dietary challenge in the ossabaw miniature swine</dc:title><dc:creator>Liang T.</dc:creator><prism:publicationName>PLoS ONE</prism:publicationName><prism:eIssn>19326203</prism:eIssn><prism:volume>10</prism:volume><prism:issueIdentifier>5</prism:issueIdentifier><prism:coverDate>2015-05-15</prism:coverDate><prism:coverDisplayDate>15 May 2015</prism:coverDisplayDate><prism:doi>10.1371/journal.pone.0124173</prism:doi><dc:description>© 2015 Liang et al. Background Ossabaw miniature swine when fed a diet high in fructose, saturated fat and cholesterol (NASH diet) develop metabolic syndrome and nonalcoholic steatohepatitis (NASH) characterized by liver injury and fibrosis. This study was conducted to further characterize the development of NASH in this large animal model. Methods Ossabaw swine were fed standard chow (control group; n = 6) or NASH diet (n = 6) for 24 weeks. Blood and liver tissue were collected and liver histology were characterized at 0, 8, 16 and 24 weeks of dietary intervention. Hepatic apoptosis and lipid levels were assessed at week 24. Results The NASH diet group developed metabolic syndrome and progressive histologic features of NASH including: (a) hepatocyte ballooning at 8 weeks which progressed to extensive ballooning (&gt; 90% hepatocytes), (b) hepatic fibrosis at week 16, which progressed to moderate fibrosis, and (c) Kupffer cell accumulation with vacuolization at 8 weeks which progressed through week 24. The NASH diet group showed increased hepatocyte apoptosis that correlated with hepatic total and free cholesterol and free fatty acids, but not esterified cholesterol or triglycerides. Conclusions This report further characterizes the progression of diet-induced NASH in the Ossabaw swine model. In Ossabaw swine fed the NASH diet: (a) hepatocyte injury and fibrosis can occur without macrovesicular steatosis or excess triglyceride accumulation; (b) hepatocyte ballooning generally precedes the development of fibrosis; (c) there is increased hepatocyte apoptosis, and it is correlated more significantly with hepatic free cholesterol than hepatic free fatty acids and had no correlation with hepatic triglycerides.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021947</affiliation-url><afid>60021947</afid><affilname>Indiana University School of Medicine Indianapolis</affilname><name-variant>Indiana University School of Medicine</name-variant><affiliation-city>Indianapolis</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021947</affiliation-url><afid>60021947</afid><affilname>Indiana University School of Medicine Indianapolis</affilname><name-variant>Indiana University School of Medicine</name-variant><affiliation-city>Indianapolis</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021947</affiliation-url><afid>60021947</afid><affilname>Indiana University School of Medicine Indianapolis</affilname><name-variant>Indiana University School of Medicine</name-variant><affiliation-city>Indianapolis</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009254</affiliation-url><afid>60009254</afid><affilname>Purdue University</affilname><name-variant>Purdue University</name-variant><affiliation-city>West Lafayette</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009254</affiliation-url><afid>60009254</afid><affilname>Purdue University</affilname><name-variant>Purdue University</name-variant><affiliation-city>West Lafayette</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024812</affiliation-url><afid>60024812</afid><affilname>Semmelweis Egyetem</affilname><name-variant>Semmelweis University</name-variant><affiliation-city>Budapest</affiliation-city><affiliation-country>Hungary</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">13</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56591483700</author-url><authid>56591483700</authid><authname>Liang T.</authname><surname>Liang</surname><given-name>Tiebing</given-name><initials>T.</initials><afid>60021947</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:13407134000</author-url><authid>13407134000</authid><authname>Alloosh M.</authname><surname>Alloosh</surname><given-name>Mouhamad</given-name><initials>M.</initials><afid>60021947</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:8568021000</author-url><authid>8568021000</authid><authname>Bell L.</authname><surname>Bell</surname><given-name>Lauren N.</given-name><initials>L.N.</initials><afid>60021947</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:45960930900</author-url><authid>45960930900</authid><authname>Fullenkamp A.</authname><surname>Fullenkamp</surname><given-name>Allison</given-name><initials>A.</initials><afid>60021947</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56643949900</author-url><authid>56643949900</authid><authname>Saxena R.</authname><surname>Saxena</surname><given-name>Romil</given-name><initials>R.</initials><afid>60021947</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7004360117</author-url><authid>7004360117</authid><authname>Van Alstine W.</authname><surname>Van Alstine</surname><given-name>William</given-name><initials>W.</initials><afid>60009254</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56644676300</author-url><authid>56644676300</authid><authname>Bybee P.</authname><surname>Bybee</surname><given-name>Phelan</given-name><initials>P.</initials><afid>60009254</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:6602116584</author-url><authid>6602116584</authid><authname>Werling K.</authname><surname>Werling</surname><given-name>Klára</given-name><initials>K.</initials><afid>60024812</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56564134800</author-url><authid>56564134800</authid><authname>Sturek M.</authname><surname>Sturek</surname><given-name>Michael</given-name><initials>M.</initials><afid>60021947</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7005601417</author-url><authid>7005601417</authid><authname>Chalasani N.</authname><surname>Chalasani</surname><given-name>Naga</given-name><initials>N.</initials><afid>60021947</afid><afid>60021947</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7005601417</author-url><authid>7005601417</authid><authname>Chalasani N.</authname><surname>Chalasani</surname><given-name>Naga</given-name><initials>N.</initials><afid>60021947</afid><afid>60021947</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:56644351300</author-url><authid>56644351300</authid><authname>Masuoka H.</authname><surname>Masuoka</surname><given-name>Howard C.</given-name><initials>H.C.</initials><afid>60021947</afid><afid>60021947</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:56644351300</author-url><authid>56644351300</authid><authname>Masuoka H.</authname><surname>Masuoka</surname><given-name>Howard C.</given-name><initials>H.C.</initials><afid>60021947</afid><afid>60021947</afid></author><intid>35943763</intid><article-number>0124173</article-number><source-id>10600153309</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929340864"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929340864?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929340864&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929340864&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929340864</prism:url><dc:identifier>SCOPUS_ID:84929340864</dc:identifier><eid>2-s2.0-84929340864</eid><dc:title>Phosphatidylserine decarboxylase 1 autocatalysis and function does not require a mitochondrial-specific factor</dc:title><dc:creator>Onguka O.</dc:creator><prism:publicationName>Journal of Biological Chemistry</prism:publicationName><prism:issn>00219258</prism:issn><prism:eIssn>1083351X</prism:eIssn><prism:volume>290</prism:volume><prism:issueIdentifier>20</prism:issueIdentifier><prism:pageRange>12744-12752</prism:pageRange><prism:coverDate>2015-05-15</prism:coverDate><prism:coverDisplayDate>15 May 2015</prism:coverDisplayDate><prism:doi>10.1074/jbc.M115.641118</prism:doi><dc:description>© 2015 by The American Society for Biochemistry and Molecular Biology, Inc. Phosphatidylethanolamine (PE) is a major cellular phospholipid that can be made by four separate pathways, one of which resides in the mitochondrion. The mitochondrial enzyme that generates PE is phosphatidylserine decarboxylase 1 (Psd1p). The pool of PE produced by Psd1p, which cannot be compensated for by the other cellular PE metabolic pathways, is important for numerous mitochondrial functions, including oxidative phosphorylation and mitochondrial dynamics and morphology, and is essential for murine development. To become catalytically active, Psd1p undergoes an autocatalytic processing step involving a conserved LGST motif that separates the enzyme into α and β subunits that remain non-covalently attached and are anchored to the inner membrane by virtue of the membrane-embedded β subunit. It was speculated that Psd1p autocatalysis requires a mitochondrial-specific factor and that for Psd1p to function in vivo, it had to be embedded with the correct topology in the mitochondrial inner membrane. However, the identity of the mitochondrial factor required for Psd1p autocatalysis has not been identified. With the goal of defining molecular requirements for Psd1p autocatalysis, we demonstrate that: 1) despite the conservation of the LGST motif from bacteria to humans, only the serine residue is absolutely required for Psd1p autocatalysis and function; 2) yeast Psd1p does not require its substrate phosphatidylserine for autocatalysis; and 3) contrary to a prior report, yeast Psd1p autocatalysis does not require mitochondrial-specific phospholipids, proteins, or co-factors, because Psd1p re-directed to the secretory pathway undergoes autocatalysis normally and is fully functional in vivo.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001117</affiliation-url><afid>60001117</afid><affilname>The Johns Hopkins School of Medicine</affilname><name-variant>Johns Hopkins School of Medicine</name-variant><affiliation-city>Baltimore</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:49762044700</author-url><authid>49762044700</authid><authname>Onguka O.</authname><surname>Onguka</surname><given-name>Ouma</given-name><initials>O.</initials><afid>60001117</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56644506600</author-url><authid>56644506600</authid><authname>Calzada E.</authname><surname>Calzada</surname><given-name>Elizabeth</given-name><initials>E.</initials><afid>60001117</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56644694200</author-url><authid>56644694200</authid><authname>Ogunbona O.</authname><surname>Ogunbona</surname><given-name>Oluwaseun B.</given-name><initials>O.B.</initials><afid>60001117</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56664738600</author-url><authid>56664738600</authid><authname>Claypool S.</authname><surname>Claypool</surname><given-name>Steven M.</given-name><initials>S.M.</initials><afid>60001117</afid></author><intid>2035939832</intid><source-id>17592</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929325553"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929325553?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929325553&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929325553&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929325553</prism:url><dc:identifier>SCOPUS_ID:84929325553</dc:identifier><eid>2-s2.0-84929325553</eid><dc:title>Silencing of receptor tyrosine kinase ROR1 inhibits tumor-cell proliferation via PI3K/AKT/mTOR signaling pathway in lung adenocarcinoma</dc:title><dc:creator>Liu Y.</dc:creator><prism:publicationName>PLoS ONE</prism:publicationName><prism:eIssn>19326203</prism:eIssn><prism:volume>10</prism:volume><prism:issueIdentifier>5</prism:issueIdentifier><prism:coverDate>2015-05-15</prism:coverDate><prism:coverDisplayDate>15 May 2015</prism:coverDisplayDate><prism:doi>10.1371/journal.pone.0127092</prism:doi><dc:description>© 2015 Liu et al. Receptor tyrosine kinase ROR1, an embryonic protein involved in organogenesis, is expressed in certain hematological malignancies and solid tumors, but is generally absent in adult tissues. This makes the protein an ideal drug target for cancer therapy. In order to assess the suitability of ROR1 as a cell surface antigen for targeted therapy of lung adenocarcinoma, we carried out a comprehensive analysis of ROR1 protein expression in human lung adenocarcinoma tissues and cell lines. Our data show that ROR1 protein is selectively expressed on lung adenocarcinoma cells, but do not support the hypothesis that expression levels of ROR1 are associated with aggressive disease. However silencing of ROR1 via siRNA treatment significantly down-regulates the activity of the PI3K/AKT/mTOR signaling pathway. This is associated with significant apoptosis and anti-proliferation of tumor cells. We found ROR1 protein expressed in lung adenocarcinoma but almost absent in tumor-adjacent tissues of the patients. The finding of ROR1-mediated proliferation signals in both tyrosine kinase inhibitor (TKI)-sensitive and -resistant tumor cells provides encouragement to develop ROR1-directed targeted therapy in lung adenocarcinoma, especially those with TKI resistance.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018910</affiliation-url><afid>60018910</afid><affilname>Kunming Institute of Botany Chinese Academy of Sciences</affilname><name-variant>Chinese Academy of Sciences</name-variant><affiliation-city>Kunming</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:105238303</affiliation-url><afid>105238303</afid><affilname>First People's Hospital of Yunnan Province</affilname><name-variant>First People's Hospital of Yunnan Province</name-variant><affiliation-city>Kunming</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:105238303</affiliation-url><afid>105238303</afid><affilname>First People's Hospital of Yunnan Province</affilname><name-variant>First People's Hospital of Yunnan Province</name-variant><affiliation-city>Kunming</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56645040600</author-url><authid>56645040600</authid><authname>Liu Y.</authname><surname>Liu</surname><given-name>Yanchun</given-name><initials>Y.</initials><afid>60018910</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56498028200</author-url><authid>56498028200</authid><authname>Yang H.</authname><surname>Yang</surname><given-name>Hui</given-name><initials>H.</initials><afid>105238303</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56643430900</author-url><authid>56643430900</authid><authname>Chen T.</authname><surname>Chen</surname><given-name>Tianxing</given-name><initials>T.</initials><afid>105238303</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56643469700</author-url><authid>56643469700</authid><authname>Luo Y.</authname><surname>Luo</surname><given-name>Yongbin</given-name><initials>Y.</initials><afid>60018910</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56643341600</author-url><authid>56643341600</authid><authname>Xu Z.</authname><surname>Xu</surname><given-name>Zheyuan</given-name><initials>Z.</initials><afid>105238303</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56549070100</author-url><authid>56549070100</authid><authname>Li Y.</authname><surname>Li</surname><given-name>Ying</given-name><initials>Y.</initials><afid>105238303</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56643535400</author-url><authid>56643535400</authid><authname>Yang J.</authname><surname>Yang</surname><given-name>Jiahui</given-name><initials>J.</initials><afid>60018910</afid></author><intid>2035940249</intid><article-number>0127092</article-number><source-id>10600153309</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929353032"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929353032?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929353032&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929353032&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929353032</prism:url><dc:identifier>SCOPUS_ID:84929353032</dc:identifier><eid>2-s2.0-84929353032</eid><dc:title>Molecular connections between cancer cell metabolism and the tumor microenvironment</dc:title><dc:creator>Justus C.</dc:creator><prism:publicationName>International Journal of Molecular Sciences</prism:publicationName><prism:issn>16616596</prism:issn><prism:eIssn>14220067</prism:eIssn><prism:volume>16</prism:volume><prism:issueIdentifier>5</prism:issueIdentifier><prism:pageRange>11055-11086</prism:pageRange><prism:coverDate>2015-05-15</prism:coverDate><prism:coverDisplayDate>15 May 2015</prism:coverDisplayDate><prism:doi>10.3390/ijms160511055</prism:doi><dc:description>© 2015 by the authors; licensee MDPI, Basel, Switzerland. Cancer cells preferentially utilize glycolysis, instead of oxidative phosphorylation, for metabolism even in the presence of oxygen. This phenomenon of aerobic glycolysis, referred to as the “Warburg effect”, commonly exists in a variety of tumors. Recent studies further demonstrate that both genetic factors such as oncogenes and tumor suppressors and microenvironmental factors such as spatial hypoxia and acidosis can regulate the glycolytic metabolism of cancer cells. Reciprocally, altered cancer cell metabolism can modulate the tumor microenvironment which plays important roles in cancer cell somatic evolution, metastasis, and therapeutic response. In this article, we review the progression of current understandings on the molecular interaction between cancer cell metabolism and the tumor microenvironment. In addition, we discuss the implications of these interactions in cancer therapy and chemoprevention.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018917</affiliation-url><afid>60018917</afid><affilname>The Brody School of Medicine</affilname><name-variant>East Carolina University</name-variant><affiliation-city>Greenville</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018917</affiliation-url><afid>60018917</afid><affilname>The Brody School of Medicine</affilname><name-variant>East Carolina University</name-variant><affiliation-city>Greenville</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018917</affiliation-url><afid>60018917</afid><affilname>The Brody School of Medicine</affilname><name-variant>East Carolina University</name-variant><affiliation-city>Greenville</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025111</affiliation-url><afid>60025111</afid><affilname>The University of North Carolina at Chapel Hill</affilname><name-variant>University of North Carolina at Chapel Hill</name-variant><affiliation-city>Chapel Hill</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55608587000</author-url><authid>55608587000</authid><authname>Justus C.</authname><surname>Justus</surname><given-name>Calvin R.</given-name><initials>C.R.</initials><afid>60018917</afid><afid>60018917</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55608587000</author-url><authid>55608587000</authid><authname>Justus C.</authname><surname>Justus</surname><given-name>Calvin R.</given-name><initials>C.R.</initials><afid>60018917</afid><afid>60018917</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56538628800</author-url><authid>56538628800</authid><authname>Sanderlin E.</authname><surname>Sanderlin</surname><given-name>Edward J.</given-name><initials>E.J.</initials><afid>60018917</afid><afid>60018917</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56538628800</author-url><authid>56538628800</authid><authname>Sanderlin E.</authname><surname>Sanderlin</surname><given-name>Edward J.</given-name><initials>E.J.</initials><afid>60018917</afid><afid>60018917</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56643460700</author-url><authid>56643460700</authid><authname>Yang L.</authname><surname>Yang</surname><given-name>Li V.</given-name><initials>L.V.</initials><afid>60018917</afid><afid>60018917</afid><afid>60018917</afid><afid>60025111</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56643460700</author-url><authid>56643460700</authid><authname>Yang L.</authname><surname>Yang</surname><given-name>Li V.</given-name><initials>L.V.</initials><afid>60018917</afid><afid>60018917</afid><afid>60018917</afid><afid>60025111</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56643460700</author-url><authid>56643460700</authid><authname>Yang L.</authname><surname>Yang</surname><given-name>Li V.</given-name><initials>L.V.</initials><afid>60018917</afid><afid>60018917</afid><afid>60018917</afid><afid>60025111</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56643460700</author-url><authid>56643460700</authid><authname>Yang L.</authname><surname>Yang</surname><given-name>Li V.</given-name><initials>L.V.</initials><afid>60018917</afid><afid>60018917</afid><afid>60018917</afid><afid>60025111</afid></author><authkeywords>Acidosis | Cancer cell metabolism | Cancer therapy | Hypoxia | Tumor microenvironment</authkeywords><intid>535946972</intid><source-id>25879</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84900851950"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84900851950?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84900851950&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84900851950&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84900851950</prism:url><dc:identifier>SCOPUS_ID:84900851950</dc:identifier><eid>2-s2.0-84900851950</eid><dc:title>Role of mitochondria in nonalcoholic fatty liver disease</dc:title><dc:creator>Nassir F.</dc:creator><prism:publicationName>International Journal of Molecular Sciences</prism:publicationName><prism:issn>16616596</prism:issn><prism:eIssn>14220067</prism:eIssn><prism:volume>15</prism:volume><prism:issueIdentifier>5</prism:issueIdentifier><prism:pageRange>8713-8742</prism:pageRange><prism:coverDate>2015-05-15</prism:coverDate><prism:coverDisplayDate>15 May 2015</prism:coverDisplayDate><prism:doi>10.3390/ijms15058713</prism:doi><dc:description>Nonalcoholic fatty liver disease (NAFLD) affects about 30% of the general population in the United States and includes a spectrum of disease that includes simple steatosis, non-alcoholic steatohepatitis (NASH), fibrosis and cirrhosis. Significant insight has been gained into our understanding of the pathogenesis of NALFD; however the key metabolic aberrations underlying lipid accumulation in hepatocytes and the progression of NAFLD remain to be elucidated. Accumulating and emerging evidence indicate that hepatic mitochondria play a critical role in the development and pathogenesis of steatosis and NAFLD. Here, we review studies that document a link between the pathogenesis of NAFLD and hepatic mitochondrial dysfunction with particular focus on new insights into the role of impaired fatty acid oxidation, the transcription factor peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α), and sirtuins in development and progression of NAFLD. © 2014 by the authors; licensee MDPI, Basel, Switzerland.</dc:description><citedby-count>2</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006173</affiliation-url><afid>60006173</afid><affilname>University of Missouri-Columbia</affilname><name-variant>University of Missouri</name-variant><affiliation-city>Columbia</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><pubmed-id>24837835</pubmed-id><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6602178877</author-url><authid>6602178877</authid><authname>Nassir F.</authname><surname>Nassir</surname><given-name>Fatiha</given-name><initials>F.</initials><afid>60006173</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6701773057</author-url><authid>6701773057</authid><authname>Ibdah J.</authname><surname>Ibdah</surname><given-name>Jamal A.</given-name><initials>J.A.</initials><afid>60006173</afid></author><authkeywords>Fatty acid oxidation | Liver | Mitochondria | NAFLD | NASH | PGC-1α | Sirtuin-1 (SIRT1) | Sirtuin-3 (SIRT3) | Steatosis</authkeywords><intid>531202758</intid><source-id>25879</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929340129"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929340129?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929340129&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929340129&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929340129</prism:url><dc:identifier>SCOPUS_ID:84929340129</dc:identifier><eid>2-s2.0-84929340129</eid><dc:title>Retinoic acid homeostasis through aldh1a2 and cyp26a1 mediates meiotic entry in Nile tilapia (Oreochromis niloticus)</dc:title><dc:creator>Feng R.</dc:creator><prism:publicationName>Scientific Reports</prism:publicationName><prism:eIssn>20452322</prism:eIssn><prism:volume>5</prism:volume><prism:coverDate>2015-05-15</prism:coverDate><prism:coverDisplayDate>15 May 2015</prism:coverDisplayDate><prism:doi>10.1038/srep10131</prism:doi><pii>srep10131</pii><dc:description>© 2015 Macmillan Publishers Limited. Meiosis is a process unique to the differentiation of germ cells. Retinoic acid (RA) is the key factor controlling the sex-specific timing of meiotic initiation in tetrapods; however, the role of RA in meiotic initiation in teleosts has remained unclear. In this study, the genes encoding RA synthase aldh1a2, and catabolic enzyme cyp26a1 were isolated from Nile tilapia (Oreochromis niloticus), a species without stra8. The expression of aldh1a2 was up-regulated and expression of cyp26a1 was down-regulated before the meiotic initiation in ovaries and in testes. Treatment with RA synthase inhibitor or disruption of Aldh1a2 by CRISPR/Cas9 resulted in delayed meiotic initiation, with simultaneous down-regulation of cyp26a1 and up-regulation of sycp3. By contrast, treatment with an inhibitor of RA catabolic enzyme and disruption of cyp26a1 resulted in earlier meiotic initiation, with increased expression of aldh1a2 and sycp3. Additionally, treatment of XY fish with estrogen (E2) and XX fish with fadrozole led to sex reversal and reversion of meiotic initiation. These results indicate that RA is indispensable for meiotic initiation in teleosts via a stra8 independent signaling pathway where both aldh1a2 and cyp26a1 are critical. In contrast to mammals, E2 is a major regulator of sex determination and meiotic initiation in teleosts.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023863</affiliation-url><afid>60023863</afid><affilname>Southwest China Normal University</affilname><name-variant>Southwest University</name-variant><affiliation-city>Chongqing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56644015100</author-url><authid>56644015100</authid><authname>Feng R.</authname><surname>Feng</surname><given-name>Ruijuan</given-name><initials>R.</initials><afid>60023863</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56201595400</author-url><authid>56201595400</authid><authname>Fang L.</authname><surname>Fang</surname><given-name>Lingling</given-name><initials>L.</initials><afid>60023863</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56029844000</author-url><authid>56029844000</authid><authname>Cheng Y.</authname><surname>Cheng</surname><given-name>Yunying</given-name><initials>Y.</initials><afid>60023863</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56643455200</author-url><authid>56643455200</authid><authname>He X.</authname><surname>He</surname><given-name>Xue</given-name><initials>X.</initials><afid>60023863</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56643579500</author-url><authid>56643579500</authid><authname>Jiang W.</authname><surname>Jiang</surname><given-name>Wentao</given-name><initials>W.</initials><afid>60023863</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:37067337200</author-url><authid>37067337200</authid><authname>Dong R.</authname><surname>Dong</surname><given-name>Ranran</given-name><initials>R.</initials><afid>60023863</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55736488100</author-url><authid>55736488100</authid><authname>Shi H.</authname><surname>Shi</surname><given-name>Hongjuan</given-name><initials>H.</initials><afid>60023863</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56206291300</author-url><authid>56206291300</authid><authname>Jiang D.</authname><surname>Jiang</surname><given-name>Dongneng</given-name><initials>D.</initials><afid>60023863</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56643469000</author-url><authid>56643469000</authid><authname>Sun L.</authname><surname>Sun</surname><given-name>Lina</given-name><initials>L.</initials><afid>60023863</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:55737080500</author-url><authid>55737080500</authid><authname>Wang D.</authname><surname>Wang</surname><given-name>Deshou</given-name><initials>D.</initials><afid>60023863</afid></author><intid>1035938951</intid><article-number>10131</article-number><source-id>21100200805</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929319418"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929319418?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929319418&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929319418&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929319418</prism:url><dc:identifier>SCOPUS_ID:84929319418</dc:identifier><eid>2-s2.0-84929319418</eid><dc:title>Increased expression of angiogenic and inflammatory proteins in the vitreous of patients with ischemic central retinal vein occlusion</dc:title><dc:creator>Ehlken C.</dc:creator><prism:publicationName>PLoS ONE</prism:publicationName><prism:eIssn>19326203</prism:eIssn><prism:volume>10</prism:volume><prism:issueIdentifier>5</prism:issueIdentifier><prism:coverDate>2015-05-15</prism:coverDate><prism:coverDisplayDate>15 May 2015</prism:coverDisplayDate><prism:doi>10.1371/journal.pone.0126859</prism:doi><dc:description>© 2015 Ehlken et al. Background Central retinal vein occlusion (CRVO) is a common disease characterized by a disrupted retinal blood supply and a high risk of subsequent vision loss due to retinal edema and neovascular disease. This study was designed to assess the concentrations of selected signaling proteins in the vitreous and blood of patients with ischemic CRVO. Methods Vitreous and blood samples were collected from patients undergoing surgery for ischemic CRVO (radial optic neurotomy (RON), n = 13), epiretinal gliosis or macular hole (control group, n = 13). Concentrations of 40 different proteins were determined by an ELISA-type antibody microarray. Results Expression of proteins enriched in the vitreous (CCL2, IGFBP2, MMP10, HGF, TNFRSF11B (OPG)) was localized by immunohistochemistry in eyes of patients with severe ischemic CRVO followed by secondary glaucoma. Vitreal expression levels were higher in CRVO patients than in the control group (CRVO / control; p &lt; 0.05) for ADIPOQ (13.6), ANGPT2 (20.5), CCL2 (MCP1) (3.2), HGF (4.7), IFNG (13.9), IGFBP1 (14.7), IGFBP2 (1.8), IGFBP3 (4.1), IGFBP4 (1.7), IL6 (10.8), LEP (3.4), MMP3 (4.3), MMP9 (3.6), MMP10 (5.4), PPBP (CXCL7 or NAP2) (11.8), TIMP4 (3.8), and VEGFA (85.3). In CRVO patients, vitreal levels of CCL2 (4.2), HGF (23.3), IGFBP2 (1.23), MMP10 (2.47), TNFRSF11B (2.96), and VEGFA (29.2) were higher than the blood levels (vitreous / blood, p &lt; 0.05). Expression of CCL2, IGFBP2, MMP10, HGF, and TNFRSF11B was preferentially localized to the retina and the retinal pigment epithelium (RPE). Conclusion Proteins related to hypoxia, angiogenesis, and inflammation were significantly elevated in the vitreous of CRVO patients. Moreover, some markers known to indicate atherosclerosis may be related to a basic vascular disease underlying RVO. This would imply that local therapeutic targeting might not be sufficient for a long term therapy in a systemic disease but hypothetically reduce local changes as an initial therapeutic approach.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024805</affiliation-url><afid>60024805</afid><affilname>Universitats Klinikum Freiburg und Medizinische Fakultat</affilname><name-variant>University Hospital Freiburg</name-variant><affiliation-city>Freiburg im Breisgau</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024052</affiliation-url><afid>60024052</afid><affilname>Medizinische Hochschule Hannover (MHH)</affilname><name-variant>Hannover Medical School</name-variant><affiliation-city>Hannover</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021110</affiliation-url><afid>60021110</afid><affilname>Universitatsmedizin Gottingen</affilname><affiliation-city>Gottingen</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">13</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:18633482500</author-url><authid>18633482500</authid><authname>Ehlken C.</authname><surname>Ehlken</surname><given-name>Christoph</given-name><initials>C.</initials><afid>60024805</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:54388417700</author-url><authid>54388417700</authid><authname>Grundel B.</authname><surname>Grundel</surname><given-name>Bastian</given-name><initials>B.</initials><afid>60024805</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:54388393500</author-url><authid>54388393500</authid><authname>Michels D.</authname><surname>Michels</surname><given-name>Daniel</given-name><initials>D.</initials><afid>60024805</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:8937727700</author-url><authid>8937727700</authid><authname>Junker B.</authname><surname>Junker</surname><given-name>Bernd</given-name><initials>B.</initials><afid>60024805</afid><afid>60024052</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:8937727700</author-url><authid>8937727700</authid><authname>Junker B.</authname><surname>Junker</surname><given-name>Bernd</given-name><initials>B.</initials><afid>60024805</afid><afid>60024052</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:35337957600</author-url><authid>35337957600</authid><authname>Stahl A.</authname><surname>Stahl</surname><given-name>Andreas</given-name><initials>A.</initials><afid>60024805</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6603360287</author-url><authid>6603360287</authid><authname>Schlunck G.</authname><surname>Schlunck</surname><given-name>Günther</given-name><initials>G.</initials><afid>60024805</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:35588971400</author-url><authid>35588971400</authid><authname>Hansen L.</authname><surname>Hansen</surname><given-name>Lutz L.</given-name><initials>L.L.</initials><afid>60024805</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:6603172586</author-url><authid>6603172586</authid><authname>Feltgen N.</authname><surname>Feltgen</surname><given-name>Nicolas</given-name><initials>N.</initials><afid>60021110</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7404678881</author-url><authid>7404678881</authid><authname>Martin G.</authname><surname>Martin</surname><given-name>Gottfried</given-name><initials>G.</initials><afid>60024805</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7003418841</author-url><authid>7003418841</authid><authname>Agostini H.</authname><surname>Agostini</surname><given-name>Hansjürgen T.</given-name><initials>H.T.</initials><afid>60024805</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:6506186460</author-url><authid>6506186460</authid><authname>Pielen A.</authname><surname>Pielen</surname><given-name>Amelie</given-name><initials>A.</initials><afid>60024805</afid><afid>60024052</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:6506186460</author-url><authid>6506186460</authid><authname>Pielen A.</authname><surname>Pielen</surname><given-name>Amelie</given-name><initials>A.</initials><afid>60024805</afid><afid>60024052</afid></author><intid>535947198</intid><article-number>0126859</article-number><source-id>10600153309</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84919327964"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84919327964?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84919327964&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84919327964&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0308814614018639"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84919327964</prism:url><dc:identifier>SCOPUS_ID:84919327964</dc:identifier><eid>2-s2.0-84919327964</eid><dc:title>Changes in physicochemical characteristics and free amino acids of hawthorn (Crataegus pinnatifida) fruits during maturation</dc:title><dc:creator>Li W.</dc:creator><prism:publicationName>Food Chemistry</prism:publicationName><prism:issn>03088146</prism:issn><prism:eIssn>18737072</prism:eIssn><prism:volume>175</prism:volume><prism:pageRange>50-56</prism:pageRange><prism:coverDate>2015-05-15</prism:coverDate><prism:coverDisplayDate>15 May 2015</prism:coverDisplayDate><prism:doi>10.1016/j.foodchem.2014.11.125</prism:doi><pii>S0308814614018639</pii><dc:description>© 2014 Elsevier Ltd. All rights reserved. In this study, changes in physicochemical characteristics associated with fruit quality and free amino acids were investigated during maturation of hawthorn fruits. Significant differences in these parameters were found during maturation. The color turned progressively from mature green to semi-red, to reach bright red; the shape changed gradually from oval to round or approached round; the size, weight, and edible part (flesh/core ratio) of hawthorns increased while the density of intact fruits did not change. The content of moisture, total soluble sugars, soluble pectin, reduced ascorbic acid, total ascorbic acid, fructose, and sucrose increased while crude protein content decreased significantly. The levels of starch, sucrose, titratable acidity, protopectin, pectin, total free amino acids, and total essential amino acids initially increased and then decreased gradually during maturation. The outcomes of this study provide additional and useful information for fresh consumption and processing as well as utilization of dropped unripe hawthorn fruits.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010206</affiliation-url><afid>60010206</afid><affilname>Shanxi Normal University</affilname><name-variant>Shanxi Normal University</name-variant><affiliation-city>Linfen</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010206</affiliation-url><afid>60010206</afid><affilname>Shanxi Normal University</affilname><name-variant>Shanxi Normal University</name-variant><affiliation-city>Linfen</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55797974300</author-url><authid>55797974300</authid><authname>Li W.</authname><surname>Li</surname><given-name>Wei Qin</given-name><initials>W.Q.</initials><afid>60010206</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55775964200</author-url><authid>55775964200</authid><authname>Hu Q.</authname><surname>Hu</surname><given-name>Qing Ping</given-name><initials>Q.P.</initials><afid>60010206</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55714159100</author-url><authid>55714159100</authid><authname>Xu J.</authname><surname>Xu</surname><given-name>Jian Guo</given-name><initials>J.G.</initials><afid>60010206</afid></author><authkeywords>Free amino acids | Hawthorn | Maturation | Physicochemical characteristics</authkeywords><intid>34298589</intid><source-id>24039</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84922272101"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84922272101?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84922272101&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84922272101&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0039914015000144"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84922272101</prism:url><dc:identifier>SCOPUS_ID:84922272101</dc:identifier><eid>2-s2.0-84922272101</eid><dc:title>Anamperometric superoxide anion radicalbiosensor based on SOD/PtPd-PDARGO modified electrode</dc:title><dc:creator>Tang J.</dc:creator><prism:publicationName>Talanta</prism:publicationName><prism:issn>00399140</prism:issn><prism:volume>137</prism:volume><prism:pageRange>18-24</prism:pageRange><prism:coverDate>2015-05-15</prism:coverDate><prism:coverDisplayDate>15 May 2015</prism:coverDisplayDate><prism:doi>10.1016/j.talanta.2015.01.009</prism:doi><pii>S0039914015000144</pii><dc:description>© 2015 Elsevier B.V. All rights reserved. In the present work, a high-performance enzyme-based electrochemical sensor for the detection of superoxide anion radical (O2 -) is reported. Firstly, we employed a facile approach to synthesize PtPd nanoparticles (PtPd NPs) on chemically reduced graphene oxide (RGO) coated with polydopamine (PDA). The prepared PtPd-PDARGO composite was well characterized by transmission electron microscopy, scanning electron microscopy, Fourier transform infrared spectra, X-ray diffraction, X-ray photoelectron spectroscopy and electrochemical methods. Then the assembled composite was used as a desired electrochemcial interface for superoxide dismutase (SOD) immobilization. Owing to the PDA layer as well as the synergistic effect of PtPd NPs, the fabricated SOD/PtPd-PDARGO sensor exhibited an outstanding sensitivity of 909.7 μA mM-1 cm-2 upon O2 - in a linear range from 0.016 mM to 0.24 mM (R2=0.992), with a low detection limit of 2 μM (S/N=3) and excellent selectivity, good reproducibility as well as favorable long-term stability.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011069</affiliation-url><afid>60011069</afid><affilname>East China University of Science and Technology</affilname><name-variant>East China University of Science and Technology</name-variant><affiliation-city>Shanghai</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60073651</affiliation-url><afid>60073651</afid><affilname>State Key Laboratory of Bioreactor Engineering Shanghai</affilname><name-variant>State Key Laboratory of Bioreactor Engineering</name-variant><affiliation-city>Shanghai</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56270538000</author-url><authid>56270538000</authid><authname>Tang J.</authname><surname>Tang</surname><given-name>Jie</given-name><initials>J.</initials><afid>60011069</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56270907900</author-url><authid>56270907900</authid><authname>Zhu X.</authname><surname>Zhu</surname><given-name>Xiang</given-name><initials>X.</initials><afid>60011069</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56424922400</author-url><authid>56424922400</authid><authname>Niu X.</authname><surname>Niu</surname><given-name>Xiangheng</given-name><initials>X.</initials><afid>60011069</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56504159300</author-url><authid>56504159300</authid><authname>Liu T.</authname><surname>Liu</surname><given-name>Tingting</given-name><initials>T.</initials><afid>60011069</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:24170337700</author-url><authid>24170337700</authid><authname>Zhao H.</authname><surname>Zhao</surname><given-name>Hongli</given-name><initials>H.</initials><afid>60011069</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7102783247</author-url><authid>7102783247</authid><authname>Lan M.</authname><surname>Lan</surname><given-name>Minbo</given-name><initials>M.</initials><afid>60011069</afid><afid>60073651</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7102783247</author-url><authid>7102783247</authid><authname>Lan M.</authname><surname>Lan</surname><given-name>Minbo</given-name><initials>M.</initials><afid>60011069</afid><afid>60073651</afid></author><authkeywords>NPs | PDARGO | PtPd | Superoxide anion radical | Superoxide dismutase</authkeywords><intid>1034780989</intid><source-id>24555</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84919372204"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84919372204?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84919372204&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84919372204&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0308814614018147"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84919372204</prism:url><dc:identifier>SCOPUS_ID:84919372204</dc:identifier><eid>2-s2.0-84919372204</eid><dc:title>Antioxidant components of Viburnum opulus L. determined by on-line HPLC-UV-ABTS radical scavenging and LC-UV-ESI-MS methods</dc:title><dc:creator>Karaçelik A.</dc:creator><prism:publicationName>Food Chemistry</prism:publicationName><prism:issn>03088146</prism:issn><prism:eIssn>18737072</prism:eIssn><prism:volume>175</prism:volume><prism:pageRange>106-114</prism:pageRange><prism:coverDate>2015-05-15</prism:coverDate><prism:coverDisplayDate>15 May 2015</prism:coverDisplayDate><prism:doi>10.1016/j.foodchem.2014.11.085</prism:doi><pii>S0308814614018147</pii><dc:description>© 2014 Published by Elsevier Ltd. Antioxidant activity of the juice and seed and skin extracts prepared with methanol, acetonitrile, and water of Viburnum opulus L. grown in Eastern Black Sea Region were studied with an on-line HPLC-ABTS method and off-line antioxidant methods, among which a linear positive correlation was observed. The fruit extracts were analysed with the HPLC-UV method optimised with 14 standard phenolics. Identification of the phenolic components in the juice was made using an HPLC-UV-ESI-MS method. Nineteen phenolic compounds in juice were identified by comparing the retention times and mass spectra with those of the standards and the phenolics reported in the literature. The major peaks in the juice belonged to coumaroyl-quinic acid, chlorogenic acid, procyanidin B2, and procyanidin trimer. Quite different antioxidant composition profiles were obtained from the extracts with the solvents of different polarities. The antioxidant activities of the seed extracts were higher than those of the skin extracts in general.</dc:description><citedby-count>2</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:100762461</affiliation-url><afid>100762461</afid><affilname>Giresun University</affilname><name-variant>Giresun University</name-variant><affiliation-city>Giresun</affiliation-city><affiliation-country>Turkey</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60104497</affiliation-url><afid>60104497</afid><affilname>Gumushane Universitesi</affilname><name-variant>Gumushane University</name-variant><affiliation-city>Gumushane</affiliation-city><affiliation-country>Turkey</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023355</affiliation-url><afid>60023355</afid><affilname>Karadeniz Teknik Universitesi</affilname><name-variant>Karadeniz Technical University</name-variant><affiliation-city>Trabzon</affiliation-city><affiliation-country>Turkey</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027981</affiliation-url><afid>60027981</afid><affilname>Marmara Universitesi</affilname><name-variant>Marmara University</name-variant><affiliation-city>Istanbul</affiliation-city><affiliation-country>Turkey</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60033316</affiliation-url><afid>60033316</afid><affilname>Universiteit Gent</affilname><name-variant>Ghent University</name-variant><affiliation-city>Ghent</affiliation-city><affiliation-country>Belgium</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56453339100</author-url><authid>56453339100</authid><authname>Karaçelik A.</authname><surname>Karaçelik</surname><given-name>Ayça Aktaş</given-name><initials>A.A.</initials><afid>100762461</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:20334751800</author-url><authid>20334751800</authid><authname>Küçük M.</authname><surname>Küçük</surname><given-name>Murat</given-name><initials>M.</initials><afid>60104497</afid><afid>60023355</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:20334751800</author-url><authid>20334751800</authid><authname>Küçük M.</authname><surname>Küçük</surname><given-name>Murat</given-name><initials>M.</initials><afid>60104497</afid><afid>60023355</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55865257800</author-url><authid>55865257800</authid><authname>Iskefiyeli Z.</authname><surname>Iskefiyeli</surname><given-name>Zeynep</given-name><initials>Z.</initials><afid>60023355</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56452700400</author-url><authid>56452700400</authid><authname>Aydemir S.</authname><surname>Aydemir</surname><given-name>Sezgin</given-name><initials>S.</initials><afid>60027981</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:36879095900</author-url><authid>36879095900</authid><authname>De Smet S.</authname><surname>De Smet</surname><given-name>Seppe</given-name><initials>S.</initials><afid>60033316</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:35491273200</author-url><authid>35491273200</authid><authname>Miserez B.</authname><surname>Miserez</surname><given-name>Bram</given-name><initials>B.</initials><afid>60033316</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7102901266</author-url><authid>7102901266</authid><authname>Sandra P.</authname><surname>Sandra</surname><given-name>Patrick</given-name><initials>P.</initials><afid>60033316</afid></author><authkeywords>FRAP | Gilaburu | On-line HPLC-ABTS/DPPH | Polyphenols | Snowball | Viburnum opulus</authkeywords><intid>534303846</intid><source-id>24039</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929439617"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929439617?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929439617&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929439617&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929439617</prism:url><dc:identifier>SCOPUS_ID:84929439617</dc:identifier><eid>2-s2.0-84929439617</eid><dc:title>Kidney disease in heart failure: the importance of novel biomarkers for type 1 cardio-renal syndrome detection</dc:title><dc:creator>Palazzuoli A.</dc:creator><prism:publicationName>Internal and Emergency Medicine</prism:publicationName><prism:issn>18280447</prism:issn><prism:eIssn>19709366</prism:eIssn><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.1007/s11739-015-1246-0</prism:doi><dc:description>© 2015 SIMI Chronic kidney disease (CKD) in heart failure (HF) has been recognized as an independent risk factor for adverse outcome, although the most important clinical trials tend to exclude patients with moderate and severe renal insufficiency. Despite this common association, the precise pathophysiological connection and liaison between heart and kidney is partially understood. Moreover, is it not enough considering how much cardio-renal syndrome type 1 is attributable to previous CKD, and how much to new-onset acute kidney injury (AKI). Neither development of AKI, its progression and time nor duration is related to an adverse outcome. An AKI definition is not universally recognized, and many confounding terms have been used in literature: “worsening renal function”, “renal impairment”, “renal dysfunction”, etc., are all names that contribute to misunderstanding, and do not facilitate an universal classification. Therefore, AKI development should be the consequence of the basal clinical characteristics of patients, different primitive kidney disease and hemodynamic status. AKI could also be the mirror of several underlying associated diseases poorly controlled. Finally, it is not clear which is the optimal laboratory tool for identifying patients with an increased risk of AKI. In the current report, we review the different kidney diseases’ impact in HF, and we analyze the modalities for AKI recognition during HF focusing our attention about some new biomarkers with potential application in the current setting.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002838</affiliation-url><afid>60002838</afid><affilname>Universita degli Studi di Siena</affilname><name-variant>Università di Siena</name-variant><affiliation-city>Siena</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031742</affiliation-url><afid>60031742</afid><affilname>Baylor University Medical Center at Dallas</affilname><name-variant>Baylor University Medical Center</name-variant><affiliation-city>Dallas</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025304</affiliation-url><afid>60025304</afid><affilname>Ospedale San Bortolo</affilname><name-variant>S. Bortolo Hospital</name-variant><affiliation-city>Vicenza</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ip</subtype><subtypeDescription>Article in Press</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6603722091</author-url><authid>6603722091</authid><authname>Palazzuoli A.</authname><surname>Palazzuoli</surname><given-name>Alberto</given-name><initials>A.</initials><afid>60002838</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7102834118</author-url><authid>7102834118</authid><authname>McCullough P.</authname><surname>McCullough</surname><given-name>Peter A.</given-name><initials>P.A.</initials><afid>60031742</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:36079196600</author-url><authid>36079196600</authid><authname>Ronco C.</authname><surname>Ronco</surname><given-name>Claudio</given-name><initials>C.</initials><afid>60025304</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7006273080</author-url><authid>7006273080</authid><authname>Nuti R.</authname><surname>Nuti</surname><given-name>Ranuccio</given-name><initials>R.</initials><afid>60002838</afid></author><authkeywords>Acute kidney injury | Biomarkers | Cardio-renal syndrome | Chronic kidney disease | Heart failure</authkeywords><intid>2035949597</intid><source-id>5000154606</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929378516"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929378516?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929378516&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929378516&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929378516</prism:url><dc:identifier>SCOPUS_ID:84929378516</dc:identifier><eid>2-s2.0-84929378516</eid><dc:title>Heart rate variability monitoring during sleep based on capacitively coupled textile electrodes on a bed</dc:title><dc:creator>Lee H.</dc:creator><prism:publicationName>Sensors (Switzerland)</prism:publicationName><prism:issn>14248220</prism:issn><prism:volume>15</prism:volume><prism:issueIdentifier>5</prism:issueIdentifier><prism:pageRange>11295-11311</prism:pageRange><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.3390/s150511295</prism:doi><dc:description>© 2015 by the authors; licensee MDPI, Basel, Switzerland. In this study, we developed and tested a capacitively coupled electrocardiogram (ECG) measurement system using conductive textiles on a bed, for long-term healthcare monitoring. The system, which was designed to measure ECG in a bed with no constraints of sleep position and posture, included a foam layer to increase the contact region with the curvature of the body and a cover to ensure durability and easy installation. Nine healthy subjects participated in the experiment during polysomnography (PSG), and the heart rate (HR) coverage and heart rate variability (HRV) parameters were analyzed to evaluate the system. The experimental results showed that the mean of R-peak coverage was 98.0% (95.5%–99.7%), and the normalized errors of HRV time and spectral measures between the Ag/AgCl system and our system ranged from 0.15% to 4.20%. The root mean square errors for inter-beat (RR) intervals and HR were 1.36 ms and 0.09 bpm, respectively. We also showed the potential of our developed system for rapid eye movement (REM) sleep and wake detection as well as for recording of abnormal states.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013682</affiliation-url><afid>60013682</afid><affilname>Seoul National University</affilname><name-variant>Seoul National University</name-variant><affiliation-city>Seoul</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013682</affiliation-url><afid>60013682</afid><affilname>Seoul National University</affilname><name-variant>Seoul National University</name-variant><affiliation-city>Seoul</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55510959900</author-url><authid>55510959900</authid><authname>Lee H.</authname><surname>Lee</surname><given-name>Hong Ji</given-name><initials>H.J.</initials><afid>60013682</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55224481600</author-url><authid>55224481600</authid><authname>Hwang S.</authname><surname>Hwang</surname><given-name>Su Hwan</given-name><initials>S.H.</initials><afid>60013682</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55984252300</author-url><authid>55984252300</authid><authname>Yoon H.</authname><surname>Yoon</surname><given-name>Hee Nam</given-name><initials>H.N.</initials><afid>60013682</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:16513843000</author-url><authid>16513843000</authid><authname>Lee W.</authname><surname>Lee</surname><given-name>Won Kyu</given-name><initials>W.K.</initials><afid>60013682</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56531013700</author-url><authid>56531013700</authid><authname>Park K.</authname><surname>Park</surname><given-name>Kwang Suk</given-name><initials>K.S.</initials><afid>60013682</afid></author><authkeywords>Capacitively coupled electrodes | Conductive textiles | ECG | HRV monitoring</authkeywords><intid>1535943888</intid><source-id>130124</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929430064"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929430064?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929430064&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929430064&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929430064</prism:url><dc:identifier>SCOPUS_ID:84929430064</dc:identifier><eid>2-s2.0-84929430064</eid><dc:title>TGF-β1 and TIMP-4 regulate atrial fibrosis in atrial fibrillation secondary to rheumatic heart disease</dc:title><dc:creator>Sun Y.</dc:creator><prism:publicationName>Molecular and Cellular Biochemistry</prism:publicationName><prism:issn>03008177</prism:issn><prism:eIssn>15734919</prism:eIssn><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.1007/s11010-015-2431-1</prism:doi><dc:description>© 2015 Springer Science+Business Media New York To investigate the involvement of transforming growth factor-β1 (TGF-β1) and tissue inhibitor of metalloproteinase 4 (TIMP-4) in influencing the severity of atrial fibrosis in rheumatic heart disease (RHD) patients with atrial fibrillation (AF). The degree of myocardial fibrosis was evaluated using Masson staining. The expression levels of TGF-β1, TIMP-4, matrix metalloproteinase-2 (MMP-2), type I collagen, and type III collagen were estimated by Western blot analysis. Additionally, TGF-β1 and TIMP-4 mRNA levels were quantified by qRT-PCR. The effect of TGF-β1 stimulation on TIMP-4 expression was assessed by in vitro stimulation of freshly isolated human atrial fibroblasts with recombinant human TGF-β1, followed by Western blot analysis to detect changes in TIMP-4 levels. Masson stain revealed that the left atrial diameter and collagen volume fraction were obviously increased in AF patients, compared to sinus rhythm (SR) controls (both P &lt; 0.05). Western blot analysis showed significantly elevated levels of the AF markers MMP-2, type I collagen, and type III collagen in the AF group, in comparison to the SR controls (all P &lt; 0.05). In the AF group, TGF-β1 expression was relatively higher, while TIMP-4 expression was apparently lower than the SR group (all P &lt; 0.05). TIMP-4 expression level showed a negative association with TGF-β1 expression level (r = −0.98, P &lt; 0.01) and TGF-β1 stimulation of atrial fibroblasts led to a sharp decrease in TIMP-4 protein level. Increased TGF-β1 expression and decreased TIMP-4 expression correlated with atrial fibrosis and ECM changes in the atria of RHD patients with AF. Notably, TGF-β1 suppressed TIMP-4 expression, suggesting that selective TGF-β1 inhibitors may be useful therapeutic agents.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005206</affiliation-url><afid>60005206</afid><affilname>Fujian Medical University</affilname><name-variant>Fujian Medical University</name-variant><affiliation-city>Fuzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115245637</affiliation-url><afid>115245637</afid><affilname>Binzhou City Center Hospital</affilname><name-variant>Binzhou City Center Hospital</name-variant><affiliation-city/><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ip</subtype><subtypeDescription>Article in Press</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56645114600</author-url><authid>56645114600</authid><authname>Sun Y.</authname><surname>Sun</surname><given-name>Yu</given-name><initials>Y.</initials><afid>60005206</afid><afid>115245637</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56645114600</author-url><authid>56645114600</authid><authname>Sun Y.</authname><surname>Sun</surname><given-name>Yu</given-name><initials>Y.</initials><afid>60005206</afid><afid>115245637</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56638820200</author-url><authid>56638820200</authid><authname>Huang Z.</authname><surname>Huang</surname><given-name>Zi Yang</given-name><initials>Z.Y.</initials><afid>60005206</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55904060900</author-url><authid>55904060900</authid><authname>Wang Z.</authname><surname>Wang</surname><given-name>Zhen Hua</given-name><initials>Z.H.</initials><afid>60005206</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56645112200</author-url><authid>56645112200</authid><authname>Li C.</authname><surname>Li</surname><given-name>Cui Ping</given-name><initials>C.P.</initials><afid>115245637</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56645366600</author-url><authid>56645366600</authid><authname>Meng X.</authname><surname>Meng</surname><given-name>Xian Liang</given-name><initials>X.L.</initials><afid>115245637</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56645109300</author-url><authid>56645109300</authid><authname>Zhang Y.</authname><surname>Zhang</surname><given-name>Yun Jiao</given-name><initials>Y.J.</initials><afid>60005206</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56581191800</author-url><authid>56581191800</authid><authname>Su F.</authname><surname>Su</surname><given-name>Feng</given-name><initials>F.</initials><afid>60005206</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56645733700</author-url><authid>56645733700</authid><authname>Ma N.</authname><surname>Ma</surname><given-name>Nan</given-name><initials>N.</initials><afid>60005206</afid></author><authkeywords>Atrial fibrillation | Atrial fibrosis | Matrix metalloproteinase-2 | Rheumatic heart disease | Tissue inhibitor metalloproteinase 4 | Transforming growth factor-β1</authkeywords><intid>1535955918</intid><source-id>14134</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929346702"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929346702?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929346702&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929346702&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929346702</prism:url><dc:identifier>SCOPUS_ID:84929346702</dc:identifier><eid>2-s2.0-84929346702</eid><dc:title>Prenatal exposure to lipopolysaccharide results in myocardial fibrosis in rat offspring</dc:title><dc:creator>Chen X.</dc:creator><prism:publicationName>International Journal of Molecular Sciences</prism:publicationName><prism:issn>16616596</prism:issn><prism:eIssn>14220067</prism:eIssn><prism:volume>16</prism:volume><prism:issueIdentifier>5</prism:issueIdentifier><prism:pageRange>10986-10996</prism:pageRange><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.3390/ijms160510986</prism:doi><dc:description>© 2015 by the authors; licensee MDPI, Basel, Switzerland. The epigenetic plasticity hypothesis indicates that exposure during pregnancy may cause adult-onset disorders, including hypertension, myocardial infarction and heart failure. Moreover, myocardial fibrosis coincides with hypertension, myocardial infarction and heart failure. This study was designed to investigate the effects of prenatal exposure to lipopolysaccharide (LPS) on myocardial fibrosis. The result showed that at six and 16 weeks of age, the LPS-treated offspring exhibited increased collagen synthesis, an elevated cardiac index (CI), higher mRNA levels of TIMP-2 and TGFβ and a reduced mRNA level of MMP2. The protein levels corresponded to the mRNA levels. The offspring that were prenatally treated with pyrrolidine dithiocarbamic acid (PDTC), an inhibitor of NF-κB, displayed improvements in the CI and in collagen synthesis. Moreover, PDTC ameliorated the expression of cytokines and proteins associated with myocardial fibrosis. The results showed that maternal inflammation can induce myocardial fibrosis in offspring during aging accompanied by an imbalance of TIMP-2/MMP2 and TGFβ expression.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023797</affiliation-url><afid>60023797</afid><affilname>Third Military Medical University</affilname><name-variant>Third Military Medical University</name-variant><affiliation-city>Chongqing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112323957</affiliation-url><afid>112323957</afid><affilname>Xiangyang Central Hospital</affilname><name-variant>Xiangyang Central Hospital</name-variant><affiliation-city/><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56643421200</author-url><authid>56643421200</authid><authname>Chen X.</authname><surname>Chen</surname><given-name>Xin</given-name><initials>X.</initials><afid>60023797</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56643446300</author-url><authid>56643446300</authid><authname>Tang Y.</authname><surname>Tang</surname><given-name>Yujie</given-name><initials>Y.</initials><afid>112323957</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56412354400</author-url><authid>56412354400</authid><authname>Gao M.</authname><surname>Gao</surname><given-name>Meng</given-name><initials>M.</initials><afid>60023797</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56643796300</author-url><authid>56643796300</authid><authname>Qin S.</authname><surname>Qin</surname><given-name>Shugang</given-name><initials>S.</initials><afid>60023797</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:16246805500</author-url><authid>16246805500</authid><authname>Zhou J.</authname><surname>Zhou</surname><given-name>Jianzhi</given-name><initials>J.</initials><afid>60023797</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55718174400</author-url><authid>55718174400</authid><authname>Li X.</authname><surname>Li</surname><given-name>Xiaohui</given-name><initials>X.</initials><afid>60023797</afid></author><authkeywords>Lipopolysaccharide | Myocardial fibrosis | Pregnant | Pyrrolidine dithiocarbamic acid</authkeywords><intid>535945200</intid><source-id>25879</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929325584"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929325584?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929325584&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929325584&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929325584</prism:url><dc:identifier>SCOPUS_ID:84929325584</dc:identifier><eid>2-s2.0-84929325584</eid><dc:title>Surgical repair of a giant congenital right atrial aneurysm: A case report</dc:title><dc:creator>Jonavicius K.</dc:creator><prism:publicationName>Journal of Cardiothoracic Surgery</prism:publicationName><prism:eIssn>17498090</prism:eIssn><prism:volume>10</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>May 14, 2015</prism:coverDisplayDate><prism:doi>10.1186/s13019-015-0277-y</prism:doi><dc:description>© Jonavicius et al.; licensee BioMed Central. Giant congenital right atrial aneurysms are rare defects of the heart. Though usually asymptomatic, they can be potentially life-threatening. Major risks include heart failure, supraventricular arrhythmias, rupture of the wall of the aneurysm. This defect is usually diagnosed incidentally. It is commonly found when transthoracic echocardiography or chest X-ray is performed. In some cases computed tomography or cardiac magnetic resonance imaging is needed to establish the diagnosis. Potential therapeutic options include surgery, catheter ablation and conservative follow-up. Currently preferred method for correcting this defect is surgical excision of the aneurysm, when surgical indications are met. In this article we describe a successful aneurysmectomy performed on a 16-month old female infant, who at the time of hospitalization presented with severe heart failure and symptoms of cardiac tamponade.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60041628</affiliation-url><afid>60041628</afid><affilname>Vilnius University Faculty of Medicine</affilname><name-variant>Vilnius University</name-variant><affiliation-city>Vilnius</affiliation-city><affiliation-country>Lithuania</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60059987</affiliation-url><afid>60059987</afid><affilname>Vilnius University</affilname><name-variant>Vilnius University</name-variant><affiliation-city>Vilnius</affiliation-city><affiliation-country>Lithuania</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60041628</affiliation-url><afid>60041628</afid><affilname>Vilnius University Faculty of Medicine</affilname><name-variant>Vilnius University</name-variant><affiliation-city>Vilnius</affiliation-city><affiliation-country>Lithuania</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56641892400</author-url><authid>56641892400</authid><authname>Jonavicius K.</authname><surname>Jonavicius</surname><given-name>Karolis</given-name><initials>K.</initials><afid>60041628</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:26645134600</author-url><authid>26645134600</authid><authname>Lipnevicius A.</authname><surname>Lipnevicius</surname><given-name>Arturas</given-name><initials>A.</initials><afid>60059987</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:12773197100</author-url><authid>12773197100</authid><authname>Sudikiene R.</authname><surname>Sudikiene</surname><given-name>Rita</given-name><initials>R.</initials><afid>60059987</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:25633267100</author-url><authid>25633267100</authid><authname>Zurauskas E.</authname><surname>Zurauskas</surname><given-name>Edvardas</given-name><initials>E.</initials><afid>60041628</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:12773123600</author-url><authid>12773123600</authid><authname>Lebetkevicius V.</authname><surname>Lebetkevicius</surname><given-name>Virgilijus</given-name><initials>V.</initials><afid>60059987</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:12772862400</author-url><authid>12772862400</authid><authname>Tarutis V.</authname><surname>Tarutis</surname><given-name>Virgilijus</given-name><initials>V.</initials><afid>60059987</afid></author><authkeywords>Atrial dilatation | Congenital right atrial aneurysm | Heart defects</authkeywords><intid>1535944254</intid><article-number>72</article-number><source-id>5800179605</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929377789"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929377789?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929377789&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929377789&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929377789</prism:url><dc:identifier>SCOPUS_ID:84929377789</dc:identifier><eid>2-s2.0-84929377789</eid><dc:title>Slow breathing and hypoxic challenge: Cardiorespiratory consequences and their central neural substrates</dc:title><dc:creator>Critchley H.</dc:creator><prism:publicationName>PLoS ONE</prism:publicationName><prism:eIssn>19326203</prism:eIssn><prism:volume>10</prism:volume><prism:issueIdentifier>5</prism:issueIdentifier><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.1371/journal.pone.0127082</prism:doi><dc:description>© 2015 Critchley et al. Controlled slow breathing (at 6/min, a rate frequently adopted during yoga practice) can benefit cardiovascular function, including responses to hypoxia. We tested the neural substrates of cardiorespiratory control in humans during volitional controlled breathing and hypoxic challenge using functional magnetic resonance imaging (fMRI). Twenty healthy volunteers were scanned during paced (slow and normal rate) breathing and during spontaneous breathing of normoxic and hypoxic (13% inspired O&lt;inf&gt;2&lt;/inf&gt;) air. Cardiovascular and respiratory measures were acquired concurrently, including beat-to-beat blood pressure from a subset of participants (N = 7). Slow breathing was associated with increased tidal ventilatory volume. Induced hypoxia raised heart rate and suppressed heart rate variability. Within the brain, slow breathing activated dorsal pons, periaqueductal grey matter, cerebellum, hypothalamus, thalamus and lateral and anterior insular cortices. Blocks of hypoxia activated mid pons, bilateral amygdalae, anterior insular and occipitotemporal cortices. Interaction between slow breathing and hypoxia was expressed in ventral striatal and frontal polar activity. Across conditions, within brainstem, dorsal medullary and pontine activity correlated with tidal volume and inversely with heart rate. Activity in rostroventral medulla correlated with beat-to-beat blood pressure and heart rate variability. Widespread insula and striatal activity tracked decreases in heart rate, while subregions of insular cortex correlated with momentary increases in tidal volume. Our findings define slow breathing effects on central and cardiovascular responses to hypoxic challenge. They highlight the recruitment of discrete brainstem nuclei to cardiorespiratory control, and the engagement of corticostriatal circuitry in support of physiological responses that accompany breathing regulation during hypoxic challenge.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017317</affiliation-url><afid>60017317</afid><affilname>University of Sussex</affilname><name-variant>University of Sussex</name-variant><affiliation-city>Sussex</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017317</affiliation-url><afid>60017317</afid><affilname>University of Sussex</affilname><name-variant>University of Sussex</name-variant><affiliation-city>Sussex</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007904</affiliation-url><afid>60007904</afid><affilname>National Health Service</affilname><name-variant>NHS Trust</name-variant><affiliation-city/><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032350</affiliation-url><afid>60032350</afid><affilname>Universita degli Studi di Roma La Sapienza</affilname><affiliation-city>Rome</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031004</affiliation-url><afid>60031004</afid><affilname>University of Queensland</affilname><name-variant>The University of Queensland</name-variant><affiliation-city>Brisbane</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014416</affiliation-url><afid>60014416</afid><affilname>IRCCS Fondazione Santa Lucia</affilname><name-variant>Santa Lucia Foundation</name-variant><affiliation-city>Rome</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60103762</affiliation-url><afid>60103762</afid><affilname>IRCCS Foundation Rome</affilname><name-variant>IRCCS</name-variant><affiliation-city>Rome</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015197</affiliation-url><afid>60015197</afid><affilname>Universita degli Studi di Pavia</affilname><name-variant>Università di Pavia</name-variant><affiliation-city>Pavia</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7006731538</author-url><authid>7006731538</authid><authname>Critchley H.</authname><surname>Critchley</surname><given-name>Hugo D.</given-name><initials>H.D.</initials><afid>60017317</afid><afid>60017317</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7006731538</author-url><authid>7006731538</authid><authname>Critchley H.</authname><surname>Critchley</surname><given-name>Hugo D.</given-name><initials>H.D.</initials><afid>60017317</afid><afid>60017317</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:9637919300</author-url><authid>9637919300</authid><authname>Nicotra A.</authname><surname>Nicotra</surname><given-name>Alessia</given-name><initials>A.</initials><afid>60007904</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56644411500</author-url><authid>56644411500</authid><authname>Chiesa P.</authname><surname>Chiesa</surname><given-name>Patrizia A.</given-name><initials>P.A.</initials><afid>60032350</afid><afid>60031004</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56644411500</author-url><authid>56644411500</authid><authname>Chiesa P.</authname><surname>Chiesa</surname><given-name>Patrizia A.</given-name><initials>P.A.</initials><afid>60032350</afid><afid>60031004</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:37065170500</author-url><authid>37065170500</authid><authname>Nagai Y.</authname><surname>Nagai</surname><given-name>Yoko</given-name><initials>Y.</initials><afid>60017317</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:8738246700</author-url><authid>8738246700</authid><authname>Gray M.</authname><surname>Gray</surname><given-name>Marcus A.</given-name><initials>M.A.</initials><afid>60014416</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:15844021600</author-url><authid>15844021600</authid><authname>Minati L.</authname><surname>Minati</surname><given-name>Ludovico</given-name><initials>L.</initials><afid>60103762</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7101652116</author-url><authid>7101652116</authid><authname>Bernardi L.</authname><surname>Bernardi</surname><given-name>Luciano</given-name><initials>L.</initials><afid>60015197</afid></author><intid>1535944013</intid><article-number>e0127082</article-number><source-id>10600153309</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929613748"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929613748?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929613748&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929613748&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929613748</prism:url><dc:identifier>SCOPUS_ID:84929613748</dc:identifier><eid>2-s2.0-84929613748</eid><dc:title>Trans-radial approach for coronary angiography in an adult postoperative patient with tetralogy of Fallot with complex anatomy</dc:title><dc:creator>Rahman N.</dc:creator><prism:publicationName>BMJ Case Reports</prism:publicationName><prism:eIssn>1757790X</prism:eIssn><prism:volume>2015</prism:volume><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.1136/bcr-2014-207407</prism:doi><dc:description>Copyright 2015 BMJ Publishing Group. All rights reserved. A 42-year-old, postoperative patient with tetralogy of Fallot (TOF) with right-sided aortic arch, presented with heart failure secondary to left ventricular dysfunction, severe valvular regurgitation and residual ventricular septal defect (VSD). After initial stabilisation, he underwent successful coronary angiography through a trans-radial approach followed by aortic valve replacement, pulmonary valve and VSD repair, and was discharged home in stable condition. This case report highlights the trans-radial approach as a feasible option for coronary angiography in postoperative patients with TOF with right-sided aortic arch.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60067302</affiliation-url><afid>60067302</afid><affilname>The Aga Khan University Hospital</affilname><name-variant>Aga Khan University</name-variant><affiliation-city>Karachi</affiliation-city><affiliation-country>Pakistan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:22981186100</author-url><authid>22981186100</authid><authname>Rahman N.</authname><surname>Rahman</surname><given-name>Nasir</given-name><initials>N.</initials><afid>60067302</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56651992100</author-url><authid>56651992100</authid><authname>Gul I.</authname><surname>Gul</surname><given-name>Ibrahim</given-name><initials>I.</initials><afid>60067302</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:14028131700</author-url><authid>14028131700</authid><authname>Ali A.</authname><surname>Ali</surname><given-name>Ashique</given-name><initials>A.</initials><afid>60067302</afid></author><intid>1035983836</intid><article-number>A750</article-number><source-id>19700201654</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929332193"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929332193?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929332193&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929332193&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929332193</prism:url><dc:identifier>SCOPUS_ID:84929332193</dc:identifier><eid>2-s2.0-84929332193</eid><dc:title>Dual phosphodiesterase type 5 inhibitor therapy for refractory pulmonary arterial hypertension: A pilot study</dc:title><dc:creator>Kimura M.</dc:creator><prism:publicationName>BMC Pulmonary Medicine</prism:publicationName><prism:eIssn>14712466</prism:eIssn><prism:volume>15</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>May 14, 2015</prism:coverDisplayDate><prism:doi>10.1186/s12890-015-0037-8</prism:doi><dc:description>© Kimura et al.; licensee BioMed Central. Background: Recent vasodilating drugs have improved prognosis of Pulmonary arterial hypertension (PAH). Some reports describe the merits of combination therapies for PAH, and this study evaluated the efficacy and safety of phosphodiesterase type 5 inhibitors (PDE5i) combination therapy, using sildenafil and tadalafil, for multi-drug-resistant PAH. Methods: We retrospectively analyzed 7 consecutive refractory patients with PAH administered either sildenafil 60 mg or tadalafil 40 mg as well as both ERA and prostanoid as combination therapies. All were started on the dual PDE5i (sildenafil and tadalafil at maximum dose). Results: Treatment was generally well tolerated without severe adverse events. On completion of the study, the seven patients received right heart catheterization and the 6-minute walk test (6WMT) 9.6 ± 1.4 months after initiation of the dual PDE5i therapy, showing significant improvements in hemodynamic parameters and exercise tolerance. Mean pulmonary arterial pressure and pulmonary vascular resistance decreased from 47.9 ± 9.7 to 41.7 ± 9.2 mmHg (P = 0.004) and 9.3 ± 2.7 to 6.7 ± 2.9 mmHg (P = 0.018), respectively. Cardiac index and 6MWT also increased from 2.8 ± 0.9 to 3.1 ± 0.8 L/min/m&lt;sup&gt;2&lt;/sup&gt; (P = 0.026) and 353 ± 60 to 382 ± 62 m (P = 0.014), respectively. Conclusion: The findings support dual PDE5i therapy as a new treatment option for refractory PAH.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025252</affiliation-url><afid>60025252</afid><affilname>Keio University School of Medicine</affilname><name-variant>Keio University School of Medicine</name-variant><affiliation-city>Tokyo</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018600</affiliation-url><afid>60018600</afid><affilname>Nippon Medical School</affilname><name-variant>Nippon Medical School</name-variant><affiliation-city>Tokyo</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019092</affiliation-url><afid>60019092</afid><affilname>Kyorin University School of Medicine</affilname><name-variant>Kyorin University School of Medicine</name-variant><affiliation-city>Mitaka</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56116746500</author-url><authid>56116746500</authid><authname>Kimura M.</authname><surname>Kimura</surname><given-name>Mai</given-name><initials>M.</initials><afid>60025252</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:36840745700</author-url><authid>36840745700</authid><authname>Tamura Y.</authname><surname>Tamura</surname><given-name>Yuichi</given-name><initials>Y.</initials><afid>60025252</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55365612500</author-url><authid>55365612500</authid><authname>Takei M.</authname><surname>Takei</surname><given-name>Makoto</given-name><initials>M.</initials><afid>60025252</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55365562100</author-url><authid>55365562100</authid><authname>Yamamoto T.</authname><surname>Yamamoto</surname><given-name>Tsunehisa</given-name><initials>T.</initials><afid>60025252</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55270572700</author-url><authid>55270572700</authid><authname>Ono T.</authname><surname>Ono</surname><given-name>Tomohiko</given-name><initials>T.</initials><afid>60025252</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:35379928800</author-url><authid>35379928800</authid><authname>Fujita J.</authname><surname>Fujita</surname><given-name>Jun</given-name><initials>J.</initials><afid>60025252</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:23479673700</author-url><authid>23479673700</authid><authname>Kataoka M.</authname><surname>Kataoka</surname><given-name>Masaharu</given-name><initials>M.</initials><afid>60025252</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7007110532</author-url><authid>7007110532</authid><authname>Kuwana M.</authname><surname>Kuwana</surname><given-name>Masataka</given-name><initials>M.</initials><afid>60018600</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:36593615200</author-url><authid>36593615200</authid><authname>Satoh T.</authname><surname>Satoh</surname><given-name>Toru</given-name><initials>T.</initials><afid>60019092</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7403522079</author-url><authid>7403522079</authid><authname>Fukuda K.</authname><surname>Fukuda</surname><given-name>Keiichi</given-name><initials>K.</initials><afid>60025252</afid></author><authkeywords>New treatment option | Phosphodiesterase type 5 inhibitor | Pulmonary arterial hypertension</authkeywords><intid>1035940217</intid><article-number>62</article-number><source-id>18026</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929207184"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929207184?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929207184&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929207184&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929207184</prism:url><dc:identifier>SCOPUS_ID:84929207184</dc:identifier><eid>2-s2.0-84929207184</eid><dc:title>Surgical repair of a giant congenital right atrial aneurysm: A case report</dc:title><dc:creator>Jonavicius K.</dc:creator><prism:publicationName>Journal of Cardiothoracic Surgery</prism:publicationName><prism:eIssn>17498090</prism:eIssn><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>May 14, 2015</prism:coverDisplayDate><prism:doi>10.1186/s13019-015-0277-y</prism:doi><dc:description>© 2015 Jonavicius et al.; licensee BioMed Central. Giant congenital right atrial aneurysms are rare defects of the heart. Though usually asymptomatic, they can be potentially life-threatening. Major risks include heart failure, supraventricular arrhythmias, rupture of the wall of the aneurysm. This defect is usually diagnosed incidentally. It is commonly found when transthoracic echocardiography or chest X-ray is performed. In some cases computed tomography or cardiac magnetic resonance imaging is needed to establish the diagnosis. Potential therapeutic options include surgery, catheter ablation and conservative follow-up. Currently preferred method for correcting this defect is surgical excision of the aneurysm, when surgical indications are met. In this article we describe a successful aneurysmectomy performed on a 16-month old female infant, who at the time of hospitalization presented with severe heart failure and symptoms of cardiac tamponade.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60041628</affiliation-url><afid>60041628</afid><affilname>Vilnius University Faculty of Medicine</affilname><name-variant>Vilnius University</name-variant><affiliation-city>Vilnius</affiliation-city><affiliation-country>Lithuania</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60059987</affiliation-url><afid>60059987</afid><affilname>Vilnius University</affilname><name-variant>Vilnius University</name-variant><affiliation-city>Vilnius</affiliation-city><affiliation-country>Lithuania</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60041628</affiliation-url><afid>60041628</afid><affilname>Vilnius University Faculty of Medicine</affilname><name-variant>Vilnius University</name-variant><affiliation-city>Vilnius</affiliation-city><affiliation-country>Lithuania</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ip</subtype><subtypeDescription>Article in Press</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56641892400</author-url><authid>56641892400</authid><authname>Jonavicius K.</authname><surname>Jonavicius</surname><given-name>Karolis</given-name><initials>K.</initials><afid>60041628</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:26645134600</author-url><authid>26645134600</authid><authname>Lipnevicius A.</authname><surname>Lipnevicius</surname><given-name>Arturas</given-name><initials>A.</initials><afid>60059987</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:12773197100</author-url><authid>12773197100</authid><authname>Sudikiene R.</authname><surname>Sudikiene</surname><given-name>Rita</given-name><initials>R.</initials><afid>60059987</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:25633267100</author-url><authid>25633267100</authid><authname>Zurauskas E.</authname><surname>Zurauskas</surname><given-name>Edvardas</given-name><initials>E.</initials><afid>60041628</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:12773123600</author-url><authid>12773123600</authid><authname>Lebetkevicius V.</authname><surname>Lebetkevicius</surname><given-name>Virgilijus</given-name><initials>V.</initials><afid>60059987</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:12772862400</author-url><authid>12772862400</authid><authname>Tarutis V.</authname><surname>Tarutis</surname><given-name>Virgilijus</given-name><initials>V.</initials><afid>60059987</afid></author><authkeywords>Atrial dilatation | Congenital right atrial aneurysm | Heart defects</authkeywords><intid>535920037</intid><source-id>5800179605</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929774313"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929774313?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929774313&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929774313&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929774313</prism:url><dc:identifier>SCOPUS_ID:84929774313</dc:identifier><eid>2-s2.0-84929774313</eid><dc:title>Cost-utility analysis of percutaneous mitral valve repair in inoperable patients with functional mitral regurgitation in German settings</dc:title><dc:creator>Borisenko O.</dc:creator><prism:publicationName>BMC Cardiovascular Disorders</prism:publicationName><prism:eIssn>14712261</prism:eIssn><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>May 14, 2015</prism:coverDisplayDate><prism:doi>10.1186/s12872-015-0039-8</prism:doi><dc:description>© 2015 Borisenko et al.; licensee BioMed Central. Background: To determine the cost-effectiveness of the percutaneous mitral valve repair (PMVR) using Carillon® Mitral Contour System® (Cardiac Dimensions Inc., Kirkland, WA, USA) in patients with congestive heart failure accompanied by moderate to severe functional mitral regurgitation (FMR) compared to the prolongation of optimal medical treatment (OMT). Methods: Cost-utility analysis using a combination of a decision tree and Markov process was performed. The clinical effectiveness was determined based on the results of the Transcatheter Implantation of Carillon Mitral Annuloplasty Device (TITAN) trial. The mean age of the target population was 62 years, 77 % of the patients were males, 64 % of the patients had severe FMR and all patients had New York Heart Association functional class III. The epidemiological, cost and utility data were derived from the literature. The analysis was performed from the German statutory health insurance perspective over 10-year time horizon. Results: Over 10 years, the total cost was €36,785 in the PMVR arm and €18,944 in the OMT arm. However, PMVR provided additional benefits to patients with an 1.15 incremental quality-adjusted life years (QALY) and an 1.41 incremental life years. The percutaneous procedure was cost-effective in comparison to OMT with an incremental cost-effectiveness ratio of €15,533/QALY. Results were robust in the deterministic sensitivity analysis. In the probabilistic sensitivity analysis with a willingness-to-pay threshold of €35,000/QALY, PMVR had a 84 % probability of being cost-effective. Conclusions: Percutaneous mitral valve repair may be cost-effective in inoperable patients with FMR due to heart failure.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114513269</affiliation-url><afid>114513269</afid><affilname>Synergus AB</affilname><name-variant>Synergus AB</name-variant><affiliation-city>Danderyd</affiliation-city><affiliation-country>Sweden</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023892</affiliation-url><afid>60023892</afid><affilname>Lukas-Krankenhaus</affilname><name-variant>Lukas Krankenhaus</name-variant><affiliation-city>Bunde</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014976</affiliation-url><afid>60014976</afid><affilname>Paracelsus Medizinische Privatuniversitat</affilname><name-variant>Paracelsus Medical University Salzburg</name-variant><affiliation-city>Salzburg</affiliation-city><affiliation-country>Austria</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60069010</affiliation-url><afid>60069010</afid><affilname>Poznan University of Medical Sciences</affilname><name-variant>University of Medical Sciences</name-variant><affiliation-city>Poznan</affiliation-city><affiliation-country>Poland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:101844501</affiliation-url><afid>101844501</afid><affilname>Pôle Santé République</affilname><name-variant>Pôle Santé République</name-variant><affiliation-city>Clermont-Ferrand</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015481</affiliation-url><afid>60015481</afid><affilname>University of Washington Seattle</affilname><name-variant>University of Washington</name-variant><affiliation-city>Seattle</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:107393002</affiliation-url><afid>107393002</afid><affilname>Cardiac Dimensions, Inc.</affilname><name-variant>Cardiac Dimensions Inc.</name-variant><affiliation-city>Kirkland</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012311</affiliation-url><afid>60012311</afid><affilname>Karolinska Institutet</affilname><name-variant>Karolinska Institutet</name-variant><affiliation-city>Stockholm</affiliation-city><affiliation-country>Sweden</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018922</affiliation-url><afid>60018922</afid><affilname>Children's Hospital and Regional Medical Center</affilname><name-variant>Children's Hospital and Regional Medical Center</name-variant><affiliation-city>Seattle</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ip</subtype><subtypeDescription>Article in Press</subtypeDescription><author-count limit="100">11</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7004328188</author-url><authid>7004328188</authid><authname>Borisenko O.</authname><surname>Borisenko</surname><given-name>Oleg</given-name><initials>O.</initials><afid>114513269</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7006762859</author-url><authid>7006762859</authid><authname>Haude M.</authname><surname>Haude</surname><given-name>Michael</given-name><initials>M.</initials><afid>60023892</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7101650810</author-url><authid>7101650810</authid><authname>Hoppe U.</authname><surname>Hoppe</surname><given-name>Uta C.</given-name><initials>U.C.</initials><afid>60014976</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7003505685</author-url><authid>7003505685</authid><authname>Siminiak T.</authname><surname>Siminiak</surname><given-name>Tomasz</given-name><initials>T.</initials><afid>60069010</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:26642913800</author-url><authid>26642913800</authid><authname>Lipiecki J.</authname><surname>Lipiecki</surname><given-name>Janusz</given-name><initials>J.</initials><afid>101844501</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55325443000</author-url><authid>55325443000</authid><authname>Goldberg S.</authname><surname>Goldberg</surname><given-name>Steve L.</given-name><initials>S.L.</initials><afid>60015481</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56654803100</author-url><authid>56654803100</authid><authname>Mehta N.</authname><surname>Mehta</surname><given-name>Nawzer</given-name><initials>N.</initials><afid>107393002</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56655182500</author-url><authid>56655182500</authid><authname>Bouknight O.</authname><surname>Bouknight</surname><given-name>Omari V.</given-name><initials>O.V.</initials><afid>107393002</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:6602990483</author-url><authid>6602990483</authid><authname>Bjessmo S.</authname><surname>Bjessmo</surname><given-name>Staffan</given-name><initials>S.</initials><afid>114513269</afid><afid>60012311</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:6602990483</author-url><authid>6602990483</authid><authname>Bjessmo S.</authname><surname>Bjessmo</surname><given-name>Staffan</given-name><initials>S.</initials><afid>114513269</afid><afid>60012311</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7005508328</author-url><authid>7005508328</authid><authname>Reuter D.</authname><surname>Reuter</surname><given-name>David G.</given-name><initials>D.G.</initials><afid>60018922</afid></author><authkeywords>Cost-utility analysis | Functional mitral regurgitation | Germany | Heart failure | Percutaneous valve repair treatment</authkeywords><intid>1786020103</intid><source-id>22487</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929430731"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929430731?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929430731&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929430731&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929430731</prism:url><dc:identifier>SCOPUS_ID:84929430731</dc:identifier><eid>2-s2.0-84929430731</eid><dc:title>Nipro extra-corporeal left ventricular assist device fitting after left ventricular reconstruction with mitral valve plasty</dc:title><dc:creator>Arakawa M.</dc:creator><prism:publicationName>Journal of Artificial Organs</prism:publicationName><prism:issn>14347229</prism:issn><prism:eIssn>16190904</prism:eIssn><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.1007/s10047-015-0837-x</prism:doi><dc:description>© 2015 The Japanese Society for Artificial Organs Both left ventricular assist device and left ventricular reconstruction are treatment choices for severe heart failure conditions. Our institution performed a left ventricular assist device installation following a left ventricular reconstruction procedure on a 42-year-old male patient who presented with dilated cardiomyopathy and low cardiac output syndrome. A mitral valve plasty was used to correct the acute mitral valve regurgitation and we performed a Nipro extra-corporeal left ventricular assist device installation on post-operative day 14. Due to the left ventricular reconstruction that the patient had in a previous operation, we needed to attach an apical cuff on posterior apex, insert the inflow cannula with a large curve, and shift the skin insertion site laterally to the left. We assessed the angle between the cardiac longitudinal axis and the inflow cannula using computed tomography. The patient did not complain of any subjective symptoms of heart failure. Although Nipro extra-corporeal left ventricular assist device installation after left ventricular reconstruction has several difficulties historically, we have experienced a successful case.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60102128</affiliation-url><afid>60102128</afid><affilname>Jichi Medical University</affilname><name-variant>Jichi Medical University</name-variant><affiliation-city>Kawachi District</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024572</affiliation-url><afid>60024572</afid><affilname>Tokyo Metropolitan Geriatric Medical Center</affilname><name-variant>Tokyo Metropolitan Geriatric Hosp.</name-variant><affiliation-city>Tokyo</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ip</subtype><subtypeDescription>Article in Press</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55523178100</author-url><authid>55523178100</authid><authname>Arakawa M.</authname><surname>Arakawa</surname><given-name>Mamoru</given-name><initials>M.</initials><afid>60102128</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55666737700</author-url><authid>55666737700</authid><authname>Yamaguchi A.</authname><surname>Yamaguchi</surname><given-name>Atsushi</given-name><initials>A.</initials><afid>60102128</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56431860400</author-url><authid>56431860400</authid><authname>Nishimura T.</authname><surname>Nishimura</surname><given-name>Takashi</given-name><initials>T.</initials><afid>60024572</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56645590700</author-url><authid>56645590700</authid><authname>Itoh S.</authname><surname>Itoh</surname><given-name>Satoshi</given-name><initials>S.</initials><afid>60102128</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7005715875</author-url><authid>7005715875</authid><authname>Yuri K.</authname><surname>Yuri</surname><given-name>Koichi</given-name><initials>K.</initials><afid>60102128</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7101706398</author-url><authid>7101706398</authid><authname>Kyo S.</authname><surname>Kyo</surname><given-name>Shunei</given-name><initials>S.</initials><afid>60024572</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56535511500</author-url><authid>56535511500</authid><authname>Adachi H.</authname><surname>Adachi</surname><given-name>Hideo</given-name><initials>H.</initials><afid>60102128</afid></author><authkeywords>Cardiac low output syndrome | Left ventricular assist device | Left ventricular reconstruction | Severe heart failure</authkeywords><intid>1035949825</intid><source-id>27215</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929336431"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929336431?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929336431&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929336431&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929336431</prism:url><dc:identifier>SCOPUS_ID:84929336431</dc:identifier><eid>2-s2.0-84929336431</eid><dc:title>Simple methods for tracking stem cells with &lt;sup&gt;64&lt;/sup&gt;Cu-labeled DOTA-hexadecyl-benzoate</dc:title><dc:creator>Kim M.</dc:creator><prism:publicationName>ACS Medicinal Chemistry Letters</prism:publicationName><prism:eIssn>19485875</prism:eIssn><prism:volume>6</prism:volume><prism:issueIdentifier>5</prism:issueIdentifier><prism:pageRange>528-530</prism:pageRange><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.1021/acsmedchemlett.5b00021</prism:doi><dc:description>© 2015 American Chemical Society. The purpose of this study was to evaluate &lt;sup&gt;64&lt;/sup&gt;Cu-labeled hexadecyl-1,4,7,10-tetraazacyclododecane-tetraacetic acid-benzoate (&lt;sup&gt;64&lt;/sup&gt;Cu-DOTA-HB) (1) as positron emission tomography (PET) radiotracer for stem cell imaging. Hexadecyl-DOTA-benzoate (DOTA-HB) (2) was efficiently labeled with &lt;sup&gt;64&lt;/sup&gt;Cu (&gt;99%), and cell labeling efficiency with adipose-derived stem cells (ADSCs) was over 50%. Labeling with 1 did not compromise cell viability. In the PET imaging, intramuscularly transplanted 1-labeled ADSCs were monitored for 18 h in normal rat heart. These results indicate that 1 can be utilized as a promising radiotracer for monitoring of transplanted stem cells.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60068722</affiliation-url><afid>60068722</afid><affilname>Korea Institute of Radiological and Medical Sciences</affilname><name-variant>Korea Institute of Radiological and Medical Sciences</name-variant><affiliation-city>Seoul</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005273</affiliation-url><afid>60005273</afid><affilname>Korea University</affilname><name-variant>Korea University</name-variant><affiliation-city>Seoul</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">11</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55792265700</author-url><authid>55792265700</authid><authname>Kim M.</authname><surname>Kim</surname><given-name>Min Hwan</given-name><initials>M.H.</initials><afid>60068722</afid><afid>60005273</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55792265700</author-url><authid>55792265700</authid><authname>Kim M.</authname><surname>Kim</surname><given-name>Min Hwan</given-name><initials>M.H.</initials><afid>60068722</afid><afid>60005273</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:12752961800</author-url><authid>12752961800</authid><authname>Woo S.</authname><surname>Woo</surname><given-name>Sang Keun</given-name><initials>S.K.</initials><afid>60068722</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56374332600</author-url><authid>56374332600</authid><authname>Kim K.</authname><surname>Kim</surname><given-name>Kwang Il</given-name><initials>K.I.</initials><afid>60068722</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56373507600</author-url><authid>56373507600</authid><authname>Lee T.</authname><surname>Lee</surname><given-name>Tae Sup</given-name><initials>T.S.</initials><afid>60068722</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56588101700</author-url><authid>56588101700</authid><authname>Kim C.</authname><surname>Kim</surname><given-name>Chan Wha</given-name><initials>C.W.</initials><afid>60005273</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:36484709000</author-url><authid>36484709000</authid><authname>Kang J.</authname><surname>Kang</surname><given-name>Joo Hyun</given-name><initials>J.H.</initials><afid>60068722</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56374591300</author-url><authid>56374591300</authid><authname>Kim B.</authname><surname>Kim</surname><given-name>Byung Il</given-name><initials>B.I.</initials><afid>60068722</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:34868326200</author-url><authid>34868326200</authid><authname>Lim S.</authname><surname>Lim</surname><given-name>Sang Moo</given-name><initials>S.M.</initials><afid>60068722</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:42661704100</author-url><authid>42661704100</authid><authname>Lee K.</authname><surname>Lee</surname><given-name>Kyo Chul</given-name><initials>K.C.</initials><afid>60068722</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:18935432000</author-url><authid>18935432000</authid><authname>Lee Y.</authname><surname>Lee</surname><given-name>Yong Jin</given-name><initials>Y.J.</initials><afid>60068722</afid></author><authkeywords>Adipose-derived stem cells | copper-64 | hexadecyl benzoate | PET | radiotracer</authkeywords><intid>35943672</intid><source-id>19700177127</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929629567"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929629567?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929629567&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929629567&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929629567</prism:url><dc:identifier>SCOPUS_ID:84929629567</dc:identifier><eid>2-s2.0-84929629567</eid><dc:title>Errtatum: Bmi1 limits dilated cardiomyopathy and heart failure by inhibiting cardiac senescence (Nature Communications 6:6473 DOI: 10.1038/ncomms7473 (2015))</dc:title><dc:creator>Gonzalez-Valdes I.</dc:creator><prism:publicationName>Nature Communications</prism:publicationName><prism:eIssn>20411723</prism:eIssn><prism:volume>6</prism:volume><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.1038/ncomms8242</prism:doi><pii>ncomms8242</pii><citedby-count>0</citedby-count><prism:aggregationType>Journal</prism:aggregationType><subtype>er</subtype><subtypeDescription>Erratum</subtypeDescription><author-count limit="100">14</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56543511000</author-url><authid>56543511000</authid><authname>Gonzalez-Valdes I.</authname><surname>Gonzalez-Valdes</surname><given-name>I.</given-name><initials>I.</initials></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55101504900</author-url><authid>55101504900</authid><authname>Hidalgo I.</authname><surname>Hidalgo</surname><given-name>I.</given-name><initials>I.</initials></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56543759600</author-url><authid>56543759600</authid><authname>Bujarrabal A.</authname><surname>Bujarrabal</surname><given-name>A.</given-name><initials>A.</initials></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6602943432</author-url><authid>6602943432</authid><authname>Lara-Pezzi E.</authname><surname>Lara-Pezzi</surname><given-name>E.</given-name><initials>E.</initials></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:16686644300</author-url><authid>16686644300</authid><authname>Padron-Barthe L.</authname><surname>Padron-Barthe</surname><given-name>L.</given-name><initials>L.</initials></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:10045076500</author-url><authid>10045076500</authid><authname>Garcia-Pavia P.</authname><surname>Garcia-Pavia</surname><given-name>P.</given-name><initials>P.</initials></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:6506180533</author-url><authid>6506180533</authid><authname>Gómez-Del Arco P.</authname><surname>Gómez-Del Arco</surname><given-name>Pablo</given-name><initials>P.</initials></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56542882900</author-url><authid>56542882900</authid><authname>Redondo J.</authname><surname>Redondo</surname><given-name>J. M.</given-name><initials>J.M.</initials></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56543079100</author-url><authid>56543079100</authid><authname>Ruiz-Cabello J.</authname><surname>Ruiz-Cabello</surname><given-name>J. M.</given-name><initials>J.M.</initials></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:22957695400</author-url><authid>22957695400</authid><authname>Jimenez-Borreguero L.</authname><surname>Jimenez-Borreguero</surname><given-name>L. J.</given-name><initials>L.J.</initials></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:56651922300</author-url><authid>56651922300</authid><authname>Enriquez J.</authname><surname>Enriquez</surname><given-name>J. A.</given-name><initials>J.A.</initials></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:56046028100</author-url><authid>56046028100</authid><authname>De La Pompa J.</authname><surname>De La Pompa</surname><given-name>J. L.</given-name><initials>J.L.</initials></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:56542772000</author-url><authid>56542772000</authid><authname>Hidalgo A.</authname><surname>Hidalgo</surname><given-name>A.</given-name><initials>A.</initials></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:7202199987</author-url><authid>7202199987</authid><authname>Gonzalez S.</authname><surname>Gonzalez</surname><given-name>S.</given-name><initials>S.</initials></author><intid>535990395</intid><article-number>7242</article-number><source-id>19700182758</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929587535"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929587535?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929587535&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929587535&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929587535</prism:url><dc:identifier>SCOPUS_ID:84929587535</dc:identifier><eid>2-s2.0-84929587535</eid><dc:title>Tricuspid valve tissue in the left ventricular outflow tract following ventricular septal defect repair</dc:title><dc:creator>Skinner G.</dc:creator><prism:publicationName>BMJ Case Reports</prism:publicationName><prism:eIssn>1757790X</prism:eIssn><prism:volume>2015</prism:volume><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.1136/bcr-2015-210338</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007904</affiliation-url><afid>60007904</afid><affilname>National Health Service</affilname><name-variant>NHS Trust</name-variant><affiliation-city/><affiliation-country>United Kingdom</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>no</subtype><subtypeDescription>Note</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56392580400</author-url><authid>56392580400</authid><authname>Skinner G.</authname><surname>Skinner</surname><given-name>Gregory James</given-name><initials>G.J.</initials><afid>60007904</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:12239718100</author-url><authid>12239718100</authid><authname>Shebani S.</authname><surname>Shebani</surname><given-name>Suhair Omar</given-name><initials>S.O.</initials><afid>60007904</afid></author><intid>1785982166</intid><article-number>210338</article-number><source-id>19700201654</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929438696"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929438696?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929438696&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929438696&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929438696</prism:url><dc:identifier>SCOPUS_ID:84929438696</dc:identifier><eid>2-s2.0-84929438696</eid><dc:title>An Investigation of the Molecular Mechanism of Double cMyBP-C Mutation in a Patient with End-Stage Hypertrophic Cardiomyopathy</dc:title><dc:creator>Gajendrarao P.</dc:creator><prism:publicationName>Journal of Cardiovascular Translational Research</prism:publicationName><prism:issn>19375387</prism:issn><prism:eIssn>19375395</prism:eIssn><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.1007/s12265-015-9624-6</prism:doi><dc:description>© 2015 Springer Science+Business Media New York Mutations in the gene coding for cardiac myosin binding protein-C (cMyBP-C), a multi-domain (C0-C10) protein, are a major causative factor for inherited hypertrophic cardiomyopathy. Patients carrying mutations in this gene have an extremely heterogeneous clinical course, with some progressing to end-stage heart failure. The cause of this variability is unknown. We here describe molecular modeling of a double mutation in domains C1 (E258K) and C2 (E441K) in a patient with severe HCM phenotype. The three-dimensional structure for the C1-motif-C2 complex was constructed with double and single mutations being introduced. Molecular dynamic simulations were performed for 10 ns under physiological conditions. The results showed that both E258K and E441K in isolation can predominantly affect the native domain as well as the nearby motif via conformational changes and result in an additive effect when they coexist. These changes involve important regions of the motif such as phosphorylation and potential actin-binding sites. Moreover, the charge reversal mutations altered the surface electrostatic properties of the complex. In addition, we studied protein expression, which showed that the mutant proteins were expressed and we can suppose that the severe phenotype was not due to haploinsufficiency. However, additional studies on human gene expression will need to confirm this hypothesis. The double mutation affecting the regulatory N-terminal of cMyBP-C have the potential of synergistically interfering with the binding to neighbouring domains and other sarcomeric proteins. These effects may account for the severe phenotype and clinical course observed in the complex cMyBP-C genotypes.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:106614032</affiliation-url><afid>106614032</afid><affilname>Qatar Foundation</affilname><name-variant>Qatar Foundation</name-variant><affiliation-city>Doha</affiliation-city><affiliation-country>Qatar</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021921</affiliation-url><afid>60021921</afid><affilname>Azienda Ospedaliera Careggi</affilname><name-variant>Azienda Ospedaliera Careggi</name-variant><affiliation-city>Florence</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021921</affiliation-url><afid>60021921</afid><affilname>Azienda Ospedaliera Careggi</affilname><name-variant>Azienda Ospedaliera Careggi</name-variant><affiliation-city>Florence</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010719</affiliation-url><afid>60010719</afid><affilname>National Heart and Lung Institute</affilname><name-variant>National Heart and Lung Institute</name-variant><affiliation-city>London</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ip</subtype><subtypeDescription>Article in Press</subtypeDescription><author-count limit="100">11</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:26221351300</author-url><authid>26221351300</authid><authname>Gajendrarao P.</authname><surname>Gajendrarao</surname><given-name>Poornima</given-name><initials>P.</initials><afid>106614032</afid><afid>60010719</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:26221351300</author-url><authid>26221351300</authid><authname>Gajendrarao P.</authname><surname>Gajendrarao</surname><given-name>Poornima</given-name><initials>P.</initials><afid>106614032</afid><afid>60010719</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:26221218600</author-url><authid>26221218600</authid><authname>Krishnamoorthy N.</authname><surname>Krishnamoorthy</surname><given-name>Navaneethakrishnan</given-name><initials>N.</initials><afid>106614032</afid><afid>60010719</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:26221218600</author-url><authid>26221218600</authid><authname>Krishnamoorthy N.</authname><surname>Krishnamoorthy</surname><given-name>Navaneethakrishnan</given-name><initials>N.</initials><afid>106614032</afid><afid>60010719</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56646018300</author-url><authid>56646018300</authid><authname>Selvaraj S.</authname><surname>Selvaraj</surname><given-name>Senthil</given-name><initials>S.</initials><afid>106614032</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6602447243</author-url><authid>6602447243</authid><authname>Girolami F.</authname><surname>Girolami</surname><given-name>Francesca</given-name><initials>F.</initials><afid>60021921</afid><afid>60021921</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6602447243</author-url><authid>6602447243</authid><authname>Girolami F.</authname><surname>Girolami</surname><given-name>Francesca</given-name><initials>F.</initials><afid>60021921</afid><afid>60021921</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55074508200</author-url><authid>55074508200</authid><authname>Cecchi F.</authname><surname>Cecchi</surname><given-name>Franco</given-name><initials>F.</initials><afid>60021921</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7005289080</author-url><authid>7005289080</authid><authname>Olivotto I.</authname><surname>Olivotto</surname><given-name>Iacopo</given-name><initials>I.</initials><afid>60021921</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:36041927900</author-url><authid>36041927900</authid><authname>Yacoub M.</authname><surname>Yacoub</surname><given-name>Magdi</given-name><initials>M.</initials><afid>106614032</afid><afid>60010719</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:36041927900</author-url><authid>36041927900</authid><authname>Yacoub M.</authname><surname>Yacoub</surname><given-name>Magdi</given-name><initials>M.</initials><afid>106614032</afid><afid>60010719</afid></author><authkeywords>Cardiac myosin binding protein-C | Double mutation | Hypertrophic cardiomyopathy | Molecular dynamics simulation | Protein expression | Structure–function relationship</authkeywords><intid>2035949228</intid><source-id>14500154702</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929991241"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929991241?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929991241&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929991241&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929991241</prism:url><dc:identifier>SCOPUS_ID:84929991241</dc:identifier><eid>2-s2.0-84929991241</eid><dc:title>Well-described concertina effect during coronary angioplasty</dc:title><dc:creator>Edem E.</dc:creator><prism:publicationName>BMJ Case Reports</prism:publicationName><prism:eIssn>1757790X</prism:eIssn><prism:volume>2015</prism:volume><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.1136/bcr-2015-209895</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021494</affiliation-url><afid>60021494</afid><affilname>Sakarya Universitesi</affilname><name-variant>Sakarya University</name-variant><affiliation-city>Sakarya</affiliation-city><affiliation-country>Turkey</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60086184</affiliation-url><afid>60086184</afid><affilname>T. C. Saglik Bakanligi, Mersin Devlet Hastanesi</affilname><name-variant>Mersin State Hospital</name-variant><affiliation-city>Mersin</affiliation-city><affiliation-country>Turkey</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113825980</affiliation-url><afid>113825980</afid><affilname>Tinaztepe Hospital</affilname><name-variant>Tinaztepe Hospital</name-variant><affiliation-city>Izmir</affiliation-city><affiliation-country>Turkey</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>no</subtype><subtypeDescription>Note</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56658732100</author-url><authid>56658732100</authid><authname>Edem E.</authname><surname>Edem</surname><given-name>Efe</given-name><initials>E.</initials><afid>60021494</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56658740000</author-url><authid>56658740000</authid><authname>Pabuccu M.</authname><surname>Pabuccu</surname><given-name>Mustafa Türker</given-name><initials>M.T.</initials><afid>60021494</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56658417500</author-url><authid>56658417500</authid><authname>Tekin I.</authname><surname>Tekin</surname><given-name>Işik</given-name><initials>I.</initials><afid>60086184</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56465073500</author-url><authid>56465073500</authid><authname>Kirdök A.</authname><surname>Kirdök</surname><given-name>Ali Hikmet</given-name><initials>A.H.</initials><afid>113825980</afid></author><intid>536050763</intid><article-number>209895</article-number><source-id>19700201654</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929353126"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929353126?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929353126&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929353126&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929353126</prism:url><dc:identifier>SCOPUS_ID:84929353126</dc:identifier><eid>2-s2.0-84929353126</eid><dc:title>A Draft map of rhesus monkey tissue proteome for biomedical research</dc:title><dc:creator>Lee J.</dc:creator><prism:publicationName>PLoS ONE</prism:publicationName><prism:eIssn>19326203</prism:eIssn><prism:volume>10</prism:volume><prism:issueIdentifier>5</prism:issueIdentifier><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.1371/journal.pone.0126243</prism:doi><dc:description>© 2015 Lee et al. Though the rhesus monkey is one of the most valuable non-human primate animal models for various human diseases because of its manageable size and genetic and proteomic similarities with humans, proteomic research using rhesus monkeys still remains challenging due to the lack of a complete protein sequence database and effective strategy. To investigate the most effective and high-throughput proteomic strategy, comparative data analysis was performed employing various protein databases and search engines. The UniProt databases of monkey, human, bovine, rat and mouse were used for the comparative analysis and also a universal database with all protein sequences from all available species was tested. At the same time, de novo sequencing was compared to the SEQUEST search algorithm to identify an optimal work flow for monkey proteomics. Employing the most effective strategy, proteomic profiling of monkey organs identified 3,481 proteins at 0.5% FDR from 9 male and 10 female tissues in an automated, high-throughput manner. Data are available via ProteomeXchange with identifier PXD001972. Based on the success of this alternative interpretation of MS data, the list of proteins identified from 12 organs of male and female subjects will benefit future rhesus monkey proteome research.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017501</affiliation-url><afid>60017501</afid><affilname>Carolinas HealthCare System</affilname><name-variant>Carolinas HealthCare System</name-variant><affiliation-city>Charlotte</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015057</affiliation-url><afid>60015057</afid><affilname>Eastern Virginia Medical School</affilname><name-variant>Eastern Virginia Medical School</name-variant><affiliation-city>Norfolk</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030071</affiliation-url><afid>60030071</afid><affilname>Tulane National Primate Research Center</affilname><name-variant>Tulane National Primate Research Center</name-variant><affiliation-city>Covington</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000209</affiliation-url><afid>60000209</afid><affilname>University of Connecticut Health Center</affilname><name-variant>Univ. of Connecticut Health Center</name-variant><affiliation-city>Farmington</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56425922800</author-url><authid>56425922800</authid><authname>Lee J.</authname><surname>Lee</surname><given-name>Jin Gyun</given-name><initials>J.G.</initials><afid>60017501</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:37067647900</author-url><authid>37067647900</authid><authname>McKinney K.</authname><surname>McKinney</surname><given-name>Kimberly Q.</given-name><initials>K.Q.</initials><afid>60017501</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56643322200</author-url><authid>56643322200</authid><authname>Lee Y.</authname><surname>Lee</surname><given-name>Yong Yook</given-name><initials>Y.Y.</initials><afid>60017501</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56643629300</author-url><authid>56643629300</authid><authname>Chung H.</authname><surname>Chung</surname><given-name>Hae Na</given-name><initials>H.N.</initials><afid>60017501</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56645000300</author-url><authid>56645000300</authid><authname>Pavlopoulos A.</authname><surname>Pavlopoulos</surname><given-name>Antonis J.</given-name><initials>A.J.</initials><afid>60017501</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56643722600</author-url><authid>56643722600</authid><authname>Jung K.</authname><surname>Jung</surname><given-name>Kook Y.</given-name><initials>K.Y.</initials><afid>60017501</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56643477600</author-url><authid>56643477600</authid><authname>Kim W.</authname><surname>Kim</surname><given-name>Woong Ki</given-name><initials>W.K.</initials><afid>60015057</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56643981700</author-url><authid>56643981700</authid><authname>Kuroda M.</authname><surname>Kuroda</surname><given-name>Marcelo J.</given-name><initials>M.J.</initials><afid>60030071</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56643627000</author-url><authid>56643627000</authid><authname>Han D.</authname><surname>Han</surname><given-name>David K.</given-name><initials>D.K.</initials><afid>60000209</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:36162251500</author-url><authid>36162251500</authid><authname>Hwang S.</authname><surname>Hwang</surname><given-name>Sunil</given-name><initials>S.</initials><afid>60017501</afid></author><intid>1785945049</intid><article-number>e0126243</article-number><source-id>10600153309</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930009247"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930009247?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930009247&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930009247&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930009247</prism:url><dc:identifier>SCOPUS_ID:84930009247</dc:identifier><eid>2-s2.0-84930009247</eid><dc:title>A device to narrow the coronary sinus for angina</dc:title><dc:creator>Auer J.</dc:creator><prism:publicationName>The New England journal of medicine</prism:publicationName><prism:eIssn>15334406</prism:eIssn><prism:volume>372</prism:volume><prism:issueIdentifier>20</prism:issueIdentifier><prism:pageRange>1967</prism:pageRange><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.1056/NEJMc1503672#SA4</prism:doi><citedby-count>0</citedby-count><pubmed-id>25970062</pubmed-id><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56658349200</author-url><authid>56658349200</authid><authname>Auer J.</authname><surname>Auer</surname><given-name>Johann</given-name><initials>J.</initials></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7006334796</author-url><authid>7006334796</authid><authname>Berent R.</authname><surname>Berent</surname><given-name>Robert</given-name><initials>R.</initials></author><intid>1786050817</intid><source-id>15847</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929993357"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929993357?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929993357&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929993357&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929993357</prism:url><dc:identifier>SCOPUS_ID:84929993357</dc:identifier><eid>2-s2.0-84929993357</eid><dc:title>A device to narrow the coronary sinus for angina</dc:title><dc:creator>Cordeiro M.</dc:creator><prism:publicationName>The New England journal of medicine</prism:publicationName><prism:eIssn>15334406</prism:eIssn><prism:volume>372</prism:volume><prism:issueIdentifier>20</prism:issueIdentifier><prism:pageRange>1966-1967</prism:pageRange><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.1056/NEJMc1503672#SA3</prism:doi><citedby-count>0</citedby-count><pubmed-id>25970061</pubmed-id><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">1</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56644184800</author-url><authid>56644184800</authid><authname>Cordeiro M.</authname><surname>Cordeiro</surname><given-name>Marco A S</given-name><initials>M.A.S.</initials></author><intid>536050308</intid><source-id>15847</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930007089"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930007089?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930007089&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930007089&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0028479315302112"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930007089</prism:url><dc:identifier>SCOPUS_ID:84930007089</dc:identifier><eid>2-s2.0-84930007089</eid><dc:title>A device to narrow the coronary sinus for angina</dc:title><dc:creator>Pizarro G.</dc:creator><prism:publicationName>The New England journal of medicine</prism:publicationName><prism:eIssn>15334406</prism:eIssn><prism:volume>372</prism:volume><prism:issueIdentifier>20</prism:issueIdentifier><prism:pageRange>1965-1966</prism:pageRange><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.1056/NEJMc1503672#SA1</prism:doi><citedby-count>0</citedby-count><pubmed-id>25970059</pubmed-id><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:34880524600</author-url><authid>34880524600</authid><authname>Pizarro G.</authname><surname>Pizarro</surname><given-name>Gonzalo</given-name><initials>G.</initials></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6701705050</author-url><authid>6701705050</authid><authname>Sánchez-Quintana D.</authname><surname>Sánchez-Quintana</surname><given-name>Damián</given-name><initials>D.</initials></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7202882405</author-url><authid>7202882405</authid><authname>Cabrera J.</authname><surname>Cabrera</surname><given-name>José A.</given-name><initials>J.A.</initials></author><intid>1786050921</intid><source-id>15847</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930000077"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930000077?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930000077&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930000077&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930000077</prism:url><dc:identifier>SCOPUS_ID:84930000077</dc:identifier><eid>2-s2.0-84930000077</eid><dc:title>A device to narrow the coronary sinus for angina</dc:title><dc:creator>Ormerod J.</dc:creator><prism:publicationName>The New England journal of medicine</prism:publicationName><prism:eIssn>15334406</prism:eIssn><prism:volume>372</prism:volume><prism:issueIdentifier>20</prism:issueIdentifier><prism:pageRange>1966</prism:pageRange><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.1056/NEJMc1503672#SA2</prism:doi><citedby-count>0</citedby-count><pubmed-id>25970060</pubmed-id><prism:aggregationType>Journal</prism:aggregationType><subtype>le</subtype><subtypeDescription>Letter</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56644426900</author-url><authid>56644426900</authid><authname>Ormerod J.</authname><surname>Ormerod</surname><given-name>Julian O M</given-name><initials>J.O.M.</initials></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55640209300</author-url><authid>55640209300</authid><authname>Gamble J.</authname><surname>Gamble</surname><given-name>James H P</given-name><initials>J.H.P.</initials></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56658386200</author-url><authid>56658386200</authid><authname>Betts T.</authname><surname>Betts</surname><given-name>Timothy R.</given-name><initials>T.R.</initials></author><intid>36048549</intid><source-id>15847</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929587329"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929587329?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929587329&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929587329&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929587329</prism:url><dc:identifier>SCOPUS_ID:84929587329</dc:identifier><eid>2-s2.0-84929587329</eid><dc:title>Broadening the scope of thoracic oncological intervention:A novel minimally invasive method for the diagnosis of primary cardiac lymphoma</dc:title><dc:creator>Sayal K.</dc:creator><prism:publicationName>BMJ Case Reports</prism:publicationName><prism:eIssn>1757790X</prism:eIssn><prism:volume>2015</prism:volume><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.1136/bcr-2014-208632</prism:doi><dc:description>Copyright 2015 BMJ Publishing Group. All rights reserved. Primary cardiac lymphoma is a rare and aggressive form of non-Hodgkin's lymphoma. It presents with nonspecific symptoms which depend on the degree of cardiac infiltration. Appropriate management and early initiation of therapy depends on an understanding of the imaging characteristics and early histological diagnosis. Obtaining histology can be challenging. This is more widely performed using endomyocardial biopsy. However, this technique is associated with recognised morbidity and mortality. We present a novel diagnostic method for the investigation of myocardial and pericardial lesions. This is the first documented case of the diagnosis of primary cardiac lymphoma using endobronchial ultrasound. Endobronchial ultrasound has a welldocumented and excellent safety profile.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015137</affiliation-url><afid>60015137</afid><affilname>Papworth Hospital NHS Foundation Trust</affilname><name-variant>Papworth Hospital NHS Foundation Trust</name-variant><affiliation-city>Cambridge</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015137</affiliation-url><afid>60015137</afid><affilname>Papworth Hospital NHS Foundation Trust</affilname><name-variant>Papworth Hospital NHS Foundation Trust</name-variant><affiliation-city>Cambridge</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029204</affiliation-url><afid>60029204</afid><affilname>NHS Foundation Trust</affilname><name-variant>NHS Foundation Trust</name-variant><affiliation-city>Leeds</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56650823100</author-url><authid>56650823100</authid><authname>Sayal K.</authname><surname>Sayal</surname><given-name>Karen</given-name><initials>K.</initials><afid>60015137</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56650659500</author-url><authid>56650659500</authid><authname>Ali T.</authname><surname>Ali</surname><given-name>Tariq</given-name><initials>T.</initials><afid>60015137</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56650777300</author-url><authid>56650777300</authid><authname>Tasker A.</authname><surname>Tasker</surname><given-name>Angela</given-name><initials>A.</initials><afid>60015137</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7102819334</author-url><authid>7102819334</authid><authname>Carroll N.</authname><surname>Carroll</surname><given-name>Nicholas</given-name><initials>N.</initials><afid>60029204</afid></author><intid>1535982045</intid><article-number>208632</article-number><source-id>19700201654</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929688953"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929688953?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929688953&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929688953&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929688953</prism:url><dc:identifier>SCOPUS_ID:84929688953</dc:identifier><eid>2-s2.0-84929688953</eid><dc:title>The Prognostic Value of High-Sensitive Troponin I in Stable Coronary Artery Disease Depends on Age and Other Clinical Variables</dc:title><dc:creator>Carda R.</dc:creator><prism:publicationName>Cardiology (Switzerland)</prism:publicationName><prism:issn>00086312</prism:issn><prism:eIssn>14219751</prism:eIssn><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.1159/000381259</prism:doi><pii>000381259</pii><dc:description>Copyright © 2015, S. Karger AG. All rights reserved. Objectives: To study the prognostic value of high-sensitive troponin (hs-cTn) I in stable coronary artery disease. Methods: In total, we studied 705 patients. Secondary outcomes were the incidence of: (1) acute ischemic events and (2) heart failure or death. The primary outcome was the composite of them. Results: Patients with hs-cTnI &gt;0 ng/ml (62.1%) were older, had a lower estimated glomerular filtration rate, more frequent a history of hypertension, atrial fibrillation, ejection fraction &lt;40%, and therapy with angiotensin-converting enzyme inhibitors, diuretics and acenocumarol. The follow-up period was 2.2 ± 0.99 years. Fifty-three patients suffered an acute ischemic event, 33 died or suffered heart failure and 78 developed the primary outcome. By univariate Cox's regression analysis, hs-cTnI &gt;0 was associated with a higher risk of developing the primary outcome [relative risk = 2.360 (1.359-4.099); p = 0.001] and heart failure or death [relative risk = 5.932 (1.806-19.482); p &lt; 0.001], but not with acute ischemic events. Statistical significance was lost after controlling for age. By logistic regression analysis, age [relative risk = 1.026 (1.009-1.044); p = 0.003], ejection fraction &lt;40% [relative risk = 4.099 (2.043-8.224); p &lt; 0.001], use of anticoagulants [relative risk = 2.785 (1.049-7.395); p = 0.040] and therapy with angiotensin-converting enzyme inhibitors [relative risk = 1.471 (1.064-2.034); p = 0.020], and estimated glomerular filtration rate [relative risk = 0.988 (0.977-0.999); p = 0.027] were associated with hs-cTnI &gt;0. Conclusions: In stable coronary disease, hs-cTnI is associated with the incidence of heart failure or death, but this relationship depends on other variables. © 2015 S. Karger AG, Basel</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021046</affiliation-url><afid>60021046</afid><affilname>Hospital de Fuenlabrada</affilname><name-variant>Hospital de Fuenlabrada</name-variant><affiliation-city>Madrid</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ip</subtype><subtypeDescription>Article in Press</subtypeDescription><author-count limit="100">15</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:19337270800</author-url><authid>19337270800</authid><authname>Carda R.</authname><surname>Carda</surname><given-name>Rocío</given-name><initials>R.</initials><afid>60021046</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56144825500</author-url><authid>56144825500</authid><authname>Aceña Á.</authname><surname>Aceña</surname><given-name>Álvaro</given-name><initials>Á.</initials></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:12238887800</author-url><authid>12238887800</authid><authname>Pello A.</authname><surname>Pello</surname><given-name>Ana</given-name><initials>A.</initials></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6602105954</author-url><authid>6602105954</authid><authname>Cristóbal C.</authname><surname>Cristóbal</surname><given-name>Carmen</given-name><initials>C.</initials></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:16025612000</author-url><authid>16025612000</authid><authname>Tarín N.</authname><surname>Tarín</surname><given-name>Nieves</given-name><initials>N.</initials></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6603633413</author-url><authid>6603633413</authid><authname>Huelmos A.</authname><surname>Huelmos</surname><given-name>Ana</given-name><initials>A.</initials></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7403482132</author-url><authid>7403482132</authid><authname>Alonso J.</authname><surname>Alonso</surname><given-name>Joaquín</given-name><initials>J.</initials></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56006624300</author-url><authid>56006624300</authid><authname>Asensio D.</authname><surname>Asensio</surname><given-name>Dolores</given-name><initials>D.</initials></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:54379474900</author-url><authid>54379474900</authid><authname>Lorenzo Ó.</authname><surname>Lorenzo</surname><given-name>Óscar</given-name><initials>Ó.</initials></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:6603416582</author-url><authid>6603416582</authid><authname>Martín-Ventura J.</authname><surname>Martín-Ventura</surname><given-name>José Luis</given-name><initials>J.L.</initials></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:6602113538</author-url><authid>6602113538</authid><authname>Blanco-Colio L.</authname><surname>Blanco-Colio</surname><given-name>Luis</given-name><initials>L.</initials></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:35466999500</author-url><authid>35466999500</authid><authname>Farré J.</authname><surname>Farré</surname><given-name>Jerónimo</given-name><initials>J.</initials></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:7006198162</author-url><authid>7006198162</authid><authname>López Bescós L.</authname><surname>López Bescós</surname><given-name>Lorenzo</given-name><initials>L.</initials></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:56653119500</author-url><authid>56653119500</authid><authname>Egido J.</authname><surname>Egido</surname><given-name>Jesús</given-name><initials>J.</initials></author><author seq="15"><author-url>http://api.elsevier.com/content/author/author_id:8388289700</author-url><authid>8388289700</authid><authname>Tuñón J.</authname><surname>Tuñón</surname><given-name>José</given-name><initials>J.</initials></author><intid>35996264</intid><source-id>22522</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929448296"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929448296?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929448296&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929448296&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929448296</prism:url><dc:identifier>SCOPUS_ID:84929448296</dc:identifier><eid>2-s2.0-84929448296</eid><dc:title>The role of clock genes and circadian rhythm in the development of cardiovascular diseases</dc:title><dc:creator>Takeda N.</dc:creator><prism:publicationName>Cellular and Molecular Life Sciences</prism:publicationName><prism:issn>1420682X</prism:issn><prism:eIssn>14209071</prism:eIssn><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.1007/s00018-015-1923-1</prism:doi><dc:description>© 2015 Springer Basel The time of onset of cardiovascular disorders such as myocardial infarctions or ventricular arrhythmias exhibits a circadian rhythm. Diurnal variations in autonomic nervous activity, plasma cortisol level or renin–angiotensin activity underlie the pathogenesis of cardiovascular diseases. Transcriptional–translational feedback loop of the clock genes constitute a molecular clock system. In addition to the central clock in the suprachiasmatic nucleus, clock genes are also expressed in a circadian fashion in each organ to make up the peripheral clock. The peripheral clock seems to be beneficial for anticipating external stimuli and thus contributes to the maintenance of organ homeostasis. Loss of synchronization between the central and peripheral clocks also augments disease progression. Moreover, accumulating evidence shows that clock genes affect inflammatory and intracellular metabolic signaling. Elucidating the roles of the molecular clock in cardiovascular pathology through the identification of clock controlled genes will help to establish a novel therapeutic approach for cardiovascular disorders.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002354</affiliation-url><afid>60002354</afid><affilname>University of Tokyo Faculty of Medicine</affilname><name-variant>University of Tokyo</name-variant><affiliation-city>Tokyo</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011846</affiliation-url><afid>60011846</afid><affilname>Nagasaki University</affilname><name-variant>Nagasaki University Graduate School of Biomedical Sciences</name-variant><affiliation-city>Nagasaki</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ip</subtype><subtypeDescription>Article in Press</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7402088414</author-url><authid>7402088414</authid><authname>Takeda N.</authname><surname>Takeda</surname><given-name>Norihiko</given-name><initials>N.</initials><afid>60002354</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56600097300</author-url><authid>56600097300</authid><authname>Maemura K.</authname><surname>Maemura</surname><given-name>Koji</given-name><initials>K.</initials><afid>60011846</afid></author><authkeywords>Arrhythmia | Biological clock | Endothelial function | Heart | Molecular clock | Myocardial infarction | Vasculature</authkeywords><intid>2035950775</intid><source-id>13903</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929330382"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929330382?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929330382&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929330382&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929330382</prism:url><dc:identifier>SCOPUS_ID:84929330382</dc:identifier><eid>2-s2.0-84929330382</eid><dc:title>Phase 1/2 study of carfilzomib plus melphalan and prednisone in patients aged over 65 years with newly diagnosed multiple myeloma</dc:title><dc:creator>Moreau P.</dc:creator><prism:publicationName>Blood</prism:publicationName><prism:issn>00064971</prism:issn><prism:eIssn>15280020</prism:eIssn><prism:volume>125</prism:volume><prism:issueIdentifier>20</prism:issueIdentifier><prism:pageRange>3100-3104</prism:pageRange><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.1182/blood-2015-02-626168</prism:doi><dc:description>© 2015 by The American Society of Hematology. This phase 1/2 dose-escalation study investigated the combination of carfilzomib with melphalan and prednisone (CMP) in patients aged &gt;65 years with newly diagnosed multiple myeloma (MM). Melphalan and prednisone were administered orally on days 1 to 4; carfilzomib was IV administered on days 1, 2, 8, 9, 22, 23, 29, and 30 of a 42-day cycle. Patients received up to 9 cycles of CMP. In the phase 1 dose-escalation portion, the primary objectives were to determine the incidence of dose-limiting toxicities during the first cycle of CMP treatment to define the maximal tolerated dose (MTD) of carfilzomib. In the phase 2 portion, the primary objective was to evaluate the overall response rate (ORR) of CMP. In the phase 1 portion of the study, 24 patients received CMP at carfilzomib dosing levels of 20 mg/m&lt;sup&gt;2&lt;/sup&gt;, 27 mg/m&lt;sup&gt;2&lt;/sup&gt;, 36 mg/m&lt;sup&gt;2&lt;/sup&gt;, and 45 mg/m&lt;sup&gt;2&lt;/sup&gt;. The MTD was established as 36 mg/m&lt;sup&gt;2&lt;/sup&gt;. In the phase 2 portion of the study, 44 patients were enrolled at the MTD. Among 50 efficacy-evaluable patients treated at the MTD, the ORR was 90%. The projected 3-year overall survival rate was 80%. The combination of CMP was observed to be effective in elderly patients with newly diagnosed MM. This trial was registered at www.clinicaltrials.gov as #NCT01279694 (Eudract identifier 2010-019462-92).</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025861</affiliation-url><afid>60025861</afid><affilname>Hotel Dieu CHU de Nantes</affilname><name-variant>CHU Hôtel Dieu</name-variant><affiliation-city>Nantes</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020540</affiliation-url><afid>60020540</afid><affilname>CHU de Reims</affilname><name-variant>CHU de Reims</name-variant><affiliation-city>Reims</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024960</affiliation-url><afid>60024960</afid><affilname>CHU de Toulouse</affilname><name-variant>CHU de Toulouse</name-variant><affiliation-city>Toulouse</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030713</affiliation-url><afid>60030713</afid><affilname>Centre Hospitalier Universitaire de Dijon</affilname><name-variant>CHU</name-variant><affiliation-city>Dijon</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016638</affiliation-url><afid>60016638</afid><affilname>Centre Hospitalier Regional et Universitaire de Tours</affilname><name-variant>CHU</name-variant><affiliation-city>Tours</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:108498555</affiliation-url><afid>108498555</afid><affilname>University Hospital</affilname><name-variant>University Hospital</name-variant><affiliation-city>La Roche-sur-Yon</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017724</affiliation-url><afid>60017724</afid><affilname>Centre Hospitalier Regional Universitaire de Lille</affilname><name-variant>CHU</name-variant><affiliation-city>Lille</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:108498555</affiliation-url><afid>108498555</afid><affilname>University Hospital</affilname><name-variant>University Hospital</name-variant><affiliation-city>La Roche-sur-Yon</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002900</affiliation-url><afid>60002900</afid><affilname>Hopital Saint-Louis</affilname><name-variant>Hôpital Saint-Louis</name-variant><affiliation-city>Paris</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020606</affiliation-url><afid>60020606</afid><affilname>CHU de Nancy</affilname><name-variant>CHU</name-variant><affiliation-city>Nancy</affiliation-city><affiliation-country>France</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">17</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56022988500</author-url><authid>56022988500</authid><authname>Moreau P.</authname><surname>Moreau</surname><given-name>Philippe</given-name><initials>P.</initials><afid>60025861</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:19640372300</author-url><authid>19640372300</authid><authname>Kolb B.</authname><surname>Kolb</surname><given-name>Brigitte</given-name><initials>B.</initials><afid>60020540</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:26643054300</author-url><authid>26643054300</authid><authname>Attal M.</authname><surname>Attal</surname><given-name>Michel</given-name><initials>M.</initials><afid>60024960</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55763259800</author-url><authid>55763259800</authid><authname>Caillot D.</authname><surname>Caillot</surname><given-name>Denis</given-name><initials>D.</initials><afid>60030713</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6603955133</author-url><authid>6603955133</authid><authname>Benboubker L.</authname><surname>Benboubker</surname><given-name>Lotfi</given-name><initials>L.</initials><afid>60016638</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6701827817</author-url><authid>6701827817</authid><authname>Tiab M.</authname><surname>Tiab</surname><given-name>Mourad</given-name><initials>M.</initials><afid>108498555</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:23010838500</author-url><authid>23010838500</authid><authname>Touzeau C.</authname><surname>Touzeau</surname><given-name>Cyrille</given-name><initials>C.</initials><afid>60025861</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:6701748692</author-url><authid>6701748692</authid><authname>Leleu X.</authname><surname>Leleu</surname><given-name>Xavier</given-name><initials>X.</initials><afid>60017724</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:25422947300</author-url><authid>25422947300</authid><authname>Roussel M.</authname><surname>Roussel</surname><given-name>Murielle</given-name><initials>M.</initials><afid>60024960</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:6506393740</author-url><authid>6506393740</authid><authname>Chaleteix C.</authname><surname>Chaleteix</surname><given-name>Carine</given-name><initials>C.</initials><afid>108498555</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:35176343600</author-url><authid>35176343600</authid><authname>Planche L.</authname><surname>Planche</surname><given-name>Lucie</given-name><initials>L.</initials><afid>60025861</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:56038182700</author-url><authid>56038182700</authid><authname>Chiffoleau A.</authname><surname>Chiffoleau</surname><given-name>Anne</given-name><initials>A.</initials><afid>60025861</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:56644189700</author-url><authid>56644189700</authid><authname>Fortin J.</authname><surname>Fortin</surname><given-name>June</given-name><initials>J.</initials><afid>60025861</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:35468172900</author-url><authid>35468172900</authid><authname>Avet-Loiseau H.</authname><surname>Avet-Loiseau</surname><given-name>Hervé</given-name><initials>H.</initials><afid>60024960</afid></author><author seq="15"><author-url>http://api.elsevier.com/content/author/author_id:7006064936</author-url><authid>7006064936</authid><authname>Mary J.</authname><surname>Mary</surname><given-name>Jean Yves</given-name><initials>J.Y.</initials><afid>60002900</afid></author><author seq="16"><author-url>http://api.elsevier.com/content/author/author_id:7003576160</author-url><authid>7003576160</authid><authname>Hulin C.</authname><surname>Hulin</surname><given-name>Cyrille</given-name><initials>C.</initials><afid>60020606</afid></author><author seq="17"><author-url>http://api.elsevier.com/content/author/author_id:35407501900</author-url><authid>35407501900</authid><authname>Facon T.</authname><surname>Facon</surname><given-name>Thierry</given-name><initials>T.</initials><afid>60017724</afid></author><intid>1035941651</intid><source-id>25454</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929000885"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929000885?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929000885&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929000885&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929000885</prism:url><dc:identifier>SCOPUS_ID:84929000885</dc:identifier><eid>2-s2.0-84929000885</eid><dc:title>Bacterial contamination of suction catheter tips during aortic valve replacement surgery: A prospective observational cohort study</dc:title><dc:creator>Larsson J.</dc:creator><prism:publicationName>Patient Safety in Surgery</prism:publicationName><prism:eIssn>17549493</prism:eIssn><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>May 14, 2015</prism:coverDisplayDate><prism:doi>10.1186/s13037-015-0066-5</prism:doi><dc:description>© 2015 Larsson et al.; licensee BioMed Central. Background: Bacterial mediastinitis is a severe complication after open heart surgery. The infection causes prolonged hospitalization and an increased mortality risk. Observations from orthopaedic surgery showed that the suction catheter used during surgery is commonly contaminated with bacteria. The aim of this study was to describe the prevalence of suction catheter contamination in cardiac surgery and to study if suction time influences the contamination risk. Methods: Fifty suction catheter tips were collected during 25 aortic valve replacement operations. The suction tip was exchanged once during the operation (after aortotomy closure). The tips were subjected to bacterial contamination analysis. Results: In 20 of the 25 investigated cases (80%), bacterial contamination was detected on one or both tips. The tip used during the beginning of the operation showed bacterial contamination in 13/25 cases (52%) and the second tip in 12/25 (48%). In 5/25 cases (20%) both tips were contaminated. There was no association between bacterial contamination and suction time. Coagulase-negative staphylococcus was the most commonly detected microorganism. Conclusions: The suction device should be considered as a potential source of bacterial contamination in cardiac surgery. The results suggest that the suction catheter should be replaced before key moments like valve implantation and sternal closure.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027675</affiliation-url><afid>60027675</afid><affilname>Sahlgrenska Academy</affilname><name-variant>Göteborg University</name-variant><affiliation-city>Gothenburg</affiliation-city><affiliation-country>Sweden</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031699</affiliation-url><afid>60031699</afid><affilname>Sahlgrenska Universitetssjukhuset</affilname><name-variant>Sahlgrenska University Hospital</name-variant><affiliation-city>Molndal</affiliation-city><affiliation-country>Sweden</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031699</affiliation-url><afid>60031699</afid><affilname>Sahlgrenska Universitetssjukhuset</affilname><name-variant>Sahlgrenska University Hospital</name-variant><affiliation-city>Molndal</affiliation-city><affiliation-country>Sweden</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027675</affiliation-url><afid>60027675</afid><affilname>Sahlgrenska Academy</affilname><name-variant>Göteborg University</name-variant><affiliation-city>Gothenburg</affiliation-city><affiliation-country>Sweden</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ip</subtype><subtypeDescription>Article in Press</subtypeDescription><author-count limit="100">11</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56625580500</author-url><authid>56625580500</authid><authname>Larsson J.</authname><surname>Larsson</surname><given-name>Johanna</given-name><initials>J.</initials><afid>60027675</afid><afid>60031699</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56625580500</author-url><authid>56625580500</authid><authname>Larsson J.</authname><surname>Larsson</surname><given-name>Johanna</given-name><initials>J.</initials><afid>60027675</afid><afid>60031699</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56625614800</author-url><authid>56625614800</authid><authname>Sutherland S.</authname><surname>Sutherland</surname><given-name>Sofia</given-name><initials>S.</initials><afid>60027675</afid><afid>60031699</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56625614800</author-url><authid>56625614800</authid><authname>Sutherland S.</authname><surname>Sutherland</surname><given-name>Sofia</given-name><initials>S.</initials><afid>60027675</afid><afid>60031699</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56625864400</author-url><authid>56625864400</authid><authname>Söderström Å.</authname><surname>Söderström</surname><given-name>Åsa</given-name><initials>Å.</initials><afid>60031699</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55632887900</author-url><authid>55632887900</authid><authname>Roman-Emanuel C.</authname><surname>Roman-Emanuel</surname><given-name>Christine</given-name><initials>C.</initials><afid>60031699</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7005509590</author-url><authid>7005509590</authid><authname>Jeppsson A.</authname><surname>Jeppsson</surname><given-name>Anders</given-name><initials>A.</initials><afid>60031699</afid><afid>60027675</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7005509590</author-url><authid>7005509590</authid><authname>Jeppsson A.</authname><surname>Jeppsson</surname><given-name>Anders</given-name><initials>A.</initials><afid>60031699</afid><afid>60027675</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56625837400</author-url><authid>56625837400</authid><authname>Olofsson E.</authname><surname>Olofsson</surname><given-name>Elisabeth Hansson</given-name><initials>E.H.</initials><afid>60027675</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7103121381</author-url><authid>7103121381</authid><authname>Svensson P.</authname><surname>Svensson</surname><given-name>Per Arne</given-name><initials>P.A.</initials><afid>60027675</afid><afid>60027675</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7103121381</author-url><authid>7103121381</authid><authname>Svensson P.</authname><surname>Svensson</surname><given-name>Per Arne</given-name><initials>P.A.</initials><afid>60027675</afid><afid>60027675</afid></author><authkeywords>Bacterial contamination | Suction catheter tip | Thoracic surgery</authkeywords><intid>35883535</intid><source-id>19700182810</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929429521"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929429521?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929429521&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929429521&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929429521</prism:url><dc:identifier>SCOPUS_ID:84929429521</dc:identifier><eid>2-s2.0-84929429521</eid><dc:title>Assessment of heavy metals and metalloids in tissues of two frog species: Rana tigrina and Euphlyctis cyanophlyctis from industrial city Sialkot, Pakistan</dc:title><dc:creator>Qureshi I.</dc:creator><prism:publicationName>Environmental Science and Pollution Research</prism:publicationName><prism:issn>09441344</prism:issn><prism:eIssn>16147499</prism:eIssn><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.1007/s11356-015-4454-2</prism:doi><dc:description>© 2015 Springer-Verlag Berlin Heidelberg In the present study, we investigated the concentrations of Ni, Fe, Pb, Cu, Co, Zn, Cd, Mn, and Cr in selected body tissues (liver, stomach, kidney, heart, lungs, and skeletal muscles) of two frog species: Rana tigrina and Euphlyctis cyanophlyctis captured from industrial wastewater of Sialkot city known worldwide for its tanning industry. The both frog species had darker appearance, distinctively different wet body weight, and snout-vent length. The results revealed that the heavy metal concentrations were high in the samples collected from industrial sites as compared to non-industrial sites. The different tissues of R. tigrina and E. cyanophlyctis exhibited little significant differences from two sites. The concentrations of heavy metals were more in tissues of R. tigrina as compared to E. cyanophlyctis. Mean concentration of Cd, Fe, Ni, Mn, Cu, and Cr was comparatively greater in R. tigrina, whereas Pb and Co were higher in E. cyanophlyctis. The concentration of Cu and Cd in the liver and kidney were relatively more in both species as compared to other organs. Further, the results indicated that frogs collected from industrial sites showed decreased body length and weight, and greater metal accumulation. The results will help the authorities for the conservation of these frog species which are under the influence of heavy metal contamination.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60064058</affiliation-url><afid>60064058</afid><affilname>Quaid-i-Azam University</affilname><name-variant>Quaid-i-Azam University</name-variant><affiliation-city>Islamabad</affiliation-city><affiliation-country>Pakistan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003970</affiliation-url><afid>60003970</afid><affilname>Zhejiang University</affilname><name-variant>Zhejiang University</name-variant><affiliation-city>Hangzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60064058</affiliation-url><afid>60064058</afid><affilname>Quaid-i-Azam University</affilname><name-variant>Quaid-i-Azam University</name-variant><affiliation-city>Islamabad</affiliation-city><affiliation-country>Pakistan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60034410</affiliation-url><afid>60034410</afid><affilname>Bahauddin Zakariya University</affilname><name-variant>Bahauddin Zakariya University</name-variant><affiliation-city>Multan</affiliation-city><affiliation-country>Pakistan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60034410</affiliation-url><afid>60034410</afid><affilname>Bahauddin Zakariya University</affilname><name-variant>Bahauddin Zakariya University</name-variant><affiliation-city>Multan</affiliation-city><affiliation-country>Pakistan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ip</subtype><subtypeDescription>Article in Press</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:12139303300</author-url><authid>12139303300</authid><authname>Qureshi I.</authname><surname>Qureshi</surname><given-name>Irfan Zia</given-name><initials>I.Z.</initials><afid>60064058</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56646430600</author-url><authid>56646430600</authid><authname>Kashif Z.</authname><surname>Kashif</surname><given-name>Zeshan</given-name><initials>Z.</initials><afid>60064058</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55511807800</author-url><authid>55511807800</authid><authname>Hashmi M.</authname><surname>Hashmi</surname><given-name>Muhammad Zaffar</given-name><initials>M.Z.</initials><afid>60003970</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56645475800</author-url><authid>56645475800</authid><authname>Su X.</authname><surname>Su</surname><given-name>Xiaomei</given-name><initials>X.</initials><afid>60064058</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:8635303900</author-url><authid>8635303900</authid><authname>Malik R.</authname><surname>Malik</surname><given-name>Riffat Naseem</given-name><initials>R.N.</initials><afid>60034410</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56589663100</author-url><authid>56589663100</authid><authname>Ullah K.</authname><surname>Ullah</surname><given-name>Kalim</given-name><initials>K.</initials><afid>60003970</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56215546200</author-url><authid>56215546200</authid><authname>Hu J.</authname><surname>Hu</surname><given-name>Jinxing</given-name><initials>J.</initials><afid>60034410</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:55951534600</author-url><authid>55951534600</authid><authname>Dawood M.</authname><surname>Dawood</surname><given-name>Muhammad</given-name><initials>M.</initials><afid>60034410</afid></author><authkeywords>Euphlyctis cyanophlyctis | Heavy metals toxicity | Industrial pollution | Rana tigrina | Sialkot</authkeywords><intid>2035950674</intid><source-id>23918</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929302002"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929302002?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929302002&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929302002&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929302002</prism:url><dc:identifier>SCOPUS_ID:84929302002</dc:identifier><eid>2-s2.0-84929302002</eid><dc:title>Perfringolysin o: The underrated clostridium perfringens toxin?</dc:title><dc:creator>Verherstraeten S.</dc:creator><prism:publicationName>Toxins</prism:publicationName><prism:eIssn>20726651</prism:eIssn><prism:volume>7</prism:volume><prism:issueIdentifier>5</prism:issueIdentifier><prism:pageRange>1702-1721</prism:pageRange><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.3390/toxins7051702</prism:doi><dc:description>© 2015 by the authors; licensee MDPI, Basel, Switzerland. The anaerobic bacterium Clostridium perfringens expresses multiple toxins that promote disease development in both humans and animals. One such toxin is perfringolysin O (PFO, classically referred to as θ toxin), a pore-forming cholesterol-dependent cytolysin (CDC). PFO is secreted as a water-soluble monomer that recognizes and binds membranes via cholesterol. Membrane-bound monomers undergo structural changes that culminate in the formation of an oligomerized prepore complex on the membrane surface. The prepore then undergoes conversion into the bilayer-spanning pore measuring approximately 250–300 Å in diameter. PFO is expressed in nearly all identified C. perfringens strains and harbors interesting traits that suggest a potential undefined role for PFO in disease development. Research has demonstrated a role for PFO in gas gangrene progression and bovine necrohemorrhagic enteritis, but there is limited data available to determine if PFO also functions in additional disease presentations caused by C. perfringens. This review summarizes the known structural and functional characteristics of PFO, while highlighting recent insights into the potential contributions of PFO to disease pathogenesis.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60033316</affiliation-url><afid>60033316</afid><affilname>Universiteit Gent</affilname><name-variant>Ghent University</name-variant><affiliation-city>Ghent</affiliation-city><affiliation-country>Belgium</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60033316</affiliation-url><afid>60033316</afid><affilname>Universiteit Gent</affilname><name-variant>Ghent University</name-variant><affiliation-city>Ghent</affiliation-city><affiliation-country>Belgium</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029833</affiliation-url><afid>60029833</afid><affilname>University of Oklahoma Health Sciences Center</affilname><name-variant>Univ. of Oklahoma Hlth. Sci. Center</name-variant><affiliation-city>Oklahoma City</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">11</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55620070900</author-url><authid>55620070900</authid><authname>Verherstraeten S.</authname><surname>Verherstraeten</surname><given-name>Stefanie</given-name><initials>S.</initials><afid>60033316</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55766251500</author-url><authid>55766251500</authid><authname>Goossens E.</authname><surname>Goossens</surname><given-name>Evy</given-name><initials>E.</initials><afid>60033316</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:54279622200</author-url><authid>54279622200</authid><authname>Valgaeren B.</authname><surname>Valgaeren</surname><given-name>Bonnie</given-name><initials>B.</initials><afid>60033316</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:26321150700</author-url><authid>26321150700</authid><authname>Pardon B.</authname><surname>Pardon</surname><given-name>Bart</given-name><initials>B.</initials><afid>60033316</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:8904584600</author-url><authid>8904584600</authid><authname>Timbermont L.</authname><surname>Timbermont</surname><given-name>Leen</given-name><initials>L.</initials><afid>60033316</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7101763889</author-url><authid>7101763889</authid><authname>Haesebrouck F.</authname><surname>Haesebrouck</surname><given-name>Freddy</given-name><initials>F.</initials><afid>60033316</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:17433840300</author-url><authid>17433840300</authid><authname>Ducatelle R.</authname><surname>Ducatelle</surname><given-name>Richard</given-name><initials>R.</initials><afid>60033316</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7101612249</author-url><authid>7101612249</authid><authname>Deprez P.</authname><surname>Deprez</surname><given-name>Piet</given-name><initials>P.</initials><afid>60033316</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56121635100</author-url><authid>56121635100</authid><authname>Wade K.</authname><surname>Wade</surname><given-name>Kristin R.</given-name><initials>K.R.</initials><afid>60029833</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56664773200</author-url><authid>56664773200</authid><authname>Tweten R.</authname><surname>Tweten</surname><given-name>Rodney</given-name><initials>R.</initials><afid>60029833</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:24759181700</author-url><authid>24759181700</authid><authname>Immerseel F.</authname><surname>Immerseel</surname><given-name>Filip Van</given-name><initials>F.V.</initials><afid>60033316</afid></author><authkeywords>Calves | Cholesterol-dependent cytolysin | Enterotoxaemia | Gas gangrene | Myonecrosis | Necrohemorrhagic enteritis</authkeywords><intid>35944586</intid><source-id>19700188352</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929430548"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929430548?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929430548&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929430548&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929430548</prism:url><dc:identifier>SCOPUS_ID:84929430548</dc:identifier><eid>2-s2.0-84929430548</eid><dc:title>Magnitude and determinants of change in objectively-measured physical activity, sedentary time and sleep duration from ages 15 to 17.5y in UK adolescents: The ROOTS study</dc:title><dc:creator>Collings P.</dc:creator><prism:publicationName>International Journal of Behavioral Nutrition and Physical Activity</prism:publicationName><prism:eIssn>14795868</prism:eIssn><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>May 14, 2015</prism:coverDisplayDate><prism:doi>10.1186/s12966-015-0222-4</prism:doi><dc:description>© 2015 Collings et al.; licensee BioMed Central. Background: Self-reported physical activity (PA) and sleep duration (SLP) change markedly throughout adolescence. We sought to quantify changes in objectively-measured PA, sedentary time (ST) and SLP through adolescence, and to investigate baseline body composition and baseline activity levels as determinants of change. Methods: Individually calibrated combined heart rate and movement sensing was used to estimate PA energy expenditure (PAEE), SLP, daily ST and time in light (LPA), moderate (MPA), vigorous (VPA), and moderate-to-vigorous physical activity (MVPA) in 144 adolescents (50 % boys) of mean age 15.1(±0.3)y at baseline and 17.5(±0.3)y at follow-up. Changes in PA ({increment}PA), ST ({increment}ST) and SLP ({increment}SLP) were calculated as follow-up minus baseline values. Waist circumference (WC) was measured at baseline and follow-up, as was fat mass index (FMI) and fat-free mass index (FFMI) by a pooled estimation method including bio-impedance. Comparison of baseline and follow-up activity was made by mixed-model ANOVA. Linear regression adjusted for baseline demographics, total and weekend hours of monitor wear time and the seasons of activity measurements, was used to investigate baseline body composition as determinants of {increment}PA, {increment}ST and {increment}SLP. A further model adjusted for baseline of the outcome assessed baseline activity as a predictor of behaviour change, and investigated associations for baseline body composition independent of the baseline level of the outcome. Results: From baseline to follow-up levels of MPA and VPA declined (p ≤ 0.039). The annual decline in MVPA was equivalent to -4.5 and -3.0 min/d in boys and girls, respectively. Baseline FMI, FFMI and WC were positively associated with {increment}LPA and negatively associated with {increment}ST in boys when adjusted for baseline of the outcome (p ≤ 0.037 for all). SLP increased from baseline to follow-up (p = 0.004) but {increment}SLP was not associated with baseline body composition (p ≥ 0.13). For all variables, higher baseline levels were associated with greater declines over time (p ≤ 0.003). Conclusions: Levels of higher-intensity PA decline from mid-to-late adolescence, whereas the duration of sleep increases. Changes in LPA and ST may be associated with baseline body composition, but the baseline level of the outcome is consistently the strongest predictor of changes in adolescent activity.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031101</affiliation-url><afid>60031101</afid><affilname>University of Cambridge</affilname><name-variant>University of Cambridge</name-variant><affiliation-city>Cambridge</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031101</affiliation-url><afid>60031101</afid><affilname>University of Cambridge</affilname><name-variant>University of Cambridge</name-variant><affiliation-city>Cambridge</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004030</affiliation-url><afid>60004030</afid><affilname>Norges idrettshogskole</affilname><name-variant>Norwegian School of Sport Sciences</name-variant><affiliation-city>Oslo</affiliation-city><affiliation-country>Norway</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ip</subtype><subtypeDescription>Article in Press</subtypeDescription><author-count limit="100">11</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55969492300</author-url><authid>55969492300</authid><authname>Collings P.</authname><surname>Collings</surname><given-name>Paul J.</given-name><initials>P.J.</initials><afid>60031101</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:8614240700</author-url><authid>8614240700</authid><authname>Wijndaele K.</authname><surname>Wijndaele</surname><given-name>Katrien</given-name><initials>K.</initials><afid>60031101</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:23026950100</author-url><authid>23026950100</authid><authname>Corder K.</authname><surname>Corder</surname><given-name>Kirsten</given-name><initials>K.</initials><afid>60031101</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:37089662600</author-url><authid>37089662600</authid><authname>Westgate K.</authname><surname>Westgate</surname><given-name>Kate</given-name><initials>K.</initials><afid>60031101</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:26868005700</author-url><authid>26868005700</authid><authname>Ridgway C.</authname><surname>Ridgway</surname><given-name>Charlotte L.</given-name><initials>C.L.</initials><afid>60031101</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:24367076500</author-url><authid>24367076500</authid><authname>Sharp S.</authname><surname>Sharp</surname><given-name>Stephen J.</given-name><initials>S.J.</initials><afid>60031101</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7003749366</author-url><authid>7003749366</authid><authname>Dunn V.</authname><surname>Dunn</surname><given-name>Valerie</given-name><initials>V.</initials><afid>60031101</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7005728308</author-url><authid>7005728308</authid><authname>Goodyer I.</authname><surname>Goodyer</surname><given-name>Ian</given-name><initials>I.</initials><afid>60031101</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7004141339</author-url><authid>7004141339</authid><authname>Ekelund U.</authname><surname>Ekelund</surname><given-name>Ulf</given-name><initials>U.</initials><afid>60031101</afid><afid>60004030</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7004141339</author-url><authid>7004141339</authid><authname>Ekelund U.</authname><surname>Ekelund</surname><given-name>Ulf</given-name><initials>U.</initials><afid>60031101</afid><afid>60004030</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7003968294</author-url><authid>7003968294</authid><authname>Brage S.</authname><surname>Brage</surname><given-name>Soren</given-name><initials>S.</initials><afid>60031101</afid></author><authkeywords>Adolescents | Energy Expenditure | Motor activity | Physical activity intensity | Reverse causation | Sedentary time | Sleep duration</authkeywords><intid>535957495</intid><source-id>14875</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929401711"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929401711?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929401711&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929401711&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929401711</prism:url><dc:identifier>SCOPUS_ID:84929401711</dc:identifier><eid>2-s2.0-84929401711</eid><dc:title>Mechanotransduction Mechanisms for Intraventricular Diastolic Vortex Forces and Myocardial Deformations: Part 2</dc:title><dc:creator>Pasipoularides A.</dc:creator><prism:publicationName>Journal of Cardiovascular Translational Research</prism:publicationName><prism:issn>19375387</prism:issn><prism:eIssn>19375395</prism:eIssn><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.1007/s12265-015-9630-8</prism:doi><dc:description>© 2015 Springer Science+Business Media New York Epigenetic mechanisms are fundamental in cardiac adaptations, remodeling, reverse remodeling, and disease. A primary goal of translational cardiovascular research is recognizing whether disease-related changes in phenotype can be averted by eliminating or reducing the effects of environmental epigenetic risks. There may be significant medical benefits in using gene-by-environment interaction knowledge to prevent or reverse organ abnormalities and disease. This survey proposes that “environmental” forces associated with diastolic RV/LV rotatory flows exert important, albeit still unappreciated, epigenetic actions influencing functional and morphological cardiac adaptations. Mechanisms analogous to Murray’s law of hydrodynamic shear-induced endothelial cell modulation of vascular geometry are likely to link diastolic vortex-associated shear, torque and “squeeze” forces to RV/LV adaptations. The time has come to explore a new paradigm in which such forces play a fundamental epigenetic role, and to work out how heart cells react to them. Findings from various imaging modalities, computational fluid dynamics, molecular cell biology and cytomechanics are considered. The following are examined, among others: structural dynamics of myocardial cells (endocardium, cardiomyocytes, and fibroblasts), cytoskeleton, nucleoskeleton, and extracellular matrix; mechanotransduction and signaling; and mechanical epigenetic influences on genetic expression. To help integrate and focus relevant pluridisciplinary research, rotatory RV/LV filling flow is placed within a working context that has a cytomechanics perspective. This new frontier in cardiac research should uncover versatile mechanistic insights linking filling vortex patterns and attendant forces to variable expressions of gene regulation in RV/LV myocardium. In due course, it should reveal intrinsic homeostatic arrangements that support ventricular myocardial function and adaptability.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005200</affiliation-url><afid>60005200</afid><affilname>Duke University School of Medicine</affilname><name-variant>Duke University Medical Center</name-variant><affiliation-city>Durham</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114939999</affiliation-url><afid>114939999</afid><affilname>Duke/NSF Research Center for Emerging Cardiovascular Technologies</affilname><name-variant>Duke/NSF Research Center for Emerging Cardiovascular Technologies</name-variant><affiliation-city>Durham</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ip</subtype><subtypeDescription>Article in Press</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6701772840</author-url><authid>6701772840</authid><authname>Pasipoularides A.</authname><surname>Pasipoularides</surname><given-name>Ares</given-name><initials>A.</initials><afid>60005200</afid><afid>114939999</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6701772840</author-url><authid>6701772840</authid><authname>Pasipoularides A.</authname><surname>Pasipoularides</surname><given-name>Ares</given-name><initials>A.</initials><afid>60005200</afid><afid>114939999</afid></author><authkeywords>Cardiac cytomechanics | Cardiac gene regulation | Endocardial vortical shear and squeeze | Epigenetic factors | Filling vortex forces | Flow-imaging modalities | Intracardiac flow | Next Generation Sequencing (NGS) technologies</authkeywords><intid>535956316</intid><source-id>14500154702</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929441606"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929441606?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929441606&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929441606&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929441606</prism:url><dc:identifier>SCOPUS_ID:84929441606</dc:identifier><eid>2-s2.0-84929441606</eid><dc:title>Relationship between lumbar spinal stenosis and psychosocial factors: a multicenter cross-sectional study (DISTO project)</dc:title><dc:creator>Sekiguchi M.</dc:creator><prism:publicationName>European Spine Journal</prism:publicationName><prism:issn>09406719</prism:issn><prism:eIssn>14320932</prism:eIssn><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.1007/s00586-015-4002-2</prism:doi><dc:description>© 2015 The Author(s) Introduction: Lumbar spinal stenosis (LSS) is a lumbar spinal disorder that causes leg symptoms and intermittent claudication. It is reported that the risk factors for low back pain include age, family history, smoking, obesity, work-related physical load, exercise, and depression. This was a multicenter, cross-sectional survey, and the aim of this study was to investigate the prevalence of LSS by age and the relationships between LSS and psychosocial factors and job satisfaction. Methods: This study enrolled subjects aged 50 years and over from a survey of LSS in 2177 hospitals and general practices nationwide. The clinical characteristics of the LSS and non-LSS groups were compared using the χ&lt;sup&gt;2&lt;/sup&gt; test, and the multivariate logistic regression analysis was performed to examine associations between exercise, perceived stress, strenuous use of the low back or legs, job satisfaction, and LSS. Results: In total, 18,642 patients (8338 males, 10,267 females) were analyzed. The rate of LSS was 38.3 % and it increased with age. Regular exercise was less common among those in the LSS group than those in the non-LSS group (p &lt; 0.001). Satisfaction in all job-related items was less in the LSS group than in the non-LSS group (p &lt; 0.001). The odds for having LSS were higher in subjects having perceived stress and strenuous use of the low back or legs (p = 0.001). The odds ratios of heart diseases and hypertension (p &lt; 0.001) were higher in the LSS group. Conclusion: This study investigated factors associated with LSS. The prevalence of LSS increased with age. Perceived stress and strenuous use of the low back or legs might be associated with LSS, and job satisfaction was lower with LSS.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002948</affiliation-url><afid>60002948</afid><affilname>Fukushima Medical University</affilname><name-variant>Fukushima Medical College</name-variant><affiliation-city>Fukushima</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022116</affiliation-url><afid>60022116</afid><affilname>Kurume University</affilname><name-variant>Kurume University</name-variant><affiliation-city>Kurume</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ip</subtype><subtypeDescription>Article in Press</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7202624192</author-url><authid>7202624192</authid><authname>Sekiguchi M.</authname><surname>Sekiguchi</surname><given-name>Miho</given-name><initials>M.</initials><afid>60002948</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56526528200</author-url><authid>56526528200</authid><authname>Yonemoto K.</authname><surname>Yonemoto</surname><given-name>Koji</given-name><initials>K.</initials><afid>60022116</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7005355397</author-url><authid>7005355397</authid><authname>Kakuma T.</authname><surname>Kakuma</surname><given-name>Tatsuyuki</given-name><initials>T.</initials><afid>60022116</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:20235424700</author-url><authid>20235424700</authid><authname>Nikaido T.</authname><surname>Nikaido</surname><given-name>Takuya</given-name><initials>T.</initials><afid>60002948</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56172003700</author-url><authid>56172003700</authid><authname>Watanabe K.</authname><surname>Watanabe</surname><given-name>Kazuyuki</given-name><initials>K.</initials><afid>60002948</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:24448100800</author-url><authid>24448100800</authid><authname>Kato K.</authname><surname>Kato</surname><given-name>Kinshi</given-name><initials>K.</initials><afid>60002948</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7102620962</author-url><authid>7102620962</authid><authname>Otani K.</authname><surname>Otani</surname><given-name>Koji</given-name><initials>K.</initials><afid>60002948</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56646050500</author-url><authid>56646050500</authid><authname>Yabuki S.</authname><surname>Yabuki</surname><given-name>Shoji</given-name><initials>S.</initials><afid>60002948</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56479921200</author-url><authid>56479921200</authid><authname>Kikuchi S.</authname><surname>Kikuchi</surname><given-name>Shin ichi</given-name><initials>S.i.</initials><afid>60002948</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56519275700</author-url><authid>56519275700</authid><authname>Konno S.</authname><surname>Konno</surname><given-name>Shin ichi</given-name><initials>S.i.</initials><afid>60002948</afid></author><authkeywords>Job satisfaction | LSS diagnostic support tool | Lumbar spinal stenosis | Psychosocial factors</authkeywords><intid>1535955259</intid><source-id>21129</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929441284"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929441284?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929441284&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929441284&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929441284</prism:url><dc:identifier>SCOPUS_ID:84929441284</dc:identifier><eid>2-s2.0-84929441284</eid><dc:title>Assessment of absolute Tc-99m tetrofosmin retention in the myocardium as an index of myocardial blood flow and coronary flow reserve by gated-SPECT/CT: a feasibility study</dc:title><dc:creator>Apostolopoulos D.</dc:creator><prism:publicationName>Annals of Nuclear Medicine</prism:publicationName><prism:issn>09147187</prism:issn><prism:eIssn>18646433</prism:eIssn><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.1007/s12149-015-0982-6</prism:doi><dc:description>© 2015 The Japanese Society of Nuclear Medicine Objective: Estimation of myocardial blood flow (MBF) and coronary flow reserve (CFR) by SPECT myocardial perfusion imaging (MPI) remains challenging. Our aim was to approximate MBF and CFR by quantifying the absolute Tc-99m tetrofosmin retention in the myocardium via gated-SPECT/CT MPI. Methods: Tracer retention was calculated on the basis of the microsphere kinetic model and served as an index of MBF at stress and rest (sMBFi, rMBFi). CFR was given by the sMBFi/rMBFi ratio. A planar first-pass acquisition during dipyridamole stress and at rest provided the data for tracer input determination. The input was represented by the integral of a gamma variate fitted on the time-activity curve of the left ventricle. Gated-SPECT/CT was performed 1 h post tracer injection and myocardial activity was measured in attenuation-corrected transaxial slices by a threshold VOI. The input was also compensated for tissue attenuation by measuring the distance from the centre of the left ventricle to the body surface on fused SPECT/CT slices. Input and uptake results were adjusted for planar-SPECT counting geometry differences by the aid of a phantom experiment. Thirty-nine subjects with low probability of coronary artery disease (CAD), age lower than 75 years and normal MPI (control group) were compared with 57 patients with documented CAD (CAD group). Results: CFR and sMBFi values of CAD patients (1.39 ± 0.37 and 1.42 ± 0.35 ml/min/g) were considerably lower (p &lt; 0.0001) than controls (1.68 ± 0.25 and 1.72 ± 0.37 ml/min/g). Significant difference in CFR (p = 0.03) was also noted between CAD patients with normal MPI (1.48 ± 0.38) and controls. However, sMBFi managed to discriminate certain CAD subgroups (normal MPI/ischemia/scar/scar and ischemia) more efficiently than CFR. Maximum heart rate-blood pressure product (RPP) during stress was an independent predictor of sMBFi and CFR. The other independent CFR correlates were resting RPP and diabetes mellitus, while sMBFi was associated with age, sex, smoking, and stress perfusion defects. Conclusions: Despite the low myocardial extraction fraction of Tc-99m tetrofosmin, an approximation of MBF and CFR is feasible with gated-SPECT/CT MPI. These flow indices together were able to discriminate CAD patients from controls and stratify different patient subgroups.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024484</affiliation-url><afid>60024484</afid><affilname>University of Patras, School of Medicine</affilname><name-variant>University Hospital of Patras</name-variant><affiliation-city>Patra</affiliation-city><affiliation-country>Greece</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024484</affiliation-url><afid>60024484</afid><affilname>University of Patras, School of Medicine</affilname><name-variant>University Hospital of Patras</name-variant><affiliation-city>Patra</affiliation-city><affiliation-country>Greece</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ip</subtype><subtypeDescription>Article in Press</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:24068454400</author-url><authid>24068454400</authid><authname>Apostolopoulos D.</authname><surname>Apostolopoulos</surname><given-name>Dimitris J.</given-name><initials>D.J.</initials><afid>60024484</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56646485900</author-url><authid>56646485900</authid><authname>Kaspiri A.</authname><surname>Kaspiri</surname><given-name>Agaristi</given-name><initials>A.</initials><afid>60024484</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:54416396300</author-url><authid>54416396300</authid><authname>Spyridonidis T.</authname><surname>Spyridonidis</surname><given-name>Trifon</given-name><initials>T.</initials><afid>60024484</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6507515995</author-url><authid>6507515995</authid><authname>Patsouras N.</authname><surname>Patsouras</surname><given-name>Nikolaos</given-name><initials>N.</initials><afid>60024484</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:23095233900</author-url><authid>23095233900</authid><authname>Savvopoulos C.</authname><surname>Savvopoulos</surname><given-name>Christos A.</given-name><initials>C.A.</initials><afid>60024484</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56646156100</author-url><authid>56646156100</authid><authname>Davlouros P.</authname><surname>Davlouros</surname><given-name>Pericles</given-name><initials>P.</initials><afid>60024484</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7005228220</author-url><authid>7005228220</authid><authname>Vassilakos P.</authname><surname>Vassilakos</surname><given-name>P. J.</given-name><initials>P.J.</initials><afid>60024484</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7006042805</author-url><authid>7006042805</authid><authname>Alexopoulos D.</authname><surname>Alexopoulos</surname><given-name>Dimitrios</given-name><initials>D.</initials><afid>60024484</afid></author><authkeywords>Coronary flow reserve | Myocardial blood flow | SPECT/CT | Tetrofosmin</authkeywords><intid>35953887</intid><source-id>16558</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929493146"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929493146?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929493146&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929493146&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929493146</prism:url><dc:identifier>SCOPUS_ID:84929493146</dc:identifier><eid>2-s2.0-84929493146</eid><dc:title>Efficacy and safety of non-vitamin K antagonist oral anticoagulants versus vitamin K antagonist oral anticoagulants in patients undergoing radiofrequency catheter ablation of atrial fibrillation: A meta-analysis</dc:title><dc:creator>Santarpia G.</dc:creator><prism:publicationName>PLoS ONE</prism:publicationName><prism:eIssn>19326203</prism:eIssn><prism:volume>10</prism:volume><prism:issueIdentifier>5</prism:issueIdentifier><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.1371/journal.pone.0126512</prism:doi><dc:description>© 2015 Santarpia et al. Background: Use of the non-vitamin K antagonist oral anticoagulants (NOACs) is endorsed by current guidelines for stroke prevention in patients with atrial fibrillation (AF). However efficacy and safety of NOACs in patients undergoing catheter ablation (RFCA) of AF has not been well established yet. Objectives: To perform a meta-analysis of all studies comparing NOACs and vitamin K antagonist oral anticoagulants (VKAs) in patients undergoing RFCA. Data Sources: Studies were searched for in PubMed and Google Scholar databases. Study Eligibility Criteria: Studies were considered eligible if: they evaluated the clinical impact of NOACs versus VKAs; they specifically analyzed the use of anticoagulants during periprocedural phase of RFCA; they reported clinical outcome data. Study Appraisal and Synthesis Methods: 25 studies were selected, including 9881 cases. The summary measure used was the risk ratio (RR) with 95% confidence interval (CI). The random-effects or the fixed effect model were used to synthesize results from the selected studies. Results: There was no significant difference in thromboembolic complications (RR 1.39; p=0.13). Bleeding complications were significantly lower in the NOACs-treated arm as compared to VKAs (RR=0.67, p&lt;0.001). Interestingly, a larger number of thromboembolic events was found in the VKAs-treated arm in those studies where VKAs had been interrupted during the periprocedural phase (RR=0.68; p = ns). In this same subgroup a significantly higher incidence of both minor (RR=0.54; p=0.002) and major bleeding (RR=0.41; p=0.01) events was recorded. Conversely, the incidence of thromboembolic events in the VKAs-treated arm was significantly lower in those studies with uninterrupted periprocedural anticoagulation treatment (RR=1.89; p=0.02). Limitations: As with every meta-analysis, no patients-level data were available. Conclusions and Implications: The use of NOACs in patients undergoing RFCA is safe, given the lower incidence of bleedings observed with NOACs. On the other side, periprocedural interruption of VKAs and bridging with heparin is associated with a higher bleeding rate with no significant benefit on onset of thromboembolic events.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60069616</affiliation-url><afid>60069616</afid><affilname>Universita degli studi Magna Graecia di Catanzaro</affilname><name-variant>University of Catanzaro</name-variant><affiliation-city>Catanzaro</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021199</affiliation-url><afid>60021199</afid><affilname>Consiglio Nazionale delle Ricerche</affilname><name-variant>CNR</name-variant><affiliation-city>Rome</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6506887294</author-url><authid>6506887294</authid><authname>Santarpia G.</authname><surname>Santarpia</surname><given-name>Giuseppe</given-name><initials>G.</initials><afid>60069616</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35562776600</author-url><authid>35562776600</authid><authname>De Rosa S.</authname><surname>De Rosa</surname><given-name>Salvatore</given-name><initials>S.</initials><afid>60069616</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55331621200</author-url><authid>55331621200</authid><authname>Polimeni A.</authname><surname>Polimeni</surname><given-name>Alberto</given-name><initials>A.</initials><afid>60069616</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55805712300</author-url><authid>55805712300</authid><authname>Giampà S.</authname><surname>Giampà</surname><given-name>Salvatore</given-name><initials>S.</initials><afid>60069616</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55804947100</author-url><authid>55804947100</authid><authname>Micieli M.</authname><surname>Micieli</surname><given-name>Mariella</given-name><initials>M.</initials><afid>60069616</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6701742956</author-url><authid>6701742956</authid><authname>Curcio A.</authname><surname>Curcio</surname><given-name>Antonio</given-name><initials>A.</initials><afid>60069616</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7006678139</author-url><authid>7006678139</authid><authname>Indolfi C.</authname><surname>Indolfi</surname><given-name>Ciro</given-name><initials>C.</initials><afid>60069616</afid><afid>60021199</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7006678139</author-url><authid>7006678139</authid><authname>Indolfi C.</authname><surname>Indolfi</surname><given-name>Ciro</given-name><initials>C.</initials><afid>60069616</afid><afid>60021199</afid></author><intid>535965292</intid><article-number>e0126512</article-number><source-id>10600153309</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929448430"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929448430?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929448430&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929448430&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929448430</prism:url><dc:identifier>SCOPUS_ID:84929448430</dc:identifier><eid>2-s2.0-84929448430</eid><dc:title>Predictors of high-risk coronary artery disease in subjects with normal SPECT myocardial perfusion imaging</dc:title><dc:creator>Nakanishi R.</dc:creator><prism:publicationName>Journal of Nuclear Cardiology</prism:publicationName><prism:issn>10713581</prism:issn><prism:eIssn>15326551</prism:eIssn><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.1007/s12350-015-0150-3</prism:doi><dc:description>© 2015 American Society of Nuclear Cardiology Background: While uncommon, normal stress SPECT myocardial perfusion imaging (MPI) can be seen in patients with high-risk coronary artery disease (CAD) by invasive coronary angiography (ICA).The predictors of high-risk CAD in patients with normal SPECT-MPI have not been described. Methods: We studied 580 patients (age 64 ± 12 years, 49% men) without known CAD who underwent stress-gated SPECT-MPI [exercise (41%) or vasodilator (59%)] &lt;2 months before ICA and had summed stress score (SSS) &lt;4. High-risk CAD was defined as 3 vessels with ≥70% stenosis, 2 vessels with ≥70% stenosis including proximal left anterior descending, or left main with ≥50% stenosis. Obstructive non-high-risk CAD was defined by the presence of a ≥70% stenosis but without having other high-risk criteria. Tenfold cross-validated receiver operating characteristic (ROC) estimates were obtained to assess the predictors of high-risk CAD. Results: Forty-two subjects (7.2%) had high-risk CAD and 168 (29.0%) had obstructive non-high-risk CAD. Variables associated with high-risk CAD were pretest probability of CAD ≥66% (Odds ratio [OR] 3.63, 95% CI 1.6-8.3, P = .002), SSS &gt; 0 (OR 7.46, 95% CI 2.6-21.1, P &lt; 0.001), and abnormal TID (OR 2.16, 95% CI 1.0-4.5, P = 0.044). When substituted for TID, EF change was also predictive of high-risk CAD (OR 0.93, 95% CI 0.9-1.0, P = 0.023). The prevalence of high-risk CAD increased as the number of these predictors increased. In a sub-analysis of patients in whom quantitative total perfusion deficit (TPD) was available, TPD &gt; 0 was also a predictor of high-risk CAD (OR 6.01, 95% CI 1.5-22.2, P = 0.011). Conclusion: Several clinical, stress, and SPECT-MPI findings are associated high-risk CAD among patients with normal SPECT-MPI. Consideration of these factors may improve the overall assessment of the likelihood of high-risk CAD in patients undergoing stress SPECT-MPI.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016173</affiliation-url><afid>60016173</afid><affilname>Cedars-Sinai Medical Center</affilname><name-variant>Cedars-Sinai Medical Center</name-variant><affiliation-city>Los Angeles</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:109507977</affiliation-url><afid>109507977</afid><affilname>Sacred Heart Medical Center</affilname><name-variant>Sacred Heart Medical Center</name-variant><affiliation-city>Springfield</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021334</affiliation-url><afid>60021334</afid><affilname>University of Arizona College of Medicine</affilname><name-variant>Univ. of Arizona College of Medicine</name-variant><affiliation-city>Tucson</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000928</affiliation-url><afid>60000928</afid><affilname>Emory University</affilname><name-variant>Emory University</name-variant><affiliation-city>Atlanta</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026273</affiliation-url><afid>60026273</afid><affilname>St. Luke's-Roosevelt Hospital Center</affilname><name-variant>St. Luke's-Roosevelt Hospital Center</name-variant><affiliation-city>New York</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005247</affiliation-url><afid>60005247</afid><affilname>David Geffen School of Medicine at UCLA</affilname><name-variant>University of California</name-variant><affiliation-city>Los Angeles</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ip</subtype><subtypeDescription>Article in Press</subtypeDescription><author-count limit="100">16</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56646057200</author-url><authid>56646057200</authid><authname>Nakanishi R.</authname><surname>Nakanishi</surname><given-name>Rine</given-name><initials>R.</initials><afid>60016173</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:8527308300</author-url><authid>8527308300</authid><authname>Gransar H.</authname><surname>Gransar</surname><given-name>Heidi</given-name><initials>H.</initials><afid>60016173</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7003438436</author-url><authid>7003438436</authid><authname>Slomka P.</authname><surname>Slomka</surname><given-name>Piotr</given-name><initials>P.</initials><afid>60016173</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:36835294300</author-url><authid>36835294300</authid><authname>Arsanjani R.</authname><surname>Arsanjani</surname><given-name>Reza</given-name><initials>R.</initials><afid>60016173</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:24831380000</author-url><authid>24831380000</authid><authname>Shalev A.</authname><surname>Shalev</surname><given-name>Aryeh</given-name><initials>A.</initials><afid>60016173</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:43361672400</author-url><authid>43361672400</authid><authname>Otaki Y.</authname><surname>Otaki</surname><given-name>Yuka</given-name><initials>Y.</initials><afid>60016173</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7401866230</author-url><authid>7401866230</authid><authname>Friedman J.</authname><surname>Friedman</surname><given-name>John D.</given-name><initials>J.D.</initials><afid>60016173</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7202407561</author-url><authid>7202407561</authid><authname>Hayes S.</authname><surname>Hayes</surname><given-name>Sean W.</given-name><initials>S.W.</initials><afid>60016173</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56645980200</author-url><authid>56645980200</authid><authname>Thomson L.</authname><surname>Thomson</surname><given-name>Louise E B</given-name><initials>L.E.B.</initials><afid>60016173</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:14219086900</author-url><authid>14219086900</authid><authname>Fish M.</authname><surname>Fish</surname><given-name>Mathews</given-name><initials>M.</initials><afid>109507977</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:7102798632</author-url><authid>7102798632</authid><authname>Germano G.</authname><surname>Germano</surname><given-name>Guido</given-name><initials>G.</initials><afid>60016173</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:7004024557</author-url><authid>7004024557</authid><authname>Abidov A.</authname><surname>Abidov</surname><given-name>Aiden</given-name><initials>A.</initials><afid>60021334</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:7402573002</author-url><authid>7402573002</authid><authname>Shaw L.</authname><surname>Shaw</surname><given-name>Leslee</given-name><initials>L.</initials><afid>60000928</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:7005523102</author-url><authid>7005523102</authid><authname>Rozanski A.</authname><surname>Rozanski</surname><given-name>Alan</given-name><initials>A.</initials><afid>60026273</afid></author><author seq="15"><author-url>http://api.elsevier.com/content/author/author_id:35376162800</author-url><authid>35376162800</authid><authname>Berman D.</authname><surname>Berman</surname><given-name>Daniel S.</given-name><initials>D.S.</initials><afid>60016173</afid><afid>60005247</afid></author><author seq="15"><author-url>http://api.elsevier.com/content/author/author_id:35376162800</author-url><authid>35376162800</authid><authname>Berman D.</authname><surname>Berman</surname><given-name>Daniel S.</given-name><initials>D.S.</initials><afid>60016173</afid><afid>60005247</afid></author><authkeywords>High risk of coronary artery disease | Single-photon emission computed tomography myocardial perfusion imaging | SPECT-MPI</authkeywords><intid>1785956523</intid><source-id>17229</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929231854"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929231854?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929231854&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929231854&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929231854</prism:url><dc:identifier>SCOPUS_ID:84929231854</dc:identifier><eid>2-s2.0-84929231854</eid><dc:title>Unusual location of the Libman–Sacks endocarditis in a teenager: a case report</dc:title><dc:creator>Wałdoch A.</dc:creator><prism:publicationName>Cardiology in the Young</prism:publicationName><prism:issn>10479511</prism:issn><prism:eIssn>14671107</prism:eIssn><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.1017/S1047951115000712</prism:doi><pii>S1047951115000712</pii><dc:description>© Cambridge University Press 2015 Libman–Sacks endocarditis may be the first manifestation of systemic lupus erythematosus. The risk of its occurrence increases with the co-existence of the anti-phospholipid syndrome. Changes usually involve the mitral valve and the aortic valve. In this report, we present a case of Libman–Sacks endocarditis of the tricuspid valve in a teenage girl.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012383</affiliation-url><afid>60012383</afid><affilname>Akademia Medyczna w Gdansku</affilname><name-variant>Medical University of Gdańsk</name-variant><affiliation-city>Gdansk</affiliation-city><affiliation-country>Poland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012383</affiliation-url><afid>60012383</afid><affilname>Akademia Medyczna w Gdansku</affilname><name-variant>Medical University of Gdańsk</name-variant><affiliation-city>Gdansk</affiliation-city><affiliation-country>Poland</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ip</subtype><subtypeDescription>Article in Press</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35070640600</author-url><authid>35070640600</authid><authname>Wałdoch A.</authname><surname>Wałdoch</surname><given-name>Anna</given-name><initials>A.</initials><afid>60012383</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55940317100</author-url><authid>55940317100</authid><authname>Kwiatkowska J.</authname><surname>Kwiatkowska</surname><given-name>Joanna</given-name><initials>J.</initials><afid>60012383</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55788732700</author-url><authid>55788732700</authid><authname>Dorniak K.</authname><surname>Dorniak</surname><given-name>Karolina</given-name><initials>K.</initials><afid>60012383</afid></author><authkeywords>children | Libman–Sacks endocarditis | tricuspid valve</authkeywords><intid>1535924037</intid><source-id>22531</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929428677"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929428677?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929428677&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929428677&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929428677</prism:url><dc:identifier>SCOPUS_ID:84929428677</dc:identifier><eid>2-s2.0-84929428677</eid><dc:title>Infectious Myocarditis on FDG-PET Imaging Mimicking Sarcoidosis</dc:title><dc:creator>Sperry B.</dc:creator><prism:publicationName>Journal of Nuclear Cardiology</prism:publicationName><prism:issn>10713581</prism:issn><prism:eIssn>15326551</prism:eIssn><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.1007/s12350-015-0160-1</prism:doi><dc:description>© 2015 American Society of Nuclear Cardiology Cardiac positron emission tomography with fluorine-18 fluorodeoxyglucose (FDG-PET) is often used for the diagnosis of cardiac involvement in sarcoidosis. Areas of segmental perfusion defects coupled with FDG uptake are considered to represent active inflammation. However, these findings may be associated with other inflammatory myocardial diseases. We describe a case of tuberculous myocarditis with imaging findings mimicking those found in cardiac sarcoidosis.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021160</affiliation-url><afid>60021160</afid><affilname>Cleveland Clinic Foundation</affilname><name-variant>Cleveland Clinic Foundation</name-variant><affiliation-city>Cleveland</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021160</affiliation-url><afid>60021160</afid><affilname>Cleveland Clinic Foundation</affilname><name-variant>Cleveland Clinic Foundation</name-variant><affiliation-city>Cleveland</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021160</affiliation-url><afid>60021160</afid><affilname>Cleveland Clinic Foundation</affilname><name-variant>Cleveland Clinic Foundation</name-variant><affiliation-city>Cleveland</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ip</subtype><subtypeDescription>Article in Press</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55279425900</author-url><authid>55279425900</authid><authname>Sperry B.</authname><surname>Sperry</surname><given-name>Brett W.</given-name><initials>B.W.</initials><afid>60021160</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6505823987</author-url><authid>6505823987</authid><authname>Oldan J.</authname><surname>Oldan</surname><given-name>Jorge D.</given-name><initials>J.D.</initials><afid>60021160</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:16835308800</author-url><authid>16835308800</authid><authname>Hsich E.</authname><surname>Hsich</surname><given-name>Eileen M.</given-name><initials>E.M.</initials><afid>60021160</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56645550100</author-url><authid>56645550100</authid><authname>Reynolds J.</authname><surname>Reynolds</surname><given-name>Jordan P.</given-name><initials>J.P.</initials><afid>60021160</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56582692100</author-url><authid>56582692100</authid><authname>Tamarappoo B.</authname><surname>Tamarappoo</surname><given-name>Balaji K.</given-name><initials>B.K.</initials><afid>60021160</afid></author><authkeywords>Cardiomyopathy | fluorodeoxyglucose (FDG) | inflammation | metabolism: PET | PET imaging</authkeywords><intid>535957022</intid><source-id>17229</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929448984"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929448984?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929448984&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929448984&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929448984</prism:url><dc:identifier>SCOPUS_ID:84929448984</dc:identifier><eid>2-s2.0-84929448984</eid><dc:title>Association between muscular strength and inflammatory markers among elderly persons with cardiac disease: results from the KORA-Age study</dc:title><dc:creator>Volaklis K.</dc:creator><prism:publicationName>Clinical Research in Cardiology</prism:publicationName><prism:issn>18610684</prism:issn><prism:eIssn>18610692</prism:eIssn><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.1007/s00392-015-0867-7</prism:doi><dc:description>© 2015 Springer-Verlag Berlin Heidelberg Little is known about the association between muscle strength and inflammation in diseased individuals and particularly in cardiac patients. Thus, our purpose was to examine the association of muscular strength with the inflammatory status in older adults with and without cardiac disease. The cross-sectional analysis was based on 1079 adults aged 65–94 years, who participated in the KORA-Age study. Participants underwent an interview and extensive physical examinations including anthropometric measurements, registration of diseases and drug intake, determination of health-related behaviors, collection of blood samples for measurements of interleukin-6 and hs-CRP and muscle strength measurement using hand-grip dynamometry. Cardiac patients (n = 323) had higher levels of IL-6 and poorer muscle strength compared with older adults without cardiac disease. Among persons with cardiac diseases, muscle strength in the lower tertile compared to the upper tertile was significantly associated with increased odds of having elevated IL-6 levels (OR 3.53, 95 % CI 1.18–10.50, p = 0.024) after controlling for age, gender, body fat, alcohol intake, smoking status, diseases, medications and physical activity, whereas the association between muscle strength and hs-CRP remained borderline significant (OR 2.80, 95 % CI 0.85–9.24, p = 0.092). The same trends, with slightly lower odds ratios, were also observed in older adults without cardiac disease. Lower levels of muscular strength are associated with higher concentrations of IL-6 and hs-CRP in elderly individuals with and without cardiac disease suggesting a significant contribution of the muscular system in reducing low-grade inflammation that accompanies cardiac disease and aging.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019722</affiliation-url><afid>60019722</afid><affilname>Technische Universitat Munchen</affilname><name-variant>Technische Universität München</name-variant><affiliation-city>Munich</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>7FIT Cardiac Rehabilitation Center</affilname><affiliation-city>Augsburg</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113642928</affiliation-url><afid>113642928</afid><affilname>DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance</affilname><name-variant>DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance</name-variant><affiliation-city>Munich</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:101158679</affiliation-url><afid>101158679</afid><affilname>Else-Kröner-Fresenius-Zentrum</affilname><name-variant>Else Kröner-Fresenius-Zentrum für Ernährungsmedizin</name-variant><affiliation-city>Munich</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010586</affiliation-url><afid>60010586</afid><affilname>Universitat Ulm</affilname><name-variant>Universität Ulm</name-variant><affiliation-city>Ulm</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019722</affiliation-url><afid>60019722</afid><affilname>Technische Universitat Munchen</affilname><name-variant>Technische Universität München</name-variant><affiliation-city>Munich</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028717</affiliation-url><afid>60028717</afid><affilname>Ludwig-Maximilians-Universitat Munchen</affilname><name-variant>University of Munich</name-variant><affiliation-city>Munich</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024007</affiliation-url><afid>60024007</afid><affilname>Helmholtz Center Munich German Research Center for Environmental Health</affilname><affiliation-city>Neuherberg</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115245823</affiliation-url><afid>115245823</afid><affilname>Institute for Nutritional Sciences and Physiology</affilname><name-variant>Institute for Nutritional Sciences and Physiology</name-variant><affiliation-city/><affiliation-country>Austria</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024007</affiliation-url><afid>60024007</afid><affilname>Helmholtz Center Munich German Research Center for Environmental Health</affilname><affiliation-city>Neuherberg</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ip</subtype><subtypeDescription>Article in Press</subtypeDescription><author-count limit="100">16</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6507524785</author-url><authid>6507524785</authid><authname>Volaklis K.</authname><surname>Volaklis</surname><given-name>K. A.</given-name><initials>K.A.</initials><afid>60019722</afid><afid/></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6507524785</author-url><authid>6507524785</authid><authname>Volaklis K.</authname><surname>Volaklis</surname><given-name>K. A.</given-name><initials>K.A.</initials><afid>60019722</afid><afid/></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56462320400</author-url><authid>56462320400</authid><authname>Halle M.</authname><surname>Halle</surname><given-name>M.</given-name><initials>M.</initials><afid>60019722</afid><afid>113642928</afid><afid>101158679</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56462320400</author-url><authid>56462320400</authid><authname>Halle M.</authname><surname>Halle</surname><given-name>M.</given-name><initials>M.</initials><afid>60019722</afid><afid>113642928</afid><afid>101158679</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56462320400</author-url><authid>56462320400</authid><authname>Halle M.</authname><surname>Halle</surname><given-name>M.</given-name><initials>M.</initials><afid>60019722</afid><afid>113642928</afid><afid>101158679</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7202478539</author-url><authid>7202478539</authid><authname>Koenig W.</authname><surname>Koenig</surname><given-name>W.</given-name><initials>W.</initials><afid>60010586</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6701686659</author-url><authid>6701686659</authid><authname>Oberhoffer R.</authname><surname>Oberhoffer</surname><given-name>R.</given-name><initials>R.</initials><afid>60019722</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:8406649400</author-url><authid>8406649400</authid><authname>Grill E.</authname><surname>Grill</surname><given-name>E.</given-name><initials>E.</initials><afid>60028717</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56427452100</author-url><authid>56427452100</authid><authname>Peters A.</authname><surname>Peters</surname><given-name>A.</given-name><initials>A.</initials><afid>60024007</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56646164100</author-url><authid>56646164100</authid><authname>Strasser B.</authname><surname>Strasser</surname><given-name>B.</given-name><initials>B.</initials><afid>115245823</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:6701522355</author-url><authid>6701522355</authid><authname>Heier M.</authname><surname>Heier</surname><given-name>M.</given-name><initials>M.</initials><afid>60024007</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:6506853838</author-url><authid>6506853838</authid><authname>Emeny R.</authname><surname>Emeny</surname><given-name>R.</given-name><initials>R.</initials><afid>60024007</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:55648979600</author-url><authid>55648979600</authid><authname>Schulz H.</authname><surname>Schulz</surname><given-name>H.</given-name><initials>H.</initials><afid>60024007</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:7005806521</author-url><authid>7005806521</authid><authname>Ladwig K.</authname><surname>Ladwig</surname><given-name>K. H.</given-name><initials>K.H.</initials><afid>60024007</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:56415982900</author-url><authid>56415982900</authid><authname>Meisinger C.</authname><surname>Meisinger</surname><given-name>C.</given-name><initials>C.</initials><afid>60024007</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:6603102917</author-url><authid>6603102917</authid><authname>Thorand B.</authname><surname>Thorand</surname><given-name>B.</given-name><initials>B.</initials><afid>60024007</afid></author><authkeywords>Aging | Cardiac disease | Inflammation | Muscle strength</authkeywords><intid>1035951051</intid><source-id>3100147501</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929439044"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929439044?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929439044&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929439044&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929439044</prism:url><dc:identifier>SCOPUS_ID:84929439044</dc:identifier><eid>2-s2.0-84929439044</eid><dc:title>The serum CXCL13 level is associated with the Glasgow Prognostic Score in extranodal NK/T-cell lymphoma patients</dc:title><dc:creator>Kim S.</dc:creator><prism:publicationName>Journal of Hematology and Oncology</prism:publicationName><prism:eIssn>17568722</prism:eIssn><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>May 14, 2015</prism:coverDisplayDate><prism:doi>10.1186/s13045-015-0142-4</prism:doi><dc:description>© 2015 Kim et al. ; licensee BioMed Central. Background: The Glasgow Prognostic Score (GPS) measures inflammation and proves its prognostic value in patients with extranodal natural killer (NK)/T-cell lymphoma (ENKTL) which is commonly combined with inflammatory lesion. Given inflammatory chemokines play an important role in tumor progression, we hypothesized that chemokines might influence ENKTL aggressiveness through interaction with their receptors in the tumor tissue. Methods: We measured the serum levels of C-X-C motif ligand 13 (CXCL13) in 69 patients with ENKTL who received non-anthracycline-based chemotherapy and/or concurrent chemoradiotherapy because CXCL13 is thought to have a pro-tumor effect through interaction with its receptor, the C-X-C chemokine receptor 5 (CXCR5). We analyzed the association of serum CXCL13 with the GPS, and their prognostic relevance. The levels of CXCL13 were measured using a multiplex chemokine assay on archived frozen serum samples. Results: Patients were categorized into high and low CXCL13 groups if they had CXCL13 levels above or below the median value of 29.1 pg/mL, respectively. The high CXCL13 group and grouping by the GPS showed a significant association with poor progression-free survival. The elevated serum levels of CXCL13 were also significantly associated with a high score of the GPS. High CXCL13 levels and GPS were significantly associated with high tumor burden predicting poor prognosis including stages III/IV, extranasal presentation, bone marrow invasion, and presence of Epstein-Barr virus (EBV) DNA in blood. Furthermore, serum CXCL13 and GPS discriminated patients at risk of treatment failure among patients with low tumor burden (stage I/II) and non-detectable EBV DNA. Conclusions: Serum levels of CXCL13 were associated with the prognostic value of GPS. Grouping by the serum CXCL13 might predict survival outcomes in patients with ENKTL, suggesting that it is a potential therapeutic target.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016329</affiliation-url><afid>60016329</afid><affilname>SungKyunKwan University, School of Medicine</affilname><name-variant>Sungkyunkwan University School of Medicine</name-variant><affiliation-city>Suwon</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020857</affiliation-url><afid>60020857</afid><affilname>Samsung Medical Center, Sungkyunkwan University</affilname><name-variant>Samsung Medical Center</name-variant><affiliation-city>Seoul</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018986</affiliation-url><afid>60018986</afid><affilname>Hallym University</affilname><name-variant>Hallym University</name-variant><affiliation-city>Chuncheon</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016329</affiliation-url><afid>60016329</afid><affilname>SungKyunKwan University, School of Medicine</affilname><name-variant>Sungkyunkwan University School of Medicine</name-variant><affiliation-city>Suwon</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016329</affiliation-url><afid>60016329</afid><affilname>SungKyunKwan University, School of Medicine</affilname><name-variant>Sungkyunkwan University School of Medicine</name-variant><affiliation-city>Suwon</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ip</subtype><subtypeDescription>Article in Press</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:8702924000</author-url><authid>8702924000</authid><authname>Kim S.</authname><surname>Kim</surname><given-name>Seok Jin</given-name><initials>S.J.</initials><afid>60016329</afid><afid>60016329</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:8702924000</author-url><authid>8702924000</authid><authname>Kim S.</authname><surname>Kim</surname><given-name>Seok Jin</given-name><initials>S.J.</initials><afid>60016329</afid><afid>60016329</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:48663068000</author-url><authid>48663068000</authid><authname>Ryu K.</authname><surname>Ryu</surname><given-name>Kyung Ju</given-name><initials>K.J.</initials><afid>60020857</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56645556300</author-url><authid>56645556300</authid><authname>Hong M.</authname><surname>Hong</surname><given-name>Mineui</given-name><initials>M.</initials><afid>60018986</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:16646069600</author-url><authid>16646069600</authid><authname>Ko Y.</authname><surname>Ko</surname><given-name>Young Hyeh</given-name><initials>Y.H.</initials><afid>60016329</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:34975082200</author-url><authid>34975082200</authid><authname>Kim W.</authname><surname>Kim</surname><given-name>Won Seog</given-name><initials>W.S.</initials><afid>60016329</afid></author><authkeywords>Chemokine | CXCL13 | Extranodal NK/T-cell lymphoma | GPS | Inflammation</authkeywords><intid>2035949761</intid><source-id>17900156736</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929379729"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929379729?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929379729&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929379729&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929379729</prism:url><dc:identifier>SCOPUS_ID:84929379729</dc:identifier><eid>2-s2.0-84929379729</eid><dc:title>Prevalence of dyslipidaemia and associated risk factors in a rural population in South-Western Uganda: A community based survey</dc:title><dc:creator>Asiki G.</dc:creator><prism:publicationName>PLoS ONE</prism:publicationName><prism:eIssn>19326203</prism:eIssn><prism:volume>10</prism:volume><prism:issueIdentifier>5</prism:issueIdentifier><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.1371/journal.pone.0126166</prism:doi><dc:description>© 2015 Asiki et al. Background: The burden of dyslipidaemia is rising in many low income countries. However, there are few data on the prevalence of, or risk factors for, dyslipidaemia in Africa. Methods: In 2011, we used the WHO Stepwise approach to collect cardiovascular risk data within a general population cohort in rural south-western Uganda. Dyslipidaemia was defined by high total cholesterol (TC) ≥ 5.2mmol/L or low high density lipoprotein cholesterol (HDL-C) &lt;1 mmol/L in men, and &lt;1.3 mmol/L in women. Logistic regression was used to explore correlates of dyslipidaemia. Results: Low HDL-C prevalence was 71.3% and high TC was 6.0%. In multivariate analysis, factors independently associated with low HDL-C among both men and women were: decreasing age, tribe (prevalence highest among Rwandese tribe), lower education, alcohol consumption (comparing current drinkers to never drinkers: men adjusted (a)OR=0.44, 95%CI=0.35-0.55; women aOR=0.51, 95%CI=0.41-0.64), consuming &lt;5 servings of fruit/vegetable per day, daily vigorous physical activity (comparing those with none vs those with 5 days a week: men aOR=0.83 95%CI=0.67-1.02; women aOR=0.76, 95%CI=0.55-0.99), blood pressure (comparing those with hypertension to those with normal blood pressure: men aOR=0.57, 95%CI=0.43-0.75; women aOR=0.69, 95%CI=0.52-0.93) and HIV infection (HIV infected without ART vs. HIV negative: men aOR=2.45, 95%CI=1.53-3.94; women aOR=1.88, 95%CI=1.19-2.97). The odds of low HDL-C was also higher among men with high BMI or HbA1c ≤6%, and women who were single or with abdominal obesity. Among both men and women, high TC was independently associated with increasing age, non-Rwandese tribe, high waist circumference (men aOR=5.70, 95%CI=1.97-16.49; women aOR=1.58, 95%CI=1.10-2.28), hypertension (men aOR=3.49, 95%CI=1.74-7.00; women aOR=1.47, 95%CI=0.96-2.23) and HbA1c &gt;6% (men aOR=3.00, 95%CI=1.37-6.59; women aOR=2.74, 95%CI=1.77-4.27). The odds of high TC was also higher among married men, and women with higher education or high BMI. Conclusion: Low HDL-C prevalence in this relatively young rural population is high whereas high TC prevalence is low. The consequences of dyslipidaemia in African populations remain unclear and prospective follow-up is required.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60071671</affiliation-url><afid>60071671</afid><affilname>Uganda Virus Research Institute</affilname><name-variant>Uganda Virus Research Institute</name-variant><affiliation-city>Entebbe</affiliation-city><affiliation-country>Uganda</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008936</affiliation-url><afid>60008936</afid><affilname>Nuffield Department of Clinical Medicine</affilname><name-variant>University of Oxford</name-variant><affiliation-city>Oxford</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031331</affiliation-url><afid>60031331</afid><affilname>London School of Hygiene &amp; Tropical Medicine</affilname><name-variant>London School of Hygiene and Tropical Medicine</name-variant><affiliation-city>London</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031101</affiliation-url><afid>60031101</afid><affilname>University of Cambridge</affilname><name-variant>University of Cambridge</name-variant><affiliation-city>Cambridge</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005517</affiliation-url><afid>60005517</afid><affilname>Wellcome Trust Sanger Institute</affilname><name-variant>The Wellcome Trust Sanger Institute</name-variant><affiliation-city>Cambridge</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">14</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:12752430200</author-url><authid>12752430200</authid><authname>Asiki G.</authname><surname>Asiki</surname><given-name>Gershim</given-name><initials>G.</initials><afid>60071671</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7402791510</author-url><authid>7402791510</authid><authname>Murphy G.</authname><surname>Murphy</surname><given-name>Georgina A V</given-name><initials>G.A.V.</initials><afid>60008936</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6602372286</author-url><authid>6602372286</authid><authname>Baisley K.</authname><surname>Baisley</surname><given-name>Kathy</given-name><initials>K.</initials><afid>60031331</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:36806561500</author-url><authid>36806561500</authid><authname>Nsubuga R.</authname><surname>Nsubuga</surname><given-name>Rebecca N.</given-name><initials>R.N.</initials><afid>60071671</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:35743262800</author-url><authid>35743262800</authid><authname>Karabarinde A.</authname><surname>Karabarinde</surname><given-name>Alex</given-name><initials>A.</initials><afid>60071671</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55658055833</author-url><authid>55658055833</authid><authname>Newton R.</authname><surname>Newton</surname><given-name>Robert</given-name><initials>R.</initials><afid>60071671</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7005429371</author-url><authid>7005429371</authid><authname>Seeley J.</authname><surname>Seeley</surname><given-name>Janet</given-name><initials>J.</initials><afid>60071671</afid><afid>60031331</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7005429371</author-url><authid>7005429371</authid><authname>Seeley J.</authname><surname>Seeley</surname><given-name>Janet</given-name><initials>J.</initials><afid>60071671</afid><afid>60031331</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56463450100</author-url><authid>56463450100</authid><authname>Young E.</authname><surname>Young</surname><given-name>Elizabeth H.</given-name><initials>E.H.</initials><afid>60031101</afid><afid>60005517</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56463450100</author-url><authid>56463450100</authid><authname>Young E.</authname><surname>Young</surname><given-name>Elizabeth H.</given-name><initials>E.H.</initials><afid>60031101</afid><afid>60005517</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:55799638600</author-url><authid>55799638600</authid><authname>Kamali A.</authname><surname>Kamali</surname><given-name>Anatoli</given-name><initials>A.</initials><afid>60071671</afid><afid>60031331</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:55799638600</author-url><authid>55799638600</authid><authname>Kamali A.</authname><surname>Kamali</surname><given-name>Anatoli</given-name><initials>A.</initials><afid>60071671</afid><afid>60031331</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7004012378</author-url><authid>7004012378</authid><authname>Sandhu M.</authname><surname>Sandhu</surname><given-name>Manjinder S.</given-name><initials>M.S.</initials><afid>60031101</afid><afid>60005517</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7004012378</author-url><authid>7004012378</authid><authname>Sandhu M.</authname><surname>Sandhu</surname><given-name>Manjinder S.</given-name><initials>M.S.</initials><afid>60031101</afid><afid>60005517</afid></author><intid>535947640</intid><article-number>e0126166</article-number><source-id>10600153309</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929376779"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929376779?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929376779&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929376779&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929376779</prism:url><dc:identifier>SCOPUS_ID:84929376779</dc:identifier><eid>2-s2.0-84929376779</eid><dc:title>High incidence of ACE/PAI-1 in association to a spectrum of other polymorphic cardiovascular genes involving PBMCs proinflammatory cytokines in hypertensive hypercholesterolemic patients: Reversibility with a combination of ACE inhibitor and statin</dc:title><dc:creator>AlBacha J.</dc:creator><prism:publicationName>PLoS ONE</prism:publicationName><prism:eIssn>19326203</prism:eIssn><prism:volume>10</prism:volume><prism:issueIdentifier>5</prism:issueIdentifier><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.1371/journal.pone.0127266</prism:doi><dc:description>© 2015 AlBacha et al. Cardiovascular diseases (CVDs) are significantly high in the Lebanese population with the two most predominant forms being atherosclerosis and venous thrombosis. The purpose of our study was to assess the association of a spectrum of CVD related genes and combined state of hypertension hypercholesterolemia (HH) in unrelated Lebanese. Twelve polymorphisms were studied by multiplex PCR and reverse hybridization of DNA from 171 healthy individuals and 144 HH subjects. Two genes were significantly associated with HH: ACE (OR: 9.20, P&lt;0.0001) and PAI-1 (OR: 2.29, P=0.007), respectively with the occurrence of the risky alleles "Del" and "4G". The frequencies of the Del and 4G alleles were found to be 0.98 and 0.90 in the HH group versus 0.84 and 0.79 in the healthy group, respectively. Serum ACE activity and PAI-I increased significantly with Del/Del and 4G/5G genotypes. The co-expression of Del/4G(+/+) was detected in 113 out of 171 (66.0%) controls and 125 out of 144 (86.8%) HH subjects. Del/4G(-/-) was detected in only 6 (3.5%) controls and undetected in the HH group. Three venous thrombosis related genes [FV(Leiden), MTHFR (A1298C) and FXIII(V34L)] were significantly related to the prominence of the co-expression of Del/4G(+/+). A range of 2 to 8 combined polymorphisms co-expressed per subject where 5 mutations were the most detected. In Del/4G(+/+) subjects, peripheral blood mononuclear cells (PBMCs) produced significant elevated levels of IFN-γ and TNF-α contrary to IL-10, and no variations occurred for IL-4. ACE inhibitor (ramipril) in combination with statin (atorvastatin) and not alone reversed significantly the situation. This first report from Lebanon sheds light on an additional genetic predisposition of a complex spectrum of genes involved in CVD and suggests that the most requested gene FVL by physicians may not be sufficient to diagnose eventual future problems that can occur in the cardiovascular system. Subjects expressing the double mutations (Del/4G) are at high risk for the onset of CVDs.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115242403</affiliation-url><afid>115242403</afid><affilname>Middle East Institute of Health Hospital</affilname><name-variant>Middle East Institute of Health Hospital</name-variant><affiliation-city/><affiliation-country>Lebanon</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60068774</affiliation-url><afid>60068774</afid><affilname>Universite Libanaise</affilname><name-variant>Lebanese University</name-variant><affiliation-city>Beirut</affiliation-city><affiliation-country>Lebanon</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60068774</affiliation-url><afid>60068774</afid><affilname>Universite Libanaise</affilname><name-variant>Lebanese University</name-variant><affiliation-city>Beirut</affiliation-city><affiliation-country>Lebanon</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">11</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56644766000</author-url><authid>56644766000</authid><authname>AlBacha J.</authname><surname>AlBacha</surname><given-name>Jeanne D Arc</given-name><initials>J.D.A.</initials><afid>115242403</afid><afid>60068774</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56644766000</author-url><authid>56644766000</authid><authname>AlBacha J.</authname><surname>AlBacha</surname><given-name>Jeanne D Arc</given-name><initials>J.D.A.</initials><afid>115242403</afid><afid>60068774</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56644151600</author-url><authid>56644151600</authid><authname>Khoury M.</authname><surname>Khoury</surname><given-name>Mira</given-name><initials>M.</initials><afid>115242403</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55362383700</author-url><authid>55362383700</authid><authname>Mouawad C.</authname><surname>Mouawad</surname><given-name>Charbel</given-name><initials>C.</initials><afid>60068774</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:17534101400</author-url><authid>17534101400</authid><authname>Haddad K.</authname><surname>Haddad</surname><given-name>Katia</given-name><initials>K.</initials><afid>60068774</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6508289197</author-url><authid>6508289197</authid><authname>Hamoui S.</authname><surname>Hamoui</surname><given-name>Samar</given-name><initials>S.</initials><afid>60068774</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56644319900</author-url><authid>56644319900</authid><authname>Azar A.</authname><surname>Azar</surname><given-name>Albert</given-name><initials>A.</initials><afid>115242403</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56165472400</author-url><authid>56165472400</authid><authname>Fajloun Z.</authname><surname>Fajloun</surname><given-name>Ziad</given-name><initials>Z.</initials><afid>115242403</afid><afid>60068774</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56165472400</author-url><authid>56165472400</authid><authname>Fajloun Z.</authname><surname>Fajloun</surname><given-name>Ziad</given-name><initials>Z.</initials><afid>115242403</afid><afid>60068774</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56644995300</author-url><authid>56644995300</authid><authname>Makdissy N.</authname><surname>Makdissy</surname><given-name>Nehman</given-name><initials>N.</initials><afid>115242403</afid><afid>60068774</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56644995300</author-url><authid>56644995300</authid><authname>Makdissy N.</authname><surname>Makdissy</surname><given-name>Nehman</given-name><initials>N.</initials><afid>115242403</afid><afid>60068774</afid></author><intid>1035940145</intid><article-number>e0127266</article-number><source-id>10600153309</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929428245"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929428245?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929428245&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929428245&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929428245</prism:url><dc:identifier>SCOPUS_ID:84929428245</dc:identifier><eid>2-s2.0-84929428245</eid><dc:title>Admission glucose and risk of early death in non-diabetic patients with ST-segment elevation myocardial infarction: A meta-analysis</dc:title><dc:creator>Zhao C.</dc:creator><prism:publicationName>Medical Science Monitor</prism:publicationName><prism:issn>12341010</prism:issn><prism:eIssn>16433750</prism:eIssn><prism:volume>21</prism:volume><prism:pageRange>1387-1394</prism:pageRange><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.12659/MSM.894249</prism:doi><dc:description>© Med Sci Monit. Background: Impaired admission glucose (AG) is considered to significantly increase risk on both early and late death of the patients with ST-segment elevation myocardial infarction (STEMI), especially for non-diabetic patients; however, some reports contradict the relationship. We therefore conducted a meta-analysis to clarify this issue. Material/Methods: PubMed, EMBASE, Web of Science, and Cochrane Library databases were systematically searched to identify all related prospective cohort studies. The relative risks (RR) with their 95% confidence interval (CI) were pooled quantitatively. Results: The pooled RR of early outcome events indicated patients with glucose concentrations ≥6.1–11.1 mmol/L had a 4.38-fold (95% CI, 3.23–5.94) higher early mortality. The pooled RR of late outcome events indicated that the patients with glucose concentrations ≥7.8-11.1 mmol/L had a 1.65-fold (95% CI, 1.33–2.04) higher late mortality based on in-hospital or 30-day survivors. Conclusions: High AG may be a helpful prognostic marker of significantly increased risk on early death in non-diabetic patients with STEMI, and has an explicit but prognostic adverse impact on long-term mortality but not early mortality in these patients.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60073704</affiliation-url><afid>60073704</afid><affilname>Shaanxi Provincial People's Hospital</affilname><name-variant>Shanxi Provincial People's Hospital</name-variant><affiliation-city>Xi'an</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60073733</affiliation-url><afid>60073733</afid><affilname>Henan Provincial People's Hospital</affilname><name-variant>Henan Provincial People's Hospital</name-variant><affiliation-city>Zhengzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018308</affiliation-url><afid>60018308</afid><affilname>Xi'an Jiaotong University</affilname><name-variant>Xi'an Jiaotong University</name-variant><affiliation-city>Xi'an</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56645326200</author-url><authid>56645326200</authid><authname>Zhao C.</authname><surname>Zhao</surname><given-name>Cheng Jin</given-name><initials>C.J.</initials><afid>60073704</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56564692600</author-url><authid>56564692600</authid><authname>Hao Z.</authname><surname>Hao</surname><given-name>Zhen Xuan</given-name><initials>Z.X.</initials><afid>60073733</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35472925800</author-url><authid>35472925800</authid><authname>Liu R.</authname><surname>Liu</surname><given-name>Rong</given-name><initials>R.</initials><afid>60018308</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55539185600</author-url><authid>55539185600</authid><authname>Liu Y.</authname><surname>Liu</surname><given-name>Yang</given-name><initials>Y.</initials><afid>60073733</afid></author><authkeywords>Blood glucose | Meta-analysis | Myocardial infarction</authkeywords><intid>1035949909</intid><source-id>18344</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929376805"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929376805?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929376805&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929376805&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929376805</prism:url><dc:identifier>SCOPUS_ID:84929376805</dc:identifier><eid>2-s2.0-84929376805</eid><dc:title>Identifying vulnerable atherosclerotic plaque in rabbits using DMSA-USPIO enhanced magnetic resonance imaging to investigate the effect of atorvastatin</dc:title><dc:creator>Qi C.</dc:creator><prism:publicationName>PLoS ONE</prism:publicationName><prism:eIssn>19326203</prism:eIssn><prism:volume>10</prism:volume><prism:issueIdentifier>5</prism:issueIdentifier><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.1371/journal.pone.0125677</prism:doi><dc:description>© 2015 Qi et al. Background: Rupture of an atherosclerotic plaque is the primary cause of acute cardiovascular and cerebrovascular syndromes. Early and non-invasive detection of vulnerable atherosclerotic plaques (VP) would be significant in preventing some aspects of these syndromes. As a new contrast agent, dimercaptosuccinic acid (DMSA) modified ultra-small super paramagnetic iron oxide (USPIO) was synthesized and used to identify VP and rupture plaque by magnetic resonance imaging (MRI). Methods: Atherosclerosis was induced in male New Zealand White rabbits by feeding a high cholesterol diet (n = 30). Group A with atherosclerosis plaque (n = 10) were controls. VP was established in groups B (n = 10) and C (n = 10) using balloon-induced endothelial injury of the abdominal aorta. Adenovirus-carrying p53 genes were injected into the aortic segments rich in plaques after 8 weeks. Group C was treated with atorvastatin for 8 weeks. Sixteen weeks later, all rabbits underwent pharmacological triggering, and imaging were taken daily for 5 d after DMSA-USPIO infusion. At the first day and before being killed, serum MMP-9, sCD40L, and other lipid indicators were measured. Results: DMSA-USPIO particles accumulated in VP and rupture plaques. Rupture plaques appeared as areas of hyper-intensity on DMSA-USPIO enhanced MRI, especially T2∗-weighted sequences, with a signal strength peaking at 96 h. The group given atorvastatin showed few DMSA-USPIO particles and had lower levels of serum indicators. MMP-9 and sCD40L levels in group B were significantly higher than in the other 2 groups (P &lt;0.05). Conclusion: After successfully establishing a VP model in rabbits, DMSA-USPIO was used to enhance MRI for clear identification of plaque inflammation and rupture. Rupture plaques were detectable in this way probably due to an activating inflammatory process. Atorvastatin reduced the inflammatory response and stabilizing VP possibly by decreasing MMP-9 and sCD40L levels.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115242537</affiliation-url><afid>115242537</afid><affilname>General Hospital of Nanjing Military Region</affilname><name-variant>General Hospital of Nanjing Military Region</name-variant><affiliation-city>Xuzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022050</affiliation-url><afid>60022050</afid><affilname>Xuzhou Medical College</affilname><name-variant>Affiliated Hospital of Xuzhou Medical College</name-variant><affiliation-city>Xuzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022050</affiliation-url><afid>60022050</afid><affilname>Xuzhou Medical College</affilname><name-variant>Affiliated Hospital of Xuzhou Medical College</name-variant><affiliation-city>Xuzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022050</affiliation-url><afid>60022050</afid><affilname>Xuzhou Medical College</affilname><name-variant>Affiliated Hospital of Xuzhou Medical College</name-variant><affiliation-city>Xuzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005244</affiliation-url><afid>60005244</afid><affilname>Southeast University</affilname><name-variant>Southeast University</name-variant><affiliation-city>Nanjing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">12</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:16837006000</author-url><authid>16837006000</authid><authname>Qi C.</authname><surname>Qi</surname><given-name>Chunmei</given-name><initials>C.</initials><afid>115242537</afid><afid>60022050</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:16837006000</author-url><authid>16837006000</authid><authname>Qi C.</authname><surname>Qi</surname><given-name>Chunmei</given-name><initials>C.</initials><afid>115242537</afid><afid>60022050</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56643755200</author-url><authid>56643755200</authid><authname>Deng L.</authname><surname>Deng</surname><given-name>Liangrong</given-name><initials>L.</initials><afid>60022050</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:36067299600</author-url><authid>36067299600</authid><authname>Li D.</authname><surname>Li</surname><given-name>Dongye</given-name><initials>D.</initials><afid>115242537</afid><afid>60022050</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:36067299600</author-url><authid>36067299600</authid><authname>Li D.</authname><surname>Li</surname><given-name>Dongye</given-name><initials>D.</initials><afid>115242537</afid><afid>60022050</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7407079334</author-url><authid>7407079334</authid><authname>Wu W.</authname><surname>Wu</surname><given-name>Weiheng</given-name><initials>W.</initials><afid>60022050</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:36195519900</author-url><authid>36195519900</authid><authname>Gong L.</authname><surname>Gong</surname><given-name>Lei</given-name><initials>L.</initials><afid>60022050</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55822938100</author-url><authid>55822938100</authid><authname>Li Y.</authname><surname>Li</surname><given-name>Yong</given-name><initials>Y.</initials><afid>60022050</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56643374500</author-url><authid>56643374500</authid><authname>Zhang Q.</authname><surname>Zhang</surname><given-name>Qingdui</given-name><initials>Q.</initials><afid>60022050</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:35212776400</author-url><authid>35212776400</authid><authname>Zhang T.</authname><surname>Zhang</surname><given-name>Tao</given-name><initials>T.</initials><afid>60022050</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:35789377500</author-url><authid>35789377500</authid><authname>Zhang C.</authname><surname>Zhang</surname><given-name>Chao</given-name><initials>C.</initials><afid>60022050</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:9843355900</author-url><authid>9843355900</authid><authname>Zhang Y.</authname><surname>Zhang</surname><given-name>Yu</given-name><initials>Y.</initials><afid>60005244</afid></author><intid>35945145</intid><article-number>e0125677</article-number><source-id>10600153309</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929340312"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929340312?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929340312&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929340312&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929340312</prism:url><dc:identifier>SCOPUS_ID:84929340312</dc:identifier><eid>2-s2.0-84929340312</eid><dc:title>Identical microRNAs regulate liver protection during anaesthetic and ischemic preconditioning in rats: An animal study</dc:title><dc:creator>Morita T.</dc:creator><prism:publicationName>PLoS ONE</prism:publicationName><prism:eIssn>19326203</prism:eIssn><prism:volume>10</prism:volume><prism:issueIdentifier>5</prism:issueIdentifier><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.1371/journal.pone.0125866</prism:doi><dc:description>© 2015 Morita et al. Anaesthetic preconditioning (APC) and ischemic preconditioning (IPC) ameliorate liver ischemia-reperfusion (I/R) injury and are important for regulating hepatic I/R injury. Micro-RNAs (miRNAs) are short, noncoding RNA molecules of 21-23 nucleotides in length, and are currently under intensive investigation regarding their ability to regulate gene expression in a wide range of species. miRNA activity is involved in controlling a wide range of biological functions and processes. We evaluated whether APC and IPC are mediated by the same miRNAs by performing comprehensive miRNA screening experiments in a rat model of hepatic I/R injury. Twenty-one rats were randomly divided into three groups (n = 7/group): control (mock preconditioning), APC, and IPC. Control rats were subjected to 60 min of hepatic ischemia followed by 4 h of reperfusion, whereas the APC and IPC groups were preconditioned with 2% sevoflurane and hepatic ischemia for 10 min prior to ischemia-reperfusion, respectively. Liver samples were collected to measure miRNA levels after 3 h of reperfusion, and gene networks and canonical pathways were identified using Ingenuity Pathway Analysis (IPA). Blood samples were collected to measure the levels of aspartate aminotransferase (AST) and alanine aminotransferase (ALT). Although haemodynamic parameters did not vary among the groups, AST and ALT levels were significantly higher in the control group than in the APC and IPC groups. Comprehensive miRNA screening experiments revealed that most miRNAs altered in the APC group were common to those in the IPC group. IPA identified five miRNAs related to the Akt-glycogen synthase kinase-3β(GSK-3β)-cyclin D1 pathway that were significantly affected by both preconditioning strategies. The application of either APC or IPC to ameliorate hepatic I/R injury results in expression of several common miRNAs that are related to the Akt-GSK-cyclin D1 pathway.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018600</affiliation-url><afid>60018600</afid><affilname>Nippon Medical School</affilname><name-variant>Nippon Medical School</name-variant><affiliation-city>Tokyo</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56643788000</author-url><authid>56643788000</authid><authname>Morita T.</authname><surname>Morita</surname><given-name>Tomonori</given-name><initials>T.</initials><afid>60018600</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55416753600</author-url><authid>55416753600</authid><authname>Ishikawa M.</authname><surname>Ishikawa</surname><given-name>Masashi</given-name><initials>M.</initials><afid>60018600</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7201516353</author-url><authid>7201516353</authid><authname>Sakamoto A.</authname><surname>Sakamoto</surname><given-name>Atsuhiro</given-name><initials>A.</initials><afid>60018600</afid></author><intid>1785945307</intid><article-number>e0125866</article-number><source-id>10600153309</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929346915"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929346915?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929346915&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929346915&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929346915</prism:url><dc:identifier>SCOPUS_ID:84929346915</dc:identifier><eid>2-s2.0-84929346915</eid><dc:title>A new gender-specific model for skin autofluorescence risk stratification</dc:title><dc:creator>Ahmad M.</dc:creator><prism:publicationName>Scientific Reports</prism:publicationName><prism:eIssn>20452322</prism:eIssn><prism:volume>5</prism:volume><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.1038/srep10198</prism:doi><dc:description>© 2015, Nature Publishing Group. All rights reserved. Advanced glycation endproducts (AGEs) are believed to play a significant role in the pathophysiology of a variety of diseases including diabetes and cardiovascular diseases. Non-invasive skin autofluorescence (SAF) measurement serves as a proxy for tissue accumulation of AGEs. We assessed reference SAF and skin reflectance (SR) values in a Saudi population (n = 1,999) and evaluated the existing risk stratification scale. The mean SAF of the study cohort was 2.06 (SD = 0.57) arbitrary units (AU), which is considerably higher than the values reported for other populations. We show a previously unreported and significant difference in SAF values between men and women, with median (range) values of 1.77 AU (0.79-4.84 AU) and 2.20 AU (0.75-4.59 AU) respectively (p-value « 0.01). Age, presence of diabetes and BMI were the most influential variables in determining SAF values in men, whilst in female participants, SR was also highly correlated with SAF. Diabetes, hypertension and obesity all showed strong association with SAF, particularly when gender differences were taken into account. We propose an adjusted, gender-specific disease risk stratification scheme for Middle Eastern populations. SAF is a potentially valuable clinical screening tool for cardiovascular risk assessment but risk scores should take gender and ethnicity into consideration for accurate diagnosis.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004582</affiliation-url><afid>60004582</afid><affilname>King Abdulaziz University</affilname><name-variant>King Abdulaziz University</name-variant><affiliation-city>Jeddah</affiliation-city><affiliation-country>Saudi Arabia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004582</affiliation-url><afid>60004582</afid><affilname>King Abdulaziz University</affilname><name-variant>King Abdulaziz University</name-variant><affiliation-city>Jeddah</affiliation-city><affiliation-country>Saudi Arabia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015150</affiliation-url><afid>60015150</afid><affilname>Imperial College London</affilname><name-variant>Imperial College</name-variant><affiliation-city>London</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004582</affiliation-url><afid>60004582</afid><affilname>King Abdulaziz University</affilname><name-variant>King Abdulaziz University</name-variant><affiliation-city>Jeddah</affiliation-city><affiliation-country>Saudi Arabia</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56643707900</author-url><authid>56643707900</authid><authname>Ahmad M.</authname><surname>Ahmad</surname><given-name>Muhammad S.</given-name><initials>M.S.</initials><afid>60004582</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6602394147</author-url><authid>6602394147</authid><authname>Damanhouri Z.</authname><surname>Damanhouri</surname><given-name>Zoheir A.</given-name><initials>Z.A.</initials><afid>60004582</afid><afid>60004582</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6602394147</author-url><authid>6602394147</authid><authname>Damanhouri Z.</authname><surname>Damanhouri</surname><given-name>Zoheir A.</given-name><initials>Z.A.</initials><afid>60004582</afid><afid>60004582</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56644805800</author-url><authid>56644805800</authid><authname>Kimhofer T.</authname><surname>Kimhofer</surname><given-name>Torben</given-name><initials>T.</initials><afid>60015150</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55356077500</author-url><authid>55356077500</authid><authname>Mosli H.</authname><surname>Mosli</surname><given-name>Hala H.</given-name><initials>H.H.</initials><afid>60004582</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7201667063</author-url><authid>7201667063</authid><authname>Holmes E.</authname><surname>Holmes</surname><given-name>Elaine</given-name><initials>E.</initials><afid>60004582</afid><afid>60015150</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7201667063</author-url><authid>7201667063</authid><authname>Holmes E.</authname><surname>Holmes</surname><given-name>Elaine</given-name><initials>E.</initials><afid>60004582</afid><afid>60015150</afid></author><intid>1035939506</intid><article-number>10198</article-number><source-id>21100200805</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929839116"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929839116?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929839116&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929839116&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929839116</prism:url><dc:identifier>SCOPUS_ID:84929839116</dc:identifier><eid>2-s2.0-84929839116</eid><dc:title>Forming a consensus opinion on exercise prehabilitation in elderly colorectal cancer patients: a Delphi study</dc:title><dc:creator>Boereboom C.</dc:creator><prism:publicationName>Techniques in Coloproctology</prism:publicationName><prism:issn>11236337</prism:issn><prism:eIssn>1128045X</prism:eIssn><prism:volume>19</prism:volume><prism:issueIdentifier>6</prism:issueIdentifier><prism:pageRange>347-354</prism:pageRange><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.1007/s10151-015-1317-2</prism:doi><dc:description>© 2015, Springer-Verlag Italia Srl. Background: There is no consensus amongst colorectal surgeons as to whether preoperative exercise is beneficial in the management of colorectal cancer patients. Research has shown higher rates of postoperative complications in patients who are less fit. Agreement needs to be sought on whether improving fitness via exercise should be a part of preoperative care. The Delphi process is an iterative process designed to refine opinions on a subject, until consensus agreement is reached within an expert group. Methods: We performed a Delphi survey with a group of consultant colorectal surgeons. Statements achieving &gt;80 % agreement were taken as consensus, those achieving &gt;80 % disagreement were removed, and those in between were revised in the following round. The process ended with a group of statements which achieved consensus. Results: Thirty-two statements were included in the first round of the survey. After three rounds of the survey, 21 statements were accepted as consensus, six statements were rejected, and seven statements did not reach consensus. It was agreed that exercise training should form part of preoperative care and would be supported by surgeons. That suitable programmes pose significant risk to patients was rejected. There was no consensus reached on the strength of current available evidence or whether it would be possible to deliver exercise programmes. Conclusions: This work is the first to produce a set of statements on which expert consensus opinion has been agreed regarding preoperative exercise in colorectal cancer patients. Future work, informed by this study, will design interventions to produce rapid improvements in fitness before surgery.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015138</affiliation-url><afid>60015138</afid><affilname>University of Nottingham</affilname><name-variant>University of Nottingham</name-variant><affiliation-city>Nottingham</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:100909407</affiliation-url><afid>100909407</afid><affilname>Royal Derby Hospital</affilname><name-variant>Royal Derby Hospital</name-variant><affiliation-city>Derby</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015138</affiliation-url><afid>60015138</afid><affilname>University of Nottingham</affilname><name-variant>University of Nottingham</name-variant><affiliation-city>Nottingham</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:27367514400</author-url><authid>27367514400</authid><authname>Boereboom C.</authname><surname>Boereboom</surname><given-name>C. L.</given-name><initials>C.L.</initials><afid>60015138</afid><afid>100909407</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:27367514400</author-url><authid>27367514400</authid><authname>Boereboom C.</authname><surname>Boereboom</surname><given-name>C. L.</given-name><initials>C.L.</initials><afid>60015138</afid><afid>100909407</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7409576039</author-url><authid>7409576039</authid><authname>Williams J.</authname><surname>Williams</surname><given-name>J. P.</given-name><initials>J.P.</initials><afid>60015138</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56646128900</author-url><authid>56646128900</authid><authname>Leighton P.</authname><surname>Leighton</surname><given-name>P.</given-name><initials>P.</initials><afid>60015138</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55428977200</author-url><authid>55428977200</authid><authname>Lund J.</authname><surname>Lund</surname><given-name>J. N.</given-name><initials>J.N.</initials><afid>60015138</afid><afid>100909407</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55428977200</author-url><authid>55428977200</authid><authname>Lund J.</authname><surname>Lund</surname><given-name>J. N.</given-name><initials>J.N.</initials><afid>60015138</afid><afid>100909407</afid></author><authkeywords>Colorectal cancer | Consensus | Delphi | Exercise | Prehabilitation | Surgeon</authkeywords><intid>2036016991</intid><source-id>25374</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929376876"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929376876?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929376876&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929376876&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929376876</prism:url><dc:identifier>SCOPUS_ID:84929376876</dc:identifier><eid>2-s2.0-84929376876</eid><dc:title>Finding and tracing human MSC in 3D microenvironments with the photoconvertible protein Dendra2</dc:title><dc:creator>Caires H.</dc:creator><prism:publicationName>Scientific Reports</prism:publicationName><prism:eIssn>20452322</prism:eIssn><prism:volume>5</prism:volume><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.1038/srep10079</prism:doi><dc:description>© 2015, Nature Publishing Group. All rights reserved. Mesenchymal Stem/Stromal Cells (MSC) are a promising cell type for cell-based therapies - from tissue regeneration to treatment of autoimmune diseases - due to their capacity to migrate to damaged tissues, to differentiate in different lineages and to their immunomodulatory and paracrine properties. Here, a simple and reliable imaging technique was developed to study MSC dynamical behavior in natural and bioengineered 3D matrices. Human MSC were transfected to express a fluorescent photoswitchable protein, Dendra2, which was used to highlight and follow the same group of cells for more than seven days, even if removed from the microscope to the incubator. This strategy provided reliable tracking in 3D microenvironments with different properties, including the hydrogels Matrigel and alginate as well as chitosan porous scaffolds. Comparison of cells mobility within matrices with tuned physicochemical properties revealed that MSC embedded in Matrigel migrated 64% more with 5.2mg protein/mL than with 9.6mg/mL and that MSC embedded in RGD-alginate migrated 51% faster with 1% polymer concentration than in 2% RGD-alginate. This platform thus provides a straightforward approach to characterize MSC dynamics in 3D and has applications in the field of stem cell biology and for the development of biomaterials for tissue regeneration.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007249</affiliation-url><afid>60007249</afid><affilname>Universidade do Porto</affilname><name-variant>Universidade do Porto</name-variant><affiliation-city>Porto</affiliation-city><affiliation-country>Portugal</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007249</affiliation-url><afid>60007249</afid><affilname>Universidade do Porto</affilname><name-variant>Universidade do Porto</name-variant><affiliation-city>Porto</affiliation-city><affiliation-country>Portugal</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007249</affiliation-url><afid>60007249</afid><affilname>Universidade do Porto</affilname><name-variant>Universidade do Porto</name-variant><affiliation-city>Porto</affiliation-city><affiliation-country>Portugal</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007249</affiliation-url><afid>60007249</afid><affilname>Universidade do Porto</affilname><name-variant>Universidade do Porto</name-variant><affiliation-city>Porto</affiliation-city><affiliation-country>Portugal</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007249</affiliation-url><afid>60007249</afid><affilname>Universidade do Porto</affilname><name-variant>Universidade do Porto</name-variant><affiliation-city>Porto</affiliation-city><affiliation-country>Portugal</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007249</affiliation-url><afid>60007249</afid><affilname>Universidade do Porto</affilname><name-variant>Universidade do Porto</name-variant><affiliation-city>Porto</affiliation-city><affiliation-country>Portugal</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007249</affiliation-url><afid>60007249</afid><affilname>Universidade do Porto</affilname><name-variant>Universidade do Porto</name-variant><affiliation-city>Porto</affiliation-city><affiliation-country>Portugal</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">23</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56644725700</author-url><authid>56644725700</authid><authname>Caires H.</authname><surname>Caires</surname><given-name>Hugo R.</given-name><initials>H.R.</initials><afid>60007249</afid><afid>60007249</afid><afid>60007249</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56644725700</author-url><authid>56644725700</authid><authname>Caires H.</authname><surname>Caires</surname><given-name>Hugo R.</given-name><initials>H.R.</initials><afid>60007249</afid><afid>60007249</afid><afid>60007249</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56644725700</author-url><authid>56644725700</authid><authname>Caires H.</authname><surname>Caires</surname><given-name>Hugo R.</given-name><initials>H.R.</initials><afid>60007249</afid><afid>60007249</afid><afid>60007249</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:8970700200</author-url><authid>8970700200</authid><authname>Gomez-Lazaro M.</authname><surname>Gomez-Lazaro</surname><given-name>Maria</given-name><initials>M.</initials><afid>60007249</afid><afid>60007249</afid><afid>60007249</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:8970700200</author-url><authid>8970700200</authid><authname>Gomez-Lazaro M.</authname><surname>Gomez-Lazaro</surname><given-name>Maria</given-name><initials>M.</initials><afid>60007249</afid><afid>60007249</afid><afid>60007249</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:8970700200</author-url><authid>8970700200</authid><authname>Gomez-Lazaro M.</authname><surname>Gomez-Lazaro</surname><given-name>Maria</given-name><initials>M.</initials><afid>60007249</afid><afid>60007249</afid><afid>60007249</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56020190800</author-url><authid>56020190800</authid><authname>Oliveira C.</authname><surname>Oliveira</surname><given-name>Carla M.</given-name><initials>C.M.</initials><afid>60007249</afid><afid>60007249</afid><afid>60007249</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56020190800</author-url><authid>56020190800</authid><authname>Oliveira C.</authname><surname>Oliveira</surname><given-name>Carla M.</given-name><initials>C.M.</initials><afid>60007249</afid><afid>60007249</afid><afid>60007249</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56020190800</author-url><authid>56020190800</authid><authname>Oliveira C.</authname><surname>Oliveira</surname><given-name>Carla M.</given-name><initials>C.M.</initials><afid>60007249</afid><afid>60007249</afid><afid>60007249</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:24343754200</author-url><authid>24343754200</authid><authname>Gomes D.</authname><surname>Gomes</surname><given-name>David</given-name><initials>D.</initials><afid>60007249</afid><afid>60007249</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:24343754200</author-url><authid>24343754200</authid><authname>Gomes D.</authname><surname>Gomes</surname><given-name>David</given-name><initials>D.</initials><afid>60007249</afid><afid>60007249</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:23991314800</author-url><authid>23991314800</authid><authname>Mateus D.</authname><surname>Mateus</surname><given-name>Denisa D.</given-name><initials>D.D.</initials><afid>60007249</afid><afid>60007249</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:23991314800</author-url><authid>23991314800</authid><authname>Mateus D.</authname><surname>Mateus</surname><given-name>Denisa D.</given-name><initials>D.D.</initials><afid>60007249</afid><afid>60007249</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56643899500</author-url><authid>56643899500</authid><authname>Oliveira C.</authname><surname>Oliveira</surname><given-name>Carla</given-name><initials>C.</initials><afid>60007249</afid><afid>60007249</afid><afid>60007249</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56643899500</author-url><authid>56643899500</authid><authname>Oliveira C.</authname><surname>Oliveira</surname><given-name>Carla</given-name><initials>C.</initials><afid>60007249</afid><afid>60007249</afid><afid>60007249</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56643899500</author-url><authid>56643899500</authid><authname>Oliveira C.</authname><surname>Oliveira</surname><given-name>Carla</given-name><initials>C.</initials><afid>60007249</afid><afid>60007249</afid><afid>60007249</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:9250507300</author-url><authid>9250507300</authid><authname>Barrias C.</authname><surname>Barrias</surname><given-name>Cristina C.</given-name><initials>C.C.</initials><afid>60007249</afid><afid>60007249</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:9250507300</author-url><authid>9250507300</authid><authname>Barrias C.</authname><surname>Barrias</surname><given-name>Cristina C.</given-name><initials>C.C.</initials><afid>60007249</afid><afid>60007249</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:55946191500</author-url><authid>55946191500</authid><authname>Barbosa M.</authname><surname>Barbosa</surname><given-name>Mário A.</given-name><initials>M.A.</initials><afid>60007249</afid><afid>60007249</afid><afid>60007249</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:55946191500</author-url><authid>55946191500</authid><authname>Barbosa M.</authname><surname>Barbosa</surname><given-name>Mário A.</given-name><initials>M.A.</initials><afid>60007249</afid><afid>60007249</afid><afid>60007249</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:55946191500</author-url><authid>55946191500</authid><authname>Barbosa M.</authname><surname>Barbosa</surname><given-name>Mário A.</given-name><initials>M.A.</initials><afid>60007249</afid><afid>60007249</afid><afid>60007249</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56651207100</author-url><authid>56651207100</authid><authname>Almeida C.</authname><surname>Almeida</surname><given-name>Catarina R.</given-name><initials>C.R.</initials><afid>60007249</afid><afid>60007249</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56651207100</author-url><authid>56651207100</authid><authname>Almeida C.</authname><surname>Almeida</surname><given-name>Catarina R.</given-name><initials>C.R.</initials><afid>60007249</afid><afid>60007249</afid></author><intid>35943202</intid><article-number>10079</article-number><source-id>21100200805</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929379756"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929379756?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929379756&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929379756&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929379756</prism:url><dc:identifier>SCOPUS_ID:84929379756</dc:identifier><eid>2-s2.0-84929379756</eid><dc:title>A multicenter, randomized, controlled trial of osteopathic manipulative treatment on preterms</dc:title><dc:creator>Cerritelli F.</dc:creator><prism:publicationName>PLoS ONE</prism:publicationName><prism:eIssn>19326203</prism:eIssn><prism:volume>10</prism:volume><prism:issueIdentifier>5</prism:issueIdentifier><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.1371/journal.pone.0127370</prism:doi><dc:description>© 2015 Cerritelli et al. Background: Despite some preliminary evidence, it is still largely unknown whether osteopathic manipulative treatment improves preterm clinical outcomes. Materials and Methods: The present multi-center randomized single blind parallel group clinical trial enrolled newborns who met the criteria for gestational age between 29 and 37 weeks, without any congenital complication from 3 different public neonatal intensive care units. Preterm infants were randomly assigned to usual prenatal care (control group) or osteopathic manipulative treatment (study group). The primary outcome was the mean difference in length of hospital stay between groups. Results: A total of 695 newborns were randomly assigned to either the study group (n= 352) or the control group (n=343). A statistical significant difference was observed between the two groups for the primary outcome (13.8 and 17.5 days for the study and control group respectively, p&lt;0.001, effect size: 0.31). Multivariate analysis showed a reduction of the length of stay of 3.9 days (95% CI -5.5 to -2.3, p&lt;0.001). Furthermore, there were significant reductions with treatment as compared to usual care in cost (difference between study and control group: 1,586.01€; 95% CI 1,087.18 to 6,277.28; p&lt;0.001) but not in daily weight gain. There were no complications associated to the intervention. Conclusions: Osteopathic treatment reduced significantly the number of days of hospitalization and is cost-effective on a large cohort of preterm infants.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114448663</affiliation-url><afid>114448663</afid><affilname>Centre for Osteopathic Medicine - C.O.ME. Collaboration</affilname><name-variant>COME Collaboration</name-variant><affiliation-city>Pescara</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115144148</affiliation-url><afid>115144148</afid><affilname>AIOT - Accademia Italiana Osteopatia Tradizionale</affilname><name-variant>Accademia Italiana Osteopatia Tradizionale</name-variant><affiliation-city>Pescara</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:106340902</affiliation-url><afid>106340902</afid><affilname>Desio General Hospital</affilname><name-variant>Desio General Hospital</name-variant><affiliation-city>Desio</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:101568011</affiliation-url><afid>101568011</afid><affilname>Macerata Hospital</affilname><name-variant>Macerata Hospital</name-variant><affiliation-city>Macerata</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:100351336</affiliation-url><afid>100351336</afid><affilname>Pescara Hospital</affilname><name-variant>Pescara Hospital</name-variant><affiliation-city>Pescara</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">22</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36008373800</author-url><authid>36008373800</authid><authname>Cerritelli F.</authname><surname>Cerritelli</surname><given-name>Francesco</given-name><initials>F.</initials><afid>114448663</afid><afid>115144148</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36008373800</author-url><authid>36008373800</authid><authname>Cerritelli F.</authname><surname>Cerritelli</surname><given-name>Francesco</given-name><initials>F.</initials><afid>114448663</afid><afid>115144148</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:37093823600</author-url><authid>37093823600</authid><authname>Pizzolorusso G.</authname><surname>Pizzolorusso</surname><given-name>Gianfranco</given-name><initials>G.</initials><afid>115144148</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:37093843200</author-url><authid>37093843200</authid><authname>Renzetti C.</authname><surname>Renzetti</surname><given-name>Cinzia</given-name><initials>C.</initials><afid>115144148</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:37092625500</author-url><authid>37092625500</authid><authname>Cozzolino V.</authname><surname>Cozzolino</surname><given-name>Vincenzo</given-name><initials>V.</initials><afid>115144148</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55237517500</author-url><authid>55237517500</authid><authname>D'Orazio M.</authname><surname>D'Orazio</surname><given-name>Marianna</given-name><initials>M.</initials><afid>115144148</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56554187600</author-url><authid>56554187600</authid><authname>Lupacchini M.</authname><surname>Lupacchini</surname><given-name>Mariacristina</given-name><initials>M.</initials><afid>115144148</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56554281600</author-url><authid>56554281600</authid><authname>Marinelli B.</authname><surname>Marinelli</surname><given-name>Benedetta</given-name><initials>B.</initials><afid>115144148</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56140669000</author-url><authid>56140669000</authid><authname>Accorsi A.</authname><surname>Accorsi</surname><given-name>Alessandro</given-name><initials>A.</initials><afid>114448663</afid><afid>115144148</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56140669000</author-url><authid>56140669000</authid><authname>Accorsi A.</authname><surname>Accorsi</surname><given-name>Alessandro</given-name><initials>A.</initials><afid>114448663</afid><afid>115144148</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56142602000</author-url><authid>56142602000</authid><authname>Lucci C.</authname><surname>Lucci</surname><given-name>Chiara</given-name><initials>C.</initials><afid>114448663</afid><afid>115144148</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56142602000</author-url><authid>56142602000</authid><authname>Lucci C.</authname><surname>Lucci</surname><given-name>Chiara</given-name><initials>C.</initials><afid>114448663</afid><afid>115144148</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56441773000</author-url><authid>56441773000</authid><authname>Lancellotti J.</authname><surname>Lancellotti</surname><given-name>Jenny</given-name><initials>J.</initials><afid>115144148</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:56644874700</author-url><authid>56644874700</authid><authname>Ballabio S.</authname><surname>Ballabio</surname><given-name>Silvia</given-name><initials>S.</initials><afid>106340902</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:56644307900</author-url><authid>56644307900</authid><authname>Castelli C.</authname><surname>Castelli</surname><given-name>Carola</given-name><initials>C.</initials><afid>106340902</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:56644506100</author-url><authid>56644506100</authid><authname>Molteni D.</authname><surname>Molteni</surname><given-name>Daniela</given-name><initials>D.</initials><afid>106340902</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:56644589500</author-url><authid>56644589500</authid><authname>Besana R.</authname><surname>Besana</surname><given-name>Roberto</given-name><initials>R.</initials><afid>106340902</afid></author><author seq="15"><author-url>http://api.elsevier.com/content/author/author_id:6505988313</author-url><authid>6505988313</authid><authname>Tubaldi L.</authname><surname>Tubaldi</surname><given-name>Lucia</given-name><initials>L.</initials><afid>101568011</afid></author><author seq="16"><author-url>http://api.elsevier.com/content/author/author_id:56652464000</author-url><authid>56652464000</authid><authname>Perri F.</authname><surname>Perri</surname><given-name>Francesco Paolo</given-name><initials>F.P.</initials><afid>101568011</afid></author><author seq="17"><author-url>http://api.elsevier.com/content/author/author_id:8231629100</author-url><authid>8231629100</authid><authname>Fusilli P.</authname><surname>Fusilli</surname><given-name>Paola</given-name><initials>P.</initials><afid>100351336</afid></author><author seq="18"><author-url>http://api.elsevier.com/content/author/author_id:17034189500</author-url><authid>17034189500</authid><authname>D'Incecco C.</authname><surname>D'Incecco</surname><given-name>Carmine</given-name><initials>C.</initials><afid>100351336</afid></author><author seq="19"><author-url>http://api.elsevier.com/content/author/author_id:37092523400</author-url><authid>37092523400</authid><authname>Barlafante G.</authname><surname>Barlafante</surname><given-name>Gina</given-name><initials>G.</initials><afid>115144148</afid></author><intid>1035939040</intid><article-number>e0127370</article-number><source-id>10600153309</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929353124"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929353124?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929353124&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929353124&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929353124</prism:url><dc:identifier>SCOPUS_ID:84929353124</dc:identifier><eid>2-s2.0-84929353124</eid><dc:title>Deletion of protein tyrosine phosphatase 1B (PTP1B) enhances endothelial cyclooxygenase 2 expression and protects mice from type 1 diabetes-induced endothelial dysfunction</dc:title><dc:creator>Herre D.</dc:creator><prism:publicationName>PLoS ONE</prism:publicationName><prism:eIssn>19326203</prism:eIssn><prism:volume>10</prism:volume><prism:issueIdentifier>5</prism:issueIdentifier><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.1371/journal.pone.0126866</prism:doi><dc:description>© 2015 Herre et al. Protein tyrosine phosphatase 1B (PTP1B) dephosphorylates receptors tyrosine kinase and acts as a molecular brake on insulin signaling pathway. Conditions of metabolic dysfunction increase PTP1B, when deletion of PTP1B protects against metabolic disorders by increasing insulin signaling. Although vascular insulin signaling contributes to the control of glucose disposal, little is known regarding the direct role of PTP1B in the control of endothelial function. We hypothesized that metabolic dysfunctions increase PTP1B expression in endothelial cells and that PTP1B deletion prevents endothelial dysfunction in situation of diminished insulin secretion. Type I diabetes (T1DM) was induced in wild-type (WT) and PTP1B-deficient mice (KO) with streptozotocin (STZ) injection. After 28 days of T1DM, KO mice exhibited a similar reduction in body weight and plasma insulin levels and a comparable increase in glycemia (WT: 384±20 vs. Ko: 432±29 mg/dL), cholesterol and triglycerides, as WT mice. T1DM increased PTP1B expression and impaired endothelial NO-dependent relaxation, in mouse aorta. PTP1B deletion did not affect baseline endothelial function, but preserved endothelium-dependent relaxation, in T1DM mice. NO synthase inhibition with L-NAME abolished endothelial relaxation in control and T1DM WT mice, whereas L-NAME and the cyclooxygenases inhibitor indomethacin were required to abolish endothelium relaxation in T1DM KO mice. PTP1B deletion increased COX-2 expression and PGI2 levels, in mouse aorta and plasma respectively, in T1DM mice. In parallel, simulation of diabetic conditions increased PTP1B expression and knockdown of PTP1B increased COX-2 but not COX-1 expression, in primary human aortic endothelial cells. Taken together these data indicate that deletion of PTP1B protected endothelial function by compensating the reduction in NO bioavailability by increasing COX-2-mediated release of the vasodilator prostanoid PGI&lt;inf&gt;2&lt;/inf&gt;, in T1DM mice.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024399</affiliation-url><afid>60024399</afid><affilname>Medical College of Georgia</affilname><name-variant>Medical College of Georgia</name-variant><affiliation-city>Augusta</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002494</affiliation-url><afid>60002494</afid><affilname>McGill University</affilname><name-variant>McGill University</name-variant><affiliation-city>Montreal</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56644964500</author-url><authid>56644964500</authid><authname>Herre D.</authname><surname>Herre</surname><given-name>David J.</given-name><initials>D.J.</initials><afid>60024399</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56643976900</author-url><authid>56643976900</authid><authname>Norman J.</authname><surname>Norman</surname><given-name>J. Blake</given-name><initials>J.B.</initials><afid>60024399</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56643513200</author-url><authid>56643513200</authid><authname>Anderson R.</authname><surname>Anderson</surname><given-name>Ruchi</given-name><initials>R.</initials><afid>60024399</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7202066888</author-url><authid>7202066888</authid><authname>Tremblay M.</authname><surname>Tremblay</surname><given-name>Michel L.</given-name><initials>M.L.</initials><afid>60002494</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:35095294100</author-url><authid>35095294100</authid><authname>Huby A.</authname><surname>Huby</surname><given-name>Anne Cecile</given-name><initials>A.C.</initials><afid>60024399</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56644700900</author-url><authid>56644700900</authid><authname>De Chantemèle E.</authname><surname>De Chantemèle</surname><given-name>Eric J Belin</given-name><initials>E.J.B.</initials><afid>60024399</afid></author><intid>1035940869</intid><article-number>e0126866</article-number><source-id>10600153309</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929359019"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929359019?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929359019&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929359019&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929359019</prism:url><dc:identifier>SCOPUS_ID:84929359019</dc:identifier><eid>2-s2.0-84929359019</eid><dc:title>Mass spectrometry-based proteomics for pre-eclampsia and preterm birth</dc:title><dc:creator>Law K.</dc:creator><prism:publicationName>International Journal of Molecular Sciences</prism:publicationName><prism:issn>16616596</prism:issn><prism:eIssn>14220067</prism:eIssn><prism:volume>16</prism:volume><prism:issueIdentifier>5</prism:issueIdentifier><prism:pageRange>10952-10985</prism:pageRange><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.3390/ijms160510952</prism:doi><dc:description>© 2015 by the authors; licensee MDPI, Basel, Switzerland. Pregnancy-related complications such as pre-eclampsia and preterm birth now represent a notable burden of adverse health. Pre-eclampsia is a hypertensive disorder unique to pregnancy. It is an important cause of maternal death worldwide and a leading cause of fetal growth restriction and iatrogenic prematurity. Fifteen million infants are born preterm each year globally, but more than one million of those do not survive their first month of life. Currently there are no predictive tests available for diagnosis of these pregnancy-related complications and the biological mechanisms of the diseases have not been fully elucidated. Mass spectrometry-based proteomics have all the necessary attributes to provide the needed breakthrough in understanding the pathophysiology of complex human diseases thorough the discovery of biomarkers. The mass spectrometry methodologies employed in the studies for pregnancy-related complications are evaluated in this article. Top-down proteomic and peptidomic profiling by laser mass spectrometry, liquid chromatography or capillary electrophoresis coupled to mass spectrometry, and bottom-up quantitative proteomics and targeted proteomics by liquid chromatography mass spectrometry have been applied to elucidate protein biomarkers and biological mechanism of pregnancy-related complications. The proteomes of serum, urine, amniotic fluid, cervical-vaginal fluid, placental tissue, and cytotrophoblastic cells have all been investigated. Numerous biomarkers or biomarker candidates that could distinguish complicated pregnancies from healthy controls have been proposed. Nevertheless, questions as to the clinically utility and the capacity to elucidate the pathogenesis of the pre-eclampsia and preterm birth remain to be answered.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020870</affiliation-url><afid>60020870</afid><affilname>Chongqing University of Medical Sciences</affilname><name-variant>Chongqing Medical University</name-variant><affiliation-city>Chongqing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005686</affiliation-url><afid>60005686</afid><affilname>University of Auckland</affilname><name-variant>University of Auckland</name-variant><affiliation-city>Auckland</affiliation-city><affiliation-country>New Zealand</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020870</affiliation-url><afid>60020870</afid><affilname>Chongqing University of Medical Sciences</affilname><name-variant>Chongqing Medical University</name-variant><affiliation-city>Chongqing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56644073800</author-url><authid>56644073800</authid><authname>Law K.</authname><surname>Law</surname><given-name>Kai P.</given-name><initials>K.P.</initials><afid>60020870</afid><afid>60005686</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56644073800</author-url><authid>56644073800</authid><authname>Law K.</authname><surname>Law</surname><given-name>Kai P.</given-name><initials>K.P.</initials><afid>60020870</afid><afid>60005686</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55123656600</author-url><authid>55123656600</authid><authname>Han T.</authname><surname>Han</surname><given-name>Ting Li</given-name><initials>T.L.</initials><afid>60020870</afid><afid>60005686</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55123656600</author-url><authid>55123656600</authid><authname>Han T.</authname><surname>Han</surname><given-name>Ting Li</given-name><initials>T.L.</initials><afid>60020870</afid><afid>60005686</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56643972500</author-url><authid>56643972500</authid><authname>Tong C.</authname><surname>Tong</surname><given-name>Chao</given-name><initials>C.</initials><afid>60020870</afid><afid>60020870</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56643972500</author-url><authid>56643972500</authid><authname>Tong C.</authname><surname>Tong</surname><given-name>Chao</given-name><initials>C.</initials><afid>60020870</afid><afid>60020870</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7402424330</author-url><authid>7402424330</authid><authname>Baker P.</authname><surname>Baker</surname><given-name>Philip N.</given-name><initials>P.N.</initials><afid>60020870</afid><afid>60005686</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7402424330</author-url><authid>7402424330</authid><authname>Baker P.</authname><surname>Baker</surname><given-name>Philip N.</given-name><initials>P.N.</initials><afid>60020870</afid><afid>60005686</afid></author><authkeywords>Mass spectrometry | Pre-eclampsia | Preterm birth | Protein biomarkers | Proteomics</authkeywords><intid>535947544</intid><source-id>25879</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929346605"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929346605?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929346605&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929346605&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929346605</prism:url><dc:identifier>SCOPUS_ID:84929346605</dc:identifier><eid>2-s2.0-84929346605</eid><dc:title>Antitumor sulfonylhydrazines: Design, structure-activity relationships, resistance mechanisms, and strategies for improving therapeutic utility</dc:title><dc:creator>Shyam K.</dc:creator><prism:publicationName>Journal of Medicinal Chemistry</prism:publicationName><prism:issn>00222623</prism:issn><prism:eIssn>15204804</prism:eIssn><prism:volume>58</prism:volume><prism:issueIdentifier>9</prism:issueIdentifier><prism:pageRange>3639-3671</prism:pageRange><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.1021/jm501459c</prism:doi><dc:description>© 2015 American Chemical Society. 1,2-Bis(sulfonyl)-1-alkylhydrazines (BSHs) were conceived as more specific DNA guanine O-6 methylating and chloroethylating agents lacking many of the undesirable toxicophores contained in antitumor nitrosoureas. O&lt;sup&gt;6&lt;/sup&gt;-Alkylguanine-DNA alkyltransferase (MGMT) is the sole repair protein for O&lt;sup&gt;6&lt;/sup&gt;-alkylguanine lesions in DNA and has been reported to be absent in 5-20% of most tumor types. Many BSHs exhibit highly selective cytotoxicity toward cells deficient in MGMT activity. The development of clinically useful MGMT assays should permit the identification of tumors with this vulnerability and allow for the preselection of patient subpopulations with a high probability of responding. The BSH system is highly versatile, permitting the synthesis of many prodrug types with the ability to incorporate an additional level of tumor-targeting due to preferential activation by tumor cells. Furthermore, it may be possible to expand the spectrum of activity of these agents to include tumors with MGMT activity by combining them with tumor-targeted MGMT inhibitors.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017994</affiliation-url><afid>60017994</afid><affilname>Yale University School of Medicine</affilname><name-variant>Yale University School of Medicine</name-variant><affiliation-city>New Haven</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015023</affiliation-url><afid>60015023</afid><affilname>University of Texas M. D. Anderson Cancer Center</affilname><name-variant>University of Texas</name-variant><affiliation-city>Houston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7004227609</author-url><authid>7004227609</authid><authname>Shyam K.</authname><surname>Shyam</surname><given-name>Krishnamurthy</given-name><initials>K.</initials><afid>60017994</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6701394272</author-url><authid>6701394272</authid><authname>Penketh P.</authname><surname>Penketh</surname><given-name>Philip G.</given-name><initials>P.G.</initials><afid>60017994</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7202556139</author-url><authid>7202556139</authid><authname>Baumann R.</authname><surname>Baumann</surname><given-name>Raymond P.</given-name><initials>R.P.</initials><afid>60017994</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7103190801</author-url><authid>7103190801</authid><authname>Finch R.</authname><surname>Finch</surname><given-name>Rick A.</given-name><initials>R.A.</initials><afid>60015023</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55740793000</author-url><authid>55740793000</authid><authname>Zhu R.</authname><surname>Zhu</surname><given-name>Rui</given-name><initials>R.</initials><afid>60017994</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56335311900</author-url><authid>56335311900</authid><authname>Zhu Y.</authname><surname>Zhu</surname><given-name>Yong Lian</given-name><initials>Y.L.</initials><afid>60017994</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56644179300</author-url><authid>56644179300</authid><authname>Sartorelli A.</authname><surname>Sartorelli</surname><given-name>Alan C.</given-name><initials>A.C.</initials><afid>60017994</afid></author><intid>1035941039</intid><source-id>23041</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929598371"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929598371?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929598371&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929598371&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929598371</prism:url><dc:identifier>SCOPUS_ID:84929598371</dc:identifier><eid>2-s2.0-84929598371</eid><dc:title>Muscle stem cells contribute to myofibres in sedentary adult mice</dc:title><dc:creator>Keefe A.</dc:creator><prism:publicationName>Nature Communications</prism:publicationName><prism:eIssn>20411723</prism:eIssn><prism:volume>6</prism:volume><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.1038/ncomms8087</prism:doi><pii>ncomms8087</pii><dc:description>Skeletal muscle is essential for mobility, stability and whole body metabolism, and muscle loss, for instance, during sarcopenia, has profound consequences. Satellite cells (muscle stem cells) have been hypothesized, but not yet demonstrated, to contribute to muscle homeostasis and a decline in their contribution to myofibre homeostasis to play a part in sarcopenia. To test their role in muscle maintenance, we genetically labelled and ablated satellite cells in adult sedentary mice. We demonstrate via genetic lineage experiments that, even in the absence of injury, satellite cells contribute to myofibres in all adult muscles, although the extent and timing differs. However, genetic ablation experiments showed that satellite cells are not globally required to maintain myofibre cross-sectional area of uninjured adult muscle.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025488</affiliation-url><afid>60025488</afid><affilname>University of Utah</affilname><name-variant>University of Utah</name-variant><affiliation-city>Salt Lake City</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025488</affiliation-url><afid>60025488</afid><affilname>University of Utah</affilname><name-variant>University of Utah</name-variant><affiliation-city>Salt Lake City</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:108432023</affiliation-url><afid>108432023</afid><affilname>Regional Centre for Biotechnology</affilname><name-variant>Regional Centre for Biotechnology</name-variant><affiliation-city>Gurgaon</affiliation-city><affiliation-country>India</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56435901200</author-url><authid>56435901200</authid><authname>Keefe A.</authname><surname>Keefe</surname><given-name>Alexandra C.</given-name><initials>A.C.</initials><afid>60025488</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:37112456300</author-url><authid>37112456300</authid><authname>Lawson J.</authname><surname>Lawson</surname><given-name>Jennifer A.</given-name><initials>J.A.</initials><afid>60025488</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35102126100</author-url><authid>35102126100</authid><authname>Flygare S.</authname><surname>Flygare</surname><given-name>Steven D.</given-name><initials>S.D.</initials><afid>60025488</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56566417300</author-url><authid>56566417300</authid><authname>Fox Z.</authname><surname>Fox</surname><given-name>Zachary D.</given-name><initials>Z.D.</initials><afid>60025488</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55386120300</author-url><authid>55386120300</authid><authname>Colasanto M.</authname><surname>Colasanto</surname><given-name>Mary P.</given-name><initials>M.P.</initials><afid>60025488</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:33167796200</author-url><authid>33167796200</authid><authname>Mathew S.</authname><surname>Mathew</surname><given-name>Sam J.</given-name><initials>S.J.</initials><afid>60025488</afid><afid>108432023</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:33167796200</author-url><authid>33167796200</authid><authname>Mathew S.</authname><surname>Mathew</surname><given-name>Sam J.</given-name><initials>S.J.</initials><afid>60025488</afid><afid>108432023</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:6601908759</author-url><authid>6601908759</authid><authname>Yandell M.</authname><surname>Yandell</surname><given-name>Mark</given-name><initials>M.</initials><afid>60025488</afid><afid>60025488</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:6601908759</author-url><authid>6601908759</authid><authname>Yandell M.</authname><surname>Yandell</surname><given-name>Mark</given-name><initials>M.</initials><afid>60025488</afid><afid>60025488</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:6602587339</author-url><authid>6602587339</authid><authname>Kardon G.</authname><surname>Kardon</surname><given-name>Gabrielle</given-name><initials>G.</initials><afid>60025488</afid></author><intid>1785981726</intid><article-number>7087</article-number><source-id>19700182758</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928962848"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928962848?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928962848&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928962848&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928962848</prism:url><dc:identifier>SCOPUS_ID:84928962848</dc:identifier><eid>2-s2.0-84928962848</eid><dc:title>Pluripotency maintenance of amniotic fluid-derived stem cells cultured on biomaterials</dc:title><dc:creator>Wang P.</dc:creator><prism:publicationName>Journal of Materials Chemistry B</prism:publicationName><prism:issn>20507518</prism:issn><prism:eIssn>2050750X</prism:eIssn><prism:volume>3</prism:volume><prism:issueIdentifier>18</prism:issueIdentifier><prism:pageRange>3858-3869</prism:pageRange><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.1039/c5tb00447k</prism:doi><dc:description>© 2015 The Royal Society of Chemistry. The stem cell fates of pluripotency and differentiation are regulated by not only soluble biological cues but also insoluble biochemical cues (i.e., extracellular matrix (ECM)) and the physical cues of cell culture biomaterials (i.e., elasticity). We investigated the maintenance of pluripotency and the differentiation lineages of human amniotic fluid-derived stem cells (hAFSCs) cultured on poly(vinyl alcohol-co-itaconic acid) (PVA) hydrogels grafted with several types of ECM and corresponding oligopeptides in expansion medium. hAFSCs cultured on soft PVA hydrogels (12.2 kPa) that were grafted with oligopeptides derived from fibronectin and vitronectin showed high pluripotency, which was evaluated by Oct4, Sox2 and Nanog expression. The hAFSCs grown on soft PVA hydrogels (12.2 kPa) grafted with each oligopeptide showed higher pluripotency, as assessed by Oct4 and Nanog expression, than hAFSCs grown on stiff PVA hydrogels (25.3 kPa) grafted with the same oligopeptides and a much higher pluripotency than those grown on rigid tissue-culture polystyrene dishes. Soft biomaterials appeared to be adequate to maintain the pluripotency of hAFSCs. Surprisingly, hAFSCs that showed higher pluripotency on PVA hydrogels grafted with oligopeptides derived from fibronectin and vitronectin also expressed higher levels of early differentiation markers for three germ layers in expansion medium. This result suggests that hAFSCs are heterogeneous and that this population contains highly pluripotent stem cells and stem cells that can be easily differentiated.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024666</affiliation-url><afid>60024666</afid><affilname>National Central University Taiwan</affilname><name-variant>National Central University</name-variant><affiliation-city>Chung-Li</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027173</affiliation-url><afid>60027173</afid><affilname>Cathay General Hospital Taiwan</affilname><name-variant>Cathay General Hospital</name-variant><affiliation-city>Taipei</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024666</affiliation-url><afid>60024666</afid><affilname>National Central University Taiwan</affilname><name-variant>National Central University</name-variant><affiliation-city>Chung-Li</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013183</affiliation-url><afid>60013183</afid><affilname>King Saud University</affilname><name-variant>King Saud University</name-variant><affiliation-city>Riyadh</affiliation-city><affiliation-country>Saudi Arabia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016648</affiliation-url><afid>60016648</afid><affilname>Riken</affilname><name-variant>RIKEN</name-variant><affiliation-city>Wako</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024666</affiliation-url><afid>60024666</afid><affilname>National Central University Taiwan</affilname><name-variant>National Central University</name-variant><affiliation-city>Chung-Li</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027173</affiliation-url><afid>60027173</afid><affilname>Cathay General Hospital Taiwan</affilname><name-variant>Cathay General Hospital</name-variant><affiliation-city>Taipei</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025577</affiliation-url><afid>60025577</afid><affilname>Universiti Putra Malaysia</affilname><name-variant>University Putra Malaysia</name-variant><affiliation-city>Serdang</affiliation-city><affiliation-country>Malaysia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029740</affiliation-url><afid>60029740</afid><affilname>Chung Yuan Christian University</affilname><name-variant>Chung-Yuan Christian University</name-variant><affiliation-city>Chung-Li</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115216877</affiliation-url><afid>115216877</afid><affilname>Gynaecology Taiwan Landseed Hospital</affilname><name-variant>Gynaecology Taiwan Landseed Hospital</name-variant><affiliation-city/><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115217139</affiliation-url><afid>115217139</afid><affilname>Medicine Taiwan Landseed Hospital</affilname><name-variant>Medicine Taiwan Landseed Hospital</name-variant><affiliation-city/><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:109863246</affiliation-url><afid>109863246</afid><affilname>Hungchi Women and Children's Hospital</affilname><name-variant>Hungchi Women and Children's Hospital</name-variant><affiliation-city>Chung-Li</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022847</affiliation-url><afid>60022847</afid><affilname>Industrial Technology Research Institute of Taiwan</affilname><name-variant>Industrial Technology Research Institute</name-variant><affiliation-city>Hsin-chu</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011828</affiliation-url><afid>60011828</afid><affilname>Triservice General Hospital Taiwan</affilname><name-variant>Tri-Service General Hospital</name-variant><affiliation-city>Taipei</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">19</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56232865000</author-url><authid>56232865000</authid><authname>Wang P.</authname><surname>Wang</surname><given-name>Pin Yu</given-name><initials>P.Y.</initials><afid>60024666</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56232701100</author-url><authid>56232701100</authid><authname>Lee H.</authname><surname>Lee</surname><given-name>Henry Hsin Chung</given-name><initials>H.H.C.</initials><afid>60027173</afid><afid>60024666</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56232701100</author-url><authid>56232701100</authid><authname>Lee H.</authname><surname>Lee</surname><given-name>Henry Hsin Chung</given-name><initials>H.H.C.</initials><afid>60027173</afid><afid>60024666</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35502581000</author-url><authid>35502581000</authid><authname>Higuchi A.</authname><surname>Higuchi</surname><given-name>Akon</given-name><initials>A.</initials><afid>60024666</afid><afid>60013183</afid><afid>60016648</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35502581000</author-url><authid>35502581000</authid><authname>Higuchi A.</authname><surname>Higuchi</surname><given-name>Akon</given-name><initials>A.</initials><afid>60024666</afid><afid>60013183</afid><afid>60016648</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35502581000</author-url><authid>35502581000</authid><authname>Higuchi A.</authname><surname>Higuchi</surname><given-name>Akon</given-name><initials>A.</initials><afid>60024666</afid><afid>60013183</afid><afid>60016648</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7005827478</author-url><authid>7005827478</authid><authname>Ling Q.</authname><surname>Ling</surname><given-name>Qing Dong</given-name><initials>Q.D.</initials><afid>60024666</afid><afid>60027173</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7005827478</author-url><authid>7005827478</authid><authname>Ling Q.</authname><surname>Ling</surname><given-name>Qing Dong</given-name><initials>Q.D.</initials><afid>60024666</afid><afid>60027173</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56623576300</author-url><authid>56623576300</authid><authname>Lin H.</authname><surname>Lin</surname><given-name>Hong Ren</given-name><initials>H.R.</initials><afid>60024666</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56624117400</author-url><authid>56624117400</authid><authname>Li H.</authname><surname>Li</surname><given-name>Hsin Fen</given-name><initials>H.F.</initials><afid>60024666</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:36449270100</author-url><authid>36449270100</authid><authname>Suresh Kumar S.</authname><surname>Suresh Kumar</surname><given-name>S.</given-name><initials>S.</initials><afid>60025577</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56623583700</author-url><authid>56623583700</authid><authname>Chang Y.</authname><surname>Chang</surname><given-name>Yung</given-name><initials>Y.</initials><afid>60029740</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56194636200</author-url><authid>56194636200</authid><authname>Alarfaj A.</authname><surname>Alarfaj</surname><given-name>Abdullah A.</given-name><initials>A.A.</initials><afid>60013183</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56020714500</author-url><authid>56020714500</authid><authname>Munusamy M.</authname><surname>Munusamy</surname><given-name>Murugan A.</given-name><initials>M.A.</initials><afid>60013183</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:56623566400</author-url><authid>56623566400</authid><authname>Chen D.</authname><surname>Chen</surname><given-name>Da Chung</given-name><initials>D.C.</initials><afid>115216877</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:56623754600</author-url><authid>56623754600</authid><authname>Hsu S.</authname><surname>Hsu</surname><given-name>Shih Tien</given-name><initials>S.T.</initials><afid>115217139</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:56464814900</author-url><authid>56464814900</authid><authname>Wang H.</authname><surname>Wang</surname><given-name>Han Chow</given-name><initials>H.C.</initials><afid>109863246</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:56623994900</author-url><authid>56623994900</authid><authname>Hsiao H.</authname><surname>Hsiao</surname><given-name>Hung Yi</given-name><initials>H.Y.</initials><afid>60022847</afid></author><author seq="15"><author-url>http://api.elsevier.com/content/author/author_id:56623634900</author-url><authid>56623634900</authid><authname>Wu G.</authname><surname>Wu</surname><given-name>Gwo Jang</given-name><initials>G.J.</initials><afid>60011828</afid></author><intid>1785877267</intid><source-id>21100229202</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929991508"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929991508?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929991508&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929991508&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929991508</prism:url><dc:identifier>SCOPUS_ID:84929991508</dc:identifier><eid>2-s2.0-84929991508</eid><dc:title>Laparoscopic retrieval of an intra-abdominal air gun pellet</dc:title><dc:creator>Oliphant Z.</dc:creator><prism:publicationName>BMJ Case Reports</prism:publicationName><prism:eIssn>1757790X</prism:eIssn><prism:volume>2015</prism:volume><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.1136/bcr-2014-208552</prism:doi><dc:description>Copyright 2015 BMJ Publishing Group. All rights reserved. A 19-year-old man presented to the emergency department following an air gun pellet injury to the abdomen. He was clinically stable and underwent laparoscopic retrieval of the pellet, which was found embedded in the small bowel mesentery. He recovered fully and was discharged after 2 days. We further discuss air gun-related injuries.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006737</affiliation-url><afid>60006737</afid><affilname>Musgrove Park Hospital</affilname><name-variant>Musgrove Park Hospital</name-variant><affiliation-city>Taunton</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023179</affiliation-url><afid>60023179</afid><affilname>Taunton and Somerset NHS Trust</affilname><name-variant>Taunton and Somerset Hospital</name-variant><affiliation-city>Taunton</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56200616900</author-url><authid>56200616900</authid><authname>Oliphant Z.</authname><surname>Oliphant</surname><given-name>Zoe</given-name><initials>Z.</initials><afid>60006737</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56658493000</author-url><authid>56658493000</authid><authname>Tudor E.</authname><surname>Tudor</surname><given-name>Edward</given-name><initials>E.</initials><afid>60006737</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56562738400</author-url><authid>56562738400</authid><authname>Bamford R.</authname><surname>Bamford</surname><given-name>Richard</given-name><initials>R.</initials><afid>60023179</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7004351050</author-url><authid>7004351050</authid><authname>Mahon D.</authname><surname>Mahon</surname><given-name>David</given-name><initials>D.</initials><afid>60006737</afid></author><intid>2036044987</intid><article-number>208552</article-number><source-id>19700201654</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929340246"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929340246?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929340246&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929340246&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929340246</prism:url><dc:identifier>SCOPUS_ID:84929340246</dc:identifier><eid>2-s2.0-84929340246</eid><dc:title>Selection of genes associated with variations in the circle of willis in gerbils using suppression subtractive hybridization</dc:title><dc:creator>Li Z.</dc:creator><prism:publicationName>PLoS ONE</prism:publicationName><prism:eIssn>19326203</prism:eIssn><prism:volume>10</prism:volume><prism:issueIdentifier>5</prism:issueIdentifier><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.1371/journal.pone.0127355</prism:doi><dc:description>© 2015 Li et al. Deformities in the Circle of Willis (CoW) can significantly increase the risk of cerebrovascular disease in humans. However, the molecular mechanisms underlying these deformities have not been understood. Based on our previous studies, variations in the CoW of gerbils are hereditary. A normal CoW is observed in approximately 60% of gerbils, a percentage that also applies to humans. Thus, gerbil is an ideal experimental model for studying variations in the CoW. To study the mechanisms underlying these variations, we selected genes associated with different types of the CoW using suppression subtractive hybridization (SSH). After evaluating the efficiency of SSH using quantitative real-time polymerase chain reaction (qPCR) on subtracted and unsubtracted cDNA and Southern blotting on SSH PCR products, 12 SSH libraries were established. We identified 4 genes (CST3, GNAS, GPx4 and PFN2) associated with variations in the CoW. These genes were identified with qPCR and Western blotting using 70 expressed sequence tags from the SSH libraries. Cloning and sequencing allowed us to demonstrate that the 4 genes were closely related to mouse genes. We may assume that these 4 genes play an important role in the development of variations in the CoW. This study provides a foundation for further research of genes related to development of variations in the CoW and the mechanisms of dysmorphosis of cerebral vessels.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026707</affiliation-url><afid>60026707</afid><affilname>Capital Medical University China</affilname><name-variant>Capital Medical University</name-variant><affiliation-city>Beijing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114680397</affiliation-url><afid>114680397</afid><affilname>National Institutes for Food and Drug Control</affilname><name-variant>National Institutes for Food and Drug Control</name-variant><affiliation-city/><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56441865900</author-url><authid>56441865900</authid><authname>Li Z.</authname><surname>Li</surname><given-name>Zhenkun</given-name><initials>Z.</initials><afid>60026707</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55710791100</author-url><authid>55710791100</authid><authname>Huo X.</authname><surname>Huo</surname><given-name>Xueyun</given-name><initials>X.</initials><afid>60026707</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56441831500</author-url><authid>56441831500</authid><authname>Zhang S.</authname><surname>Zhang</surname><given-name>Shuangyue</given-name><initials>S.</initials><afid>60026707</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56643356900</author-url><authid>56643356900</authid><authname>Lu J.</authname><surname>Lu</surname><given-name>Jing</given-name><initials>J.</initials><afid>60026707</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56441851200</author-url><authid>56441851200</authid><authname>Li C.</authname><surname>Li</surname><given-name>Changlong</given-name><initials>C.</initials><afid>60026707</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55732406700</author-url><authid>55732406700</authid><authname>Guo M.</authname><surname>Guo</surname><given-name>Meng</given-name><initials>M.</initials><afid>60026707</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56643942800</author-url><authid>56643942800</authid><authname>Fu R.</authname><surname>Fu</surname><given-name>Rui</given-name><initials>R.</initials><afid>114680397</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56643533300</author-url><authid>56643533300</authid><authname>He Z.</authname><surname>He</surname><given-name>Zhengming</given-name><initials>Z.</initials><afid>114680397</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:54398319400</author-url><authid>54398319400</authid><authname>Du X.</authname><surname>Du</surname><given-name>Xiaoyan</given-name><initials>X.</initials><afid>60026707</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:23495360800</author-url><authid>23495360800</authid><authname>Chen Z.</authname><surname>Chen</surname><given-name>Zhenwen</given-name><initials>Z.</initials><afid>60026707</afid></author><intid>2035941217</intid><article-number>e0127355</article-number><source-id>10600153309</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929471676"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929471676?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929471676&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929471676&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929471676</prism:url><dc:identifier>SCOPUS_ID:84929471676</dc:identifier><eid>2-s2.0-84929471676</eid><dc:title>The role of 64/128-slice multidetector computed tomography to assess the progression of coronary atherosclerosis</dc:title><dc:creator>Ayad S.</dc:creator><prism:publicationName>Clinical Medicine Insights: Cardiology</prism:publicationName><prism:issn>11795468</prism:issn><prism:eIssn>11795468</prism:eIssn><prism:volume>9</prism:volume><prism:pageRange>47-52</prism:pageRange><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.4137/CMC.S20606</prism:doi><dc:description>© the authors, publisher and licensee Libertas Academica Limited. Objectives: We studied the progression of coronary atherosclerosis over time as detected by multidetector computed tomography (MDCT) in relation to risk factors and plaque composition. Background: Studies using MDCT are limited to the assessment of the degree of stenosis without taking into consideration the plaque composition that is seen by MDCT. Methods: This study included 200 patients, complaining of chest pain and referred to do 64/128-contrast–enhanced MDCT for the second time, and both studies were retrieved and evaluated for the presence of plaque, plaque type, vessel wall remodeling, percent area, and diameter stenosis and compared in both studies. Plaque progression over time and its association with risk factors were determined. Results: We included 200 patients, and 348 plaques were detected by 64/128 MDCT. The duration between follow-up and baseline studies was 25.9 ± 19.2 month. In all, 200 plaques showed progression (57.47%), 122 were stable (35.06%), and 26 regressed (7.47%). In longitudinal regression analysis, the presence of history of diabetes mellitus and dyslipidemia and the absence of intraplaque calcium deposits were independently associated with plaque progression over time (P &lt; 0.0001). CONCLUSION: Coronary plaque burden of patients with chest pain and no history of acute coronary syndrome significantly increased over time. Progression is dependent on plaque composition and cardiovascular risk factors. Larger studies and longer follow-up period are needed to confirm the determinant factors for plaque progression.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60033041</affiliation-url><afid>60033041</afid><affilname>Alexandria University</affilname><name-variant>Alexandria University</name-variant><affiliation-city>Alexandria</affiliation-city><affiliation-country>Egypt</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35486751800</author-url><authid>35486751800</authid><authname>Ayad S.</authname><surname>Ayad</surname><given-name>Sherif W.</given-name><initials>S.W.</initials><afid>60033041</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55769723400</author-url><authid>55769723400</authid><authname>Elsharkawy E.</authname><surname>Elsharkawy</surname><given-name>Eman M.</given-name><initials>E.M.</initials><afid>60033041</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56648026000</author-url><authid>56648026000</authid><authname>Eltahan S.</authname><surname>Eltahan</surname><given-name>Salah M.</given-name><initials>S.M.</initials><afid>60033041</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55345664600</author-url><authid>55345664600</authid><authname>Sobhy M.</authname><surname>Sobhy</surname><given-name>Mohamed A.</given-name><initials>M.A.</initials><afid>60033041</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56648048300</author-url><authid>56648048300</authid><authname>Laymouna R.</authname><surname>Laymouna</surname><given-name>Reem H.</given-name><initials>R.H.</initials><afid>60033041</afid></author><authkeywords>Atherosclerosis | Cardiac MDCT | Plaque progression</authkeywords><intid>1535962843</intid><source-id>19700173224</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929340115"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929340115?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929340115&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929340115&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929340115</prism:url><dc:identifier>SCOPUS_ID:84929340115</dc:identifier><eid>2-s2.0-84929340115</eid><dc:title>Characterization and evaluation of neuronal trans-differentiation with electrophysiological properties of mesenchymal stem cells isolated from porcine endometrium</dc:title><dc:creator>Subbarao R.</dc:creator><prism:publicationName>International Journal of Molecular Sciences</prism:publicationName><prism:issn>16616596</prism:issn><prism:eIssn>14220067</prism:eIssn><prism:volume>16</prism:volume><prism:issueIdentifier>5</prism:issueIdentifier><prism:pageRange>10934-10951</prism:pageRange><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.3390/ijms160510934</prism:doi><dc:description>© 2015 by the authors; licensee MDPI, Basel, Switzerland. Endometrial stromal cells (EMSCs) obtained from porcine uterus (n = 6) were positive for mesenchymal stem cell markers (CD29, CD44 and CD90), and negative for epithelial marker CD9 and hematopoietic markers CD34, CD45 analyzed by flow cytometry. Further the cells were positive for expression of mesenchymal markers, CD105, CD140b, and CD144 by PCR. Pluripotent markers OCT4, SOX2, and NANOG were positively expressed in EMSCs analyzed by Western blotting and PCR. Further, differentiation into adipocytes and osteocytes was confirmed by cytochemical staining and lineage specific gene expression by quantitative realtime-PCR. Adipocyte (FABP, LPL, AP2) and osteocyte specific genes (ON, BG, RUNX2) in differentiated EMSCs showed significant (p &lt; 0.05) increase in expression compared to undifferentiated control cells. Neurogenic transdifferentiation of EMSCs exhibited distinctive dendritic morphology with axon projections and neuronal specific genes, NFM, NGF, MBP, NES, B3T and MAP2 and proteins, B3T, NFM, NGF, and TRKA were positively expressed in neuronal differentiated cells. Functional analysis of neuronal differentiated EMSCs displayed voltage-dependence and kinetics for transient outward K&lt;sup&gt;+&lt;/sup&gt; currents (I&lt;inf&gt;to&lt;/inf&gt;), at holding potential of −80 mV, Na&lt;sup&gt;+&lt;/sup&gt; currents and during current clamp, neuronal differentiated EMSCs was more negative than that of control EMSCs. Porcine EMSCs is a suitable model for studying molecular mechanism of transdifferentiation, assessment of electrophysiological properties and their efficiency during in vivo transplantation.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023075</affiliation-url><afid>60023075</afid><affilname>Gyeongsang National University</affilname><name-variant>Gyeongsang National University</name-variant><affiliation-city>Jinju</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009471</affiliation-url><afid>60009471</afid><affilname>Gyeongsang National University (GSNU), College of Medicine</affilname><name-variant>Gyeongsang National University College of Medicine</name-variant><affiliation-city>Jinju</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009471</affiliation-url><afid>60009471</afid><affilname>Gyeongsang National University (GSNU), College of Medicine</affilname><name-variant>Gyeongsang National University College of Medicine</name-variant><affiliation-city>Jinju</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023075</affiliation-url><afid>60023075</afid><affilname>Gyeongsang National University</affilname><name-variant>Gyeongsang National University</name-variant><affiliation-city>Jinju</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">11</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56625834500</author-url><authid>56625834500</authid><authname>Subbarao R.</authname><surname>Subbarao</surname><given-name>Raghavendra Baregundi</given-name><initials>R.B.</initials><afid>60023075</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56625678000</author-url><authid>56625678000</authid><authname>Ullah I.</authname><surname>Ullah</surname><given-name>Imran</given-name><initials>I.</initials><afid>60023075</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56643513000</author-url><authid>56643513000</authid><authname>Kim E.</authname><surname>Kim</surname><given-name>Eun Jin</given-name><initials>E.J.</initials><afid>60009471</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55914505400</author-url><authid>55914505400</authid><authname>Jang S.</authname><surname>Jang</surname><given-name>Si Jung</given-name><initials>S.J.</initials><afid>60023075</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56281574500</author-url><authid>56281574500</authid><authname>Lee W.</authname><surname>Lee</surname><given-name>Won Jae</given-name><initials>W.J.</initials><afid>60023075</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:51763688100</author-url><authid>51763688100</authid><authname>Jeon R.</authname><surname>Jeon</surname><given-name>Ryoung Hoon</given-name><initials>R.H.</initials><afid>60023075</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7402889355</author-url><authid>7402889355</authid><authname>Kang D.</authname><surname>Kang</surname><given-name>Dawon</given-name><initials>D.</initials><afid>60009471</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56435209100</author-url><authid>56435209100</authid><authname>Lee S.</authname><surname>Lee</surname><given-name>Sung Lim</given-name><initials>S.L.</initials><afid>60023075</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:21234242200</author-url><authid>21234242200</authid><authname>Park B.</authname><surname>Park</surname><given-name>Bong Wook</given-name><initials>B.W.</initials><afid>60009471</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:6603725057</author-url><authid>6603725057</authid><authname>Rho G.</authname><surname>Rho</surname><given-name>Gyu Jin</given-name><initials>G.J.</initials><afid>60023075</afid><afid>60023075</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:6603725057</author-url><authid>6603725057</authid><authname>Rho G.</authname><surname>Rho</surname><given-name>Gyu Jin</given-name><initials>G.J.</initials><afid>60023075</afid><afid>60023075</afid></author><authkeywords>Endometrium | Mesenchymal stem cells | Multilineage differentiation | Porcine | Transdifferentiation</authkeywords><intid>2035939112</intid><source-id>25879</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929302673"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929302673?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929302673&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929302673&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929302673</prism:url><dc:identifier>SCOPUS_ID:84929302673</dc:identifier><eid>2-s2.0-84929302673</eid><dc:title>Discovery of a potent parenterally administered factor XIa inhibitor with hydroxyquinolin-2(1H)-one as the P2′ moiety</dc:title><dc:creator>Hu Z.</dc:creator><prism:publicationName>ACS Medicinal Chemistry Letters</prism:publicationName><prism:eIssn>19485875</prism:eIssn><prism:volume>6</prism:volume><prism:issueIdentifier>5</prism:issueIdentifier><prism:pageRange>590-595</prism:pageRange><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.1021/acsmedchemlett.5b00066</prism:doi><dc:description>© 2015 American Chemical Society. Structure-activity relationship optimization of phenylalanine P1′ and P2′ regions with a phenylimidazole core resulted in a series of potent FXIa inhibitors. Introducing 4-hydroxyquinolin-2-one as the P2′ group enhanced FXIa affinity and metabolic stability. Incorporation of an N-methyl piperazine amide group to replace the phenylalanine improved both FXIa potency and aqueous solubility. Combination of the optimization led to the discovery of FXIa inhibitor 13 with a FXIa K&lt;inf&gt;i&lt;/inf&gt; of 0.04 nM and an aPTT EC&lt;inf&gt;2x&lt;/inf&gt; of 1.0 μM. Dose-dependent efficacy (EC&lt;inf&gt;50&lt;/inf&gt; of 0.53 μM) was achieved in the rabbit ECAT model with minimal bleeding time prolongation.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001149</affiliation-url><afid>60001149</afid><affilname>Bristol-Myers Squibb Research and Development</affilname><name-variant>Bristol-Myers Squibb</name-variant><affiliation-city>Princeton</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">19</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7404211468</author-url><authid>7404211468</authid><authname>Hu Z.</authname><surname>Hu</surname><given-name>Zilun</given-name><initials>Z.</initials><afid>60001149</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56447718000</author-url><authid>56447718000</authid><authname>Wong P.</authname><surname>Wong</surname><given-name>Pancras C.</given-name><initials>P.C.</initials><afid>60001149</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7005574438</author-url><authid>7005574438</authid><authname>Gilligan P.</authname><surname>Gilligan</surname><given-name>Paul J.</given-name><initials>P.J.</initials><afid>60001149</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56643685900</author-url><authid>56643685900</authid><authname>Han W.</authname><surname>Han</surname><given-name>Wei</given-name><initials>W.</initials><afid>60001149</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:9939343700</author-url><authid>9939343700</authid><authname>Pabbisetty K.</authname><surname>Pabbisetty</surname><given-name>Kumar B.</given-name><initials>K.B.</initials><afid>60001149</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7004201216</author-url><authid>7004201216</authid><authname>Bozarth J.</authname><surname>Bozarth</surname><given-name>Jeffrey M.</given-name><initials>J.M.</initials><afid>60001149</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7006107977</author-url><authid>7006107977</authid><authname>Crain E.</authname><surname>Crain</surname><given-name>Earl J.</given-name><initials>E.J.</initials><afid>60001149</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:37161532500</author-url><authid>37161532500</authid><authname>Harper T.</authname><surname>Harper</surname><given-name>Timothy</given-name><initials>T.</initials><afid>60001149</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:6603220442</author-url><authid>6603220442</authid><authname>Luettgen J.</authname><surname>Luettgen</surname><given-name>Joseph M.</given-name><initials>J.M.</initials><afid>60001149</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56525961600</author-url><authid>56525961600</authid><authname>Myers J.</authname><surname>Myers</surname><given-name>Joseph E.</given-name><initials>J.E.</initials><afid>60001149</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:15068736900</author-url><authid>15068736900</authid><authname>Ramamurthy V.</authname><surname>Ramamurthy</surname><given-name>Vidhyashankar</given-name><initials>V.</initials><afid>60001149</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:7003703475</author-url><authid>7003703475</authid><authname>Rossi K.</authname><surname>Rossi</surname><given-name>Karen A.</given-name><initials>K.A.</initials><afid>60001149</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:56212281600</author-url><authid>56212281600</authid><authname>Sheriff S.</authname><surname>Sheriff</surname><given-name>Steven</given-name><initials>S.</initials><afid>60001149</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:7402883577</author-url><authid>7402883577</authid><authname>Watson C.</authname><surname>Watson</surname><given-name>Carol A.</given-name><initials>C.A.</initials><afid>60001149</afid></author><author seq="15"><author-url>http://api.elsevier.com/content/author/author_id:56644098300</author-url><authid>56644098300</authid><authname>Wei A.</authname><surname>Wei</surname><given-name>Anzi</given-name><initials>A.</initials><afid>60001149</afid></author><author seq="16"><author-url>http://api.elsevier.com/content/author/author_id:56643505100</author-url><authid>56643505100</authid><authname>Zheng J.</authname><surname>Zheng</surname><given-name>Joanna J.</given-name><initials>J.J.</initials><afid>60001149</afid></author><author seq="17"><author-url>http://api.elsevier.com/content/author/author_id:7006511702</author-url><authid>7006511702</authid><authname>Seiffert D.</authname><surname>Seiffert</surname><given-name>Dietmar A.</given-name><initials>D.A.</initials><afid>60001149</afid></author><author seq="18"><author-url>http://api.elsevier.com/content/author/author_id:7006255173</author-url><authid>7006255173</authid><authname>Wexler R.</authname><surname>Wexler</surname><given-name>Ruth R.</given-name><initials>R.R.</initials><afid>60001149</afid></author><author seq="19"><author-url>http://api.elsevier.com/content/author/author_id:7006335450</author-url><authid>7006335450</authid><authname>Quan M.</authname><surname>Quan</surname><given-name>Mimi L.</given-name><initials>M.L.</initials><afid>60001149</afid></author><authkeywords>anticoagulant | factor XIa | Thrombosis</authkeywords><intid>35945285</intid><source-id>19700177127</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929346819"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929346819?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929346819&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929346819&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929346819</prism:url><dc:identifier>SCOPUS_ID:84929346819</dc:identifier><eid>2-s2.0-84929346819</eid><dc:title>Genetic determinants for gestational diabetes mellitus and related metabolic traits in Mexican women</dc:title><dc:creator>Huerta-Chagoya A.</dc:creator><prism:publicationName>PLoS ONE</prism:publicationName><prism:eIssn>19326203</prism:eIssn><prism:volume>10</prism:volume><prism:issueIdentifier>5</prism:issueIdentifier><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.1371/journal.pone.0126408</prism:doi><dc:description>© 2015 Huerta-Chagoya et al. Epidemiological and physiological similarities among Gestational Diabetes Mellitus (GDM) and Type 2 Diabetes (T2D) suggest that both diseases, share a common genetic background. T2D risk variants have been associated to GDM susceptibility. However, the genetic architecture of GDM is not yet completely understood. We analyzed 176 SNPs for 115 loci previously associated to T2D, GDM and body mass index (BMI), as well as a set of 118 Ancestry Informative Markers (AIMs), in 750 pregnant Mexican women. Association with GDM was found for two of the most frequently replicated T2D loci:aTCF7L2 haplotype (CTTC: rs7901695, rs4506565, rs7903146, rs12243326; P=2.16×10&lt;sup&gt;-06&lt;/sup&gt;; OR=2.95) and a KCNQ1 haplotype (TTT: rs2237892, rs163184, rs2237897; P=1.98×10&lt;sup&gt;-05&lt;/sup&gt;; OR=0.55). In addition, we found two loci associated to glycemic traits: CENTD2 (60′ OGTT glycemia: rs1552224, P=0.03727) and MTNR1B (HOMA B: rs1387153, P=0.05358). Remarkably, a major susceptibility SLC16A11 locus for T2D in Mexicans was not shown to play a role in GDM risk. The fact that two of the main T2D associated loci also contribute to the risk of developing GDM in Mexicans, confirm that both diseases share a common genetic background. However, lack of association with a Native American contribution T2D risk haplotype, SLC16A11, suggests that other genetic mechanisms may be in play for GDM.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009149</affiliation-url><afid>60009149</afid><affilname>Instituto Nacional de la Nutricion Salvador Zubiran</affilname><name-variant>Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán</name-variant><affiliation-city>Tlalpan</affiliation-city><affiliation-country>Mexico</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009149</affiliation-url><afid>60009149</afid><affilname>Instituto Nacional de la Nutricion Salvador Zubiran</affilname><name-variant>Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán</name-variant><affiliation-city>Tlalpan</affiliation-city><affiliation-country>Mexico</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014923</affiliation-url><afid>60014923</afid><affilname>Universidad Autonoma Metropolitana</affilname><name-variant>Universidad Autónoma Metropolitana</name-variant><affiliation-city>Mexico City</affiliation-city><affiliation-country>Mexico</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60069654</affiliation-url><afid>60069654</afid><affilname>Hospital General O'Horan</affilname><name-variant>Hospital General O'Horan</name-variant><affiliation-city>Merida</affiliation-city><affiliation-country>Mexico</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000409</affiliation-url><afid>60000409</afid><affilname>Universidad Autonoma de Yucatan</affilname><name-variant>Universidad Autónoma de Yucatán</name-variant><affiliation-city>Merida</affiliation-city><affiliation-country>Mexico</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000123</affiliation-url><afid>60000123</afid><affilname>Hospital 20 de Noviembre</affilname><name-variant>Cent. Hosp. '20 de Noviembre'</name-variant><affiliation-city>Mexico City</affiliation-city><affiliation-country>Mexico</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60033487</affiliation-url><afid>60033487</afid><affilname>Instituto Nacional de Perinatologia</affilname><name-variant>Instituto Nacional de Perinatología</name-variant><affiliation-city>Mexico City</affiliation-city><affiliation-country>Mexico</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003352</affiliation-url><afid>60003352</afid><affilname>Hospital General Dr. Manual Gea Gonalez, Mexico City</affilname><name-variant>Hospital General Dr. Manuel Gea González</name-variant><affiliation-city>Mexico City</affiliation-city><affiliation-country>Mexico</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115242826</affiliation-url><afid>115242826</afid><affilname>Centro de Investigación Materno Infantil GEN</affilname><name-variant>Centro de Investigación Materno Infantil GEN</name-variant><affiliation-city>Mexico City</affiliation-city><affiliation-country>Mexico</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">15</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:50061303500</author-url><authid>50061303500</authid><authname>Huerta-Chagoya A.</authname><surname>Huerta-Chagoya</surname><given-name>Alicia</given-name><initials>A.</initials><afid>60009149</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55508355800</author-url><authid>55508355800</authid><authname>Vázquez-Cárdenas P.</authname><surname>Vázquez-Cárdenas</surname><given-name>Paola</given-name><initials>P.</initials><afid>60009149</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6507133032</author-url><authid>6507133032</authid><authname>Moreno-Macías H.</authname><surname>Moreno-Macías</surname><given-name>Hortensia</given-name><initials>H.</initials><afid>60014923</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56644766300</author-url><authid>56644766300</authid><authname>Tapia-Maruri L.</authname><surname>Tapia-Maruri</surname><given-name>Leonardo</given-name><initials>L.</initials><afid>60009149</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:36057116300</author-url><authid>36057116300</authid><authname>Rodríguez-Guillén R.</authname><surname>Rodríguez-Guillén</surname><given-name>Rosario</given-name><initials>R.</initials><afid>60009149</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56644818500</author-url><authid>56644818500</authid><authname>López-Vite E.</authname><surname>López-Vite</surname><given-name>Erika</given-name><initials>E.</initials><afid>60069654</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:6504662331</author-url><authid>6504662331</authid><authname>García-Escalante G.</authname><surname>García-Escalante</surname><given-name>Guadalupe</given-name><initials>G.</initials><afid>60000409</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:6506681885</author-url><authid>6506681885</authid><authname>Escobedo-Aguirre F.</authname><surname>Escobedo-Aguirre</surname><given-name>Fernando</given-name><initials>F.</initials><afid>60000123</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:6603539595</author-url><authid>6603539595</authid><authname>Parra-Covarrubias A.</authname><surname>Parra-Covarrubias</surname><given-name>Adalberto</given-name><initials>A.</initials><afid>60033487</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56644866000</author-url><authid>56644866000</authid><authname>Cordero-Brieño R.</authname><surname>Cordero-Brieño</surname><given-name>Roberto</given-name><initials>R.</initials><afid>60003352</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:56644766600</author-url><authid>56644766600</authid><authname>Manzo-Carrillo L.</authname><surname>Manzo-Carrillo</surname><given-name>Lizette</given-name><initials>L.</initials><afid>60003352</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:15756695600</author-url><authid>15756695600</authid><authname>Zacarías-Castillo R.</authname><surname>Zacarías-Castillo</surname><given-name>Rogelio</given-name><initials>R.</initials><afid>60003352</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:55904587400</author-url><authid>55904587400</authid><authname>Vargas-García C.</authname><surname>Vargas-García</surname><given-name>Carlos</given-name><initials>C.</initials><afid>115242826</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:55989775200</author-url><authid>55989775200</authid><authname>Aguilar-Salinas C.</authname><surname>Aguilar-Salinas</surname><given-name>Carlos</given-name><initials>C.</initials><afid>60009149</afid></author><author seq="15"><author-url>http://api.elsevier.com/content/author/author_id:55509716400</author-url><authid>55509716400</authid><authname>Tusié-Luna T.</authname><surname>Tusié-Luna</surname><given-name>Teresa</given-name><initials>T.</initials><afid>60009149</afid></author><intid>35944826</intid><article-number>e0126408</article-number><source-id>10600153309</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929359238"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929359238?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929359238&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929359238&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929359238</prism:url><dc:identifier>SCOPUS_ID:84929359238</dc:identifier><eid>2-s2.0-84929359238</eid><dc:title>Multivalent Aptamer/Gold Nanoparticle-Modified Graphene Oxide for Mass Spectrometry-Based Tumor Tissue Imaging</dc:title><dc:creator>Huang R.</dc:creator><prism:publicationName>Scientific Reports</prism:publicationName><prism:eIssn>20452322</prism:eIssn><prism:volume>5</prism:volume><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.1038/srep10292</prism:doi><dc:description>© 2015, NPG-Nature Publishing Group. All rights reserved. The protein mucin1 (MUC1) is an attractive target for cancer biomarkers because it is overexpressed in most adenocarcinomas. In this study, we exploited a MUC1-binding aptamer (Apt &lt;inf&gt;MUC1&lt;/inf&gt;) as a targeting agent for nanoparticle-based imaging systems coupled with laser desorption/ionization mass spectrometry (LDI-MS). We found that Apt &lt;inf&gt;MUC1&lt;/inf&gt; -conjugated gold nanoparticles immobilized, through hydrophobic and π-π interactions, on graphene oxide (Apt &lt;inf&gt;MUC1&lt;/inf&gt; -Au NPs/GO) bound effectively to MUC1 units on tumor cell membranes. The ultrahigh density and high flexibility of Apt &lt;inf&gt;MUC1&lt;/inf&gt; on the GO surface enhanced the platform's cooperative and multivalent binding affinity for MUC1 on cell membranes. After we had labeled MUC1-overexpressing MCF-&lt;inf&gt;7&lt;/inf&gt; cells (human breast adenocarcinoma cell line) with Apt &lt;inf&gt;MUC1&lt;/inf&gt; -Au NPs/GO, we used LDI-MS to monitor Au cluster ions ([Au&lt;inf&gt;n&lt;/inf&gt; ] &lt;sup&gt;+&lt;/sup&gt;; n ;= 1-3), resulting in the detection of as few as 100 MCF-&lt;sup&gt;7&lt;/sup&gt; cells. We also employed this Apt &lt;inf&gt;MUC1&lt;/inf&gt; -Au NPs/GO-LDI-MS system to analyze four different MUC1 expression cell lines. In addition, the Apt &lt;inf&gt;MUC1&lt;/inf&gt; -Au NPs/GO platform could be used further as a labeling agent for tumor tissue imaging when coupled with LDI-MS. Thus, Apt-Au NPs/GO can function as a highly amplified signal transducer through the formation of large Au clusters ions during LDI-MS analysis.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023529</affiliation-url><afid>60023529</afid><affilname>National Taiwan Ocean University</affilname><name-variant>National Taiwan Ocean University</name-variant><affiliation-city>Keelung</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023529</affiliation-url><afid>60023529</afid><affilname>National Taiwan Ocean University</affilname><name-variant>National Taiwan Ocean University</name-variant><affiliation-city>Keelung</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012256</affiliation-url><afid>60012256</afid><affilname>Kaohsiung Medical University</affilname><name-variant>Kaohsiung Medical University</name-variant><affiliation-city>Kaohsiung</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56461849100</author-url><authid>56461849100</authid><authname>Huang R.</authname><surname>Huang</surname><given-name>Rong Cing</given-name><initials>R.C.</initials><afid>60023529</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55199280200</author-url><authid>55199280200</authid><authname>Chiu W.</authname><surname>Chiu</surname><given-name>Wei Jane</given-name><initials>W.J.</initials><afid>60023529</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56644791400</author-url><authid>56644791400</authid><authname>Po-Jung Lai I.</authname><surname>Po-Jung Lai</surname><given-name>Irving</given-name><initials>I.</initials><afid>60023529</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:16836707600</author-url><authid>16836707600</authid><authname>Huang C.</authname><surname>Huang</surname><given-name>Chih Ching</given-name><initials>C.C.</initials><afid>60023529</afid><afid>60023529</afid><afid>60012256</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:16836707600</author-url><authid>16836707600</authid><authname>Huang C.</authname><surname>Huang</surname><given-name>Chih Ching</given-name><initials>C.C.</initials><afid>60023529</afid><afid>60023529</afid><afid>60012256</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:16836707600</author-url><authid>16836707600</authid><authname>Huang C.</authname><surname>Huang</surname><given-name>Chih Ching</given-name><initials>C.C.</initials><afid>60023529</afid><afid>60023529</afid><afid>60012256</afid></author><intid>1785945095</intid><article-number>10292</article-number><source-id>21100200805</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929377539"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929377539?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929377539&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929377539&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929377539</prism:url><dc:identifier>SCOPUS_ID:84929377539</dc:identifier><eid>2-s2.0-84929377539</eid><dc:title>Effect of PKC-β signaling pathway on expression of MCP-1 and VCAM-1 in different cell models in response to advanced glycation end products (AGEs)</dc:title><dc:creator>Rempel L.</dc:creator><prism:publicationName>Toxins</prism:publicationName><prism:eIssn>20726651</prism:eIssn><prism:volume>7</prism:volume><prism:issueIdentifier>5</prism:issueIdentifier><prism:pageRange>1722-1737</prism:pageRange><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.3390/toxins7051722</prism:doi><dc:description>© 2015 by the authors; licensee MDPI, Basel, Switzerland. Advanced glycation end products (AGEs) are compounds classified as uremic toxins in patients with chronic kidney disease that have several pro-inflammatory effects and are implicated in the development of cardiovascular diseases. To explore the mechanisms of AGEs–endothelium interactions through the receptor for AGEs (RAGE) in the PKC-β pathway, we evaluated the production of MCP-1 and VCAM-1 in human endothelial cells (HUVECs), monocytes, and a coculture of both. AGEs were prepared by albumin glycation and characterized by absorbance and electrophoresis. The effect of AGEs on cell viability was assessed with an MTT assay. The cells were also treated with AGEs with and without a PKC-β inhibitor. MCP-1 and VCAM-1 in the cell supernatants were estimated by ELISA, and RAGE was evaluated by immunocytochemistry. AGEs exposure did not affect cell viability, but AGEs induced RAGE, MCP-1, and VCAM-1 expression in HUVECs. When HUVECs or monocytes were incubated with AGEs and a PKC-β inhibitor, MCP-1 and VCAM-1 expression significantly decreased. However, in the coculture, exposure to AGEs and a PKC-β inhibitor produced no significant effect. This study demonstrates, in vitro, the regulatory mechanisms involved in MCP-1 production in three cellular models and VCAM-1 production in HUVECs, and thus mimics the endothelial dysfunction caused by AGEs in early atherosclerosis. Such mechanisms could serve as therapeutic targets to reduce the harmful effects of AGEs in patients with chronic kidney disease.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015043</affiliation-url><afid>60015043</afid><affilname>Universidade Federal do Parana</affilname><name-variant>Universidade Federal do Paraná</name-variant><affiliation-city>Curitiba</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010970</affiliation-url><afid>60010970</afid><affilname>Universidade Tuiuti do Parana</affilname><name-variant>Universidade Tuiuti do Paraná</name-variant><affiliation-city>Curitiba</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015043</affiliation-url><afid>60015043</afid><affilname>Universidade Federal do Parana</affilname><name-variant>Universidade Federal do Paraná</name-variant><affiliation-city>Curitiba</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020004</affiliation-url><afid>60020004</afid><affilname>Pontificia Universidade Catolica do Parana</affilname><name-variant>Pontifical Catholic University of Paraná</name-variant><affiliation-city>Curitiba</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55823459600</author-url><authid>55823459600</authid><authname>Rempel L.</authname><surname>Rempel</surname><given-name>Lisienny C T</given-name><initials>L.C.T.</initials><afid>60015043</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56644570500</author-url><authid>56644570500</authid><authname>Finco A.</authname><surname>Finco</surname><given-name>Alessandra B.</given-name><initials>A.B.</initials><afid>60015043</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55823391900</author-url><authid>55823391900</authid><authname>Maciel R.</authname><surname>Maciel</surname><given-name>Rayana A P</given-name><initials>R.A.P.</initials><afid>60015043</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56644978500</author-url><authid>56644978500</authid><authname>Bosquetti B.</authname><surname>Bosquetti</surname><given-name>Bruna</given-name><initials>B.</initials><afid>60015043</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:8651950300</author-url><authid>8651950300</authid><authname>Alvarenga L.</authname><surname>Alvarenga</surname><given-name>Larissa M.</given-name><initials>L.M.</initials><afid>60015043</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:8723533900</author-url><authid>8723533900</authid><authname>Souza W.</authname><surname>Souza</surname><given-name>Wesley M.</given-name><initials>W.M.</initials><afid>60010970</afid><afid>60015043</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:8723533900</author-url><authid>8723533900</authid><authname>Souza W.</authname><surname>Souza</surname><given-name>Wesley M.</given-name><initials>W.M.</initials><afid>60010970</afid><afid>60015043</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7004549287</author-url><authid>7004549287</authid><authname>Pecoits-Filho R.</authname><surname>Pecoits-Filho</surname><given-name>Roberto</given-name><initials>R.</initials><afid>60020004</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:6507865179</author-url><authid>6507865179</authid><authname>Stinghen A.</authname><surname>Stinghen</surname><given-name>Andréa E M</given-name><initials>A.E.M.</initials><afid>60015043</afid></author><authkeywords>AGEs | Chronic kidney disease | Endothelial dysfunction | MCP-1 | PKC-β pathway | VCAM-1</authkeywords><intid>1035939879</intid><source-id>19700188352</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929378676"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929378676?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929378676&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929378676&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929378676</prism:url><dc:identifier>SCOPUS_ID:84929378676</dc:identifier><eid>2-s2.0-84929378676</eid><dc:title>Novel histone deacetylase inhibitors induce growth arrest, apoptosis, and differentiation in sarcoma cancer stem cells</dc:title><dc:creator>Di Pompo G.</dc:creator><prism:publicationName>Journal of Medicinal Chemistry</prism:publicationName><prism:issn>00222623</prism:issn><prism:eIssn>15204804</prism:eIssn><prism:volume>58</prism:volume><prism:issueIdentifier>9</prism:issueIdentifier><prism:pageRange>4073-4079</prism:pageRange><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.1021/acs.jmedchem.5b00126</prism:doi><dc:description>© 2015 American Chemical Society. Musculoskeletal sarcomas are aggressive malignancies of bone and soft tissues often affecting children and adolescents. Histone deacetylase inhibitors (HDACi) have been proposed to counteract cancer stem cells (CSCs) in solid neoplasms. When tested in human osteosarcoma, rhabdomyosarcoma, and Ewing's sarcoma stem cells, the new HDACi MC1742 (1) and MC2625 (2) increased acetyl-H3 and acetyl-tubulin levels and inhibited CSC growth by apoptosis induction. At nontoxic doses, 1 promoted osteogenic differentiation. Further investigation with 1 will be done in preclinical sarcoma models.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029091</affiliation-url><afid>60029091</afid><affilname>IRCCS Istituto Ortopedico Rizzoli, Bologna</affilname><name-variant>Rizzoli Orthopaedic Institute</name-variant><affiliation-city>Bologna</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028218</affiliation-url><afid>60028218</afid><affilname>Alma Mater Studiorum Universita di Bologna</affilname><name-variant>University of Bologna</name-variant><affiliation-city>Bologna</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032350</affiliation-url><afid>60032350</afid><affilname>Universita degli Studi di Roma La Sapienza</affilname><affiliation-city>Rome</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021199</affiliation-url><afid>60021199</afid><affilname>Consiglio Nazionale delle Ricerche</affilname><name-variant>CNR</name-variant><affiliation-city>Rome</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032350</affiliation-url><afid>60032350</afid><affilname>Universita degli Studi di Roma La Sapienza</affilname><affiliation-city>Rome</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">13</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55165374300</author-url><authid>55165374300</authid><authname>Di Pompo G.</authname><surname>Di Pompo</surname><given-name>Gemma</given-name><initials>G.</initials><afid>60029091</afid><afid>60028218</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55165374300</author-url><authid>55165374300</authid><authname>Di Pompo G.</authname><surname>Di Pompo</surname><given-name>Gemma</given-name><initials>G.</initials><afid>60029091</afid><afid>60028218</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:24339557600</author-url><authid>24339557600</authid><authname>Salerno M.</authname><surname>Salerno</surname><given-name>Manuela</given-name><initials>M.</initials><afid>60029091</afid><afid>60028218</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:24339557600</author-url><authid>24339557600</authid><authname>Salerno M.</authname><surname>Salerno</surname><given-name>Manuela</given-name><initials>M.</initials><afid>60029091</afid><afid>60028218</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:8577500500</author-url><authid>8577500500</authid><authname>Rotili D.</authname><surname>Rotili</surname><given-name>Dante</given-name><initials>D.</initials><afid>60032350</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7102507865</author-url><authid>7102507865</authid><authname>Valente S.</authname><surname>Valente</surname><given-name>Sergio</given-name><initials>S.</initials><afid>60032350</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:37017859900</author-url><authid>37017859900</authid><authname>Zwergel C.</authname><surname>Zwergel</surname><given-name>Clemens</given-name><initials>C.</initials><afid>60032350</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6507975142</author-url><authid>6507975142</authid><authname>Avnet S.</authname><surname>Avnet</surname><given-name>Sofia</given-name><initials>S.</initials><afid>60029091</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7004516625</author-url><authid>7004516625</authid><authname>Lattanzi G.</authname><surname>Lattanzi</surname><given-name>Giovanna</given-name><initials>G.</initials><afid>60021199</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7006625138</author-url><authid>7006625138</authid><authname>Baldini N.</authname><surname>Baldini</surname><given-name>Nicola</given-name><initials>N.</initials><afid>60029091</afid><afid>60028218</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7006625138</author-url><authid>7006625138</authid><authname>Baldini N.</authname><surname>Baldini</surname><given-name>Nicola</given-name><initials>N.</initials><afid>60029091</afid><afid>60028218</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7005565428</author-url><authid>7005565428</authid><authname>Mai A.</authname><surname>Mai</surname><given-name>Antonello</given-name><initials>A.</initials><afid>60032350</afid><afid>60032350</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7005565428</author-url><authid>7005565428</authid><authname>Mai A.</authname><surname>Mai</surname><given-name>Antonello</given-name><initials>A.</initials><afid>60032350</afid><afid>60032350</afid></author><intid>2035940160</intid><source-id>23041</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929377852"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929377852?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929377852&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929377852&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929377852</prism:url><dc:identifier>SCOPUS_ID:84929377852</dc:identifier><eid>2-s2.0-84929377852</eid><dc:title>Integrating transcriptome and genome re-sequencing data to identify key genes and mutations affecting chicken eggshell qualities</dc:title><dc:creator>Zhang Q.</dc:creator><prism:publicationName>PLoS ONE</prism:publicationName><prism:eIssn>19326203</prism:eIssn><prism:volume>10</prism:volume><prism:issueIdentifier>5</prism:issueIdentifier><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.1371/journal.pone.0125890</prism:doi><dc:description>© 2015 Zhang et al. Eggshell damages lead to economic losses in the egg production industry and are a threat to human health. We examined 49-wk-old Rhode Island White hens (Gallus gallus) that laid eggs having shells with significantly different strengths and thicknesses. We used HiSeq 2000 (Illumina) sequencing to characterize the chicken transcriptome and whole genome to identify the key genes and genetic mutations associated with eggshell calcification. We identified a total of 14,234 genes expressed in the chicken uterus, representing 89% of all annotated chicken genes. A total of 889 differentially expressed genes were identified by comparing low eggshell strength (LES) and normal eggshell strength (NES) genomes. The DEGs are enriched in calcification-related processes, including calcium ion transport and calcium signaling pathways as reveled by gene ontology (GO) and Kyoto encyclopedia of genes and genomes (KEGG) pathway analysis. Some important matrix proteins, such as OC-116, LTF and SPP1, were also expressed differentially between two groups. A total of 3,671,919 single-nucleotide polymorphisms (SNPs) and 508,035 Indels were detected in protein coding genes by whole-genome re-sequencing, including 1775 non-synonymous variations and 19 frame-shift Indels in DEGs. SNPs and Indels found in this study could be further investigated for eggshell traits. This is the first report to integrate the transcriptome and genome re-sequencing to target the genetic variations which decreased the eggshell qualities. These findings further advance our understanding of eggshell calcification in the chicken uterus.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013551</affiliation-url><afid>60013551</afid><affilname>China Agricultural University</affilname><name-variant>China Agricultural University</name-variant><affiliation-city>Beijing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56150826900</author-url><authid>56150826900</authid><authname>Zhang Q.</authname><surname>Zhang</surname><given-name>Quan</given-name><initials>Q.</initials><afid>60013551</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56150164600</author-url><authid>56150164600</authid><authname>Zhu F.</authname><surname>Zhu</surname><given-name>Feng</given-name><initials>F.</initials><afid>60013551</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56151241100</author-url><authid>56151241100</authid><authname>Liu L.</authname><surname>Liu</surname><given-name>Long</given-name><initials>L.</initials><afid>60013551</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56008569700</author-url><authid>56008569700</authid><authname>Zheng C.</authname><surname>Zheng</surname><given-name>Chuan Wei</given-name><initials>C.W.</initials><afid>60013551</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56645002700</author-url><authid>56645002700</authid><authname>De Wang H.</authname><surname>De Wang</surname><given-name>He</given-name><initials>H.</initials><afid>60013551</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:14827855400</author-url><authid>14827855400</authid><authname>Hou Z.</authname><surname>Hou</surname><given-name>Zhuo Cheng</given-name><initials>Z.C.</initials><afid>60013551</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:34873243200</author-url><authid>34873243200</authid><authname>Ning Z.</authname><surname>Ning</surname><given-name>Zhong Hua</given-name><initials>Z.H.</initials><afid>60013551</afid></author><intid>1535943150</intid><article-number>e0125890</article-number><source-id>10600153309</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927628815"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927628815?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927628815&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927628815&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927628815</prism:url><dc:identifier>SCOPUS_ID:84927628815</dc:identifier><eid>2-s2.0-84927628815</eid><dc:title>Horizontal membrane-intrinsic α-helices in the stator a-subunit of an F-type ATP synthase</dc:title><dc:creator>Allegretti M.</dc:creator><prism:publicationName>Nature</prism:publicationName><prism:issn>00280836</prism:issn><prism:eIssn>14764687</prism:eIssn><prism:volume>521</prism:volume><prism:issueIdentifier>7551</prism:issueIdentifier><prism:pageRange>237-240</prism:pageRange><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.1038/nature14185</prism:doi><dc:description>©2015 Macmillan Publishers Limited. All rights reserved. ATP, the universal energy currency of cells, is produced by F-type ATP synthases, which are ancient, membrane-bound nanomachines. F-type ATP synthases use the energy of a transmembrane electrochemical gradient to generate ATP by rotary catalysis. Protons moving across the membrane drive a rotor ring composed of 8-15 c-subunits&lt;sup&gt;1&lt;/sup&gt;. A central stalk transmits the rotation of the c-ring to the catalytic F&lt;inf&gt;1&lt;/inf&gt; head, where a series of conformational changes results in ATP synthesis&lt;sup&gt;2&lt;/sup&gt;. A key unresolved question in this fundamental process is how protons pass through the membrane to drive ATP production. Mitochondrial ATP synthases form V-shaped homodimers in cristae membranes&lt;sup&gt;3&lt;/sup&gt;. Here we report the structure of a native and active mitochondrial ATP synthase dimer, determined by single-particle electron cryomicroscopy at 6.2 Å resolution. Our structure shows four long, horizontal membrane-intrinsic α-helices in the a-subunit, arranged in two hairpins at an angle of approximately 70° relative to the c-ring helices. It has been proposed that a strictly conserved membrane-embedded arginine in the a-subunit couples proton translocation to c-ring rotation&lt;sup&gt;4&lt;/sup&gt;. A fit of the conserved carboxy-terminal a-subunit sequence places the conserved arginine next to a proton-binding c-subunit glutamate. The map shows a slanting solvent-accessible channel that extends from the mitochondrial matrix to the conserved arginine. Another hydrophilic cavity on the lumenal membrane surface defines a direct route for the protons to an essential histidine-glutamate pair&lt;sup&gt;5&lt;/sup&gt;. Our results provide unique new insights into the structure and function of rotary ATP synthases and explain how ATP production is coupled to proton translocation.</dc:description><citedby-count>2</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020952</affiliation-url><afid>60020952</afid><affilname>Max Planck Institute of Biophysics</affilname><name-variant>Max Planck Institute of Biophysics</name-variant><affiliation-city>Frankfurt am Main</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:37030548900</author-url><authid>37030548900</authid><authname>Allegretti M.</authname><surname>Allegretti</surname><given-name>Matteo</given-name><initials>M.</initials><afid>60020952</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56644978400</author-url><authid>56644978400</authid><authname>Klusch N.</authname><surname>Klusch</surname><given-name>Niklas</given-name><initials>N.</initials><afid>60020952</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7402570964</author-url><authid>7402570964</authid><authname>Mills D.</authname><surname>Mills</surname><given-name>Deryck J.</given-name><initials>D.J.</initials><afid>60020952</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6602460090</author-url><authid>6602460090</authid><authname>Vonck J.</authname><surname>Vonck</surname><given-name>Janet</given-name><initials>J.</initials><afid>60020952</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7006010107</author-url><authid>7006010107</authid><authname>Kühlbrandt W.</authname><surname>Kühlbrandt</surname><given-name>Werner</given-name><initials>W.</initials><afid>60020952</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:13907083300</author-url><authid>13907083300</authid><authname>Davies K.</authname><surname>Davies</surname><given-name>Karen M.</given-name><initials>K.M.</initials><afid>60020952</afid></author><intid>2035652500</intid><source-id>21206</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929377811"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929377811?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929377811&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929377811&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929377811</prism:url><dc:identifier>SCOPUS_ID:84929377811</dc:identifier><eid>2-s2.0-84929377811</eid><dc:title>Macro-economic conditions and infant health: A changing relationship for black and white infants in the United States</dc:title><dc:creator>Orsini C.</dc:creator><prism:publicationName>PLoS ONE</prism:publicationName><prism:eIssn>19326203</prism:eIssn><prism:volume>10</prism:volume><prism:issueIdentifier>5</prism:issueIdentifier><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.1371/journal.pone.0123501</prism:doi><dc:description>© 2015 Orsini, Avendano. We study whether the relationship between the state unemployment rate at the time of conception and infant health, infant mortality and maternal characteristics in the United States has changed over the years 1980-2004. We use microdata on births and deaths for years 1980-2004 and find that the relationship between the state unemployment rate at the time of conception and infant mortality and birthweight changes over time and is stronger for blacks than whites. For years 1980-1989 increases in the state unemployment rate are associated with a decline in infant mortality among blacks, an effect driven by mortality from gestational development and birth weight, and complications of placenta while in utero. In contrast, state economic conditions are unrelated to black infant mortality in years 1990-2004 and white infant mortality in any period, although effects vary by cause of death. We explore potential mechanisms for our findings and, including mothers younger than 18 in the analysis, uncover evidence of age-related maternal selection in response to the business cycle. In particular, in years 1980-1989 an increase in the unemployment rate at the time of conception is associated with fewer babies born to young mothers. The magnitude and direction of the relationship between business cycles and infant mortality differs by race and period. Age-related selection into motherhood in response to the business cycle is a possible explanation for this changing relationship.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003059</affiliation-url><afid>60003059</afid><affilname>London School of Economics and Political Science</affilname><name-variant>London School of Economics</name-variant><affiliation-city>London</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032499</affiliation-url><afid>60032499</afid><affilname>Harvard School of Public Health</affilname><name-variant>Harvard School of Public Health</name-variant><affiliation-city>Boston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35148091800</author-url><authid>35148091800</authid><authname>Orsini C.</authname><surname>Orsini</surname><given-name>Chiara</given-name><initials>C.</initials><afid>60003059</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:12792929100</author-url><authid>12792929100</authid><authname>Avendano M.</authname><surname>Avendano</surname><given-name>Mauricio</given-name><initials>M.</initials><afid>60003059</afid><afid>60032499</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:12792929100</author-url><authid>12792929100</authid><authname>Avendano M.</authname><surname>Avendano</surname><given-name>Mauricio</given-name><initials>M.</initials><afid>60003059</afid><afid>60032499</afid></author><intid>1035940125</intid><article-number>e0123501</article-number><source-id>10600153309</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929300455"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929300455?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929300455&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929300455&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929300455</prism:url><dc:identifier>SCOPUS_ID:84929300455</dc:identifier><eid>2-s2.0-84929300455</eid><dc:title>Discovery of benzimidazole CYP11B2 inhibitors with in vivo activity in rhesus monkeys</dc:title><dc:creator>Hoyt S.</dc:creator><prism:publicationName>ACS Medicinal Chemistry Letters</prism:publicationName><prism:eIssn>19485875</prism:eIssn><prism:volume>6</prism:volume><prism:issueIdentifier>5</prism:issueIdentifier><prism:pageRange>573-578</prism:pageRange><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.1021/acsmedchemlett.5b00054</prism:doi><dc:description>© 2015 American Chemical Society. We report the discovery of a benzimidazole series of CYP11B2 inhibitors. Hit-to-lead and lead optimization studies identified compounds such as 32, which displays potent CYP11B2 inhibition, high selectivity versus related CYP targets, and good pharmacokinetic properties in rat and rhesus. In a rhesus pharmacodynamic model, 32 produces dose-dependent aldosterone lowering efficacy, with no apparent effect on cortisol levels.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60103484</affiliation-url><afid>60103484</afid><affilname>Merck Research Laboratories</affilname><name-variant>Merck Research Laboratories</name-variant><affiliation-city/><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60103484</affiliation-url><afid>60103484</afid><affilname>Merck Research Laboratories</affilname><name-variant>Merck Research Laboratories</name-variant><affiliation-city/><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">48</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:16836800100</author-url><authid>16836800100</authid><authname>Hoyt S.</authname><surname>Hoyt</surname><given-name>Scott B.</given-name><initials>S.B.</initials><afid>60103484</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56643578500</author-url><authid>56643578500</authid><authname>Park M.</authname><surname>Park</surname><given-name>Min K.</given-name><initials>M.K.</initials><afid>60103484</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:16836675900</author-url><authid>16836675900</authid><authname>London C.</authname><surname>London</surname><given-name>Clare</given-name><initials>C.</initials><afid>60103484</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56643675400</author-url><authid>56643675400</authid><authname>Xiong Y.</authname><surname>Xiong</surname><given-name>Yusheng</given-name><initials>Y.</initials><afid>60103484</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7101690054</author-url><authid>7101690054</authid><authname>Tata J.</authname><surname>Tata</surname><given-name>Jim</given-name><initials>J.</initials><afid>60103484</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55742490500</author-url><authid>55742490500</authid><authname>Bennett D.</authname><surname>Bennett</surname><given-name>D. Jonathan</given-name><initials>D.J.</initials><afid>60103484</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7203078731</author-url><authid>7203078731</authid><authname>Cooke A.</authname><surname>Cooke</surname><given-name>Andrew</given-name><initials>A.</initials><afid>60103484</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56643704800</author-url><authid>56643704800</authid><authname>Cai J.</authname><surname>Cai</surname><given-name>Jiaqiang</given-name><initials>J.</initials><afid>60103484</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:10739194600</author-url><authid>10739194600</authid><authname>Carswell E.</authname><surname>Carswell</surname><given-name>Emma</given-name><initials>E.</initials><afid>60103484</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7405866417</author-url><authid>7405866417</authid><authname>Robinson J.</authname><surname>Robinson</surname><given-name>John</given-name><initials>J.</initials><afid>60103484</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:56644130500</author-url><authid>56644130500</authid><authname>MacLean J.</authname><surname>MacLean</surname><given-name>John</given-name><initials>J.</initials><afid>60103484</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:55469610200</author-url><authid>55469610200</authid><authname>Brown L.</authname><surname>Brown</surname><given-name>Lindsay</given-name><initials>L.</initials><afid>60103484</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:36659026100</author-url><authid>36659026100</authid><authname>Belshaw S.</authname><surname>Belshaw</surname><given-name>Simone</given-name><initials>S.</initials><afid>60103484</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:36983783100</author-url><authid>36983783100</authid><authname>Clarkson T.</authname><surname>Clarkson</surname><given-name>Thomas R.</given-name><initials>T.R.</initials><afid>60103484</afid></author><author seq="15"><author-url>http://api.elsevier.com/content/author/author_id:56643548900</author-url><authid>56643548900</authid><authname>Liu K.</authname><surname>Liu</surname><given-name>Kun</given-name><initials>K.</initials><afid>60103484</afid></author><author seq="16"><author-url>http://api.elsevier.com/content/author/author_id:56643792900</author-url><authid>56643792900</authid><authname>Liang G.</authname><surname>Liang</surname><given-name>Gui Bai</given-name><initials>G.B.</initials><afid>60103484</afid></author><author seq="17"><author-url>http://api.elsevier.com/content/author/author_id:6701332274</author-url><authid>6701332274</authid><authname>Struthers M.</authname><surname>Struthers</surname><given-name>Mary</given-name><initials>M.</initials><afid>60103484</afid></author><author seq="18"><author-url>http://api.elsevier.com/content/author/author_id:6701496767</author-url><authid>6701496767</authid><authname>Cully D.</authname><surname>Cully</surname><given-name>Doris</given-name><initials>D.</initials><afid>60103484</afid></author><author seq="19"><author-url>http://api.elsevier.com/content/author/author_id:35075337400</author-url><authid>35075337400</authid><authname>Wisniewski T.</authname><surname>Wisniewski</surname><given-name>Tom</given-name><initials>T.</initials><afid>60103484</afid></author><author seq="20"><author-url>http://api.elsevier.com/content/author/author_id:56644073200</author-url><authid>56644073200</authid><authname>Ren N.</authname><surname>Ren</surname><given-name>Ning</given-name><initials>N.</initials><afid>60103484</afid></author><author seq="21"><author-url>http://api.elsevier.com/content/author/author_id:56644377200</author-url><authid>56644377200</authid><authname>Bopp C.</authname><surname>Bopp</surname><given-name>Charlene</given-name><initials>C.</initials><afid>60103484</afid></author><author seq="22"><author-url>http://api.elsevier.com/content/author/author_id:56644701700</author-url><authid>56644701700</authid><authname>Sok A.</authname><surname>Sok</surname><given-name>Andrea</given-name><initials>A.</initials><afid>60103484</afid></author><author seq="23"><author-url>http://api.elsevier.com/content/author/author_id:56644012200</author-url><authid>56644012200</authid><authname>Cai T.</authname><surname>Cai</surname><given-name>Tian Quan</given-name><initials>T.Q.</initials><afid>60103484</afid></author><author seq="24"><author-url>http://api.elsevier.com/content/author/author_id:6506172504</author-url><authid>6506172504</authid><authname>Stribling S.</authname><surname>Stribling</surname><given-name>Sloan</given-name><initials>S.</initials><afid>60103484</afid></author><author seq="25"><author-url>http://api.elsevier.com/content/author/author_id:56644374900</author-url><authid>56644374900</authid><authname>Pai L.</authname><surname>Pai</surname><given-name>Lee Yuh</given-name><initials>L.Y.</initials><afid>60103484</afid></author><author seq="26"><author-url>http://api.elsevier.com/content/author/author_id:56643456900</author-url><authid>56643456900</authid><authname>Ma X.</authname><surname>Ma</surname><given-name>Xiuying</given-name><initials>X.</initials><afid>60103484</afid></author><author seq="27"><author-url>http://api.elsevier.com/content/author/author_id:55547117828</author-url><authid>55547117828</authid><authname>Metzger J.</authname><surname>Metzger</surname><given-name>Joe</given-name><initials>J.</initials><afid>60103484</afid></author><author seq="28"><author-url>http://api.elsevier.com/content/author/author_id:16314532400</author-url><authid>16314532400</authid><authname>Verras A.</authname><surname>Verras</surname><given-name>Andreas</given-name><initials>A.</initials><afid>60103484</afid></author><author seq="29"><author-url>http://api.elsevier.com/content/author/author_id:56253278900</author-url><authid>56253278900</authid><authname>McMasters D.</authname><surname>McMasters</surname><given-name>Daniel</given-name><initials>D.</initials><afid>60103484</afid></author><author seq="30"><author-url>http://api.elsevier.com/content/author/author_id:56643436900</author-url><authid>56643436900</authid><authname>Chen Q.</authname><surname>Chen</surname><given-name>Qing</given-name><initials>Q.</initials><afid>60103484</afid></author><author seq="31"><author-url>http://api.elsevier.com/content/author/author_id:56644404800</author-url><authid>56644404800</authid><authname>Tung E.</authname><surname>Tung</surname><given-name>Elaine</given-name><initials>E.</initials><afid>60103484</afid></author><author seq="32"><author-url>http://api.elsevier.com/content/author/author_id:56643608800</author-url><authid>56643608800</authid><authname>Tang W.</authname><surname>Tang</surname><given-name>Wei</given-name><initials>W.</initials><afid>60103484</afid></author><author seq="33"><author-url>http://api.elsevier.com/content/author/author_id:6701572897</author-url><authid>6701572897</authid><authname>Salituro G.</authname><surname>Salituro</surname><given-name>Gino</given-name><initials>G.</initials><afid>60103484</afid></author><author seq="34"><author-url>http://api.elsevier.com/content/author/author_id:56644370700</author-url><authid>56644370700</authid><authname>Buist N.</authname><surname>Buist</surname><given-name>Nicole</given-name><initials>N.</initials><afid>60103484</afid></author><author seq="35"><author-url>http://api.elsevier.com/content/author/author_id:6701550447</author-url><authid>6701550447</authid><authname>Kuethe J.</authname><surname>Kuethe</surname><given-name>Jeff</given-name><initials>J.</initials><afid>60103484</afid></author><author seq="36"><author-url>http://api.elsevier.com/content/author/author_id:7003741595</author-url><authid>7003741595</authid><authname>Rivera N.</authname><surname>Rivera</surname><given-name>Nelo</given-name><initials>N.</initials><afid>60103484</afid></author><author seq="37"><author-url>http://api.elsevier.com/content/author/author_id:6506411670</author-url><authid>6506411670</authid><authname>Clemas J.</authname><surname>Clemas</surname><given-name>Joe</given-name><initials>J.</initials><afid>60103484</afid></author><author seq="38"><author-url>http://api.elsevier.com/content/author/author_id:56643625500</author-url><authid>56643625500</authid><authname>Zhou G.</authname><surname>Zhou</surname><given-name>Gaochao</given-name><initials>G.</initials><afid>60103484</afid></author><author seq="39"><author-url>http://api.elsevier.com/content/author/author_id:55760623600</author-url><authid>55760623600</authid><authname>Gibson J.</authname><surname>Gibson</surname><given-name>Jack</given-name><initials>J.</initials><afid>60103484</afid></author><author seq="40"><author-url>http://api.elsevier.com/content/author/author_id:56644160100</author-url><authid>56644160100</authid><authname>Maxwell C.</authname><surname>Maxwell</surname><given-name>Carrie Ann</given-name><initials>C.A.</initials><afid>60103484</afid></author><author seq="41"><author-url>http://api.elsevier.com/content/author/author_id:36923224200</author-url><authid>36923224200</authid><authname>Lassman M.</authname><surname>Lassman</surname><given-name>Mike</given-name><initials>M.</initials><afid>60103484</afid></author><author seq="42"><author-url>http://api.elsevier.com/content/author/author_id:56644194100</author-url><authid>56644194100</authid><authname>McLaughlin T.</authname><surname>McLaughlin</surname><given-name>Theresa</given-name><initials>T.</initials><afid>60103484</afid></author><author seq="43"><author-url>http://api.elsevier.com/content/author/author_id:55952196500</author-url><authid>55952196500</authid><authname>Castro-Perez J.</authname><surname>Castro-Perez</surname><given-name>Jose</given-name><initials>J.</initials><afid>60103484</afid></author><author seq="44"><author-url>http://api.elsevier.com/content/author/author_id:54787069400</author-url><authid>54787069400</authid><authname>Szeto D.</authname><surname>Szeto</surname><given-name>Daphne</given-name><initials>D.</initials><afid>60103484</afid></author><author seq="45"><author-url>http://api.elsevier.com/content/author/author_id:36136862600</author-url><authid>36136862600</authid><authname>Forrest G.</authname><surname>Forrest</surname><given-name>Gail</given-name><initials>G.</initials><afid>60103484</afid></author><author seq="46"><author-url>http://api.elsevier.com/content/author/author_id:6701468521</author-url><authid>6701468521</authid><authname>Hajdu R.</authname><surname>Hajdu</surname><given-name>Richard</given-name><initials>R.</initials><afid>60103484</afid></author><author seq="47"><author-url>http://api.elsevier.com/content/author/author_id:7004342643</author-url><authid>7004342643</authid><authname>Rosenbach M.</authname><surname>Rosenbach</surname><given-name>Mark</given-name><initials>M.</initials><afid>60103484</afid></author><author seq="48"><author-url>http://api.elsevier.com/content/author/author_id:7403354894</author-url><authid>7403354894</authid><authname>Ali A.</authname><surname>Ali</surname><given-name>Amjad</given-name><initials>A.</initials><afid>60103484</afid></author><authkeywords>aldosterone synthase | CYP11B2 | hypertension</authkeywords><intid>1535945907</intid><source-id>19700177127</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929335211"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929335211?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929335211&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929335211&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929335211</prism:url><dc:identifier>SCOPUS_ID:84929335211</dc:identifier><eid>2-s2.0-84929335211</eid><dc:title>Electron cryomicroscopy observation of rotational states in a eukaryotic V-ATPase</dc:title><dc:creator>Zhao J.</dc:creator><prism:publicationName>Nature</prism:publicationName><prism:issn>00280836</prism:issn><prism:eIssn>14764687</prism:eIssn><prism:volume>521</prism:volume><prism:issueIdentifier>7551</prism:issueIdentifier><prism:pageRange>241-245</prism:pageRange><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.1038/nature14365</prism:doi><dc:description>©2015 Macmillan Publishers Limited. All rights reserved. Eukaryotic vacuolar H&lt;sup&gt;+&lt;/sup&gt;-ATPases (V-ATPases) are rotary enzymes that use energy from hydrolysis of ATP to ADP to pump protons across membranes and control the pH of many intracellular compartments. ATP hydrolysis in the soluble catalytic region of the enzyme is coupled to proton translocation through the membrane-bound region by rotation of a central rotor subcomplex, with peripheral stalks preventing the entire membrane-bound region from turning with the rotor. The eukaryotic V-ATPase is the most complex rotary ATPase: it has three peripheral stalks, a hetero-oligomeric proton-conducting proteolipid ring, several subunits not found in other rotary ATPases, and is regulated by reversible dissociation of its catalytic and proton-conducting regions. Studies of ATP synthases, V-ATPases, and bacterial/archaeal V/A-ATPases have suggested that flexibility is necessary for the catalytic mechanism of rotary ATPases, but the structures of different rotational states have never been observed experimentally. Here we use electron cryomicroscopy to obtain structures for three rotational states of the V-ATPase from the yeast Saccharomyces cerevisiae. The resulting series of structures shows ten proteolipid subunits in the c-ring, setting the ATP:H&lt;sup&gt;+&lt;/sup&gt; ratio for proton pumping by the V-ATPase at 3:10, and reveals long and highly tilted transmembrane α-helices in the a-subunit that interact with the c-ring. The three different maps reveal the conformational changes that occur to couple rotation in the symmetry-mismatched soluble catalytic region to the membrane-bound proton-translocating region. Almost all of the subunits of the enzyme undergo conformational changes during the transitions between these three rotational states. The structures of these states provide direct evidence that deformation during rotation enables the smooth transmission of power through rotary ATPases.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030319</affiliation-url><afid>60030319</afid><affilname>Hospital for Sick Children University of Toronto</affilname><name-variant>University of Toronto</name-variant><affiliation-city>Toronto</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016849</affiliation-url><afid>60016849</afid><affilname>University of Toronto</affilname><name-variant>University of Toronto</name-variant><affiliation-city>Toronto</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016849</affiliation-url><afid>60016849</afid><affilname>University of Toronto</affilname><name-variant>University of Toronto</name-variant><affiliation-city>Toronto</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55577267200</author-url><authid>55577267200</authid><authname>Zhao J.</authname><surname>Zhao</surname><given-name>Jianhua</given-name><initials>J.</initials><afid>60030319</afid><afid>60016849</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55577267200</author-url><authid>55577267200</authid><authname>Zhao J.</authname><surname>Zhao</surname><given-name>Jianhua</given-name><initials>J.</initials><afid>60030319</afid><afid>60016849</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:26040493100</author-url><authid>26040493100</authid><authname>Benlekbir S.</authname><surname>Benlekbir</surname><given-name>Samir</given-name><initials>S.</initials><afid>60030319</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7102355745</author-url><authid>7102355745</authid><authname>Rubinstein J.</authname><surname>Rubinstein</surname><given-name>John L.</given-name><initials>J.L.</initials><afid>60030319</afid><afid>60016849</afid><afid>60016849</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7102355745</author-url><authid>7102355745</authid><authname>Rubinstein J.</authname><surname>Rubinstein</surname><given-name>John L.</given-name><initials>J.L.</initials><afid>60030319</afid><afid>60016849</afid><afid>60016849</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7102355745</author-url><authid>7102355745</authid><authname>Rubinstein J.</authname><surname>Rubinstein</surname><given-name>John L.</given-name><initials>J.L.</initials><afid>60030319</afid><afid>60016849</afid><afid>60016849</afid></author><intid>535945592</intid><source-id>21206</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929378679"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929378679?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929378679&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929378679&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929378679</prism:url><dc:identifier>SCOPUS_ID:84929378679</dc:identifier><eid>2-s2.0-84929378679</eid><dc:title>Structure-related mode-of-action differences of anticancer organoruthenium complexes with β-diketonates</dc:title><dc:creator>Seršen S.</dc:creator><prism:publicationName>Journal of Medicinal Chemistry</prism:publicationName><prism:issn>00222623</prism:issn><prism:eIssn>15204804</prism:eIssn><prism:volume>58</prism:volume><prism:issueIdentifier>9</prism:issueIdentifier><prism:pageRange>3984-3996</prism:pageRange><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.1021/acs.jmedchem.5b00288</prism:doi><dc:description>© 2015 American Chemical Society. A series of organoruthenium(II) chlorido complexes with fluorinated O,O-ligands [(η&lt;sup&gt;6&lt;/sup&gt;-p-cymene)Ru(F&lt;inf&gt;3&lt;/inf&gt;C-acac-Ar)Cl] (1a-6a) and their respective 1,3,5-triaza-7-phosphaadamantane (pta) derivatives [(η&lt;sup&gt;6&lt;/sup&gt;-p-cymene)Ru(F&lt;inf&gt;3&lt;/inf&gt;C-acac-Ar)pta]PF&lt;inf&gt;6&lt;/inf&gt; (1b-6b) were synthesized and fully characterized in both solution and solid state. All complexes were inactive against nonmalignant keratinocytes but displayed variable activity against cancer cell models (ovarian, osteosarcoma). Compounds with a ligand containing the 4-chlorophenyl substituent (6a and 6b) exhibited the strongest anticancer effects. Despite a marginally lower cellular Ru accumulation compared to the chlorido complexes, pta analogues showed higher activity especially in the osteosarcoma model. Reduction of glutathione levels by buthionine sulfoximine (BSO) significantly enhanced the activity of all compounds with the most pronounced effects being observed for the pta series resulting in IC&lt;inf&gt;50&lt;/inf&gt; values down to the nanomolar range. While all chlorido complexes potently induce reactive oxygen species, DNA damage, and apoptosis, the respective pta compounds widely lacked ROS production but blocked cell cycle progression in G0/G1 phase.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031106</affiliation-url><afid>60031106</afid><affilname>University of Ljubljana</affilname><name-variant>University of Ljubljana</name-variant><affiliation-city>Ljubljana</affiliation-city><affiliation-country>Slovenia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023085</affiliation-url><afid>60023085</afid><affilname>Medical University of Vienna Institute of Cancer Research</affilname><name-variant>Medical University of Vienna</name-variant><affiliation-city>Vienna</affiliation-city><affiliation-country>Austria</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60070104</affiliation-url><afid>60070104</afid><affilname>Institute of Cell Biology National Academy of Sciences of Ukraine</affilname><name-variant>Institute of Cell Biology National Academy of Sciences of Ukraine</name-variant><affiliation-city>Lviv</affiliation-city><affiliation-country>Ukraine</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025988</affiliation-url><afid>60025988</afid><affilname>Universitat Wien</affilname><name-variant>Universität Wien</name-variant><affiliation-city>Vienna</affiliation-city><affiliation-country>Austria</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55570879600</author-url><authid>55570879600</authid><authname>Seršen S.</authname><surname>Seršen</surname><given-name>Sara</given-name><initials>S.</initials><afid>60031106</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:36172540100</author-url><authid>36172540100</authid><authname>Kljun J.</authname><surname>Kljun</surname><given-name>Jakob</given-name><initials>J.</initials><afid>60031106</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55762940200</author-url><authid>55762940200</authid><authname>Kryeziu K.</authname><surname>Kryeziu</surname><given-name>Kushtrim</given-name><initials>K.</initials><afid>60023085</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:16053553100</author-url><authid>16053553100</authid><authname>Panchuk R.</authname><surname>Panchuk</surname><given-name>Rostyslav</given-name><initials>R.</initials><afid>60070104</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56644871700</author-url><authid>56644871700</authid><authname>Alte B.</authname><surname>Alte</surname><given-name>Beatrix</given-name><initials>B.</initials><afid>60023085</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7006222957</author-url><authid>7006222957</authid><authname>Körner W.</authname><surname>Körner</surname><given-name>Wilfried</given-name><initials>W.</initials><afid>60025988</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:22979876600</author-url><authid>22979876600</authid><authname>Heffeter P.</authname><surname>Heffeter</surname><given-name>Petra</given-name><initials>P.</initials><afid>60023085</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:55156810100</author-url><authid>55156810100</authid><authname>Berger W.</authname><surname>Berger</surname><given-name>Walter</given-name><initials>W.</initials><afid>60023085</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7003316141</author-url><authid>7003316141</authid><authname>Turel I.</authname><surname>Turel</surname><given-name>Iztok</given-name><initials>I.</initials><afid>60031106</afid></author><intid>1535943554</intid><source-id>23041</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929377781"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929377781?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929377781&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929377781&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929377781</prism:url><dc:identifier>SCOPUS_ID:84929377781</dc:identifier><eid>2-s2.0-84929377781</eid><dc:title>Changes in plasma copeptin levels during hemodialysis: Are the physiological stimuli active in hemodialysis patients?</dc:title><dc:creator>Ettema E.</dc:creator><prism:publicationName>PLoS ONE</prism:publicationName><prism:eIssn>19326203</prism:eIssn><prism:volume>10</prism:volume><prism:issueIdentifier>5</prism:issueIdentifier><prism:coverDate>2015-05-14</prism:coverDate><prism:coverDisplayDate>14 May 2015</prism:coverDisplayDate><prism:doi>10.1371/journal.pone.0127116</prism:doi><dc:description>© 2015 Ettema et al. Objectives: Plasma levels of copeptin, a surrogate marker for the vasoconstrictor hormone arginine vasopressin (AVP), are increased in hemodialysis patients. Presently, it is unknown what drives copeptin levels in hemodialysis patients. We investigated whether the established physiological stimuli for copeptin release, i.e. plasma osmolality, blood volume and mean arterial pressure (MAP), are operational in hemodialysis patients. Methods: One hundred and eight prevalent, stable hemodialysis patients on a thrice-weekly dialysis schedule were studied during hemodialysis with constant ultrafiltration rate and dialysate conductivity in this observational study. Plasma levels of copeptin, sodium, MAP, and blood volume were measured before, during and after hemodialysis. Multivariate analysis was used to determine the association between copeptin (dependent variable) and the physiological stimuli plasma sodium, MAP, excess weight as well as NT-pro-BNP immediately prior to dialysis and between copeptin and changes of plasma sodium, MAP and blood volume with correction for age, sex and diabetes during dialysis treatment. Results: Patients were 63±15.6 years old and 65% were male. Median dialysis vintage was 1.6 years (IQR 0.7-4.0). Twenty-three percent of the patients had diabetes and 82% had hypertension. Median predialysis copeptin levels were 141.5 pmol/L (IQR 91.0-244.8 pmol/L). Neither predialysis plasma sodium levels, nor NT-proBNP levels, nor MAP were associated with predialysis copeptin levels. During hemodialysis, copeptin levels rose significantly (p&lt;0.01) to 163.0 pmol/L (96.0-296.0 pmol/L). Decreases in blood volume and MAP were associated with increases in copeptin levels during dialysis, whereas there was no significant association between the change in plasma sodium levels and the change in copeptin levels. Conclusions: Plasma copeptin levels are elevated predialysis and increase further during hemodialysis. Volume stimuli, i.e. decreases in MAP and blood volume, rather than osmotic stimuli, are associated with change in copeptin levels during hemodialysis.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006027</affiliation-url><afid>60006027</afid><affilname>Universitair Medisch Centrum Groningen</affilname><name-variant>University Medical Center Groningen</name-variant><affiliation-city>Groningen</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006027</affiliation-url><afid>60006027</afid><affilname>Universitair Medisch Centrum Groningen</affilname><name-variant>University Medical Center Groningen</name-variant><affiliation-city>Groningen</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006027</affiliation-url><afid>60006027</afid><affilname>Universitair Medisch Centrum Groningen</affilname><name-variant>University Medical Center Groningen</name-variant><affiliation-city>Groningen</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55328594100</author-url><authid>55328594100</authid><authname>Ettema E.</authname><surname>Ettema</surname><given-name>Esmée M.</given-name><initials>E.M.</initials><afid>60006027</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55327881100</author-url><authid>55327881100</authid><authname>Kuipers J.</authname><surname>Kuipers</surname><given-name>Johanna</given-name><initials>J.</initials><afid>60006027</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:23501318300</author-url><authid>23501318300</authid><authname>Assa S.</authname><surname>Assa</surname><given-name>Solmaz</given-name><initials>S.</initials><afid>60006027</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7006070107</author-url><authid>7006070107</authid><authname>Bakker S.</authname><surname>Bakker</surname><given-name>Stephan J L</given-name><initials>S.J.L.</initials><afid>60006027</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7005986276</author-url><authid>7005986276</authid><authname>Groen H.</authname><surname>Groen</surname><given-name>Henk</given-name><initials>H.</initials><afid>60006027</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6506727691</author-url><authid>6506727691</authid><authname>Westerhuis R.</authname><surname>Westerhuis</surname><given-name>Ralf</given-name><initials>R.</initials><afid>60006027</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56526358000</author-url><authid>56526358000</authid><authname>Gaillard C.</authname><surname>Gaillard</surname><given-name>Carlo A J M</given-name><initials>C.A.J.M.</initials><afid>60006027</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7004561961</author-url><authid>7004561961</authid><authname>Gansevoort R.</authname><surname>Gansevoort</surname><given-name>Ron T.</given-name><initials>R.T.</initials><afid>60006027</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7003868264</author-url><authid>7003868264</authid><authname>Franssen C.</authname><surname>Franssen</surname><given-name>Casper F M</given-name><initials>C.F.M.</initials><afid>60006027</afid></author><intid>535945436</intid><article-number>e0127116</article-number><source-id>10600153309</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84924580963"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84924580963?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84924580963&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84924580963&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0378874115001154"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84924580963</prism:url><dc:identifier>SCOPUS_ID:84924580963</dc:identifier><eid>2-s2.0-84924580963</eid><dc:title>Pharmacokinetics of aconitine-type alkaloids after oral administration of Fuzi (Aconiti Lateralis Radix Praeparata) in rats with chronic heart failure by microdialysis and ultra-high performance liquid chromatography-tandem mass spectrometry</dc:title><dc:creator>Yu B.</dc:creator><prism:publicationName>Journal of Ethnopharmacology</prism:publicationName><prism:issn>03788741</prism:issn><prism:eIssn>18727573</prism:eIssn><prism:volume>165</prism:volume><prism:pageRange>173-179</prism:pageRange><prism:coverDate>2015-05-13</prism:coverDate><prism:coverDisplayDate>13 May 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jep.2015.01.057</prism:doi><pii>S0378874115001154</pii><dc:description>© 2015 Elsevier Ireland Ltd. Ethnopharmacological relevance Fuzi [the lateral root of Aconitum carmichaeli Debx (Ranunculaceae)] is a well-known traditional medicinal herb used to treat chronic heart failure (CHF). Aconitine-type alkaloids are major alkaloids that are responsible for the pharmacological activity and toxicity of this herb.To investigate therapeutic effects and pharmacokinetic profiles of aconitine-type alkaloids in CHF rats. Materials and methods The plasma pharmacokinetic profiles of aconitine, mesaconitine, and hypaconitine were investigated after once treatment of Fuzi extract (containing aconitine 0.086 mg/g, mesaconitine 0.84 mg/g, and hypaconitine 1.97 mg/g) using a rapid and sensitive combinative method of ultra-high performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) and microdialysis (MD). The cardiac function and antioxidant enzyme activities were also evaluated. Results Recoveries of MD sampling ranged from 35.06% to 45.74% with RSD below 6.05%. Fuzi extract improved the myocardial function and antioxidant enzymatic activities of rats with CHF. Aconitine, mesaconitine, and hypaconitine exhibited slower absorption into the bloodstream, and yielded 11-fold less values of area under concentration-time curve (AUC) in the CHF rats than those in normal rats. The plasma AUC showed that the maximum blood concentration (Cmax) was 5.561 ng/mL for aconitine, 17.30 ng/mL for mesaconitine, and 17.78 ng/mL for hypaconitine in normal rats, while these were 0.6059 ng/mL, 2.430, and 0.7461 ng/mL in CHF rats, respectively. Conclusion Aconitine-type alkaloids associated with Fuzi's efficacy have lower intake and slower elimination in the CHF rats, indicating a non-interdependent relationship between its efficacy and toxicity. It may contribute to the depth understanding of the toxicological and pharmacological profiles of Fuzi and further benefit the herbal drug development with safety and efficacy for CHF treatment.</dc:description><citedby-count>1</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60082198</affiliation-url><afid>60082198</afid><affilname>Zhejiang Chinese Medical University</affilname><name-variant>Zhejiang Chinese Medical University</name-variant><affiliation-city>Hangzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60082198</affiliation-url><afid>60082198</afid><affilname>Zhejiang Chinese Medical University</affilname><name-variant>Zhejiang Chinese Medical University</name-variant><affiliation-city>Hangzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56544928100</author-url><authid>56544928100</authid><authname>Yu B.</authname><surname>Yu</surname><given-name>Bing</given-name><initials>B.</initials><afid>60082198</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56544854200</author-url><authid>56544854200</authid><authname>Cao Y.</authname><surname>Cao</surname><given-name>Yi</given-name><initials>Y.</initials><afid>60082198</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56544953100</author-url><authid>56544953100</authid><authname>Xiong Y.</authname><surname>Xiong</surname><given-name>Yao Kang</given-name><initials>Y.K.</initials><afid>60082198</afid></author><authkeywords>Antioxidant | Cardiac dysfunction | Hypaconitine | Mesaconitine | Toxicity</authkeywords><intid>2035163721</intid><source-id>23015</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84924358924"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84924358924?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84924358924&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84924358924&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0378874115000732"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84924358924</prism:url><dc:identifier>SCOPUS_ID:84924358924</dc:identifier><eid>2-s2.0-84924358924</eid><dc:title>In vitro chronotropic effects of Erythrina senegalensis DC (Fabaceae) aqueous extract on mouse heart slice and pluripotent stem cell-derived cardiomyocytes</dc:title><dc:creator>Nembo E.</dc:creator><prism:publicationName>Journal of Ethnopharmacology</prism:publicationName><prism:issn>03788741</prism:issn><prism:eIssn>18727573</prism:eIssn><prism:volume>165</prism:volume><prism:pageRange>163-172</prism:pageRange><prism:coverDate>2015-05-13</prism:coverDate><prism:coverDisplayDate>13 May 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jep.2015.02.002</prism:doi><pii>S0378874115000732</pii><dc:description>© 2015 Elsevier Ireland Ltd. All rights reserved. Ethnopharmacological relevance: Erythrina senegalensis DC (Fabaceae) bark is commonly used in sub-Saharan traditional medicine for the treatment of many diseases including gastrointestinal disorders and cardiovascular diseases. In this study, we investigated the effect of the aqueous extract of the stem bark of Erythrina senegalensis on the contractile properties of mouse ventricular slices and human induced pluripotent stem (hiPS) cell-derived cardiomyocytes. We also investigated the cytotoxic effect of the extract on mouse embryonic stem (ES) cells differentiating into cardiomyocytes (CMs). Materials and methods: We used well-established electrophysiological technologies to assess the effect of Erythrina senegalensis aqueous extract (ESAE) on the beating activity of mouse ventricular slices, mouse ES and hiPS cell-derived CMs. To study the cytotoxic effect of our extract, differentiating mouse ES cells were exposed to different concentrations of ESAE. EB morphology was assessed by microscopy at different stages of differentiation whereas cell viability was measured by flow cytometry, fluorometry and immunocytochemistry. The electrical activity of CMs and heart slices were respectively captured by the patch clamp technique and microelectrode array (MEA) method following ESAE acute exposure. Results: Our findings revealed that ESAE exhibits a biphasic chronotropic activity on mouse ventricular slices with an initial low dose (0.001 and 0.01 μg/mL) decrease in beating activity followed by a corresponding significant increase in chronotropic activity at higher doses above 10 μg/mL. The muscarinic receptor blocker, atropine abolished the negative chronotropic activity of ESAE, while propranolol successfully blocked its positive chronotropic activity. ESAE showed a significant dose-dependent positive chronotropic activity on hiPS cell-derived CMs. Also, though not significantly, ESAE decreased cell viability and increased total caspase-3/7 activity of mouse ES cells in a concentration-dependent manner. Conclusion: Erythrina senegalensis aqueous extract exhibits a biphasic chronotropic effect on mouse heart and a positive chronotropic activity on hiPS cell-derived CMs, suggesting a possible mechanism through muscarinic and β-adrenergic receptor pathways. Also, ESAE is not cytotoxic on mouse ES cells at concentrations up to 100 μg/mL.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024025</affiliation-url><afid>60024025</afid><affilname>Universitat zu Koln</affilname><name-variant>Universität zu Köln</name-variant><affiliation-city>Koln</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60070932</affiliation-url><afid>60070932</afid><affilname>University of Dschang</affilname><name-variant>University of Dschang</name-variant><affiliation-city>Dschang</affiliation-city><affiliation-country>Cameroon</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56364349400</author-url><authid>56364349400</authid><authname>Nembo E.</authname><surname>Nembo</surname><given-name>Erastus Nembu</given-name><initials>E.N.</initials><afid>60024025</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:13408070200</author-url><authid>13408070200</authid><authname>Atsamo A.</authname><surname>Atsamo</surname><given-name>Albert Donatien</given-name><initials>A.D.</initials><afid>60070932</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6506040169</author-url><authid>6506040169</authid><authname>Nguelefack T.</authname><surname>Nguelefack</surname><given-name>Télesphore Benoît</given-name><initials>T.B.</initials><afid>60070932</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6701535518</author-url><authid>6701535518</authid><authname>Kamanyi A.</authname><surname>Kamanyi</surname><given-name>Albert</given-name><initials>A.</initials><afid>60070932</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56213247900</author-url><authid>56213247900</authid><authname>Hescheler J.</authname><surname>Hescheler</surname><given-name>Jürgen</given-name><initials>J.</initials><afid>60024025</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:8922039800</author-url><authid>8922039800</authid><authname>Nguemo F.</authname><surname>Nguemo</surname><given-name>Filomain</given-name><initials>F.</initials><afid>60024025</afid></author><authkeywords>Cardiomyocytes | Chronotropy | Erythrina senegalensis | Heart slice | Microelectrode arrays | Patch-clamp technique | Stem cells</authkeywords><intid>2035129278</intid><source-id>23015</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929376798"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929376798?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929376798&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929376798&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929376798</prism:url><dc:identifier>SCOPUS_ID:84929376798</dc:identifier><eid>2-s2.0-84929376798</eid><dc:title>Multilocus heterozygosity and coronary heart disease: Nested case-control studies in men and women</dc:title><dc:creator>Mukamal K.</dc:creator><prism:publicationName>PLoS ONE</prism:publicationName><prism:eIssn>19326203</prism:eIssn><prism:volume>10</prism:volume><prism:issueIdentifier>5</prism:issueIdentifier><prism:coverDate>2015-05-13</prism:coverDate><prism:coverDisplayDate>13 May 2015</prism:coverDisplayDate><prism:doi>10.1371/journal.pone.0124847</prism:doi><dc:description>© 2015 Mukamal et al. Background: Generalized allelic heterozygosity has been proposed to improve reproductive fitness and has been associated with higher blood pressure, but its association with chronic disease is not well characterized. Methods: Using the Affymetrix Genome-Wide Human 6.0 array, we performed whole genome scans in parallel case-control studies of coronary heart disease (CHD) nested in the Health Professionals Follow-up Study and Nurses' Health Study. We examined ∼700,000 single nucleotide polymorphisms (SNPs) in 435 men with incident CHD and 878 matched controls and 435 women with incident CHD with 931 matched controls. We examined the relationship of genome-wide heterozygosity with risk of incident of CHD and with baseline levels of cardiovascular risk factors. Results: In both cohorts, approximately 227650 (SD 2000) SNPs were heterozygous. The number of heterozygous SNPs was not related to risk of CHD in either men or women (adjusted odds ratios per 2000 heterozygous SNPs 1.01 [95% confidence interval, 0.91-1.13] in women and 0.94 [0.84-1.06] in men). We also found no consistent associations of genome-wide heterozygosity with levels of lipids, inflammatory markers, adhesion molecules, homocysteine, adiponectin, or body-mass index. Conclusions: In these parallel nested case-control studies, we found no relationship of multilocus heterozygosity with risk of CHD or its major risk factors. Studies in other populations are needed to rule out associations with lower levels of heterozygosity.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030058</affiliation-url><afid>60030058</afid><affilname>Beth Israel Deaconess Medical Center</affilname><name-variant>Beth Israel Deaconess Medical Center</name-variant><affiliation-city>Boston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032499</affiliation-url><afid>60032499</afid><affilname>Harvard School of Public Health</affilname><name-variant>Harvard School of Public Health</name-variant><affiliation-city>Boston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011373</affiliation-url><afid>60011373</afid><affilname>Danmarks Tekniske Universitet</affilname><name-variant>Technical University of Denmark</name-variant><affiliation-city>Lyngby</affiliation-city><affiliation-country>Denmark</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030521</affiliation-url><afid>60030521</afid><affilname>Children's Hospital Boston</affilname><name-variant>Children's Hospital</name-variant><affiliation-city>Boston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030521</affiliation-url><afid>60030521</afid><affilname>Children's Hospital Boston</affilname><name-variant>Children's Hospital</name-variant><affiliation-city>Boston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001001</affiliation-url><afid>60001001</afid><affilname>Broad Institute</affilname><name-variant>Broad Institute</name-variant><affiliation-city>Cambridge</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60083843</affiliation-url><afid>60083843</afid><affilname>Institut for Sygdomsforebyggelse</affilname><name-variant>Institute of Preventive Medicine</name-variant><affiliation-city>Copenhagen</affiliation-city><affiliation-country>Denmark</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016782</affiliation-url><afid>60016782</afid><affilname>Brigham and Women's Hospital</affilname><name-variant>Brigham and Women's Hospital</name-variant><affiliation-city>Boston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032499</affiliation-url><afid>60032499</afid><affilname>Harvard School of Public Health</affilname><name-variant>Harvard School of Public Health</name-variant><affiliation-city>Boston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032499</affiliation-url><afid>60032499</afid><affilname>Harvard School of Public Health</affilname><name-variant>Harvard School of Public Health</name-variant><affiliation-city>Boston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">14</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7004034755</author-url><authid>7004034755</authid><authname>Mukamal K.</authname><surname>Mukamal</surname><given-name>Kenneth J.</given-name><initials>K.J.</initials><afid>60030058</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7401787247</author-url><authid>7401787247</authid><authname>Jensen M.</authname><surname>Jensen</surname><given-name>Majken K.</given-name><initials>M.K.</initials><afid>60032499</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:24171795400</author-url><authid>24171795400</authid><authname>Pers T.</authname><surname>Pers</surname><given-name>Tune H.</given-name><initials>T.H.</initials><afid>60011373</afid><afid>60030521</afid><afid>60030521</afid><afid>60001001</afid><afid>60083843</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:24171795400</author-url><authid>24171795400</authid><authname>Pers T.</authname><surname>Pers</surname><given-name>Tune H.</given-name><initials>T.H.</initials><afid>60011373</afid><afid>60030521</afid><afid>60030521</afid><afid>60001001</afid><afid>60083843</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:24171795400</author-url><authid>24171795400</authid><authname>Pers T.</authname><surname>Pers</surname><given-name>Tune H.</given-name><initials>T.H.</initials><afid>60011373</afid><afid>60030521</afid><afid>60030521</afid><afid>60001001</afid><afid>60083843</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:24171795400</author-url><authid>24171795400</authid><authname>Pers T.</authname><surname>Pers</surname><given-name>Tune H.</given-name><initials>T.H.</initials><afid>60011373</afid><afid>60030521</afid><afid>60030521</afid><afid>60001001</afid><afid>60083843</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:24171795400</author-url><authid>24171795400</authid><authname>Pers T.</authname><surname>Pers</surname><given-name>Tune H.</given-name><initials>T.H.</initials><afid>60011373</afid><afid>60030521</afid><afid>60030521</afid><afid>60001001</afid><afid>60083843</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56644343700</author-url><authid>56644343700</authid><authname>Pai J.</authname><surname>Pai</surname><given-name>Jennifer K.</given-name><initials>J.K.</initials><afid>60032499</afid><afid>60016782</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56644343700</author-url><authid>56644343700</authid><authname>Pai J.</authname><surname>Pai</surname><given-name>Jennifer K.</given-name><initials>J.K.</initials><afid>60032499</afid><afid>60016782</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55214760000</author-url><authid>55214760000</authid><authname>Kraft P.</authname><surname>Kraft</surname><given-name>Peter</given-name><initials>P.</initials><afid>60032499</afid><afid>60032499</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55214760000</author-url><authid>55214760000</authid><authname>Kraft P.</authname><surname>Kraft</surname><given-name>Peter</given-name><initials>P.</initials><afid>60032499</afid><afid>60032499</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7102718317</author-url><authid>7102718317</authid><authname>Rimm E.</authname><surname>Rimm</surname><given-name>Eric B.</given-name><initials>E.B.</initials><afid>60032499</afid><afid>60016782</afid><afid>60032499</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7102718317</author-url><authid>7102718317</authid><authname>Rimm E.</authname><surname>Rimm</surname><given-name>Eric B.</given-name><initials>E.B.</initials><afid>60032499</afid><afid>60016782</afid><afid>60032499</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7102718317</author-url><authid>7102718317</authid><authname>Rimm E.</authname><surname>Rimm</surname><given-name>Eric B.</given-name><initials>E.B.</initials><afid>60032499</afid><afid>60016782</afid><afid>60032499</afid></author><intid>35945936</intid><article-number>e0124847</article-number><source-id>10600153309</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929191205"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929191205?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929191205&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929191205&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929191205</prism:url><dc:identifier>SCOPUS_ID:84929191205</dc:identifier><eid>2-s2.0-84929191205</eid><dc:title>1-23I-MIBG thyroid uptake: Implications for MIBG imaging of the heart</dc:title><dc:creator>Giubbini R.</dc:creator><prism:publicationName>Journal of Nuclear Cardiology</prism:publicationName><prism:issn>10713581</prism:issn><prism:eIssn>15326551</prism:eIssn><prism:coverDate>2015-05-13</prism:coverDate><prism:coverDisplayDate>13 May 2015</prism:coverDisplayDate><prism:doi>10.1007/s12350-015-0142-3</prism:doi><dc:description>© 2015 American Society of Nuclear Cardiology Background: 123I-MIBG has been widely used in patients with heart failure and neurological disorders. The patients are pre-treated with Lugol’s oral solution or potassium perchlorate to prevent thyroid uptake of unlabeled 123I to limit the thyroid radiation exposure. However, despite the inhibition of the iodide pump, the thyroid is frequently visualized. The aim of this study was to study the pattern of thyroid uptake. Methods: We reviewed the 123I-MIBG images of 57 patients studied in three different centers in Italy for cardiac (n = 42) or neurological (n = 15) indications. They were imaged at 15 minutes and 4 hours after injection and in all patients, the thyroid was included in the imaging field of view. In 2 of the 3 centers, the patients were pre-treated with Lugol’s oral solution and/or potassium perchlorate (group 1) but in the third center, they were not (group 2). The following imaging parameters were evaluated: heart-to-mediastinum ratio (H/M), thyroid-to-mediastinum ratio (T/M) at 4 hours, and tracer wash out from the heart (HWO) and from the thyroid (TWO). Results: In the cardiac patients, the HWO was 22.98 ± 7.16% and TWO was 11.4 ± 11.86% (P &lt; .0001). The TWO was 12.2 ± 13.1% in group 1 and 10.05 ± 8.97% in group 2 (P = NS). In the neurological patients the HWO was 26 ± 8.1% and the TWO was 20.32 ± 6.41 (P &lt; .05). The difference in TWO was statistically significant (P &lt; .01) between cardiac and neurological patients, whereas the HWO was not. The 4-hour H/M was 1.49 ± 0.23 in cardiac patients vs 1.4 ± 0.39 in neurological patients (P = NS). The 4-hour T/M was 1.33 ± 0.3 in cardiac patients vs 1.15 ± 0.13 in neurological patients (P &lt; 0.05). Conclusion: The thyroid visualization in MIBG imaging is likely an expression of thyroid sympathetic innervation. The differences in TWO and T/M ratio in cardiac and neurological patients probably express differences in thyroid dopaminergic receptors. Thus, pre-treatment with potassium perchlorate or Lugol’s solution may not be justified in patients undergoing 123I-MIBG imaging in whom the risk of side effects due to pre-treatment could be higher than the risk due to thyroid radiation exposure.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011918</affiliation-url><afid>60011918</afid><affilname>Spedali Civili Di Brescia</affilname><name-variant>Spedali Civili</name-variant><affiliation-city>Brescia</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112903442</affiliation-url><afid>112903442</afid><affilname>San Giacomo Apostolo Hospital</affilname><name-variant>Hospital San Giacomo Apostolo</name-variant><affiliation-city>Castelfranco Veneto</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115234401</affiliation-url><afid>115234401</afid><affilname>Fondazione Maugeri Centro Medico</affilname><name-variant>Fondazione Maugeri Centro Medico</name-variant><affiliation-city>Veruno</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:100375605</affiliation-url><afid>100375605</afid><affilname>Medical Physics Department</affilname><name-variant>Medical Physics Department</name-variant><affiliation-city>Brescia</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115234401</affiliation-url><afid>115234401</afid><affilname>Fondazione Maugeri Centro Medico</affilname><name-variant>Fondazione Maugeri Centro Medico</name-variant><affiliation-city>Veruno</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ip</subtype><subtypeDescription>Article in Press</subtypeDescription><author-count limit="100">11</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7004319496</author-url><authid>7004319496</authid><authname>Giubbini R.</authname><surname>Giubbini</surname><given-name>Raffaele</given-name><initials>R.</initials><afid>60011918</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7004306315</author-url><authid>7004306315</authid><authname>Milan E.</authname><surname>Milan</surname><given-name>Elisa</given-name><initials>E.</initials><afid>112903442</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7003441353</author-url><authid>7003441353</authid><authname>Marcassa C.</authname><surname>Marcassa</surname><given-name>Claudio</given-name><initials>C.</initials><afid>115234401</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:9532642100</author-url><authid>9532642100</authid><authname>Paghera B.</authname><surname>Paghera</surname><given-name>Barbara</given-name><initials>B.</initials><afid>60011918</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56641048600</author-url><authid>56641048600</authid><authname>Fracassi F.</authname><surname>Fracassi</surname><given-name>Federica</given-name><initials>F.</initials><afid>60011918</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:54791955700</author-url><authid>54791955700</authid><authname>Camoni L.</authname><surname>Camoni</surname><given-name>Luca</given-name><initials>L.</initials><afid>60011918</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:31067520000</author-url><authid>31067520000</authid><authname>Rodella C.</authname><surname>Rodella</surname><given-name>Carlo</given-name><initials>C.</initials><afid>100375605</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:25632102900</author-url><authid>25632102900</authid><authname>Bertagna F.</authname><surname>Bertagna</surname><given-name>Francesco</given-name><initials>F.</initials><afid>60011918</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:36170703800</author-url><authid>36170703800</authid><authname>Motta F.</authname><surname>Motta</surname><given-name>Federica</given-name><initials>F.</initials><afid>60011918</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7004393454</author-url><authid>7004393454</authid><authname>Bertoli M.</authname><surname>Bertoli</surname><given-name>Mattia</given-name><initials>M.</initials><afid>60011918</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:6603201832</author-url><authid>6603201832</authid><authname>Campini R.</authname><surname>Campini</surname><given-name>Riccardo</given-name><initials>R.</initials><afid>115234401</afid></author><authkeywords>123I-MIBG | congestive heart failure | radiation exposure | thyroid scintigraphy</authkeywords><intid>1535916214</intid><source-id>17229</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929448334"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929448334?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929448334&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929448334&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929448334</prism:url><dc:identifier>SCOPUS_ID:84929448334</dc:identifier><eid>2-s2.0-84929448334</eid><dc:title>Pre-clinical In Vitro and In Vivo Models for Heart Valve Therapies</dc:title><dc:creator>Taramasso M.</dc:creator><prism:publicationName>Journal of Cardiovascular Translational Research</prism:publicationName><prism:issn>19375387</prism:issn><prism:eIssn>19375395</prism:eIssn><prism:coverDate>2015-05-13</prism:coverDate><prism:coverDisplayDate>13 May 2015</prism:coverDisplayDate><prism:doi>10.1007/s12265-015-9631-7</prism:doi><dc:description>© 2015 Springer Science+Business Media New York Heart valve disease is a frequently encountered pathology, related to high morbidity and mortality rates. Animal models are interesting to investigate the causality but also underlying mechanisms and potential treatments of human heart valve diseases. Strongly believing that both in vivo and ex vivo models are fundamental to support research and development of new technologies, we here report some examples of heart valve disease models, which in our experience have been actively used to support the development of new valve therapies.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019619</affiliation-url><afid>60019619</afid><affilname>UniversitatsSpital Zurich</affilname><name-variant>University Hospital Zurich</name-variant><affiliation-city>Zurich</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019619</affiliation-url><afid>60019619</afid><affilname>UniversitatsSpital Zurich</affilname><name-variant>University Hospital Zurich</name-variant><affiliation-city>Zurich</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115246662</affiliation-url><afid>115246662</afid><affilname>Biotech Research Centre for Cardiothoracic Applications CRABCC</affilname><name-variant>Biotech Research Centre for Cardiothoracic Applications CRABCC</name-variant><affiliation-city/><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019619</affiliation-url><afid>60019619</afid><affilname>UniversitatsSpital Zurich</affilname><name-variant>University Hospital Zurich</name-variant><affiliation-city>Zurich</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032323</affiliation-url><afid>60032323</afid><affilname>Klinik fur Herz- und Gefasschirurgie</affilname><name-variant>Klinik fur Herz- und Gefasschirurgie</name-variant><affiliation-city>Zurich</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ip</subtype><subtypeDescription>Article in Press</subtypeDescription><author-count limit="100">12</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:26030054700</author-url><authid>26030054700</authid><authname>Taramasso M.</authname><surname>Taramasso</surname><given-name>Maurizio</given-name><initials>M.</initials><afid>60019619</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:20734222100</author-url><authid>20734222100</authid><authname>Emmert M.</authname><surname>Emmert</surname><given-name>Maximilian Y.</given-name><initials>M.Y.</initials><afid>60019619</afid><afid>60019619</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:20734222100</author-url><authid>20734222100</authid><authname>Emmert M.</authname><surname>Emmert</surname><given-name>Maximilian Y.</given-name><initials>M.Y.</initials><afid>60019619</afid><afid>60019619</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35097695300</author-url><authid>35097695300</authid><authname>Reser D.</authname><surname>Reser</surname><given-name>Diana</given-name><initials>D.</initials><afid>60019619</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:35110386700</author-url><authid>35110386700</authid><authname>Guidotti A.</authname><surname>Guidotti</surname><given-name>Andrea</given-name><initials>A.</initials><afid>60019619</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:36569940900</author-url><authid>36569940900</authid><authname>Cesarovic N.</authname><surname>Cesarovic</surname><given-name>Nikola</given-name><initials>N.</initials><afid>60019619</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:35110387700</author-url><authid>35110387700</authid><authname>Campagnol M.</authname><surname>Campagnol</surname><given-name>Marino</given-name><initials>M.</initials><afid>115246662</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:24502638600</author-url><authid>24502638600</authid><authname>Addis A.</authname><surname>Addis</surname><given-name>Alessandro</given-name><initials>A.</initials><afid>115246662</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:6507483548</author-url><authid>6507483548</authid><authname>Nietlispach F.</authname><surname>Nietlispach</surname><given-name>Fabian</given-name><initials>F.</initials><afid>60019619</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7004435100</author-url><authid>7004435100</authid><authname>Hoerstrup S.</authname><surname>Hoerstrup</surname><given-name>Simon P.</given-name><initials>S.P.</initials><afid>60019619</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7004629354</author-url><authid>7004629354</authid><authname>Maisano F.</authname><surname>Maisano</surname><given-name>Francesco</given-name><initials>F.</initials><afid>60019619</afid><afid>60032323</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7004629354</author-url><authid>7004629354</authid><authname>Maisano F.</authname><surname>Maisano</surname><given-name>Francesco</given-name><initials>F.</initials><afid>60019619</afid><afid>60032323</afid></author><authkeywords>Animal models | Bench model | Heart valve disease</authkeywords><intid>2035949887</intid><source-id>14500154702</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929428448"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929428448?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929428448&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929428448&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929428448</prism:url><dc:identifier>SCOPUS_ID:84929428448</dc:identifier><eid>2-s2.0-84929428448</eid><dc:title>Smoking-attributable mortality in American Indians: findings from the Strong Heart Study</dc:title><dc:creator>Zhang M.</dc:creator><prism:publicationName>European Journal of Epidemiology</prism:publicationName><prism:issn>03932990</prism:issn><prism:eIssn>15737284</prism:eIssn><prism:coverDate>2015-05-13</prism:coverDate><prism:coverDisplayDate>13 May 2015</prism:coverDisplayDate><prism:doi>10.1007/s10654-015-0031-8</prism:doi><dc:description>© 2015 Springer Science+Business Media Dordrecht Cigarette smoking is the leading preventable cause of death worldwide. American Indians have the highest proportion of smoking in the United States. However, few studies have examined the impact of cigarette smoking on disease mortality in this ethnically important but traditionally understudied minority population. Here we estimated the association of cigarette smoking with cardiovascular disease (CVD), cancer and all-cause mortality in American Indians participating in the Strong Heart Study, a large community-based prospective cohort study comprising of 4549 American Indians (aged 45–74 years) followed for about 20 years (1989–2008). Hazard ratio and population attributable risk (PAR) associated with cigarette smoking were estimated by Cox proportional hazard model, adjusting for sex, study site, age, educational level, alcohol consumption, physical activity, BMI, lipids, renal function, hypertension or diabetes status at baseline, and interaction between current smoker and study site. We found that current smoking was significantly associated with cancer mortality (HR 5.0, [1.9–13.4]) in men, (HR 3.9 [1.6–9.7] in women) and all-cause mortality (HR 1.8, [1.2–2.6] in men, HR 1.6, [1.1–2.4] in women). PAR for cancer and all-cause mortality in men were 41.0 and 18.4 %, respectively, whereas the corresponding numbers in women were 24.9 and 10.9 %, respectively. Current smoking also significantly increases the risk of CVD deaths in women (HR 2.2 [1.1, 4.4]), but not men (HR 1.2 [0.6–2.4]). PAR for CVD mortality in women was 14.9 %. In summary, current smoking significantly increases the risk of CVD (in women), cancer and all-cause mortality in American Indians, independent of known risk factors. Culturally specific smoking cessation programs are urgently needed to reduce smoking-related premature deaths.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017672</affiliation-url><afid>60017672</afid><affilname>Tulane University</affilname><name-variant>Tulane University</name-variant><affiliation-city>New Orleans</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010432</affiliation-url><afid>60010432</afid><affilname>Soochow University</affilname><name-variant>Suzhou University</name-variant><affiliation-city>Suzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030931</affiliation-url><afid>60030931</afid><affilname>University of Oklahoma</affilname><name-variant>University of Oklahoma</name-variant><affiliation-city>Norman</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029833</affiliation-url><afid>60029833</afid><affilname>University of Oklahoma Health Sciences Center</affilname><name-variant>Univ. of Oklahoma Hlth. Sci. Center</name-variant><affiliation-city>Oklahoma City</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031387</affiliation-url><afid>60031387</afid><affilname>MedStar Health</affilname><name-variant>Medstar Health Research Institute</name-variant><affiliation-city>Columbia</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ip</subtype><subtypeDescription>Article in Press</subtypeDescription><author-count limit="100">11</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56645136900</author-url><authid>56645136900</authid><authname>Zhang M.</authname><surname>Zhang</surname><given-name>Mingzhi</given-name><initials>M.</initials><afid>60017672</afid><afid>60010432</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56645136900</author-url><authid>56645136900</authid><authname>Zhang M.</authname><surname>Zhang</surname><given-name>Mingzhi</given-name><initials>M.</initials><afid>60017672</afid><afid>60010432</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56645827900</author-url><authid>56645827900</authid><authname>An Q.</authname><surname>An</surname><given-name>Qiang</given-name><initials>Q.</initials><afid>60017672</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56645967800</author-url><authid>56645967800</authid><authname>Yeh F.</authname><surname>Yeh</surname><given-name>Fawn</given-name><initials>F.</initials><afid>60030931</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56646631400</author-url><authid>56646631400</authid><authname>Zhang Y.</authname><surname>Zhang</surname><given-name>Ying</given-name><initials>Y.</initials><afid>60030931</afid><afid>60029833</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56646631400</author-url><authid>56646631400</authid><authname>Zhang Y.</authname><surname>Zhang</surname><given-name>Ying</given-name><initials>Y.</initials><afid>60030931</afid><afid>60029833</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7202678559</author-url><authid>7202678559</authid><authname>Howard B.</authname><surname>Howard</surname><given-name>Barbara V.</given-name><initials>B.V.</initials><afid>60029833</afid><afid>60031387</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7202678559</author-url><authid>7202678559</authid><authname>Howard B.</authname><surname>Howard</surname><given-name>Barbara V.</given-name><initials>B.V.</initials><afid>60029833</afid><afid>60031387</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56497319000</author-url><authid>56497319000</authid><authname>Lee E.</authname><surname>Lee</surname><given-name>Elisa T.</given-name><initials>E.T.</initials><afid>60030931</afid><afid>60029833</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56497319000</author-url><authid>56497319000</authid><authname>Lee E.</authname><surname>Lee</surname><given-name>Elisa T.</given-name><initials>E.T.</initials><afid>60030931</afid><afid>60029833</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7410314762</author-url><authid>7410314762</authid><authname>Zhao J.</authname><surname>Zhao</surname><given-name>Jinying</given-name><initials>J.</initials><afid>60017672</afid></author><authkeywords>All-cause | American Indians | Cancer | Cigarette smoking | CVD | Mortality | Strong Heart Study</authkeywords><intid>1035951593</intid><source-id>13213</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929179213"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929179213?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929179213&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929179213&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929179213</prism:url><dc:identifier>SCOPUS_ID:84929179213</dc:identifier><eid>2-s2.0-84929179213</eid><dc:title>Keeping the heart empty and beating: An alternative technique to preserve hypertrophied hearts during valvular surgery</dc:title><dc:creator>Liu S.</dc:creator><prism:publicationName>Journal of Cardiothoracic Surgery</prism:publicationName><prism:eIssn>17498090</prism:eIssn><prism:coverDate>2015-05-13</prism:coverDate><prism:coverDisplayDate>May 13, 2015</prism:coverDisplayDate><prism:doi>10.1186/s13019-015-0273-2</prism:doi><dc:description>© 2015 Liu et al.; licensee BioMed Central. Introduction: To determine whether keeping the heart empty and beating is an effective technique to preserve hypertrophied pig hearts, and to investigate the underlying mechanism. Methods: Ten Bama Miniature pigs with hypertrophied hearts were divided into 2 groups (n = 5 in each group). One group underwent normothermic normokalemic simultaneous perfusion (NNSP). The other group was subjected to normothermic hypermokalemic simultaneous perfusion (NHSP) and used as controls. Cardiac contractive function, myocardial energy metabolism and myocardial perfusion were assessed using magnetic resonance imaging. Western blot analysis was carried out to determine the expression of Troponin I (cTnI), Troponin T (cTnT), SM-MHC, Casapase-3 and PARP4. TUNEL assay was used to detect apoptotic cardiomyocytes. Results: Keeping the heart empty and beating with NNSP improved the preservation of contractile function in comparison with cardioplegic arrest using NHSP. No significant differences existed in the effects of NNSP and NHSP in maintaining myocardial energy metabolism. 13 % perfusion defects areas were found in one heart in the NHSP group, whereas none was found in all other hearts in both groups. The expressions of cTnI, cTnT, Casapase-3 and PARP4 in NHSP group were abundantly increased compared to NNSP group as measured by Western blotting. Conversely, the expression of SM-MHC in NHSP group was reduced compared with NNSP group. The number of TUNEL positive nuclei per mm&lt;sup&gt;2&lt;/sup&gt; area was significantly increased in NHSP group compared with NNSP group. Conclusions: Keeping the heart beating with NNSP is an alternative technique to preserve hypertrophied hearts during valvular surgery.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60087830</affiliation-url><afid>60087830</afid><affilname>First Affiliated Hospital of Harbin Medical University</affilname><name-variant>First Affiliated Hospital of Harbin Medical University</name-variant><affiliation-city>Harbin</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60087830</affiliation-url><afid>60087830</afid><affilname>First Affiliated Hospital of Harbin Medical University</affilname><name-variant>First Affiliated Hospital of Harbin Medical University</name-variant><affiliation-city>Harbin</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ip</subtype><subtypeDescription>Article in Press</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56640039300</author-url><authid>56640039300</authid><authname>Liu S.</authname><surname>Liu</surname><given-name>Shangdian</given-name><initials>S.</initials><afid>60087830</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35201441800</author-url><authid>35201441800</authid><authname>Liu Z.</authname><surname>Liu</surname><given-name>Zonghong</given-name><initials>Z.</initials><afid>60087830</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56640718100</author-url><authid>56640718100</authid><authname>Li L.</authname><surname>Li</surname><given-name>Lulu</given-name><initials>L.</initials><afid>60087830</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56640194900</author-url><authid>56640194900</authid><authname>Liu P.</authname><surname>Liu</surname><given-name>Pengfei</given-name><initials>P.</initials><afid>60087830</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56208992500</author-url><authid>56208992500</authid><authname>Liu H.</authname><surname>Liu</surname><given-name>Hongyu</given-name><initials>H.</initials><afid>60087830</afid></author><intid>35916222</intid><source-id>5800179605</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929378680"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929378680?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929378680&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929378680&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929378680</prism:url><dc:identifier>SCOPUS_ID:84929378680</dc:identifier><eid>2-s2.0-84929378680</eid><dc:title>Optimization of catheter ablation of atrial fibrillation: Insights gained from clinically-derived computer models</dc:title><dc:creator>Zhao J.</dc:creator><prism:publicationName>International Journal of Molecular Sciences</prism:publicationName><prism:issn>16616596</prism:issn><prism:eIssn>14220067</prism:eIssn><prism:volume>16</prism:volume><prism:issueIdentifier>5</prism:issueIdentifier><prism:pageRange>10834-10854</prism:pageRange><prism:coverDate>2015-05-13</prism:coverDate><prism:coverDisplayDate>13 May 2015</prism:coverDisplayDate><prism:doi>10.3390/ijms160510834</prism:doi><dc:description>© 2015 by the authors; licensee MDPI, Basel, Switzerland. Atrial fibrillation (AF) is the most common heart rhythm disturbance, and its treatment is an increasing economic burden on the health care system. Despite recent intense clinical, experimental and basic research activity, the treatment of AF with current antiarrhythmic drugs and catheter/surgical therapies remains limited. Radiofrequency catheter ablation (RFCA) is widely used to treat patients with AF. Current clinical ablation strategies are largely based on atrial anatomy and/or substrate detected using different approaches, and they vary from one clinical center to another. The nature of clinical ablation leads to ambiguity regarding the optimal patient personalization of the therapy partly due to the fact that each empirical configuration of ablation lines made in a patient is irreversible during one ablation procedure. To investigate optimized ablation lesion line sets, in silico experimentation is an ideal solution. 3D computer models give us a unique advantage to plan and assess the effectiveness of different ablation strategies before and during RFCA. Reliability of in silico assessment is ensured by inclusion of accurate 3D atrial geometry, realistic fiber orientation, accurate fibrosis distribution and cellular kinetics; however, most of this detailed information in the current computer models is extrapolated from animal models and not from the human heart. The predictive power of computer models will increase as they are validated with human experimental and clinical data. To make the most from a computer model, one needs to develop 3D computer models based on the same functionally and structurally mapped intact human atria with high spatial resolution. The purpose of this review paper is to summarize recent developments in clinically-derived computer models and the clinical insights they provide for catheter ablation.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005686</affiliation-url><afid>60005686</afid><affilname>University of Auckland</affilname><name-variant>University of Auckland</name-variant><affiliation-city>Auckland</affiliation-city><affiliation-country>New Zealand</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026479</affiliation-url><afid>60026479</afid><affilname>University of Exeter</affilname><name-variant>University of Exeter</name-variant><affiliation-city>Exeter</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003771</affiliation-url><afid>60003771</afid><affilname>University of Manchester</affilname><name-variant>University of Manchester</name-variant><affiliation-city>Manchester</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003500</affiliation-url><afid>60003500</afid><affilname>Ohio State University</affilname><name-variant>The Ohio State University</name-variant><affiliation-city>Columbus</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025902</affiliation-url><afid>60025902</afid><affilname>Waikato Hospital</affilname><name-variant>Waikato Hospital</name-variant><affiliation-city>Hamilton</affiliation-city><affiliation-country>New Zealand</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:14065624800</author-url><authid>14065624800</authid><authname>Zhao J.</authname><surname>Zhao</surname><given-name>Jichao</given-name><initials>J.</initials><afid>60005686</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:24171112300</author-url><authid>24171112300</authid><authname>Kharche S.</authname><surname>Kharche</surname><given-name>Sanjay R.</given-name><initials>S.R.</initials><afid>60026479</afid><afid>60003771</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:24171112300</author-url><authid>24171112300</authid><authname>Kharche S.</authname><surname>Kharche</surname><given-name>Sanjay R.</given-name><initials>S.R.</initials><afid>60026479</afid><afid>60003771</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55547788300</author-url><authid>55547788300</authid><authname>Hansen B.</authname><surname>Hansen</surname><given-name>Brian J.</given-name><initials>B.J.</initials><afid>60003500</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56162796800</author-url><authid>56162796800</authid><authname>Csepe T.</authname><surname>Csepe</surname><given-name>Thomas A.</given-name><initials>T.A.</initials><afid>60003500</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56645027200</author-url><authid>56645027200</authid><authname>Wang Y.</authname><surname>Wang</surname><given-name>Yufeng</given-name><initials>Y.</initials><afid>60005686</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:35278667100</author-url><authid>35278667100</authid><authname>Stiles M.</authname><surname>Stiles</surname><given-name>Martin K.</given-name><initials>M.K.</initials><afid>60025902</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56648316700</author-url><authid>56648316700</authid><authname>Fedorov V.</authname><surname>Fedorov</surname><given-name>Vadim V.</given-name><initials>V.V.</initials><afid>60003500</afid></author><authkeywords>Atrial fibrillation | Cardiac arrhythmias | Catheter ablation | Computer model | Fibrosis | Patient specific model | Pulmonary vein isolation | Re-entry | Rotors</authkeywords><intid>535946799</intid><source-id>25879</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929431401"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929431401?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929431401&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929431401&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929431401</prism:url><dc:identifier>SCOPUS_ID:84929431401</dc:identifier><eid>2-s2.0-84929431401</eid><dc:title>Impact of left ventricular conduction defect with or without need for permanent right ventricular pacing on functional and clinical recovery after TAVR</dc:title><dc:creator>Weber M.</dc:creator><prism:publicationName>Clinical Research in Cardiology</prism:publicationName><prism:issn>18610684</prism:issn><prism:eIssn>18610692</prism:eIssn><prism:coverDate>2015-05-13</prism:coverDate><prism:coverDisplayDate>13 May 2015</prism:coverDisplayDate><prism:doi>10.1007/s00392-015-0865-9</prism:doi><dc:description>© 2015 Springer-Verlag Berlin Heidelberg Background: Left ventricular conduction disturbances (VCD) with or without need for pacemaker (PM) implantation are common after transcatheter aortic valve replacement (TAVR). Its effect on patients’ functional recovery after TAVR is unclear. Methods and results: 212 patients (Age 80.8 ± 6.4 years, logEuroscore 28.95 ± 17.37 %) underwent TAVR with the self-expanding CoreValve prosthesis and completed 9-month follow-up (FU). After TAVR 125 (59 %) patients were diagnosed with VCD. This group consists of 41 (19 %) patients with a new PM after TAVR, 33 (16 %) patients with PM prior TAVR and markedly increased ventricular stimulation rate, 48 (23 %) patients with new LBBB post-TAVR and three (1 %) patients with LBBB prior TAVR. After FU, the presence of VCD alone was associated with worse recovery of left ventricular ejection fraction (LVEF) (VCD: LVEF&lt;inf&gt;baseline&lt;/inf&gt; 51.7 ± 18.2 %, LVEF&lt;inf&gt;FU&lt;/inf&gt; 53.9 ± 13.0 %; p = 0.8; noVCD: LVEF&lt;inf&gt;baseline&lt;/inf&gt; 53.8 ± 12.9 %, LVEF&lt;inf&gt;FU&lt;/inf&gt; 63.4 ± 10.1 %; p &lt; 0.01) but had no impact on functional outcomes after TAVR (p &gt; 0.05). Especially patients with VCD caused by permanent RV pacing showed worse functional outcomes presenting with higher functional NYHA classes (p &lt; 0.05), and higher NT-proBNP levels (p &lt; 0.05). 20.4 % of patients with need for PM after TAVR remained in NYHA class ≥3, as compared to 5 % of patients without PM (VCD but no PM: 4.7 %, p &lt; 0.001; noVCD: 5.3 %, p &lt; 0.001). VCD with or without need for PM had no impact on survival after FU. Conclusion: The occurrence of VCD after TAVR is common and associated with unfavorable left ventricular functional recovery. However, only the combination of VCD with permanent right ventricular pacing has adverse impact on heart failure-related symptoms after TAVR.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030465</affiliation-url><afid>60030465</afid><affilname>Universitats-Klinikum Bonn und Medizinische Fakultat</affilname><affiliation-city>Bonn</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030465</affiliation-url><afid>60030465</afid><affilname>Universitats-Klinikum Bonn und Medizinische Fakultat</affilname><affiliation-city>Bonn</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ip</subtype><subtypeDescription>Article in Press</subtypeDescription><author-count limit="100">13</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35108302200</author-url><authid>35108302200</authid><authname>Weber M.</authname><surname>Weber</surname><given-name>Marcel</given-name><initials>M.</initials><afid>60030465</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56646197900</author-url><authid>56646197900</authid><authname>Brüggemann E.</authname><surname>Brüggemann</surname><given-name>Eva</given-name><initials>E.</initials><afid>60030465</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:38663253700</author-url><authid>38663253700</authid><authname>Schueler R.</authname><surname>Schueler</surname><given-name>Robert</given-name><initials>R.</initials><afid>60030465</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:37081616300</author-url><authid>37081616300</authid><authname>Momcilovic D.</authname><surname>Momcilovic</surname><given-name>Diana</given-name><initials>D.</initials><afid>60030465</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6506592261</author-url><authid>6506592261</authid><authname>Sinning J.</authname><surname>Sinning</surname><given-name>Jan Malte</given-name><initials>J.M.</initials><afid>60030465</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7006024462</author-url><authid>7006024462</authid><authname>Ghanem A.</authname><surname>Ghanem</surname><given-name>Alexander</given-name><initials>A.</initials><afid>60030465</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7003282209</author-url><authid>7003282209</authid><authname>Werner N.</authname><surname>Werner</surname><given-name>Nikos</given-name><initials>N.</initials><afid>60030465</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:35229033700</author-url><authid>35229033700</authid><authname>Grube E.</authname><surname>Grube</surname><given-name>Eberhard</given-name><initials>E.</initials><afid>60030465</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7004365961</author-url><authid>7004365961</authid><authname>Schiller W.</authname><surname>Schiller</surname><given-name>Wolfgang</given-name><initials>W.</initials><afid>60030465</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:6603155646</author-url><authid>6603155646</authid><authname>Mellert F.</authname><surname>Mellert</surname><given-name>Fritz</given-name><initials>F.</initials><afid>60030465</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:7006807637</author-url><authid>7006807637</authid><authname>Welz A.</authname><surname>Welz</surname><given-name>Armin</given-name><initials>A.</initials><afid>60030465</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:55618199500</author-url><authid>55618199500</authid><authname>Nickenig G.</authname><surname>Nickenig</surname><given-name>Georg</given-name><initials>G.</initials><afid>60030465</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:6507509501</author-url><authid>6507509501</authid><authname>Hammerstingl C.</authname><surname>Hammerstingl</surname><given-name>Christoph</given-name><initials>C.</initials><afid>60030465</afid></author><authkeywords>Aortic stenosis | Left ventricular recovery | Pacemaker | TAVI | TAVR | Valvular heart disease | Ventricular conduction disturbances</authkeywords><intid>1785955128</intid><source-id>3100147501</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929190958"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929190958?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929190958&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929190958&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929190958</prism:url><dc:identifier>SCOPUS_ID:84929190958</dc:identifier><eid>2-s2.0-84929190958</eid><dc:title>Silicon nanowire-induced maturation of cardiomyocytes derived from human induced pluripotent stem cells</dc:title><dc:creator>Tan Y.</dc:creator><prism:publicationName>Nano Letters</prism:publicationName><prism:issn>15306984</prism:issn><prism:eIssn>15306992</prism:eIssn><prism:volume>15</prism:volume><prism:issueIdentifier>5</prism:issueIdentifier><prism:pageRange>2765-2772</prism:pageRange><prism:coverDate>2015-05-13</prism:coverDate><prism:coverDisplayDate>13 May 2015</prism:coverDisplayDate><prism:doi>10.1021/nl502227a</prism:doi><dc:description>© 2015 American Chemical Society. The current inability to derive mature cardiomyocytes from human pluripotent stem cells has been the limiting step for transitioning this powerful technology into clinical therapies. To address this, scaffold-based tissue engineering approaches have been utilized to mimic heart development in vitro and promote maturation of cardiomyocytes derived from human pluripotent stem cells. While scaffolds can provide 3D microenvironments, current scaffolds lack the matched physical/chemical/biological properties of native extracellular environments. On the other hand, scaffold-free, 3D cardiac spheroids (i.e., spherical-shaped microtissues) prepared by seeding cardiomyocytes into agarose microwells were shown to improve cardiac functions. However, cardiomyocytes within the spheroids could not assemble in a controlled manner and led to compromised, unsynchronized contractions. Here, we show, for the first time, that incorporation of a trace amount (i.e., ∼0.004% w/v) of electrically conductive silicon nanowires (e-SiNWs) in otherwise scaffold-free cardiac spheroids can form an electrically conductive network, leading to synchronized and significantly enhanced contraction (i.e., &gt;55% increase in average contraction amplitude), resulting in significantly more advanced cellular structural and contractile maturation.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026610</affiliation-url><afid>60026610</afid><affilname>Clemson University</affilname><name-variant>Clemson Univ</name-variant><affiliation-city>Clemson</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029278</affiliation-url><afid>60029278</afid><affilname>University of Chicago</affilname><name-variant>University of Chicago</name-variant><affiliation-city>Chicago</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023222</affiliation-url><afid>60023222</afid><affilname>Medical University of South Carolina</affilname><name-variant>Medical University of South Carolina</name-variant><affiliation-city>Charleston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023222</affiliation-url><afid>60023222</afid><affilname>Medical University of South Carolina</affilname><name-variant>Medical University of South Carolina</name-variant><affiliation-city>Charleston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">11</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55228582600</author-url><authid>55228582600</authid><authname>Tan Y.</authname><surname>Tan</surname><given-name>Yu</given-name><initials>Y.</initials><afid>60026610</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56049513800</author-url><authid>56049513800</authid><authname>Richards D.</authname><surname>Richards</surname><given-name>Dylan</given-name><initials>D.</initials><afid>60026610</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56640331700</author-url><authid>56640331700</authid><authname>Xu R.</authname><surname>Xu</surname><given-name>Ruoyu</given-name><initials>R.</initials><afid>60029278</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:18438880200</author-url><authid>18438880200</authid><authname>Stewart-Clark S.</authname><surname>Stewart-Clark</surname><given-name>Skylar</given-name><initials>S.</initials><afid>60026610</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:24463301900</author-url><authid>24463301900</authid><authname>Mani S.</authname><surname>Mani</surname><given-name>Santhosh Kumar</given-name><initials>S.K.</initials><afid>60023222</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:35597974500</author-url><authid>35597974500</authid><authname>Borg T.</authname><surname>Borg</surname><given-name>Thomas Keith</given-name><initials>T.K.</initials><afid>60026610</afid><afid>60023222</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:35597974500</author-url><authid>35597974500</authid><authname>Borg T.</authname><surname>Borg</surname><given-name>Thomas Keith</given-name><initials>T.K.</initials><afid>60026610</afid><afid>60023222</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7006617906</author-url><authid>7006617906</authid><authname>Menick D.</authname><surname>Menick</surname><given-name>Donald R.</given-name><initials>D.R.</initials><afid>60023222</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56640576700</author-url><authid>56640576700</authid><authname>Tian B.</authname><surname>Tian</surname><given-name>Bozhi</given-name><initials>B.</initials><afid>60029278</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56649493800</author-url><authid>56649493800</authid><authname>Mei Y.</authname><surname>Mei</surname><given-name>Ying</given-name><initials>Y.</initials><afid>60026610</afid><afid>60023222</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56649493800</author-url><authid>56649493800</authid><authname>Mei Y.</authname><surname>Mei</surname><given-name>Ying</given-name><initials>Y.</initials><afid>60026610</afid><afid>60023222</afid></author><authkeywords>cardiac spheroids | cardiomyocytes | human induced pluripotent stem cells | maturation | silicon nanowires</authkeywords><intid>1035911554</intid><source-id>17853</source-id></entry></search-results>
